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Chapter 1 of this thesis describes two new strategies for the solution phase mixture synthesis: 
OEG-mixture synthesis (OMS) and OEG-fluorous mixture synthesis (OFMS). An OEG-mixture 
synthesis of four stereoisomers of the hydroxybutenolide unit of murisolin was pursued. A 
strategy for solution phase stereoisomer synthesis based on orthogonal separation tagging and 
double demixing was implemented with fluorous (fluoroalkyl) and oligoethylene glycol (OEG, 
[OCH2CH2]n) tags. A mixture of four stereoisomers of a dihydroxytetrahydrofuran subunit 
encoded by fluorous tags was coupled by a Kocienski-Julia olefination to a mixture of four 
stereoisomers of the hydroxybutenolide subunit encoded by OEG tags. An orchestrated sequence 
of reduction (1x), OEG demixing (1x), fluorous demixing (4x) and detagging (16x) provided 
sixteen stereoisomers of murisolin. Through this double tagging strategy, the configuration of 
sixteen compounds was encoded with only eight tags. 
 
 iii
Chapter 2 describes the synthesis of the C1-C20 and C21-C40 fragments of the natural 
product tetrafibricin. A convergent synthesis of the proposed structure of tetrafibricin has been 
explored. In this approach, we envisioned a series of the Kocienski-Julia olefination reactions 
with appropriate aldehydes and sulfones to afford fragments C35-C40, C31-C35 and C21-C30. 
The synthesis of the C35-C40 fragment has been achieved in 11 steps starting with the 
commercially available pent-4-en-1-ol in an overall 25% yield. The synthesis of the C31-C34 
fragment commenced with the commercially available (S)-2-(2,2-dimethyl-1,3-dioxolan-4-
yl)ethanol in 5 steps in an overall 46% yield. 16 steps are implemented in the synthesis of the 
C21-C30 fragment in a 4.5% overall yield. The synthesis of the C14-C20 fragment was achieved 
in 10 steps in an overall 23% yield. A synthesis of the C9-C13 fragment was established in 5 
steps in 37% overall yield. The synthesis of the C1-C8 fragment was pursued in 8 steps in an 
overall 22% yield. The assembly of the C1-C8, C9-C13 and C14-C20 fragments was performed 
to afford the C1-C20 fragment. The C21-C30, C31-C34 and C35-C40 fragments were assembled 
by a Kocienski-Julia olefination to form the C21-C40 fragment of tetrafibricin. 
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1. CHAPTER 1 
 
 
 
 
 
 
 
 
 
 
 An orthogonal tagging technique for the synthesis of 
stereoisomer libraries: Total synthesis of (+)-murisolin 
and fifteen diastereoisomers  
 
 
 
 
 
 
 
  
 
1.1. INTRODUCTION 
In early days, the structural elucidation of natural products involved the near exclusive use of 
chemical synthesis, degradation or derivatization processes. However, in most cases, the 
assignment of the relative or absolute configuration was not possible by these methods.1 By the 
late 1960s, the “classical” chemical approach was gradually replaced by advanced, non-
destructive methods such as NMR, UV spectroscopy, IR spectroscopy, mass spectrometry and 
X-ray crystallography. These methods allow the structure elucidation of highly challenging, 
complex natural products in far less time even when the compounds are available in miniscule 
amounts. However, there are numerous examples available in the literature where natural 
products were assigned an incorrect structure.1 In those cases, the chemical synthesis of 
candidate structures coupled with comparison of various physical and spectral data is generally 
pursued to uncover and fix the errors in structural assignments. In order to establish a rigorous 
structural proof for molecules with several structure possibilities, it must be shown that all 
structures but one are different from the proposed structure in one or more ways. This requires 
the synthesis of a library of stereoisomers. 
 
One major challenge in the traditional “one at a time” synthesis of stereoisomers is the huge 
amount of work involved. This has recently been supplemented by the solid-phase and solution-
phase mixture synthesis techniques. However, identification and isolation of compounds from 
the mixture are the common problems in the mixture synthesis.2 Fluorous mixture synthesis 
(FMS)3 is the first solution phase mixture synthesis that provides a predictable separation of 
compounds from a mixture at the end of the synthesis. 
2 
 
  
 
1.1.1. Fluorous mixture synthesis 
 
Fluorous mixture synthesis typically involves five stages: tagging, mixing, synthesis, demixing, 
and detagging (figure 1.1). In the first stage, a series of organic substrates (S1-Sn) are tagged with 
a series of different fluorous tags (F1-Fn). Fluorous tags contain short perfluoroalkyl chains4 
(C3F7 to C10F21), which allow the separation of tagged components at the end of mixture 
synthesis. In the second stage, the tagged substrates (S1F1-SnFn) are mixed to give a starting 
mixture MS. The resulting mixture MS is subjected to a serious of reactions to yield an 
intermediate mixture MI, which can further be split into n components (M1E-MxE) and carried 
through another series of reactions. The resulting final mixtures are separated (demixed) by 
chromatography on fluorous silica gel.5 Fluorous silica gel separates the fluorous tagged 
compounds based on their different fluorine content. Finally, the demixed compounds (F1P11) are 
individually subjected to detagging (removal of tag) to yield the final products (P11-Pxn). 
S1
MS
F1
S1F1
Fn
Fn
MI
M1E
MxE
P11F1
P1nFn
Px1F1
PxnFn
Sn Sn
P11
P1n
Px1
Pxn
    tag                       mix               mixture synthesis                      demix                    detag
S = Organic substrate; = Fluorous tag;F S1F1 = Tagged substrates;
MS = Mixture of tagged substrates; = Intermediate mixture which can be split intoMI MxEM1E  ..
= Final products before detagging;F P P = Final compounds  
Figure 1.1 Schematic representation of fluorous mixture synthesis 
3 
 
  
 
The viability of the concept of fluorous mixture synthesis was efficiently demonstrated 
by Curran and coworkers in the synthesis of a 560-compound library of mappicine analogues, 
four analogues of discodermolide,6 sixteen stereoisomers of murisolin,7 a sixteen stereoisomer 
library of pine sawfly sex pheromone8 and eight stereoisomers of passifloricin A.9
 
1.1.2. Oligoethylene glycols as new class of sorting tags 
In an effort to further empower the concept of chromatographic tagging strategies and to extend 
the concept of mixture synthesis, Wilcox and Turkyilmaz have introduced oligoethylene 
glycols10 (OEG, -[OCH2CH2]nOCH3, n = 1, 2...) as a new class of separation tags that can be used 
in solution phase mixture synthesis and polarity-based demixing. OEG derivatives containing 
five or fewer ethylene glycol subunits elute on regular silica-flash column or TLC in the order of 
increasing number of the ethylene glycol units. The trend was demonstrated1 0 by separating a 
mixture M1 of four esters 1a-d, on a standard analytical silica-TLC plate (100% ethyl acetate) 
(figure 1.2). The four esters were well separated in the order of number of ethylene glycol units. 
The ester 1a has the fewest ethylene glycol units and hence it is the least polar among the esters 
1a-d with an Rƒ of 0.7 (100% ethyl acetate). Ester 1d has the most ethylene glycol units and 
hence it is the most polar among 1a-d with an Rƒ = 0.3. The remarkable difference in the polarity 
of OEG-tags can facilitate the mixture synthesis by providing an easy separation of compounds 
from the mixture.  
4 
 
  
 
O
O(CH2CH2O)nCH3
O
        n   Rf
1a    1    0.70
1b    2    0.60
  
1c    3    0.48
1d    4    0.33
M1
 
1a     1b       1c      1d  
Figure 1.2 Simple proof of concept experiment demonstrate the predictable separation of OEG-tagged compounds 
on a silica-TLC plate (100% ethyl acetate): Figure courtesy of Prof. Wilcox. 
 
1.1.3. OEG-mixture synthesis (OMS) 
5 
The availability of OEG-tags opens the possibility for “OEG mixture synthesis” (OMS), a new 
class of solution phase mixture synthesis. The envisioned OEG-mixture synthesis, similar to 
FMS, can be carried in five steps- tagging, mixing, mixture synthesis, demixing and detagging. 
The OEG tags, similar to the fluorous tags, can be used in combination with a variety of 
protecting groups. For example the analogs 2 or 3 of the p-methoxybenzyl (PMB) protecting 
group as well as the analogs 4 or 5 of the 3,4-dimethoxy benzyl (DMB) protecting group (figure 
1.3) can be used to tether the OEG-tags to hydroxy functionality. The identity of each of the final 
compounds can be encoded from the OEG tag attached to it. However, OEG tags have an NMR 
finger print (4.2-3.0 ppm in 1H NMR), which might interfere in the characterization of some 
OEG-bound compounds.1 0 On the other hand, the OEG-finger print region in 1H-NMR spectrum 
  
 
sometimes facilitates in identifying the OEG-bound compound based on the corresponding 
integral values. 
O
Br
O
O
O
O
O
O
NH
CCl3
( )
n = 1-4
( )
n = 1-4
4 5
O
Br
O( )
n = 1-4 O
O
O( )
n = 1-4
2 3
NH
CCl3
 
Figure 1.3  Proposed analogs of PMB and DMB protecting group reagents for tethering OEG tags to a hydroxy 
group 
 
6 
The proposed OEG-mixture synthesis is a complementary type of liquid-phase synthesis 
that is very similar to fluorous mixture synthesis strategically, but very different in practice. In 
FMS, purification of the fluorous mixtures (mixture of compounds tagged with fluorous tags) 
can often be achieved on the regular silica gel without demixing the compounds since the 
fluorous demixing is tag- based instead of polarity-controlled process.4 On the other hand, in 
OMS, purification of the OEG mixtures (a mixture of compounds tethered with OEG tags) on 
silica gel will lead to simultaneous demixing since the OEG-tags are meant for polarity based 
demixing.  In other words, each chromatographic step on the silica gel in OEG mixture synthesis 
can potentially turn out to be a demixing exercise. Despite this difference, OMS brings in the 
  
 
main advantage typical of FMS: a series of reactions, workups and purifications can be carried 
on a mixture of compounds in solution phase.  
 
1.1.4. OEG-fluorous mixture synthesis (OFMS) 
The availability of two different classes of separation tags (fluorous and OEG) opens the door for 
double tagging strategies. Tagging of ‘n’ precursors with a first class of tag and ‘m’ precursors 
with a complementary second class provides ‘n+m’ precursors. However, reaction of these two 
orthogonally tagged mixtures provides a new mixture of ‘n•m’ products, wherein each product 
has a unique pair of tags. Isolation of the final products can be achieved by a double demixing 
exercise wherein each demixing targets a separate tag class.  
 
 Our envisioned double tagging strategy where four OEG and four fluorous tags are 
employed is illustrated in Figure 1.4. During the premix stage, a four-compound OEG mixture 
will be made by tethering four precursors with OEG tags (n = 1-4) and a four-compound fluorous 
mixture will be made by tethering another set of four precursors with fluorous tags (RF = C2F5-
C8F17). Reaction of the two orthogonally tagged mixtures will give a sixteen-compound mixture, 
wherein the identity of each compound is encoded from the unique pair of tags bound to them. 
We hypothesized that an initial OEG demixing (polarity based demixing) followed by fluorous 
demixing or vice versa will give sixteen individual doubly tagged compounds. This approach, 
called double demixing, is shown in Figure 1.4. 
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Figure 1.4 Schematic representation of OFMS by applying double tagging-double demixing strategy 
 
 
1.1.5. Murisolin and its stereoisomers 
8 
Murisolin, a member of the mono-THF class of acetogenins, was isolated by Cave´ and co-
workers from the seeds of Annona muricata.11 It was characterized by mass spectrometry and 2D 
homonuclear and heteronuclear correlations NMR spectroscopy. The relative stereochemistry of 
the dihydroxy-THF ring was established by 1H-NMR comparative spectral studies. Murisolin 
was also isolated by McLaughlin and co-workers12 from Asmina triloba, along with 16, 19-cis-
murisolin and murisolin A. They have assigned the structure of 16,19-cis-murisolin as 7 by a 
combination of 1H NMR studies on the natural product to establish the relative configuration of 
the dihydroxy-THF ring and Mosher ester studies to establish the absolute configuration. With 
similar methods, the structure of murisolin was refined to 6 and the structure of murisolin A was 
narrowed to two candidates, 8 and 9. These compounds show potent cytotoxic activities against 
  
 
several human cancer cell lines and act by inhibition of complex I (NADH/ubiquinone 
oxidoreductase) in mitochondrial electron transport systems.13 Recently, two independent groups 
(the Curran group7 at the University of Pittsburgh and the Tanaka group14 at Osaka University) 
have achieved the total synthesis of murisolin. The Curran group has applied fluorous mixture 
synthesis for the synthesis of murisolin and fifteen of its stereoisomers. Two compounds in the 
obtained stereoisomer library, 15R,16R,19R,20R-6 and 15S,15S,19S,20S-6 showed identical 
spectra to that of natural product murisolin. However, 15R,16R,19R,20R-6 was identical to the 
natural product murisolin by co-injection on a Chiracel OD column, while 15S,15S,19S,20S-6 
was different. This work conformed that the original stereochemical assignment of murisolin was 
correct. 
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Figure 1.5 Proposed structure of murisolin (6), 16,19-cis murisolin (7), and murisolin A (8 or 9) 
  
 
Encouraged by the fruitful results of the fluorous mixture synthesis of the 16-isomer 
library of murisolin by a 4mix/4split strategy, we aimed at advancing the solution phase mixture 
synthesis to the 16mix level by applying a double tagging technique. In a 4mix/4split strategy, a 
mixture of four compounds is split into four mixtures of four compounds to increase the diversity 
of mixture synthesis. However, in a 16mix strategy, a similar diversity can be made without the 
need to split the intermediate mixture.  To this end, we planned to explore the envisioned double 
tagging strategy by initially studying the complementarities of OEG and fluorous tags; will the 
fluorous tags interfere in the OEG demixing or vice versa? The complementarity of the tags is 
crucial for the success of our envisioned double tagging strategy. Our next goal was to examine 
the viability of our envisioned OEG-mixture synthesis (OMS) and OEG-fluorous mixture 
synthesis (OFMS) for syntheses of a sixteen isomer library of murisolin.  
 
10 
The proposed strategy for the synthesis of murisolin and its isomers by OFMS is shown 
in Figure 1.6. All sixteen isomers of 10, with C15, C16 stereocenters fixed, can be obtained by 
demixing the sixteen-compound mixture M11. Mixture M11 can be obtained by coupling two 
orthogonally tagged four-compound mixtures M12 and M13. The aldehyde mixture M12 can be 
synthesized by applying the newly envisioned OMS while the sulfone mixture M13 can be 
synthesized by FMS using the previously reported strategy.7  
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Figure 1.6  Double tagging strategy for the synthesis of murisolin and fifteen of its stereoisomers 
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The OEG-mixture synthesis strategy for accessing aldehyde mixture M12 is shown in 
Figure 1.7. The aldehyde M12 has two stereocenters (C4 and C34) and hence four stereoisomers 
are possible. In the pre-mix stage, the four tagged precursors (S)-14a, (S)-14b, (R)-14c and (R)-
14d can be made and grouped into two quasi-racemic mixtures M14a and M14b. The initial 
coding of each stereocenter (C4) with two tags permits the coding of the C34 butenolide center 
without the need for additional tags. The mixtures M14a and M14b can be advanced to a pair of 
two-compound mixtures M15a and M15b, respectively, followed by mixing them together to 
  
 
give a four-compound mixture M15.  The mixture M15 can be advanced to M12, which is the 
aldehyde component for the proposed OEG-fluorous mixture synthesis. At this stage, the OMS 
and FMS can be advanced to OFMS by the reaction of two orthogonally tagged mixtures M12 
and M13 affording a sixteen-compound mixture M11. The sixteen-compound mixture can be 
subjected to double demixing to give sixteen doubly tagged final compounds wherein the 
identity of each isomer can be encoded from the unique pair of tags attached to it. Detagging of 
the final compounds gives individual isomers of murisolin. 
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Figure 1.7 OEG-mixture synthesis strategy for the synthesis of four-compound mixture M12 
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1.2. RESULTS AND DISCUSSION 
1.2.1. Model double demixing experiments 
To address the vital issue of complementarity of OEG and fluorous tags, we decided to perform a 
model study with a mixture M16 (Figure 1.8).15 This mixture contains sixteen doubly tagged 
vanillic esters wherein each compound had one of a series of four OEG tags on the phenolic 
hydroxyl group (n = 1-4) and one of a series of four homologous fluorous tags on the carboxylate 
group (RF = C2F5, C4F9, C6F13, C8F17). The mixture M16 was readily prepared, as summarized 
below. 
OO O RF
M16       n = 1, 2, 3, 4;
RF = C2F5, C4F9, C6F13, C8F17
O(CH2CH2O)nCH3
OCH3
 
Figure 1.8 Four-compound mixture M16 for model double demixing experiments 
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Alkyl halide 18b was prepared by reaction of alcohol 17b with thionyl chloride in 92% 
yield. Similarly alkyl halides 18c (94% yield) and 18d (93%) were prepared from the 
corresponding alcohols 17c and 17d, respectively, while 1-chloro-2-methoxyethane 18a was 
obtained from commercial sources. Vanillic acid 19 was converted to methyl vanillate 2016 in 
80% yield by a standard esterification procedure (SOCl2, benzotriazole, CH3OH). O-Alkylation 
of methyl vanillate 20 with 1-chloro-2-methoxyethane 18a, employing K2CO3, KI in DMF, 
provided ester 21a in 93% yield. Similarly, OEG2-analog 22b (96% yield), OEG3 analog 21c 
(95% yield) and OEG4 analog 21d (91% yield) were prepared (Scheme 1.1).  
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Scheme 1.1 Synthesis of Vanillic esters 21a-21d 
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The rest of the experiments in this model study were carried out by Dr. Hejun Lu as 
described below (Scheme 1.2). The esters 21a, 21b, 21c and 21d were independently subjected 
to saponification (NaOH, CH3OH, reflux) to give the corresponding acids 22a (90%), 22b 
(92%), 22c (90%) and 22d (95%). The fluorous alcohol mixture M23 was prepared by mixing 
equimolar amounts of the commercially available17 p-perfluoroalkoxy benzyl alcohols 23a, 23b, 
  
 
15 
23c and 23d. Acid 22a was subjected to esterification with the fluorous alcohol mixture M23 to 
give a mixture of four doubly tagged analogs M24 (58% yield), wherein each compound had an 
OEG1 tag on the phenolic hydroxy group and one of a series of four homologous fluorous tags 
on the carboxylate group (RF = C2F5, C4F9, C6F13 and C8F17). Similarly, mixtures M25 (94% 
yield), M26 (82% yield) and M27 (97% yield) were prepared.  
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Scheme 1.2 Synthesis of Doubly-tagged Mixtures M24, M25, M26 and M27 
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TLC analysis of M24 (SiO2, 1:1 pentane/ethyl acetate) showed only one spot (Rƒ: 0.87). 
Similarly TLC analysis (SiO2, 1:1 pentane/ethyl acetate) of the mixtures M25 (Rƒ: 0.55), M26 
(Rƒ: 0.27) and M27 (Rƒ: 0.09) showed a single spot for each mixture. It is well known that 
  
 
addition of CF2 groups decreases the polarity of molecules,18 yet this effect is masked by the 
large polarity effects of the OEG tag as indicated by the single spot on TLC for the mixtures 
M24-M27. Then, an HPLC analysis of the mixture M24 was performed with an analytical 
Fluoroflash PF-C8 column (Figure 1.9).  As expected, the products in this chromatography 
eluted in the order of the fluorous tag from C2F5 to C8F17. Similar results were obtained with 
mixtures M25, M26 and M27 under the same HPLC analytical conditions (Table 1.1). The huge 
polarity effects of OEG tags are largely masked on the fluorous column by the fluorine content 
as indicated by four well separated peaks in analytical fluorous HPLC studies of the mixtures 
M24-M27.   
 
Figure 1.9 HPLC analysis of the mixture M22: HPLC analysis was carried out with a fluorous PF-C8 5-micron 150 
x 4.6 mm HPLC column, 60% acetonitrile/water to 90% acetonitrile/water for 20 min then 90% acetonitrile/water 
for 10 min 
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Retention times (min) Entry Mixture 
Peak 1 (C2F5) Peak 2 (C4F9) Peak 3 (C6F13) Peak 4 (C4F17) 
1 M24 (OEG1) 6.84 11.94 17.82 23.61 
2 M25 (OEG2) 6.48 11.52 17.5 23.49 
  
 
3 M26 (OEG3) 6.20 11.17 17.17 23.30 
4 M27 (OEG4) 5.94 10.82 16.81 23.08 
Table 1.1 HPLC analysis of mixtures M24, M25, M26 and M27 on an analytical fluorous PF-C8 (150 x 4.6 mm) 
column. 
 
A mixture of sixteen doubly tagged analogs M16 of vanillic acid was obtained by mixing 
together the four doubly-tagged vanillic acid analog mixtures M24, M25, M26 and M27. TLC 
analysis (SiO2, 1:1 pentane/ethyl acetate) of the mixture M16 showed four spots (Figure 1.10) 
wherein each spot represented a different OEG analog mixture. The identity of each spot was 
confirmed by co-analysis of individual mixtures on the TLC. The mixture M16 was separated by 
flash chromatography (SiO2, pentane/EtOAc gradient) into four fractions M24-M27 based on the 
properties of the OEG tags. This simple proof-of-concept experiment demonstrates the viability 
of OEG-demixing (separation of OEG-tagged molecules on regular silica gel) of doubly tagged 
compounds. 
O O
O RF
M16        n = 1, 2, 3, 4;
RF = C2F5, C4F9, C6F13, C8F17
M24
M25
M26
M27
O(CH2CH2O)CH3
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Figure 1.10 Analyses of sixteen vanillic acid esters M16 on standard silica gel TLC (1:1 pentane/ethyl acetate) 
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  An analytical HPLC trace of the 16 compound mixture M16 on a FluoroFlash PF-C8 
column (CH3CN/H2O, 40/60 to 90/10) is shown in Figure 1.11. The identity of each peak was 
determined by LC-MS analysis of the sixteen-compound mixture M14. The compounds emerge 
  
 
as four groups of four peaks.  The larger separations correspond to the fluorous tag, with the four 
compounds bearing the C2F5 tag eluting well before the four compounds bearing the C4F9 tag, 
etc.  The smaller separations within the groups of peaks correspond to OEG separation from the 
more polar n = 4 tag to the less polar n = 1 tag.  
 
 
Figure 1.11 Analytical HPLC trace of M16 on a FluoroFlash PF-C8 column (CH3CN/H2O, 40/60 to 90/10) 
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These simple proof-of-concept experiments are remarkable and show that fluorous and 
OEG tags are complementary in double demixing. Initial preparative separation of the doubly 
tagged analog mixture M16 (20 mg of M16 was used for this study) by silica-column 
chromatography (OEG-demixing) followed by subjecting each of the resulting four fractions 
M24 (4.5 mg), M25 (5.8 mg), M26 (2.0 mg) and M27 (6.8 mg) to fluorous HPLC (fluorous 
demixing) provided all sixteen individual compounds in an average of 1 mg quantity. The order 
of demixing can also be reversed by initially carrying out a fluorous demixing followed by an 
OEG demixing. To verify the applicability of the above demonstrated double tagging-double 
demixing strategy, we proceeded to prepare 16 stereoisomers of the acetogenin murisolin in a 
single reaction flask.  
  
 
1.2.2. Synthesis of Hydroxybutenolide (4R,34S)-35  
In the initial 16-member murisolin library,7 hydroxybutenolide 35 was synthesized by Dr. Cyrille 
Richard as summarized in Scheme 1.3.  Sharpless dihydroxylation19 of 1,8-nonadiene 28 with the 
commercially available AD-mix-β catalyst afforded diol (R)-29  in 60% yield with an 
enantiomeric ratio of 91/9. The primary hydroxylic group was selectively converted to tosylate 
30 in 85% yiled by treatment with p-TsCl/Bu2SnO.7 7 Protection of the seconday alcohol as TBS 
ether (85% yield) followed by displacement of the tosylate by iodide (NaI, acetone, reflux) 
provided 31 in 90% yield. The sodium enolate of lactone (S)-49 was alkylated20 with iodide 31 to 
afford 32 in 75% yield. Oxidation of the sulfide 32 with mCPBA followed by thermal 
elimination gave butenolide 33 in 70% yield. The terminal olefin 33 was subjected to 
hydroboration-oxidation to afford the primary alcohol 34 in 70% yield. Finally, oxidation of 34 
with PCC21 gave aldehyde (4R,34S)-35 in 70% yield.  
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 The minor (4S) enantiomer of alcohol 29 resulted in a diastereomeric impurity in lactone 
35, which was an inseperable ~9/1 mixture of epimers (C4) as assayed by 13C NMR 
spectroscopy. The diastereomeric impurity in 35 was carried through the rest of the synthesis 
resulting in minor diastereomeric impurities in each of the sixteen final murisolins. In the current 
murisolin library synthesis, we explored Jacobsen hydrolytic kinetic resolution method to access 
enantiopure 29 as described below.   
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Scheme 1.3 Synthesis of aldehyde 35 (by Dr. Cyrille Richard, Curran labs) 
 
1.2.3. Synthesis of enantiomerically pure diol 29 
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Terminal olefins are known to furnish the diols in relatively lower ee’s (80-90%) in the Os-
catalyzed asymmetric dihydroxylation reactions.22 This trend is apparent in the literature results 
wherein conversion of terminal olefin 36 to (R)-diol 37 (Scheme 1.4) occurred in 94% yield and 
in 84% enantiomeric excess (ee).23  
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Scheme 1.4 Asymmetric dihydroxylation of terminal olefin 29 
 
Hydrolytic kinetic resolution of terminal racemic epoxides with Chiral Co(Salen) 
Complexes was proven to provide terminal diols in good to excellent enantiomeric excess.24 The 
Jacobsen group reported that 38 was treated with the (R,R)-Jacobsen catalyst (R,R)-39 to give 
(S)-5-hexane-1,2-diol 40 (44% yield) in 99% enantiomeric excess (Scheme 1.5). Hence, we plan 
to examine the hydrolytic kinetic resolution method for accessing diols (R)-29 and (S)-29 in high 
enantiomeric purity.  
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Scheme 1.5 Jacobsen hydrolytic kinetic resolution of terminal epoxides 
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Our initial efforts on mono-epoxidation of the terminal diene 28 with m-CPBA or with 
oxone25 were low yielding due to the competing bis-epoxidation reaction. However, the 
epoxidation of diene 28 with m-CPBA as the limiting reagent (1 equiv) and use of an excess of 
olefin 28 (2.5 equiv) afforded the mono-epoxide 41 in 76% yield (based on m-CPBA). The 
racemic epoxide 41 was subjected to hydrolytic kinetic resolution (HKR) with the (R,R)-
Jacobsen catalyst (R,R)-39 to give the corresponding diol (S)-29 in 43% yield and in 99% 
enantiomeric excess (ee) along with the enantiomerically enriched epoxide (R)-41 (see 
experimental section for details). Epoxide (R)-41 was than subjected to Jacobsen HKR with the 
Jacobsen catalyst (S,S)-39 to yield (R)-diol (R)-29  in 44% yield (based on the quantity of 
racemic epoxide) and 99% enantiomeric excess.  
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Scheme 1.6 Hydrolytic kinetic resolution of racemic epoxide 41 
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The enantiomeric purity of diols (R)-29 and (S)-29 was assayed by 1H NMR spectroscopy 
by applying the Mosher method.26 Alcohol (R)-29 was bis-acylated with (R)-α-methoxy-α-
trifluoromethylphenylacetyl chloride (R)-42 to give the Mosher ester (R,R)-43 (Scheme 1.7). 
  
 
Alcohol (R)-29 was spiked with (S)-29 to give a sample 29a. Alcohol 29a was bis-acylated to 
give 43a (not shown in scheme).  The 1H NMR spectrum of 43a obtained at 500 MHz showed a 
doublet of doublet (dd) centered at δ 4.56 and another dd centered at δ 4.62. The 1H NMR 
spectrum of (R,R)-43 showed a doublet of doublet at centered at  δ 4.56 but none of the peak for 
the other diastereomer could be detected (figure 1.12). Hence, the enantiomeric excess of the 
alcohol (R)-29 must be higher than 99%. Similarly, the enantiomeric excess of (S)-29 was 
determined to be > 99%. 
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Scheme 1.7  Determination of enantiomeric purity by Mosher method 
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Figure 1.12 500 MHz 1H NMR spectra of (R,R)-43; insert (a) expansion of 43a (spiked sample); insert (b) 
expansion of (R,R)-43 (from HKR) 
  
 
 
The primary hydroxy group of diol (R)-29 was selectively functionalized as tosylate (R)-
30 in 74% yield by the reaction of diol (R)-29 with p-toluenesulfonyl chloride in presence of 
catalytic amount (0.2 equiv) of dibutyltin oxide77,27 Similarly, primary alcohol of diol (S)-29 was 
selectively tosylated to give(S)-30 in 76% yield (Scheme 1.8).  
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Scheme 1.8 Synthesis of sulfones (R)-30 and (S)-30 
 
Attempts to protect the sec-alcohol (R)-30 with DMBO1-bromide 4a (n = 1) under basic 
conditions were unsuccessful due to the competing displacement of the tosylate to give back 
epoxide (R)-41. Hence, we decided to examine the utility of imidate 5 under acidic conditions for 
the protection of alcohols with PMB or benzyl imidates.  
 
1.2.4. Synthesis of DMBO imidate 5 
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The DMBO imidates 5, OEG-tagged DMB protecting reagent, were readily synthesized as 
summarized in Scheme 1.9. Ester 21a was reduced with lithium aluminum hydride (LiAlH4) to 
yield alcohol 44a in 91% yield. Similarly, esters 21b, 21c and 21d were reduced to give the 
corresponding alcohols 44b (93% yield), 44c (98% yield) and 44d (95% yield) respectively. 
Alcohol 44a was converted to imidate 5a in 90% yield by treatment with NaH in THF followed 
by the addition of trichloroacetonitrile.28 Similarly the imidates 5b (80%), 5c (85%) and 5d 
  
 
(83%) were prepared from the corresponding alcohols 44b, 44c and 44d respectively. The 
resulting imidates were stored under argon at 0 oC for more than a month without any 
deterioration.  
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Scheme 1.9 Synthesis of imidates 5a-5d 
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Next our efforts were focused on identifying the conditions for tethering the OEG-tags to 
alcohols (R)-30 and (S)-30.  The secondary alcohol rac-46 was made from the commercially 
available octane-1,2-diol rac-45 in 79% yield (Scheme 1.10). Reaction of alcohol rac-46 with 
  
 
DMBO1 imidate 5a under standard Bundle28 or Yonemitsu29 conditions with catalytic amount of 
trifluoromethanesulfonic acid (TFA) (0.3-10 mole%) was unsuccessful. However, the reaction of 
alcohol rac-46 with imidate 5a in presence of catalytic amount (0.1 equiv) of camphorsulphonic 
acid30 afforded 47 in 72% yield (Table 1.2). 
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Scheme 1.10 Synthesis of rac-46 
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OCH3
OTs
OH
( )4 ( )4
rac-46 rac-47
5a, Conditions
 
Entry Conditions Yield 
1 5a (1.2 equiv), TFA (0.3 mole%), ether trace 
2 5a (2.0 equiv), TFA (0.3 mole%), ether trace 
3 5a (2.0 equiv), TFA (10 mole%), ether trace 
4 5a (2.0 equiv), TFA (10 mole%), CH2Cl2 15% 
5 5a (2.0 equiv), camphor sulfonic acid, CH2Cl2 72% 
Table 1.2 Acid catalyzed DMBO protection of alcohol rac-46 with imidate 5a 
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In our efforts to access the four tagged precursors 14a-14d for OEG mixture synthesis, 
the  secondary alcohol  (S)-29 was reacted independently with imidates 5a and 5b in presence of 
  
 
catalytic amount of camphorsulfonic acid (0.1 equiv) to afford 14a (68% yield) and 14b (66% 
yield), respectively. Similarly, 14c (70% yield) and 14d (64% yield) were obtained by the 
reaction of alcohol (R)-29 with 5c and 5d (Scheme 1.11). 
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OCH3
O(CH2CH2O)nCH3
( )5 ( )5
(S)-29
5, CSA (0.1 equiv),
CH2Cl2
(S)-29
(R)-29
(R)-29
5a
5b
5c
5d
14a 1 (68%)
14b 2 (66%)
14c 3 (70%)
14d 4 (64%)
n
 
Scheme 1.11 Acid catalyzed DMBO protection of alcohols (R)-46 and (S)-46 
 
Lactones (S)-49 (96% yield) and (R)-49 (98% yield) were readily synthesized according 
to standard literature procedure from phenylthioacetic acid and the corresponding 2-
methyloxiranes (S)-48 and (R)-48 (not shown in the Scheme), as illustrated in Scheme 1.12.31,32 
The lactones (S)-49 and (R)-49 were obtained as a 1:1 mixture of stereoisomers at C(2) (Scheme 
1.12). 
O 1. LDA, THFPhSCH2COOH
2. p-TsOH, PhH
(96%)
O
PhS
O
CH3
(S)-49(S)-48
2
 
Scheme 1.12 Synthesis of lactone (S)-49  
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Our efforts in alkylation of the sodium enolate derived from (S)-49 with the tosylate rac-
46 and iodide rac-51 were unsuccessful. However, the alkylation of the enolate was feasible 
(73% yield) with (S)-31 (TBS protecting group on the hydroxy functionality) that was 
synthesized by following Richard’s procedure (Scheme 1.3). This scenario parallels the literature 
results33 wherein alkylation of the sodium enolate of (S)-49 with 52 (MOM protecting group on 
hydroxy group) was low yielding while alkylation with 53 (TBS protecting group on the hydroxy 
group) gave 78% yield.3 3 However, we were delighted to achieve the alkylation of the sodium 
enolate of (S)-49 with iodide 56a by simply refluxing the reaction mixture for 12 h. The lactone 
(S,S)-15a was obtained in 79% yield as a 1: 6 stereoisomeric mixture at C2 (Scheme 1.13). 
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Scheme 1.13 Synthesis of (S,S)-15a 
 
In order to begin the first application of OEG-tags in quasi-racemic synthesis,34 a starting 
mixture M14a was obtained by mixing tosylates 14a (DMBO1-tagged) and 14c (DMBO3-tagged). 
The quasiracemic mixture M14a was treated with NaI in acetone and refluxed for 20 h to afford 
the iodide mixture M56a in 98% yield (Scheme 1.14). TLC analysis (SiO2, ethyl 
acetate/hexanes) of the reaction mixture after 8 h (Figure 1.13) showed two closely positioned 
spots at Rƒ = 0.53 and another set of two closely positioned spots at Rƒ = 0.20. The larger 
separation of the spots is due to the polarity difference between the OEG1 (less polar) and OEG3 
(more polar) tags while the smaller separation is due to the polarity difference between the 
tosylate 14a (slightly more polar) and the iodide 56a (slightly less polar). The Finkelstein 
reaction went to completion in 20 h as evidenced by the disappearance of the pair of slightly 
more polar spots. 
 
30 
1H NMR analysis of the crude product M56a indicated complete conversion of reactants 
M14a to products M56a; hence no purification was necessary. However, a small sample (100 
mg) of the above mixture M56a was separated by flash column chromatography on silica gel for 
  
 
characterization purposes and to study the ease of separation of the components from each 
mixture. The DMBO1 and DMBO3 analogs 56a and 56c were easily separated from the mixture 
M56a in spectroscopically pure form in a gradient elution wherein 56a was eluted (25% ethyl 
acetate/hexanes) followed by 56c (50% ethyl acetate/hexanes).  
1 2
1 = TLC analysis of reaction mixture af ter 8 h
2 = TLC analysis of the reaction mixture af ter 20 h
14a
56a
14c
56c 56c
56a
 
Figure 1.13 TLC analysis (SiO2, 50% ethyl acetate/hexanes) in conversion of tosylate M14a to iodide M56a 
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Scheme 1.14 Synthesis of iodides M56a and M56b 
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Similarly, a second quasi-racemate M14b was obtained by mixing tosylate 10b (DMBO2-
tagged) and 10d (DMBO4-tagged). The mixture M14b (n = 2, 4) was subjected to Finkelstein 
reaction with NaI in acetone to give the iodide quasi-racemate M56b (n = 2, 4) in 99% yield 
  
 
(Scheme 1.14). The mixture M56b was spectroscopically pure and hence it was taken to the next 
step without further purification. 
 
The sodium enolate of (S)-49, generated by treating (S)-49 with NaHMDS, was reacted 
with the iodide mixture M56a (n = 1, 3) to afford a mixture M15a (n = 1, 3) of diastereomers 
(S,S)-15a and (R,S)-15c (Scheme 1.15). TLC analysis (SiO2, ethyl acetate/hexanes 1:1 v/v) of the 
crude reaction mixture showed a spot at Rƒ = 0.51 corresponding to (S,S)-15a, and another spot 
at Rƒ = 0.20 corresponding to (R,S)-15c. The crude reaction product was subjected to flash 
chromatography on silica gel under gradient conditions. Initial elution with 25% ethyl 
acetate/hexanes gave (S,S)-15a (76% yield) as a stereoisomeric mixture at C2. A second elution 
with 50% ethyl acetate/hexanes gave (R,S)-15c (69% yield) as a stereoisomeric mixture at C2 
(Scheme 1.15).  
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Scheme 1.15 Alkylation of (S)-49 
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Sodium enolate of (R)-49, generated by treating (R)-49 with NaHMDS, was reacted with 
the iodide mixture M15b (n = 2, 4) to afford a mixture M15b (n = 2, 4) of alkylated products 
(S,R)-15b and (R,R)-15d (Scheme 1.16). TLC analysis (SiO2, 65% ethyl acetate/hexanes) of the 
crude reaction mixture showed a spot at Rƒ = 0.54 corresponding to (S,R)-15b, and another spot 
  
 
at Rƒ = 0.25.corresponding to (R,R)-15d. The crude reaction product was subjected to flash 
chromatography on silica gel under gradient conditions. Initial elution with 35% ethyl 
acetate/hexanes gave (S,R)-15b (72% yield) as a stereoisomeric mixture at C2. A second elution 
with 60% ethyl acetate/hexanes gave (R,R)-15c (69% yield) as a stereoisomeric mixture at C2 
(Scheme 1.16).  
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Scheme 1.16 Alkylation of (R)-49 
 
Attempts at hydroboration-oxidation of the terminal double bond either in 15 or 58 were 
unfruitful under various conditions (Scheme 1.17). Employing 1 equiv of 9-BBN35 resulted in 
recovery of starting material, while use of excess 9-BBN or catecholborane36  resulted in 
complex crude reaction product. In light of unsatisfactory results of hydroboration-oxidation of 
the terminal olefin 15 or 58, an alternative synthesis was planned wherein the terminal alkene is 
replaced with terminal alcohol. 
33 
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Scheme 1.17 Attempted hydroboration-oxidations 
 
1.2.5. Re-designed protocol for the synthesis of four-compound aldehyde mixture M62 
The protocol for the re-designed synthesis to access the aldehyde mixture M62 is shown in 
Scheme 1.18. The commercially available alcohol 60 can be advanced to a four-compound 
mixture M61 without having to pursue the difficult hydroboration reaction. A few 
transformations on the four-compound mixture M61 can give the desired aldehyde M12. 
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34 
Scheme 1.18 Re-designed strategy for the synthesis of aldehyde M62 
  
 
 
Silylation of 8-nonen-1-ol 60 with TBS-Cl give silyl ether 63 in 99% yield (Scheme 
1.19). Epoxidation of the alkene 63 with m-chloroperbenzoic acid gave the recemic epoxide rac-
64 in 98% yield. The racemic epoxide was subjected to Jacobsen hydrolytic kinetic resolution37 
with (R,R)-39 to give (S)-65 in 43% yield along with 56% of enantiomerically enriched (R)-
epoxide (R)-64. The epoxide (R)-64 was subjected to Jacobsen hydrolytic kinetic resolution with 
(S,S)-39 to give R-diol (R)-65 in 45% yield. The enantiomeric excesses of (S)-65 and (R)-65 
were determined to be greater than 98% by Mosher ester method as previously described for (R)-
29. 
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Scheme 1.19 Synthesis of (R)-64 and (S)-64 
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The primary hydroxy group of diol (R)-65 was selectively functionalized as tosylate (R)-
66 (72% yield) by the reaction of diol 65 with p-toluenesulfonyl chloride in the presence of 
catalytic amount of dibutyltin oxide.77 Similarly, primary alcohol of the diol (S)-60 was selectively 
tosylated (76% yield) (Scheme 1.20).  
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Scheme 1.20 Synthesis of sulfonates (R)-66 and (S)-66 
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In our efforts to access four tagged precursors for OEG-mixture synthesis, the  secondary 
alcohol (R)-66 was reacted with imidates 5a and 5b independently in presence of catalytic 
amount of camphorsulfonic acid (0.1 equiv) to afford 67a (60% yield) and 67b (62% yield), 
respectively. Similarly 67c (63% yield) and 67d (61% yield) were obtained by the reaction of 
alcohol (S)-66 with imidates 5c and 5d respectively (Scheme 1.21). 
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Scheme 1.21 Synthesis of OEG-tagged precursors 67a-67d 
 
 
The tosylates 67a and 67c were mixed together to give a quasi-racemate M67a. The 
quasi racemate M67a was subjected to Finkelstein reaction with NaI in refluxing acetone to give 
the corresponding iodide M68a in 98% yield (Scheme 1.22). The crude iodide M68a was pure 
by both TLC (SiO2 50% ethyl acetate/hexanes) and 1H NMR spectral analysis and hence it was 
taken to the next step with out further purification. Similarly, a quasi racemic mixture M67b was 
obtained by mixing tosylates 67b and 67d and the mixture was subjected to Finkelstein reaction 
in refluxing acetone to give the corresponding iodide mixture M68b in 99% yield.  
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Scheme 1.22 Synthesis of iodides M68a and M68b 
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The sodium enolate of (S)-49, which was generated by treating (S)-49 with NaHMDS, 
was reacted with the iodide mixture M68a to afford the alkylated products (R,S)-61a (68% yield) 
and (S,S)-61c (73% yield) as stereoisomeric mixture at C2 (Scheme 1.23). Similarly, the sodium 
enolate of (R)-49 was alkylated with the quasi-racemic iodide mixture M68b to give the 
corresponding alkylated products (R,R)-61b (71% yield) and (S,R)-61d (70% yield) as 
stereoisomeric mixtures at C2.  
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Scheme 1.23 OEG-mixture synthesis 
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  The resulting four compounds 61a-61d were mixed together to give a mixture M61. The 
sulfide M61 was oxidized with m-CPBA to sulfoxide at 0 oC and the obtained crude product in 
DMF was heated in microwave38 (150W power) at 160 oC for 5 min. TLC analysis (SiO2, 70% 
ethyl acetate/hexanes) of the above crude reaction mixture showed four major spots (Figure 
1.14). The crude reaction mixture was separated by flash column chromatography on silica gel 
  
 
under step gradient conditions (25%, 40%, 60% and 80% ethyl acetate/hexanes) into four 
fraction based on the polarity of OEG tags. The least polar fraction (eluted with 1:4 ethyl 
acetate/hexanes) contained OEG1-tagged butenolide 69a (88% yield). Succeeding fractions 
contained OEG2-, OEG3- and OEG4-tagged molecules 69b (85% yield), 69c (89% yield) and 69d 
(85% yield), respectively (Scheme 1.24).  
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Figure 1.14 TLC analysis of crude product M69 
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Scheme 1.24 Conversion of M61 to M69 
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The compounds 64a-d were mixed together to give a four-compound mixture M69. The 
mixture M69 was treated with methanolic HCl (AcCl, CH3OH) to afford the primary alcohol39 
mixture M70. Crude product M70 was carried to the next step without any further purification.  
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Scheme 1.25 Synthesis of four-compound mixture M70 
 
 The alcohol mixture M70 was oxidized to aldehyde M62 by treating it with o-
iodoxybenzoic acid (IBX) until TLC indicated complete conversion of alcohol to aldehyde M62. 
The crude reaction mixture was separated by flash column chromatography (SiO2, ethyl 
acetate/hexanes, gradient) based on the properties of OEG tag (Figure 1.15). The pure aldehydes 
62a - 62d were recombined to give the four-compound mixture M62 (Scheme 1.26). 
62a
62b
62c
62d
 
Figure 1.15 TLC analysis of M62 (SiO2, 100% ethyl acetate) 
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Scheme 1.26 Oxidation of M70 with IBX 
 
The value of the OEG-mixture synthesis is evident from this exercise: four analogues 
62a-62d of aldehyde 62 were prepared in a single synthetic sequence with only a little more 
effort than that required for one. Overall, 16 steps were saved by the mixing (multi-step 
conversion of M67 to M62). The first step (conversion of M67 to M68) demonstrated the 
application of OEG-tags in quasi-racemic synthesis. We envision that OEG-tags, similar to 
fluorous tags,40 have potential applications in multi-step quasi racemic synthesis. All mixtures in 
the synthesis that were separated during purification were characterized by NMR (1H NMR and 
13C NMR) IR and MS data.41   
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The four-compound mixture of fluorous tagged sulfones M13 was synthesized by Dr. 
Hejun Lu as summarized in Scheme 1.27.42 The four compound diol mixture M71 was 
synthesized using the previously pursued protocol for the synthesis of murisolin.7 TBS protection 
of primary alcohol in M71 followed by PMB protection of secondary alcohol and desilylation of 
primary alcohol with TBAF gave M72 50% yield (three steps). A Mitsunobu/oxidation sequence 
of the mixture M72 afforded sulfone M13. 
  
 
The OEG-mixture synthesis of aldehyde M62 afforded its precursor M69 in 1.4 mmol 
(equivmolar mixture of 69a, 69b, 69c and 69d) quantity. However, the conversion of fluorous 
mixture M71 to M72 resulted in considerable loss of the mixture and ultimately afforded 0.26 
mmol of sulfone M13 wherein the C2F5, C4F9, C6F13 and C8F17-tagged compounds were present 
in 1 : 1.28 : 1.25 : 4.59 mole ratio. Hence sulfone mixture M13 was limiting reagent for the scale 
of upcoming OEG-Fluorous mixture synthesis. We estimated that 0.26 mmol of sulfone mixture 
M13 in OFMS would result the murisolin and its isomers in an average of 1-2 mg quantity and 
proceeded to pursue the OFMS. 
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Scheme 1.27 Synthesis of sulfone mixture M13 
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A model study was carried out to test the Julia olefination and the selective reduction of 
the internal double bond in the presence of an unsaturated lactone before coupling the dihydroxy-
THF fragment M13 with the hydroxybutenolide unit M62. The sulfone 75 was synthesized from 
1-octanol 73 in 76% yield (two steps) (Scheme 1.28). The anion of the sulfone 75 was generated 
by treatment with NaHMDS in THF at −78 oC for 30 min and reacted with the aldehyde 62b to 
give the olefin 76 as a mixture of (E)- and (Z)- isomers in 85% yield (ratio was not determined). 
Attempts at selective reduction of internal double bond by hydrogenation with Wilkinson’s 
catalyst in benzene resulted recovery of starting materials. However, carrying the reduction in 
ethanol gave 77 in 98% yield. Treatment of 77 with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
(DDQ)43 (1.1 equiv) gave the detagged product 78 in 88% yield (Scheme 1.28).  
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Scheme 1.28 Synthesis of alcohol 78 
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In a second model reaction, Julia olefination reaction between the aldehyde 62b and 13-
F17 was carried out in similar manner to afford 79-O2-F17 in 66 % yield. The compound 
numbers were given based on the tags bound to them. For example, 79-O2-F17 denotes a 
compound bearing DMBO2 and PMBF17 tags. The internal double bond (alkene introduced in 
coupling) in 79-O2-F17 was selectively reduced by hydrogenation in ethanol in presence of 
catalytic amount of Wilkinson’s catalyst followed by global deprotection of three protecting 
groups (PMBF17, and DMBO2 and PMB) with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (3.2 
equiv) (DDQ) in CH2Cl2/H2O (19:1) gave 10-O2-F17 in 83% (two steps) isolated yield (Scheme 
1.29).  
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Scheme 1.29 Synthesis of compound 10-O2-F17 
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1.2.6. OEG-Fluorous mixture synthesis of murisolin isomers 
Kocienski-Julia olefination of the four-component fluorous-tagged mixture M13 with the four-
componet OEG-mixture M62 is illustrated in scheme 1.30. Deprotonation of sulfone M13 (0.26 
mmol) with NaHMDS generated the corresponding anion, which was reacted with aldehyde 
M62 (0.28 mmol) to furnish alkene M79.  
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Scheme 1.30 First example of OEG-fluorous mixture synthesis for the synthesis of stereoisomers 
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Fluorous HPLC analysis of the crude reaction mixture M79 occurred with fluorous demixing but 
not OEG demixing to provide four pairs of peaks, each pair with a ratio of about 85/15 (Figure 
1.16a). Both fluorous HPLC analysis and standard TLC analysis showed that the minor peaks 
  
 
belonged to the starting sulfones in M13. The crude mixture M79 was purified by flash column 
chromatography on silica gel with gradient elution.  First step elution with with 25% ethyl 
acetate/hexanes provided unreacted sulfone M13 followed by a fraction 79a containing four 
DMBO1-tagged molecules. The succeeding steps of the gradient elution provided fractions 79b, 
79c and 79d that contained DMBO2-, DMBO3-, and DMBO4-tagged molecules, respectively. The 
identity of the fractions 79a-79d was confIrmed by LCMS (APCI) analysis. The fractions 79a - 
79d were mixed together to give the purified sixteen-compound mixture M79. Fluorous HPLC 
analysis of the mixture M79 indicated the disappearance of minor peaks (Figure 1.16b).  
 
 
 
a: Analytical Fluorous HPLC chromatogram of crude M79; arrows show unreacted sulfones 
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b: Analytical HPLC trace after purification of mixture M79 by flash column 
 
Figure 1.16 HPLC trace of analysis of M79 on a FluoroFlash PF-C8 column (CH3CN/H2O, 80/20 to 100% CH3CN 
in 20 min then 100% CH3CN for 10 min. a: before purification of mixture M79 by flash column chromatography b: 
after purification by flash chromatography. 
 
 
47 
The internal double bond in M79 was selectively hydrogenated in ethanol with 
Wilkinson’s catalyst (Scheme 1.30). Once the reaction was complete as indicated by 1H NMR 
spectroscopy, the crude reaction product M11 (320 mg) was subjected to a simultaneous 
purification and OEG-demixing with a silica-flash chromatography with step-gradient elution 
(25%, 50%, 65% and 80% ethyl acetate/hexanes). The product M11 separated into four fractions 
11-O1, 11-O2, 11-O3 and 11-O4, based on the properties of OEG- tags (n = 1 – 4). The least 
polar fraction 11-O1 contained all four molecules bearing OEG1-tag. The succeeding fractions 
11-O2, 11-O3 and 11-O4 contained OEG2-, OEG3- and OEG4-tagged molecules, respectively. 
The identity of each fraction was confirmed by LCMS analysis of each fraction (see the 
experimental section for the LCMS data).  Mixtures 11-O2 and 11-O3 showed two closely 
positioned spots by TLC on silica gel (Figure 1.17) suggesting some separation of fluorous-
tagged diastereomers; however, these were collected togather. The most polar fraction 11-O4 co-
  
 
eluted with traces of unidentified impurities (Scheme 1.31). A combined yield of 84% for 
Wilkinson’s hydrogenation and OEG-demixing was obtained.  
11-O2
11-O1
11-O3
11-O4
 
Figure 1.17 TLC analysis (SiO2, 80% ethyl acetate/hexanes) of Mixture M11 
O
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Scheme 1.31 Demixing of mixture M11 on silica-flash column (ethyl acetate/hexanes, gradient) 
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The mixture 11-O2 was subjected to preparative separation over a FluoroFlash semi prep 
HPLC column (20 x 250 mm) under gradient conditions.  The gradient started from 85% 
CH3CN/15% H2O and changed to 100% CH3CN over 25 min. Following this was isocratic 
elution with 100% CH3CN for 10 min. The flow rate was 15 mL/min through out the elution. 
Under these conditions, the four components 11-2-F5, 11-2-F9, 11-2-F13 and 11-2-F17 were 
eluted at 10.0, 14.2, 19.0 and 23.4 min, respectively (Figure 1.18). About 20 mg of the mixture 
was injected each time. After 3 injections, the amounts of 11-2-F5, 11-2-F9, 11-2-F13 and 11-2-
F17 obtained were 6.3 (5.2 µmol), 7.4 (5.7 µmol), 9.5 (6.8 µmol) and 33.0 (21.9 µmol) mg 
respectively. The overall recovery of the preparative separation was 86% (Scheme 1.32).   
 
 
Figure 1.18 A typical chromatogram of semi-prep demixing of 11-O2 
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Scheme 1.32 Fluorous Demixing of the mixture 11-O2 
 
The mixtures 11-O1 (52 mg) was demixed on FluoroFlash semi-prep HPLC column in 
similar manner to the mixture 11-O2 to give 11-O1-F5 (2.5 mg, 2.2 µmole), 11-O1-F9 (4.7 mg, 
3.7 µmole), 11-O1-F13 (8.8 mg, 6.5 µmole) and 11-O1-F17 (22.5 mg, 15.4 µmole) with a 74% 
overall recovery of preparative separation (structures shown in appendix 1).  
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The mixtures 11-O3 (55 mg) was demixed on FluoroFlash semi-prep HPLC column in 
similar manner to the mixture 11-O2 to give 11-O3-F5 (3.8 mg, 3.0 µmole), 11-O3-F9 (5.9 mg, 
4.4 µmole), 11-O3-F13 (6 .6mg, 4.6 µmole) and 11-O3-F17 (14.8 mg, 9.6 µmole) with a 57% 
overall recovery after fluorous demixing (structures shown in appendix 1). 
  
 
The mixtures 11-O4 (44 mg) was demixed on FluoroFlash semi-prep HPLC column in 
similar manner to the mixture 11-O2 to give 11-O4-F5 (3.8 mg, 2.9 µmole), 11-O4-F9 (6.1 mg, 
4.4 µmole), 11-O4-F13 (5.4 mg, 3.6 µmole) and 11-O4-F17 (13 mg, 8.2 µmole) with a 64% 
overall recovery after fluorous demixing (structures shown in appendix 1). 
 
The fluorous PMB group, the standard PMB group and the DMBO2 group in 11-O2-F13 
were removed by treating 11-O2-F13 (9.5 mg, 6.8 µmole) with DDQ (3.3 equiv) in CH2Cl2/H2O 
(19:1). The crude reaction mixture was purified by prep-TLC (SiO2, 70% ethyl acetate/hexanes 
affording the crude detagged product 11-O2-F13 in 76% yield (Scheme 1.33). Similarly the 
other fifteen isomers were subjected to detagging (structures given in appendix 2). Of the sixteen 
tagged compounds, 11-O1-F13, 11-O1-F17, 11-O4-F5, 11-O4-F9, 11-O4-F13 and 11-O4-F17 
were detagged and purified by Dr. Hejun Lu.  
C12H25
OH
O
O
OH
OH
O
10-O2-F13
DDQ (3.3 equiv)
CH2Cl2/H2O (19:1)
11-O2-F13
(76%)
 
Scheme 1.33 Global deprotection of doubly tagged murisolin 
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The 500 MHz 1H NMR spectrum of 11-O3-F13 showed signals for unidentified 
diastereomeric impurities although TLC analysis showed single spot for the product. This 
suggests the diastereomeric impurities were co-eluting with the desired product. Hence all the 
sixteen isomers were subjected to purification with semi-prep HPLC Chiralcel OD column (2 x 
20 cm). The column was eluted under a linear gradient plus an isocratic condition for 45 min. 
The gradient started with hexanes/2-propanol (94/6) and ended with hexanes/2-propanol (90/10) 
  
 
in 30 min followed by isocratic elution with hexanes/2-propanol for (90/10) for 15 min. The flow 
rates in both are 10 mL/min.  
The sixteen isomers purified by Chiralcel OD column were then analyzed on analytical 
Chiralcel OD (4.6 x 250 mm) column and symmetry C18 (3.9 x 160 mm) column. The purity of 
each isomer by this analysis and their retention times on analytical Chiralcel OD column were 
shown in Table 1.3.  
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Murisolin 
isomers F5 F9 F13 F17 
Compd. 
C18 
chiral 
OEG1 
RT 
10-O1-F5 
99% 
100% 
16.0min 
10-O1-F9 
 96% 
100% 
17.2min 
10-O1-F13 
100% 
100% 
22.0min 
10-O1-F17 
92% 
100% 
24.6min 
Compd. 
C18 
Chiral 
OEG2 
RT 
10-O2-F5 
99% 
100% 
17.5min 
10-O2-F9 
93% 
100% 
17.9min 
10-O2-F13 
67% 
100% 
23.8min 
10-O2-F17 
100% 
100% 
26.3min 
Compd. 
C18 
Chiral 
OEG3 
RT 
10-O3-F5 
100% 
100% 
15.8min 
10-O3-F9 
96% 
100% 
16.6min 
10-O3-F13 
74% 
95% 
22.1min 
10-O3-F17 
93% 
100% 
24.5min 
Compd. 
C18 
chiral 
OEG4 
RT 
10-O4-F5 
100% 
100% 
15.6min 
10-O4-F9 
95% 
100% 
16.3min 
10-O4-F13 
98% 
100% 
21.9min 
10-O4-F17 
83% 
100% 
25.1min 
  
 
Table 1.3 Purity of sixteen murisolin isomers synthesized by double tagging strategy.  C18 = Purity of compounds 
by symmetry C18 column; Chiral = Purity of compounds by Chiralcel OD analysis;  
 
  The isomers 10-2-F13, 10-3-F13 and 10-4-F17 were then purified over Symmetry C18 
column (19 x 300 mm). The column was eluted under a linear gradient plus an isocratic for 
45min. The gradient started with 80% CH3OH/20% H2O and ended with 100% CH3OH in 
30min. The isocratic was a 100% CH3OH 15 min elution. The flow rates in both are 12mL/min. 
Optical rotation data and the individual yields of murisolin isomers are given in table 1.4.  
 
 
 
53 
Murisolin 
isomers [α]D25  
(c, CHCl3 ) 
F5 F9 F13 F17 
OEG1 
Yield*
10-O1-F5 
+4.1 (0.05) 
 
37% 
10-O1-F9 
+9.8 (0.1) 
 
59% 
10-O1-F13 
+10.3 (0.2) 
 
50% 
10-O1-F17 
+6.6 (0.27) 
 
33% 
OEG2 
Yield*
10-O2-F5 
-5.0 (0.07) 
 
13% 
10-O2-F9 
+4.1 (0.1) 
 
18% 
10-O2-F13 
-1.4 (0.09) 
-2.5 (0.05) 
18% 
10-O2-F17 
+5.2 (0.18) 
 
16% 
OEG3 
Yield*
10-O3-F5 
-11.9 (0.1) 
 
57% 
10-O3-F9 
-1.4 (0.18) 
 
66% 
10-O3-F13 
+3.4 (0.14) 
+5.9 (0.09) 
46% 
10-O3-F17 
-1.9 (0.12) 
 
19% 
OEG4 10-O4-F5 +1.5 (0.05) 
10-O4-F9 
-0.3 (0.08) 
10-O4-F13 
+4.3 (0.05) 
10-O4-F17 
-1.2 (0.09) 
  
 
Yield*
 
30% 
 
31% 
 
24% 
-0.3 (0.05) 
 
21% 
 
* Combined yield for global deprotection and purifications by Chiralcel OD column and 
Symmetry C18 column 
Table 1.4 Optical rotation data and yields of individual murisolin isomers 
 
The stereoisomer library was designed with four control compounds (OEG1 series, 
4R,34S) which were present in previous synthesis of murisolin isomers by fluorous mixture 
synthesis.  The compounds 10-1-F5, 10-1-F9, 10-1-F13 and 10-1-F17 were shown to be 
identical with first library samples (FMS) by chiral HPLC analysis, and this proves that double 
demixing worked as anticipated. 
 
Combining this and the prior library synthesis7, the Curran group has achieved the 
synthesis of two 16-member stereoisomer libraries of murisolin isomers. Among the 32 
murisolins, 28 are unique and four compounds are same in the two libraries (4R,34S series). 
Among these 28, four of the compounds of 4S,34R series from the double mixture synthesis 
(OFMS) are enantiomers of four compounds in the first library (FMS). Therefore a total of 24 of 
the 32 possible diastereomers of murisolin are made. Configurations, optical rotations, and 
retention times for the 28 murisolin isomers are shown in table 1.5. Compound numbers parallel 
with the numbers in our published work for consistency.44 
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number 
abs configuration 
(C4,15,16,19,20,34)
αD 
(c = 0.05-0.27) TRf
1.1 RRSSRS 1.1 27.8 
1.2 RRSSSS 0.7 20.3 
1.3 RRSRSS 9.9 20.6 
1.4 RRSRRS 8.2 18 
  
 
1.5 RSSSRS 1.9 22.6 
1.6 RSSSSS 2.1 20.7 
1.7 RSSRSS 7.5 14 
1.8 RSSRRS 4.5 15.9 
1.9 RSRRSS 13.5 25.3 
1.1 RSRRRS 9.5 22.1 
1.11 RSRSRS 3.1 21.6 
1.12a RSRSSS 6.9 14.3 
1.13a RRRRSS 14.0 21.6 
1.14a RRRRRS 16.1 23.2 
1.15a RRRSRS 3.0 15.9 
1.16 RRRSSS 8.1 16.4 
1.17 RRRRSR −2.5 23.8 
1.18 RRRRRR 5.2 26.3 
1.19 RRRSRR −5.0 17.5 
1.20 RRRSSR 4.1 17.9 
1.21b SRRRSR 4.3 21.9 
1.22b SRRRRR −1.2 25.1 
1.23b SRRSRR 1.5 15.6 
1.24b SRRSSR −0.3 16.3 
1.25 SRRRSS 3.4 22.1 
1.26 SRRRRS −1.9 24.5 
1.27 SRRSRS −11.9 15.8 
1.28 SRRSSS −1.4 16.6 
a Made in both first library (FMS) and second library (OFMS); b 1.21-1.24 are enantiomers of 1.5-1.8 
Table 1.5 28 Member stereoisomer library of murisolin 
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  Remarkably, each of the 28 murisolins exhibit one of only six sets of substantially 
identical 1H NMR spectra under standard conditions (CDCl3, ambient temberature, 600 MHz). 
These spectra follow directly from a local symmetry analysis of the dihydroxy-THF fragment of 
the molecule and provide no information about the configuration of the hydroxybutenolide.44 
Starting with the relative configuration, the C15 and C20 hydroxy groups can be threo (th) or 
erythro (er) with respect to adjacent stereocenter on the THF ring, and the two substituents on 
the THF ring can be cis (c) or trans (t). Making the two side chains of dihydroxybutenolide same 
  
 
in murisolins will grouping them into six classes based on local symmetry as indicated in Table 
1.6. Molecules with relative configuration er-t-th, th-t-er, er-c-th and th-c-er (group 1 and 2) have 
no local symmetry. Compound with relative configuration er-t-er (group 3) and th-t-th (group 4) 
are C2-local-symmetric while the compounds with relative configuration er-c-er (group 5) and 
th-c-th (group 6) fall into meso category. Spectra of compounds in each group are substancially 
identical (no difference in chemical shift or peak shape). There are two groups of four 
compounds (group 1 and 2) that share identical spectra, and four groups of two compounds 
(group 3-6) that cannot be differentiated either. 
 
 
Group # 
Symmetry 
Relative 
configurationa
Murisolin group numbersb
 
er-t-th 
 
O
C12H25HBC10H20
OH OH
 
1.2 RSSS 
 
O
C12H25HBC10H20
OH OH  
1.10 SRRR 
 
1 
No symmetry 
th-t-er 
O
C10H20HBC12H25
OH OH
 
1.5 SSSR 
O
C10H20HBC12H25
OH OH  
1.13 RRRS 
2 
No Symmetry 
er-c-th 
O
C12H25HBC10H20
OH OH
 
1.4 RSRR 
O
C12H25HBC10H20
OH OH
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1.12 SRSS 
  
 
th-c-er 
O
C10H20HBC12H25
OH OH
 
1.15 RRSR 
O
C10H20HBC12H25
OH OH  
1.7 SSRS 
3 
C2 
er-t-er 
O
C12H25HBC10H20
OH OH
 
1.1 RSSR 
O
C H12 25HBC H10 20
OH OH  
1.9 SRRS 
4 
C2 
th-t-th 
O
C12H25HBC10H20
OH OH
 
1.14 RRRR 
O
C H12 25HBC H10 20
OH OH  
1.6 SSSS 
5 
meso 
er-c-er 
O
C12H25HBC10H20
OH OH
 
1.3 RSRS 
O
C10H20HBC12H25
OH OH  
1.11 SRSR 
6 
meso 
th-c-th 
O
C12H25HBC10H20
OH OH
 
1.16 RRSS 
O
C H HB10 20C H12 25
OH OH  
1.8 SSRR 
a er, erythro; th, threo; c, cis; t, trans 
b HB, the hydroxybutenolide fragment, 4R,34S 
Table 1.6 Group classification of murisolin isomers on the bases of local symmetry of dihydroxy-THF fragment  
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A complete set of 1H NMR (600 MHz) and 13C NMR (151 MHz) have been recorded for 
first library of compounds with 4R,34S configurations fixed with all possible configurations at 
the remaining stereocenters in the dihydroxy-THF fragment by Drs Qisheng Zhang and Hejun 
  
 
Lu. This allowed putting forth a set of guidelines to assign the relative configuration of the 
dihydroxy-THF fragment stereocenters as summarized in Table 1.7. The six carbons (C4, C15, 
C16, C19, C20, C34) bearing oxygen resonate in region δ 70-84. Peaks at 70.09 and 78.05 
(±0.02 ppm), which belong to C4 and C34 respectively, are ignored. If there are two resonances 
remaining in this region, then the compound belongs to one of the four groups with local 
symmetry (groups 3, 4, 5 or 6). A characteristic pattern has been observed for these two 
resonances, which allows classing an unknown murisolin isomer to a particular group as 
illustrated in Table 1.7. If there are four resonances, then it belongs to one of the two groups 
lacking local symmetry (group 1 or 2). In group 1, the most down field resonance was observed 
at 83.3 ppm and in group 2 at 82.8 ppm. However, since the spectra within the groups are 
substantially identical, no further guidelines could be elicited to identify a compound within a 
group based on the spectral data. 
O
C10H20HBC12H25
OH OH
15
16
19
20
58 
 
Group # 
Configuration 
δC15,C20 δC16,19  
1 
er-t-th or th-t-er 
 
 83.3  
2 
er-c-th or th-c-er 
 
 82.8  
3 
er-t-er 
 
72.0 83.0  
4 
eh-t-th 
 
74.1 82.7  
  
 
5 
er-c-er 
 
72.8 82.4  
6 
th-c-th 
 
74.1 82.7  
Table 1.7 Assignment of the relative configuration of the dihydroxy-THF fragment of murisolins by comparing 13C 
NMR resonances 
 
The syn/anti relative configuration of the hydroxybutenolide has been determined in the 
literature either by derivativatization or Mosher ester analysis45 and no direct method has been 
reported till date. The second 16 member murisolin library (from OFMS) contains 8 
diastereomers with syn relative configuration of C4 and C34 in the hydroxybutenolide. 1H NMR 
spectra of these compounds are substantially identical to the isomers with anti configuration. 
However, we were able to identify small yet reliable differences in 13C NMR of syn and anti 
isomers as illustrated with hydroxybutenolide fragment shown in figure 1.19. Compounds 
(4R,34S)-80 and (4S,34S)-80 were obtained from 69a, 69c respectively by removal of both TBS 
(AcCl, MeOH) and DMB (DDQ, CH2Cl2) protecting groups. Both compounds exhibited very 
similar 1H and 13C NMR spectra. However, upon mixing the samples in a 2/1 ratio, doubling of 
five resonances was observed in 13C NMR spectrum. The differences in chemical shifts ranged 
from 0.03 ppm to 0.1 ppm. Enhansed ∆δ were obtained by subtraction of chemical shift of a peak 
at around 70 ppm (C4) from a peak at about 152 ppm (C34). ∆δ for the syn isomer was 82.0 
while it was 81.8 for the anti isomer. This trend (∆δ = 81.8 for anti isomer) was observed in 13C 
NMR spectra of all compounds in the first library (FMS: 4R,34S) without exception. 
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HO ( )6
O
OH
O
80
4 1
4R,34S, anti 174.60  151.82  70.00
4S,34S, syn  174.57  151.89  69.90
anti, ∆δC2−C4 = 81.8
syn, ∆δC2−C4 = 82.0
C1           C2         C4
  
Figure 1.19 Assignment of the relative configuration of the hydroxybutenolide fragment by 13C NMR data 
 
The stereochemistry of secondary alcohol stereocenters in acetogenins is commonly 
pursued by using “advanced Mosher analysis”.46 During this exercise, a secondary alcohol of 
unknown stereochemistry is reacted with both (R)- and (S)- Moscher acid chlorides [α-methoxy-
α-(trifluoromethyl)phenylacetyl chloride] to generate the corresponding (S)- and (R)-Mosher 
esters. The signs of ∆δ, calculated by subtraction of the chemical shifts of the protons of the (R)-
Moscher ester from the (S)-Mosher ester, is to assign the configuration of the stereocenter. This 
method was validated for the first murisolin library as shown in figure 1.20. Two murisolin 
isomers 1.15 and 1.17 were converted to their tris-(S)- and tris-(R)-Mosher esters 3.15/4.15 and 
3.7/4.7. The signs of ∆δ are consistent with the known configuration of 1.15 (15R,20R) and 1.17 
(15S,20S).  
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O( R) (S)
C10H20HBC12H25
OMPTA OMPTA
20 15
+ − + −
MTPA = COC(OMe)(CF3)Ph
∆δ (S − R)
∆δ (S − R) is positive ( + ) or negative ( − )
conf igs 14H 16/17H 18/19H 21H
15R,20R + − − +
15S,20R − + − +
15S,20S − + + −
15R,20S + − + −
3.7, SSRS, t ris-(S)-ester
4.7, SSRS, t ris-(R)-ester
21H 19H 16H 14H
∆δ (S − R) −0.11 +0.02 +0.14 −0.01
All four values are consistent with Mosher guidelines
3.15, RRSR, tr is-(S)-ester
4.15, RRSR, tr is-(R)-ester
21H 19H 16H 14H
∆δ (S − R) +0.11 −0.03 −0.14 +0.01
All four values are consistent with Mosher guidelines  
Figure 1.20 Assignment of absolute configurations by “advanced Mosher method”  
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A “shortcut” Mosher method is derived wherein a single Mosher ester [tris-(S) or tris-(R)] 
for each of the 16 murisolin isomers is made and resonances of that are subtracted from its 
appropriate diastereomer with the locally enantiomeric configuration in the dihydroxy-THF 
fragment (quasienantiomeric relationship in the dihydroxy-THF fragment). To test the “shortcut” 
method, resonances of 3.15 (15R,20R) are subtracted from 3.7 (15S,20S). This resulted in 
identical signs and magnitudes of the differences in chemical shifts (figure 1.21) to the 
subtraction the appropriate tris-(R)- and tris-(S)-Mosher esters. This demonstrates that making a 
pair of tris-(R)/(S)-Mosher esters for each murisolin isomer provides redundant information. (S)-
  
 
Mosher ester derivatives were prepared for the other 14 murisolin isomers and then chemical 
shifts of the relevant resonances are subtracted to provide signs and magnitude for each ∆δ.4 4 
However, the two pairs of spectra corresponding to groups 5 and 6 (3.8 and 3.16; 3.3 and 3.11) 
were substantially identical and hence it is pointless to subtract resonances of these pairs of 
spectra. Four additional pairs of spectra (3.2 and 3.5; 3.10 and 3.13; 3.4 and 3.15; 3.7 and 3.12) 
were also identical to each other. These compounds share a common feature that one can be 
converted to the other by interchanging the two side chains on C15 and C20. As a result, each of 
the 16 tris-(S)-Mosher esters of murisolin isomers exhibit only 10 sets of 1H NMR. There are 
four compounds with unique spectra; whereas six pairs of compounds have identical spectra. 
 
3.7, SSRS, t ris-(S)-ester
3.15, RRSR, t ris-(S)-ester
21H 19H 16H 14H
∆δ (3.7 − 3.15) +0.11 −0.03 −0.14 +0.01
All four values are consistent with Mosher guidelines
All four values have equal signs as ∆δ (3.7 − 4.7)  
Figure 0.21 “Short-cut” Mosher assignment 
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With well characterized 28-murisolin isomers in hand, structural assignment of three 
murisolin natural products (murisolin, 16,19-cis-murisolin and murisolin A) were assessed. 
Unambiguous structure assignment requires disproving all possible candidates but one.  
Comparison of 1H NMR data of natural product murisolin with each of the six groups of 
compounds from the current work places it in group 4 and confirms the threo-trans-threo relative 
stereochemistry originally assigned by cave and co-workers.47 Hoye’s application of the Mosher 
method conforms the relative and absolute stereochemistry (4R,34S) of the hydroxybutenolide 
  
 
fragment. This reduces the number of possible murisolin candidates from eight to two, 1.6 and 
1.14. Application of Mosher method eliminates 1.6 and puts 1.14 as the sole possible structure 
for murisolin. To further confirm the structure, a sample of natural murisolin (provided by Dr. 
Bruno Figadere) was compared with two key candidate isomers 1.6 and 1.14 as well as three 
other isomers in group 4 with differing configuration at C4 and C34 (1.18, 1.22 and 1.26). In this 
experiment, only 1.14 co-eluted with natural murisolin. 
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Comparison of the published NMR spectra of 16,19-cis-murisolin48 with  spectra of each 
of the six groups of compounds from the current work places it in group 6 and confirms relative 
stereochemistry (th-c-th) in dihydroxy-THF fragment. The relative stereochemistry of 
hydroxybutenolide fragment is conformed as C4,C34-anti, since ∆δ C2-C4 is 81.8. McLaughlin 
and co-workers made tris-(R)- and tris-(S)-Mosher esters and showed that the absolute 
configuration is C4R,C34S. This narrowed that candidate structures to 1.8 and 1.16.  McLaughlin 
proposed the structure of 16,19-cis-murisolin as 1.16 based on subtraction of resonances in pairs 
of Mosher esters. However, as described earlier, the spectra of 3.8 and 3.16 are identical and 
hence it is meaningless to perform advanced Mosher ester analysis on these molecules. Since the 
available spectral data is not useful in determining the correct structure, we resorted to compare 
available physical data. A comparison of the optical rotation and melting points of natural 16,19-
cis-murisolin, candidate structures (1.8 and 1.16) from our work (Curran and co-workers) and 
Tanaka’s work is shown in figure 1.22. Although the optical rotation data provides no clue in 
determining the structure, we can tentatively assign structure 1.8 to 16,19-cis-murisolin based on 
melting points. 
  
 
[α]D mp
natural 16,19-cis-murisolin +11.0 (c 0.1 CH2Cl2)a 67-68 oCa
OH
C12H25
OH
O
OOH
O
1.16
C12H25
OH
O
O
OH
OH
O
1.8
+4.5 (c 0.1 CH3OH)b 63-64 oCb
+9.1 (c 0.5 CH2Cl2)c 65-66 oCb
+8.1 (c 0.1 CH3OH)b 72-73 oC
+9.8 (c 0.11 CH3OH)c
+11.3 (c 0.62 CH2Cl2)d 76.5-77.5 oC
 
a) From McLaughlin; b) Curran group first library sample; c) Curran group second library sample; d) from 
Tanaka 
 
Figure 1.22: Comparison of optical rotation and melting point data for natural 16,19-cis-murisolin and synthetic 1.8 
and 1.16. 
 
McLaughlin proposed structures 1.10 and 1.13 as probable candidates for murisolin A. 
These two compounds are end-switched isomers and hence chiral derivative method is not 
suitable for structure assignment. A comparison of melting points and optical rotation data for 
synthetic and natural samples is shown in figure 1.23. Again, optical rotation data is not 
conclusive and structure 1.10 was tentatively assigned to murisolin A based on the melting 
points. 
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[α]D mp
natural murisolin A +17.0 (c 0.1 CHCl3)a 83-84 oCa
C12H25 O
OH
O
OH OOH
1.10
C12H25
OH
O
O
OH
OH
O
1.13
+14.0 (c 0.1 CH2Cl2)b 74-75 oCb
+10.3 (c 0.2 CH2Cl2)c
+9.5 (c 0.1 CH2Cl2)b 83-84 oC
 
a) From McLaughlin; b) Curran group first library sample; c) Curran group second library sample 
 
Figure 1.23 Comparison of optical rotation and melting point data for natural murisolin A and synthetic 1.10 and 
1.13. 
 
1.3. CONCLUSIONS 
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Two new solution phase mixture synthetic methods (OEG mixture synthesis, OEG-Fluorous 
mixture synthesis) have been explored. Three powerful synthetic tools in solution phase mixture 
synthesis (fluorous mixture synthesis, OEG-mixture synthesis and OEG-fluorous mixture 
synthesis) have been evaluated and applied for the synthesis of sixteen stereoisomer library of 
murisolin. The principles of the oligoethylene glycol (OEG) mixture synthesis are illustrated 
with the synthesis of all four possible stereoisomers of a hydroxyl butenolide fragment common 
to murisolin and many other acetogenins. Modified dimethoxybenzyl groups with varying 
number of OEG units (-CH2CH2O-) are used to protect alcohols and serve as code of 
configuration at two stereocenters. The encoded isomers are carried through several steps in a 
sequence of mixing prior to the reaction and then demixing during the separation to give 
  
 
individual pure products. A new tagging scheme is introduced in which a stereocenter bearing a 
hydroxyl group is given two different tags. These initially redundant tags subsequentsly serve to 
encode the configuration of another untagged stereocenter. Double mixture synthesis (OEG-
fluorous mixture synthesis) was pursued by the Kocienski-Julia olefination of sulfone mixture 
M13 (fluorous tagged) with the aldehyde mixture M62 (OEG-tagged). Double demixing, and 
detagging of the final sixteen compound mixture provided the 16 individual murisolins. Twelve 
of these isomers are new, while four match samples from the first library.7 The structure of 
murisolin was proved to be the 4R,15R,16R,19R,20R,34S isomer, where as the assignment of the 
16,19-cis-murisolin was corrected to the RSSRRS diastereomer and murisolin A is suggested to 
be RSRRRS.4 4 
 
 
 
 
 
 
 
 
 
 
 
66 
 
  
 
1.4. EXPERIMENTAL SECTION 
Proton nuclear magnetic resonance (1H NMR) spectra, carbon nuclear magnetic resonance (13C 
NMR) spectra and fluorine magnetic resonance spectra (19F) were recorded on a Bruker WH-300 
MHz, an IBM AF-300, an AM-500 or a Bruker AvanceTM 600 NMR spectrometer using 
deuteriated chloroform as the solvent.  Signal positions are given in parts per million (δ) and 
were determined relative to the residual proton signal for CHCl3 (7.27) and the carbon signal for 
CDCl3 (77.09).  The 1H NMR coupling constants (J-values) are given in Hz.  Spectral content is 
listed in the following order: chemical shift (δ), multiplicity, coupling constants (Hz), number of 
protons. Spectra were recorded at room temperature unless otherwise indicated.  
  Infrared (IR) spectra were recorded on an IBM IR/32 spectrometer and run as neat films 
or chloroform solutions on sodium chloride plates.  Low-resolution mass spectra were obtained 
on a Hewlett Packard-9000 GC-MS, and high-resolution spectra were recorded on a Varian 
MATCH-5DF instrument. HPLC analysis was performed on a Waters 600E system with UV 
detector using a Fluoflash column. LC-MS spectra were obtained on a Hewlett Packard-1100 
LC-MS using APCI mode. 
67 
Preparative silica gel thin layer chromatography was performed on commercially 
available (PF-254), glass backed plates (25 x 25 cm), precoated with silica gel 60 to a thickness 
of 0.5 mm.  Visualization of the chromatograms was accomplished with an ultraviolet light (254 
nm), heating the chromatogram after staining with commercially available (Aldrich Chemical 
Co., Inc.) phosphomolybdic acid in ethanol (1:4 ratio), a 5% aqueous solution of ammonium 
molybdate in 10% aqueous sulfuric acid (w/v), or with an aqueous 5% potassium permanganate 
solution.  Conventional flash chromatography was performed with 230-400 mesh silica gel (E. 
Merck, Silica gel 60).  
  
 
 All dry solvents were obtained by refluxing over an appropriate drying agent.  Distilled 
solvents were used immediately or stored over molecular sieves where appropriate.  Diethyl 
ether and tetrahydrofuran were dried over sodium benzophenone ketyl.  Unless stated otherwise, 
all reactions were carried out under an atmosphere of dry argon using glassware that had been 
thoroughly dried under vacuum.  
 
Cl
O( )n= 2, 3, 4  
General procedure 1:  synthesis of alkyl chlorides (18): A solution of thionyl chloride (92 
mmol) in CHCl3 (15 mL) was added slowly over 15 min to a stirred solution of 
oligoethyleneglycol monomethyl ether (72 mmol) and pyridine (72 mmol) in CHCl3 (60 mL) 
under argon followed by refluxing the above reaction mixture for 3 h. The above reaction 
mixture was washed with 300 mL of water, dried with MgSO4 and concentrated under reduced 
pressure. The crude product (yellow to brown colored) was spectroscopically pure and can be 
used in next step without further purification. However, bulb-to-bulb (Kugelrohr distillation) 
distillation into a cold receiving flask (−78 oC) under reduced pressure gave the desired alkyl 
chloride as colorless to pale yellow oils. 
Cl
O
O  
1-Chloro-2-(2-methoxyethoxy)ethane (18b):1  Performing the general procedure 1 with 2-(2-
methoxyethoxy)ethanol 17b (8.7 g, 72 mmol) gave 1-chloro-2-(2-methoxyethoxy)ethane (18b) 
(9.2 g, 92 %) as colorless oil. 
 
Cl
O
O
O
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1 CAS Reg # 52808-36-3 
  
 
1-Chloro-2-[2-(2-methoxyethoxy)ethoxy]ethane (18c):2 Performing the general procedure 1 
with 2-[2-(2-methoxyethoxy)ethoxy]ethanol 17c (12 g, 72 mmol) gave 1-chloro-2-[2-(2-
methoxyethoxy)ethoxy]ethane 18c (12 g, 94%)  as pale yellow oil. 
 
Cl O
O
O
O
 
1-Chloro-2-{2-[2-(2-methoxy ethoxy)ethoxy]ethoxy}ethane (18d):3 Performing the general 
procedure 1 with 2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}ethanol 17d (15 g, 72 mmol) gave 
1-chloro-2-{2-[2-(2-methoxy ethoxy)ethoxy]ethoxy}ethane 18d (15 g, 93%) as pale yellow oil. 
 
O
O
O O
O
 
3-Methoxy-4-(2-methoxyethoxy)benzoic acid methyl ester (21a): Potassium carbonate (10 g, 
72 mmol) and potassium iodide (1.5 g, 9.0 mmol) were added to a solution of methyl vanillate 20 
(5.0 g, 27 mmol) and 1-chloro-2-methoxyethane 18a (3.4 g, 36 mmol) in dry DMF and the 
reaction mixture was stirred for 24 h under argon. The DMF was removed by concentrating the 
reaction mixture with a rotovap equipped with dry-ice/acetone bath (−78 oC condenser). 
Dichloromethane (15 mL) was added to the above crude product and the resulting solution was 
filtered to remove the potassium salts. The filtrate was concentrated and the traces of solvents 
(CH2Cl2 and DMF) present in it were removed in vacuo (0.08 mm Hg, 45 oC) into a cold 
receiving flask (−78 oC) by bulb-to-bulb (Kugelrohr) distillation. The resulting residue was 
                                                 
2 CAS Reg # 52996-76-3 
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3 CAS Reg # 57722-04-0 
  
 
distilled bulb-to-bulb (0.08 mm Hg, 55-60 oC) into a cold receiving flask (−78 oC) to yield 3-
methoxy-4-(2-methoxyethoxy)benzoic acid methyl ester 21a (6.1 g, 93%) as pale yellow oil: 1H 
NMR (300 MHz, CDCl3) δ 3.43 (s, 3H), 3.77-3.80 (m, 2H), 3.87 (s, 3H), 3.89 (s, 3H), 4.19-4.22 
(m, 2H), 6.89 (d, J = 8.2 Hz, 1H), 7.52 (d, J = 1.6Hz, 1H), 7.63 (dd J = 8.5 Hz, 1.9Hz, 1H); 13C 
NMR (75 MHz, CDCl3) δ 51.7, 55.7, 58.9, 67.9, 70.5, 111.6, 112.0, 122.6, 123.1, 148.7, 152.0, 
166.5; IR (neat) 1720, 1600, 1513; EIMS m/z 240 (M+); HRMS for C12H16O5: calcd 240.0998; 
found 240.0985. 
O
O O
O
O
O
 
70 
3-Methoxy-4-[2-(2-methoxyethoxy)ethoxy]benzoic acid methyl ester (21b): Potassium 
carbonate (10 g, 72 mmol) and potassium iodide (1.5 g, 9.0 mmol) were added to a solution of 
methyl vanillate 20 (5.0 g, 27 mmol) and 1-(2-chloroethoxy)-2-methoxyethane 18b (4.9 g, 36 
mmol) in dry DMF (125 mL) and the reaction mixture was stirred at 60 oC for 24 h under argon. 
The DMF was removed from the reaction mixture by concentrating it with a rotovap equipped 
with a dry-ice/acetone bath (−78 oC condenser). Dichloromethane (15 mL) was added to the 
above crude product and the resulting solution was filtered to remove the potassium salts. The 
filtrate was concentrated and the traces of solvents (CH2Cl2, DMF) and excess of alkyl halide 
present in it were removed in vacuo (0.08 mm Hg, 50-55 oC) into a cold receiving flask (−78 oC) 
by bulb-to bulb distillation. The resulting residue was distilled bulb-to-bulb (0.08 mm Hg, 68-72 
oC) into a cold (−78 oC) receiving flask to yield 3-methoxy-4-[2-(2-methoxyethoxy)ethoxy] 
benzoic acid methyl ester 21b (7.5 g, 96%) as yellow oil: 1H NMR (300 MHz, CDCl3) δ 3.39 (s, 
  
 
3H), 3.56-3.59 (m, 2H), 3.72-3.75 (m, 2H), 3.90-3.94 (m, 8H), 4.94 (t, J = 5.0Hz, 2H), 6.93 (d, J 
= 8.5 Hz, 1H), 7.55 (d, J = 1.9 Hz, 1H), 7.65 (dd, J = 8.5, 1.9 Hz, 1H); 13C NMR (75 MHz, 
CDCl3) δ 51.8, 55.8, 58.9, 68.2, 69.3, 70.7, 71.8, 111.8, 112.2, 122.7, 123.3, 148.8, 152.1, 166.7; 
IR (neat) 2928, 2888, 1714, 1599; EIMS m/z 284 (M+); HRMS for C14H20O6: calcd 284.1260; 
found 284.1265. 
 
O
O O
O
O
O
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3-Methoxy-4-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}benzoic acid methyl ester (21c):  
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Potassium carbonate (10 g, 72 mmol) and potassium iodide (1.5 g, 9.0 mmol) were added to a 
solution of methyl vanillate 20 (5.0 g, 27 mmol) and 1-[2-(2-chloroethoxy)ethoxy]-2-
methoxyethane 18c (6.6 g, 36 mmol) in dry DMF (125 mL) and the reaction mixture was stirred 
at 60 oC for 24 h under argon. The DMF was removed from the reaction mixture by 
concentrating it with a rotovap equipped with a dry-ice/acetone bath (−78 oC condenser). 
Dichloromethane (15 mL) was added to the above crude product and the resulting solution was 
filtered to remove the potassium salts. The filtrate was concentrated and the traces of solvents 
(CH2Cl2, DMF) and excess of alkyl halide present in it were removed in vacuo (0.08 mm Hg, 65 
oC) into a cold receiving flask (−78 oC) by bulb-to-bulb distillation. The resulting residue was 
distilled bulb-to-bulb (0.08 mm Hg, 85-90 oC) to yield 3-methoxy-4-{2-[2-(2-methoxyethoxy) 
ethoxy]ethoxy}benzoic acid methyl ester (8.5 g, 95%) 21c as yellow oil: 1H NMR (300 MHz, 
CDCl3) δ 3.24 (s, 3H), 3.39-3.42 (m, 2H), 3.48-3.56 (m, 4H), 3.60-3.63 (m, 2H), 3.76-3.80 (m, 
8H), 4.11 (t, J = 5.0 Hz, 2H), 6.80 (d, J = 8.4 Hz, 1H), 7.41 (d, J = 1.8 Hz, 1H), 7.51 (dd, J = 8.4, 
  
 
2.0 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 51.5, 55.5, 58.6, 68.0, 69.0, 70.1, 70.2, 70.5, 71.5, 
111.6, 111.9, 122.4, 123.0, 148.6, 152.0, 166.4; IR (neat) 3085, 2870, 1716, 1508; EIMS m/z 328 
(M+); HRMS for C16H24O7: calcd 328.1522; found 328.1523. 
 
O
O O
O
O
O
O
O
 
72 
3-Methoxy-4-(2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}ethoxy)benzoic acid methyl ester 
(21d): Potassium carbonate (10 g, 72 mmol) and potassium iodide (1.5 g, 9.0 mmol) were added 
to a solution of methyl vanillate 20 (5.0 g, 27 mmol) and 1-[2-(2-chloroethoxy) ethoxy]-2-(2-
methoxyethoxy)ethane 18d (8.1 g, 36 mmol) in dry DMF (125 mL) and the reaction mixture was 
stirred at 60 oC for 24 h under argon. The DMF was removed from the reaction mixture by 
concentrating it with a rotovap equipped with a dry-ice/acetone bath. Dichloromethane (15 mL) 
was added to the above crude product and the resulting solution was filtered to remove the 
potassium salts. The filtrate was concentrated and the traces of solvents (CH2Cl2, DMF) and 
excess alkyl halide present in it were removed in vacuo (0.08 mm Hg, 65 oC) into a cold 
receiving flask (−78 oC) by bulb-to-bulb distillation. The resulting residue was distilled bulb-to-
bulb (0.08 mm Hg, 85-90 oC) into a cold receiving flask (−78 oC) to yield 3-methoxy-4-(2-{2-[2-
(2-methoxyethoxy)ethoxy]ethoxy}ethoxy) benzoic acid methyl ester 21d (9.3 g, 91%) as yellow 
oil: 1H NMR (500 MHz, CDCl3)  δ 3.19 (s, 3H), 3.35-3.38 (m, 2H), 3.46-3.51 (m, 8H), 3.55-3.59 
(m, 2H), 3.71-3.75 (m, 8H), 4.06 (t, J = 5 Hz, 2H), 6.75 (d, J = 8.5 Hz, 1H), 7.36 (d, J = 1.5Hz, 
1H), 7.46 (dd, J = 8.5, 1.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 51.4, 55.5, 58.5, 67.9, 69.0, 
  
 
70.0, 70.1, 70.4, 71.4, 111.6, 111.9, 122.4, 122.9, 148.5, 151.9, 166.24; IR (neat) 2941, 2873, 
1716, 1598, 1509; EIMS m/z 372 (M+); HRMS for C18H28O8: calcd 372.1784; found 372.1796. 
 
O
O
HO
O)n=1,2,3,4(
 
General procedure 2: Reduction of esters 21 to alcohols 44 with LiAlH4: A solution of ester 
21 (1.0 equiv) in THF was added slowly to a suspension of LiAlH4 (0.55 equiv) in THF at 0 oC 
and the resulting reaction mixture was stirred at 0 oC for 15 min followed by 30 min at room 
temperature. The reaction mixture was quenched with methanol and diluted with ethyl acetate 
and saturated sodium potassium tartarate (1:1) followed by vigorous stirring for 3.5 h. Organic 
layer was separated and the aqueous layer was extracted twice with ethyl acetate. The combined 
organic extracts were dried over MgSO4, concentrated under reduced pressure to yield the 
alcohol 44 as an oil. 
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[3-Methoxy-4-(2-methoxyethoxy)phenyl]methanol 44a:  Performing the general procedure 2  
with 3-methoxy-4-(2-methoxyethoxy)benzoic acid methyl ester (5.9 g, 24 mmol) gave [3-
methoxy-4-(2-methoxyethoxy)phenyl]methanol (4.7 g, 91%) as an oil.  1H NMR (300 MHz, 
CDCl3)  3.50 (s, 3H), 3.78 (t, J = 5.1 Hz, 2H), 3.87 (s, 3H), 4.15 (t, J = 3.1 Hz, 2H), 4.62 (s, 
  
 
2H), 6.87-6.93 (m, 3H); 13C NMR (75 MHz, CDCl3) 55.9, 59.2, 65.1, 68.5, 71.1, 110.8, 113.6, 
119.2, 134.3, 147.7; IR (neat) 3400, 2940, 2868, 1588, 1516. 
 
O
O
HO
O
O
 
{3-Methoxy-4-[2-(2-methoxyethoxy)ethoxy]phenyl}methanol 44b: Following the general 
procedure 2  with 3-methoxy-4-[2-(2-methoxyethoxy)ethoxy]benzoic acid methyl ester (7.1 g, 25 
mmol) gave  {3-methoxy-4-[2-(2-methoxyethoxy)ethoxy]phenyl}methanol (6.0 g, 93%) as an 
oil: 1H NMR (300 MHz, CDCl3) δ 3.40 (s, 3H), 3.57-3.60 (m, 2H), 3.72-3.75 (m, 2H), 3.88 (s, 
3H), 3.90 (t, J = 5.5 Hz, 2H), 4.20 (t, J = 5.0 Hz, 2H), 4.63 (s, 2H), 6.87-6.93 (m, 3H); 13C NMR 
(75 MHz, CDCl3) δ 56.0, 59.2, 65.4, 68.7, 69.8, 70.9, 72.0, 110.0, 113.7, 119.5, 134.3, 147.9, 
149.8; IR (neat) 3390, 2930, 2878, 1588, 1511; EIMS m/z 256 (M+); HRMS for C13H20O5: calcd 
256.1311; found 256.1308. 
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(3-Methoxy-4-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}phenyl)methanol 44c: Following the 
general procedure 2 with 3-methoxy-4-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}benzoic acid 
methyl ester (8.4 g, 26 mmol) gave (3-methoxy-4-{2-[2-(2-methoxyethoxy)ethoxy] 
ethoxy}phenyl)methanol (7.5 g, 98%): 1H NMR (300 MHz, CDCl3) δ 3.38 (s, 3H), 3.53-3.56 (m, 
  
 
2H), 3.64-3.70 (m, 4H), 3.72-3.79 (m, 2H), 3.87 (s, 3H), 3.88-3.90 (m, 2H), 4.17-4.21 (m, 2H), 
4.62 (s, 2H), 6.85-6.93 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 56.0, 59.1, 65.2, 68.6, 69.7, 70.6, 
70.7, 70.9, 72.0, 111.0, 113.7, 119.4, 134.4, 147.8, 149.7; IR (neat) 3426, 2929, 3868, 1593, 
1516, 1455; EIMS m/z 300 (M+); HRMS for C15H24O6: calcd 300.1573; found 300.1564. 
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[3-Methoxy-4-(2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}ethoxy)phenyl]methanol 44d:  
Following the general procedure 2 with 3-methoxy-4-(2-{2-[2-(2-methoxyethoxy)ethoxy] 
ethoxy}ethoxy) benzoic acid methyl ester (8.6 g, 23 mmol) gave [3-methoxy-4-(2-{2-[2-(2-
methoxyethoxy)ethoxy]ethoxy}ethoxy)phenyl]methanol (7.6 g, 95%): 1H NMR (300 MHz, 
CDCl3) δ 3.38 (s, 3H), 3.53-3.57 (m, 2H), 3.62-3.74 (m, 10H), 3.87 (s, 3H), 3.88-3.93 (m, 2H), 
4.18 (t, J = 5.3 Hz, 2H), 4.63 (s, 2H), 6.87-6.93 (m, 3H); 13C NMR (75 MHz, CDCl3) δ 55.9, 
59.1, 65.2, 68.7, 69.8, 70.6, 70.9, 71.0, 72.0, 111.0, 113.7, 119.4, 134.4, 147.8, 149.7; IR (neat) 
3462, 2935, 2873, 1588, 1516. 
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General procedure 3: 2,2,2-Trichloroacetimidic acid 3-methoxy-4-(2-methoxyethoxy)benzyl 
ester 5a: [3-Methoxy-4-(2-methoxyethoxy)phenyl]methanol (4.5 g, 21 mmol) was added slowly 
to a suspension of sodium hydride (51 mg, 2.1 mmol) in THF (25 mL) under argon. The reaction 
mixture was stirred at room temperature for 20 min and then cooled to 0 oC followed by slow 
addition of trichloroacetonitrile (2.1 mL, 21 mmol) over 15 min. The reaction mixture was 
allowed to warm to room temperature over 1 h followed by concentration under reduced 
pressure. To the concentrate was added a mixture of pentane/methanol (49:1, 50 mL) followed 
by vigorous shaking, filtration, and concentration of filtrate and pentane washings4 (3 x 30 mL) 
resulting 2,2,2-trichloroacetimidic acid 3-methoxy-4-(2-methoxyethoxy)benzyl ester (6.8 g, 
90%) as colorless oil: 1H NMR (300 MHz, CDCl3) δ 3.45 (s, 3H), 3.79 (t, J = 4.9 Hz, 2H), 3.87 
(s, 3H), 4.18 (t, J = 4.9 Hz, 2H), 5.29 (s, 2H), 6.90-6.98 (m, 3H), 8.38 (br s, 1H); 13C NMR (75 
MHz, CDCl3) δ 55.7, 59.0, 68.3, 70.6, 70.8, 91.3, 111.5, 113.3, 120.4, 128.4, 148.2, 149.4, 
162.3; IR (neat) 3320, 2939, 1665, 1594, 1513; EIMS m/z 355 (M+); HRMS for C13H16NO4Cl3: 
calcd 355.0145; found 355.0127. 
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2,2,2-Trichloroacetimidic acid 3-methoxy-4-[2-(2-methoxyethoxy)ethoxy]benzyl ester 5b: 
Following the general procedure 3 with {3-methoxy-4-[2-(2-methoxyethoxy) ethoxy]phenyl} 
methanol (4.2 g, 16 mmol) gave 2,2,2-trichloroacetimidic acid 3-methoxy-4-[2-(2-
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4 Wessel, H-P; Iversen, T.; Bundle, D. R. J. Chem. Soc. Perkin. Trans. I, 1985, 2247. 
  
 
methoxyethoxy)ethoxy]benzyl ester (5.2 g, 80%) as colorless oil: 1H NMR (300 MHz, CDCl3) δ 
3.35 (s, 3H), 3.53 (m, 2H), 3.68 (m, 2H), 3.82 (s, 3H), 3.85 (t, J = 5.0 Hz, 2H), 4.16 (t, J = 5.0 
Hz, 2H), 5.24 (s, 2H), 6.86 (m, 3H), 8.36 (br s, 1H); 13C NMR (75 MHz, CDCl3) δ 55.8, 58.9, 
68.4, 69.5, 70.6, 71.8, 91.4, 111.7, 113.4, 120.5, 128.4, 148.3, 149.5, 162.3; IR (neat) 3333, 
2931, 2881, 1665, 1593, 1517; HRMS for (M + Na)+ C15H20O5NCl3Na: calcd 422.0305; found 
422.0309. 
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2,2,2-Trichloroacetimidic acid 3-methoxy-4-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}benzyl 
ester 5c: Following the general procedure 3 with (3-methoxy-4-{2-[2-(2-methoxyethoxy) 
ethoxy]ethoxy}phenyl)methanol (6.5 g, 22 mmol) gave 2,2,2-trichloroacetimidic acid 3-
methoxy-4-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}benzyl ester  (8.2 g, 85%) as an oil: 1H 
NMR (500 MHz, CDCl3) δ 3.35 (s, 3H), 3.50-3.54 (m, 2H), 3.62-3.66 (m, 4H), 3.70-3.73 (m, 
2H), 3.83 (s, 3H), 3.86 (t, J = 5.0 Hz, 2H), 4.17 (t, J = 5.3 Hz, 2H), 5.25 (s, 2H), 6.87-6.96 (m, 
3H), 8.36 (br s, 1H); ); 13C NMR (125 MHz, CDCl3) δ 55.8, 59.0, 68.5, 69.5, 70.5, 70.6, 70.7, 
70.8, 71.9, 91.4, 111.7, 113.4, 120.6, 128.4, 148.3, 149.5, 162.4; IR (neat) 3332, 2931, 1665, 
1593, 1517; EIMS m/z 445 (M+). 
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2,2,2-Trichloroacetimidic acid 3-methoxy-4-(2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}etho 
xy)benzyl ester 5d: Following the general procedure 3 with [3-methoxy-4-(2-{2-[2-(2-
methoxyethoxy)ethoxy]ethoxy}ethoxy)phenyl]methanol (7.5 g, 22 mmol) gave 2,2,2-
trichloroacetimidic acid 3-methoxy-4-(2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}ethoxy)benzyl 
ester (8.8 g, 83%) as an oil: 1H NMR (500 MHz, CDCl3) δ 3.32 (s, 3H), 3.48-3.51 (m, 2H), 3.58-
3.64 (m, 8H), 3.66-3.70 (m, 2H), 3.81 (s, 3H), 3.83 (t, J = 5.3 Hz, 2H), 4.14 (t, J = 5.0 Hz, 2H), 
5.23 (s, 2H), 6.85-6.94 (m, 3H), 8.35 (br s, 1H); 13C NMR (125 MHz, CDCl3) δ 55.8, 58.9, 68.4, 
69.4, 70.4, 70.5, 70.6, 70.7, 71.8, 91.3, 111.6, 113.3, 120.5, 128.3, 148.3, 149.4, 162.3; IR (neat) 
3332, 2937, 2872, 1663, 1518; EIMS m/z 487 (M+). 
 
O  
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2-(Hept-6-enyl)oxirane 41: m-Chloroperbenzoic acid (36 g, 0.21 mol, 75% w/w in H2O) was 
added to a solution of nona-1,8-diene (44 g, 0.32 mol) in dichloromethane (325 mL) at 0 oC. The 
reaction mixture was stirred at 0 oC for 20 min, room temperature for 20 min and treated with 
saturated NaHCO3. The layers were separated and the aqueous layer was further extracted with 
dichloromethane. The combined organic layers were dried over MgSO4, concentrated under 
reduced pressure. The crude product was purified by flash column chromatography (SiO2, 15% 
ethyl acetate/hexanes) to give 2-(hept-6-enyl)oxirane (22 g, 76%) as colorless oil: 1NMR (300 
  
 
MHz, CDCl3) δ 1.38-1.56 (m, 10H), 2.02-2.06 (m, 2H), 2.46 (dd, J = 5.0, 3.0 Hz, 1H), 2.73-2.76 
(m, 1H), 2.87-2.91 (m, 1H), 4.91-5.03 (m, 2H), 5.80 (ddt, J = 16.9, 10.0, 6.0 Hz, 1H); 13C NMR 
(75 MHz, CDCl3) δ 25.8, 28.7, 28.8, 32.4, 33.6, 47.0, 57.3, 114.3, 138.9. 
 
OH
OH  
Non-8-ene-1,2-diol 29: The (R,R)-Jacobson catalyst5 (R,R)-39 (0.43g, 0.70 mmol) was dissolved 
in 2-(hept-6-enyl)oxirane (20 g, 0.14 mol), AcOH (172 µL, 2.9 mmol) and 1.4 mL THF. The 
solution was cooled to 0 oC, treated with H2O (1.16 mL, 64.5 mmol) and stirred for 12 h at room 
temperature. The reaction mixture was distilled bulb-to-bulb (Kugelrohr) under reduced pressure 
(0.08 mm Hg, 40 oC) to remove residual epoxide (11 g, 80 mmol) followed by second distillation 
(0.08 mm Hg, 125 oC) to yield (S)-non-8-ene-1,2-diol nonane-1,2-diol (9.7 g, 43%, > 99% 
enantiomeric excess based on Mosher ester analysis) as colorless oil; Similar procedure with the 
above recovered epoxide (11 g, 79 mmol) and (S,S)-Jacobson catalyst (S,S)-39 (0.43 g, 0.70 
mmol) resulted in (R)- non-8-ene-1,2-diol (10 g, 44%, > 99% ee by Mosher ester analysis6) as 
colorless oil: [α]D25 for (R)-29:  0.63 (c 4.30, CHCl3); for (S)-29 −2.1 (c1.42, CHCl3); 1H NMR 
(300 MHz, CDCl3) δ1.29-1.54 (m, 6H), 2.01-2.14 (m, 3H), 2.20-2.22 (m, 1H), 3.44 (ddd, J = 
10.9, 7.5, 4.9 Hz, 1H), 3.62-3.76 (m, 2H), 4.91-5.05 (m, 2 H), 5.81 (ddt, J = 17.1, 10.3, 6.6 Hz, 
1H); 13C NMR (300 MHz, CDCl3) 25.8, 29.2, 29.5, 33.4, 34.1, 67.2, 72.7, 114.7, 139.3; IR 
(neat): 3370, 2928, 2853, 1463; EIMS m/z 158 (M+); HRMS for C9H18O2: calcd 158.1307; found 
158.1306. 
                                                 
5 Schaus, S. E.; Brandes, B. D.; Larrow, J. F.; Tokunaga, M.; Hansen, K. B.; Gould, A. E.; Furrow, M. E.; Jacobson, 
E. N. J. Am. Chem. Soc. 2002, 124, 1307. 
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6 Dale, J. A.; Mosher, H. S. J. Am. Chem. Soc. 1973, 24, 512. 
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General procedure 4: (S)-2-Hydroxynon-8-enyl 4-methylbenzenesulfonate (S)-30: To a 
solution of (S)-non-8-ene-1,2-diol (3.3 g, 21 mmol) in CH2Cl2 (80 mL) were added Bu2SnO (1.0 
g, 4.1 mmol), p-toluenesulfonyl chloride (3.9 g, 21 mmol), and triethyl amine (2.1 g, 21 mmol). 
The reaction mixture was stirred for 3 h followed by dilution with water (50 mL). Organic layer 
was separated and the aqueous layer was extracted with CH2Cl2. The combined organic extracts 
were dried over MgSO4 and concentrated. The crude product was purified by flash 
chromatography (SiO2, 20% ethyl acetate/hexanes) to yield (S)-2-hydroxynon-8-enyl 4-
methylbenzenesulfonate (4.9 g, 76%) as white waxy solid. 
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S
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(R)-2-Hydroxynon-8-enyl 4-methylbenzenesulfonate (R)-30: Performing the general 
procedure 4 with (R)-non-8-ene-1,2-diol (5.0 g, 32 mmol), Bu2SnO (1.6 g, 6.3 mmol), p-
toluenesulfonyl chloride (6.0 g, 32 mmol) and triethyl amine (4.3 mL, 32 mmol) gave, after 
purification by chromatography (SiO2, 20% ethyl acetate/hexanes), 7.3 g (74%) of (R)-2-
hydroxynon-8-enyl 4-methylbenzenesulfonate as white waxy solid. 
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2-Hydroxyoctyl 4-methylbenzenesulfonate 39: Performing the general procedure 4 with 
octane-1,2-diol (1.0 g, 6.8 mmol), Bu2SnO (0.34 g, 1.4 mmol), p-toluenesulfonyl chloride (1.3 g, 
6.8 mmol) and triethyl amine (0.70 g, 6.8 mmol) gave, after purification by chromatography 
(SiO2, 20% ethyl acetate/hexanes), 1.6 g (79%) of 2-hydroxyoctyl 4-methylbenzenesulfonate as 
white waxy solid.1H NMR (300 MHz, CDCl3) δ 0.76 (t, J = 6.7 Hz, 3H), 1.13-1.23 (m, 10H), 
2.32 (s, 3H), 2.90 (d, J = 4.9 Hz, 1H), 3.67-3.80 (m, 1H), 3.80 (dd, J = 9.9, 6.6 Hz, 1H), 3.91 (dd, 
J = 9.9, 3.5 Hz, 1H), 7.24 (d, J = 7.9 Hz, 2H), 7.69 (d, J = 8.3 Hz); 13C NMR (75 MHz, CDCl3) 
δ 13.7, 21.2, 22.0, 24.8, 28.8, 31.3, 32.4, 68.9, 127.6, 129.6, 132.4, 144.7; IR (neat) 3535, 3057, 
2926, 1598, 1455. 
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General procedure 5: 2-(3-Methoxy-4-(2-methoxyethoxy)benzyloxy)octyl-4-methylbenzene 
sulfonate rac-47: A solution of 2-hydroxyoctyl 4-methylbenzenesulfonate (0.12 g, 0.4 mmol), 
2,2,2-trichloroacetimidic acid 3-methoxy-4-(2-methoxyethoxy)benzyl ester (0.20 g, 0.80 mmol) 
and 10-camphorsulfonic acid (9.0 mg, 0.039 mmol) in CH2Cl2 (10 mL) was stirred at room 
temperature for 24 h, and then diluted with saturated NaHCO3. The layers were separated and the 
aqueous layer was extracted twice with CH2Cl2. The combined organic layers were dried over 
MgSO4, concentrated and the crude product was purified by flash chromatography (SiO2, 25% 
  
 
ethyl acetate/hexanes) to yield rac-47  (0.14 g, 72%) as an oil: 1H NMR (300 MHz, CDCl3) 
δ 0.85 (t, J = 6.65 Hz, 1H), 1.20-1.44 (m, 10H), 2.42 (s, 3H), 3.44 (s, 3H), 3.54-3.60 (m, 1H), 
3.77 (t, J = 5.0 Hz, 2H), 3.85 (s, 3H), 3.97-4.07 (m, 2H), 4.14 (t, J = 5.0 Hz, 2H), 4.41 (d, J = 
11.4 Hz, 1H), 4.49 (d, J = 11.4 Hz, 1H), 6.76-6.87 (m, 3H), 7.31 (d, J = 8.1 Hz, 2H), 7.76 (d, J = 
8.2 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ 13.9, 21.5, 22.4, 25.0, 29.0, 31.2, 31.6, 55.7, 59.0, 
68.3, 70.9, 71.6, 71.9, 76.0, 111.6, 113.3, 120.2, 127.8, 129.7, 131.3, 132.8, 144.7, 147.8, 149.5, 
163.4; IR (neat) 2929, 2870, 1597, 1515, 1464; EIMS  m/z 494 (M+); HRMS for C26H38O7S: 
calcd 494.2338; found 494.2354. 
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(S)-2-(3-Methoxy-4-(2-methoxyethoxy)benzyloxy)non-8-enyl-4-methylbenzenesulfonate 
14a: Performing the general procedure 5 with (S)-alcohol (1.0 g, 3.2 mmol), imidate 5a (2.9 g, 
8.0 mmol) and camphorsulfonic acid (74 mg, 0.32 mmol) gave, after purification by flash 
chromatography (SiO2, 20% ethyl acetate/hexanes), 1.1 g (2.2 mmol, 68%) of (S)-2-(3-methoxy-
4-(2-methoxyethoxy)benzyloxy)non-8-enyl-4-methylbenzenesulfonate as an oil: 1H NMR (500 
MHz, CDCl3) δ 1.22-1.45 (m, 8H), 1.99 (q, J = 7.0 2H), 2.42 (s, 3H), 3.43 (s, 3H), 3.54-3.58 (m, 
1H), 3.77 (t, J = 5.0 Hz, 2H), 3.86 (s, 3H), 3.98-4.04 (m, 2H), 4.15 (t, J = 5.0 Hz, 2H), 4.41 (d, J 
= 11.4 Hz, 1H), 4.49 (d, J = 11.4 Hz, 1H), 4.91-4.98 (m, 2H), 5.76 (ddt, J = 16.9, 10.2, 6.7 Hz, 
1H), 6.76-6.90 (m, 3H), 7.31 (d, J = 8.0 Hz, 2H), 7.76 (d, J = 8.1 Hz, 2H); 13C NMR (125 MHz, 
CDCl3) δ 21.6, 24.9, 28.6, 28.9, 31.2, 33.6, 55.8, 59.1, 68.4, 70.9, 71.6, 72.0, 76.0, 109.5, 111.6, 
  
 
113.5, 114.3, 120.2, 127.9, 129.8, 131.3, 132.9, 138.8, 144.8, 147.9, 149.6; IR (neat) 3066, 2931, 
1640, 1596, 1514, 1463; EIMS m/z 506 (M+); HRMS for C27H38O7S: calcd 506.2338; found 
506.2354. 
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(S)-2-(3-Methoxy-4-(2-(2-methoxyethoxy)ethoxy)benzyloxy)non-8-enyl-4-methyl benzenesu 
lfonate 14b: Performing the general procedure 5 with (S)-alcohol (1.0 g, 3.2 mmol),  imidate 5b 
(2.6 g, 6.4 mmol) and camphorsulfonic acid (74 mg, 0.32 mmol) gave, after purification by flash 
chromatography (SiO2, 40% ethyl acetate/hexanes), 1.2 g (2.1 mmol, 66%) of(S)-2-(3-methoxy-
4-(2-(2-methoxyethoxy)ethoxy)benzyloxy)non-8-enyl-4-methylbenzenesulf onate as an oil; 1H 
NMR (300 MHz, CDCl3) δ 1.22-1.53 (m, 8H), 1.97-2.07 (m, 2H), 2.44 (s, 3H), 3.39 (s, 3H), 
3.55-3.63 (m, 3H), 3.71-3.75 (m, 2H), 3.85 (s, 3H), 3.89 (t, J = 5.1 Hz, 2H), 3.99-4.10 (m, 2H), 
4.20 (t, J = 5.2 Hz, 2H), 4.43(d, J = 11.2 Hz, 1H), 4.51 (d, J = 11.2 Hz,  1H), 5.72-5.86 (ddt, J = 
16.9, 10.2, 6.6 Hz, 1H), 6.77- 6.90(m, 2H), 7.33 (d, J = 8.2 Hz, 2H), 7.79 (d, J = 8.2 Hz, 2H); 13C 
NMR (76 MHz, CDCl3) δ 21.2, 24.5, 28.3, 28.5, 30.9, 33.2, 55.4, 58.6, 68.3, 69.2, 70.3, 71.2, 
71.6, 75.6, 111.4, 113.1, 114.0, 119.9, 127.5, 129.5, 131.0, 132.5, 138.4, 144.5, 147.5, 149.3; IR 
(neat) 3073, 2928, 1645, 1598, 1515; MS m/z 378 (M − C7H8O3S)+. 
83 
 
  
 
O
O
O
O
O
S
OO
O
O
 
(R)-2-(3-Methoxy-4-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)benzyloxy)non-8-enyl-4-methyl 
benzenesulfonate 14c: Performing the general procedure 5 with (R)-alcohol (1.3 g, 4.2 mmol), 
imidate 5c (4.1 g, 9.2 mmol) and camphorsulfonic acid (97 mg, 0.42 mmol) gave, after 
purification by flash chromatography (SiO2, 50% ethyl acetate/hexanes), 1.7 g (2.1 mmol, 70%) 
of (R)-2-(3-methoxy-4-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)benzyloxy)non-8-enyl-4-methyl 
benzenesulfonate as an oil: 1H NMR (500 MHz, CDCl3) δ 1.12-1.40 (m, 8), 1.92 (q, J = 6.9, 2H), 
2.35 (s, 3H), 3.29 (s, 3H), 3.47 (t, J = 4.6 Hz, 2H), 3.48-3.52 (m, 1H), 3.57-3.61 (m, 4H), 3.66-
3.67 (m, 2H), 3.76 (s, 3H), 3.80 (t, J = 5.0 Hz, 2H), 3.91-3.99 (m, 2H), 4.10 (t, J = 5.0 Hz, 2H), 
4.34 (d, J = 11.0 Hz, 1H), 4.41 (d, J = 11.0 Hz, 1H), 4.84-4.92 (m, 2H), 5.70 (ddt, J = 17.0, 10.3, 
6.6 Hz, 1H), 6.69-6.80 (m, 3H), 7.25 (d, J = 8.2 Hz, 2H), 7.70 (d, J = 8.2 Hz, 2H); 13C NMR 
(126 MHz, CDCl3) δ 21.3, 24.6, 28.4, 28.6, 30.9, 33.3, 55.5, 58.7, 68.3, 69.3, 70.2, 70.3, 70.5, 
71.3, 71.6, 75.6, 111.5, 113.3, 114.1, 120.0, 127.6, 129.6, 131.0, 132.6, 138.5, 144.5, 147.6, 
149.3; IR (neat) 3067, 2935, 1639, 1596, 1514, 1456; EIMS m/z 594 (M+); HRMS C31H46O9S: 
calcd 594.2863; found 594.2886. 
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(R)-2-(3-Methoxy-4-(2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethoxy)benzyloxy)non-8-enyl 
-4-methylbenzenesulfonate 14d: Performing the general procedure 5 with (R)-alcohol (1.0 g, 
3.2 mmol), imidate 5d (3.6 g, 7.4 mmol) and camphorsulfonic acid (74 mg, 0.32 mmol) gave, 
after purification by flash chromatography (SiO2, 60% ethyl acetate/hexanes) 1.3 g (66%) of (R)-
2-(3-methoxy-4-(2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethoxy)benzyloxy)non-8-enyl-4-
methylbenzenesulfonate as an oil: 1H NMR (300 MHz, CDCl3) δ 1.18-1.44 (m, 8H), 1.94-2.02 
(m, 2H), 2.42 (s, 3H), 3.35 (s, 3H), 3.47-3.57 (m, 3H), 3.60-3.73 (m, 10H), 3.82 (s, 3H), 3.83-
3.88 (m, 2H), 3.99-4.01 (m, 2H), 4.15 (t, J = 5.2 Hz, 2H), 4.39 (d, J = 11.5 Hz, 1H), 4.48-4.50 (d, 
J = 11.5 Hz, 1H), 4.88-4.99 (m, 2H), 5.75 (ddt, J = 17.0, 10.3, 6.7 Hz, 1H), 6.73-6.77 (m, 1H), 
6.83 (m, 2H), 7.30 (d, J = 8.2 Hz, 2H), 7.75 (d, J = 8.2 Hz, 2H); 13C NMR (76 MHz, CDCl3) δ 
21.6, 24.9, 28.6, 28.9, 31.2, 33.6, 55.8, 58.9, 68.5, 69.5, 70.5, 70.7, 71.6, 71.8, 72.0, 76.0, 111.7, 
113.4, 114.3, 120.3, 127.8, 129.8, 131.2, 132.8, 138.8, 144.8, 147.9, 149.6; IR (neat) 3078, 2927, 
1644, 1608, 1515, 1454. 
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4-((1-Iodooctan-2-yloxy)methyl)-2-methoxy-1-(2-methoxyethoxy)benzene rac-51: A solution 
of rac-47 (0.13 g, 0.26 mmol) and NaI (0.39 g, 2.6 mmol) in acetone was refluxed for 20 h 
followed by concentration of the reaction mixture. The concentrate was diluted with water (20 
mL) and ethyl acetate (20 mL). The layers were separated and the aqueous layer was extracted 
with ethyl acetate. The combined organic layers were dried over MgSO4 and concentrated to 
yield rac-51 as light brown oil (0.12 g, 98%):1H NMR (300 MHz, CDCl3) δ 0.87 (t, J = 6.9 Hz, 
3H), 1.25-1.62 (m, 10H), 3.28-3.28 (m, 2H), 3.44 (s, 3H), 3.79 (t, J = 5.0 Hz,  2H), 3.87 (s, 3H), 
4.15 (t, J = 5.0 Hz, 2H), 4.43 (d, J = 11.3 Hz, 1H), 4.54 (d, J = 11.3 Hz, 1H), 6.86 (s, 2H), 6.97 
(s, 1H). 
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General procedure 6: mixture M56a of (S)-4-((1-Iodonon-8-en-2-yloxy)methyl)-2-methoxy-
1-(2-methoxyethoxy)benzene 56a and (S)-4-((1-Iodonon-8-en-2-yloxy)methyl)-2-methoxy-1-
(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)benzene 56c: A solution of 14a (0.99 g, 2.0 mmol), 
14c (0.76 g, 1.3 mmol) and NaI (2.4 g, 16 mmol) in acetone (35 mL) was refluxed for 20 h 
followed by concentration under reduced pressure. The concentrate was treated with water and 
extracted with ethyl acetate. The combined organic extracts were dried over MgSO4 and 
concentrated to yield a mixture of 56a and 56c as light brown oil (1.6 g, 99%) which was used in 
next step with out further purification. However, for characterization purposes, a small sample 
(90 mg) of the above mixture was separated by flash column chromatography (SiO2) upon which 
56a (ethyl acetate/hexanes = 1:4) eluted followed by 56c (ethyl acetate/hexanes = 1:1) as 
  
 
colorless oils. For 56a: 1H NMR (300 MHz, CDCl3) δ 1.27-1.61 (m, 8H), 1.97-2.11 (m, 2H), 
3.21-3.35 (m, 3H), 3.43 (s, 3H), 3.76 (t, J = 4.9 Hz, 2H), 3.86 (s, 3H), 4.14 (t, J = 4.9 Hz, 2H), 
4.41 (d, J = 11.2 Hz, 1H), 4.54 (d, J = 11.5 Hz, 1H), 4.89-5.03 (m, 2H), 5.78 (ddt, J = 17.0, 10.2, 
6.6 Hz, 1H), 6.85 (s, 2H), 6.95 (s, 1H); 13C NMR (76 MHz, CDCl3) δ 10.4, 25.0, 28.7, 28.9, 
33.6, 34.5, 55.8, 59.1, 68.5, 70.9, 71.2, 77.4, 111.8, 113.5, 114.3, 120.2, 131.4, 138.8, 147.8, 
149.6; EIMS m/z 462; HRMS C20H31O4I: calcd 462.1267; found 462.1244; for 56c: 1H NMR 
(300 MHz, CDCl3) δ 1.27-1.57  (m, 8H), 1.98 (q, J = 7.0, 2H), 3.20-3.26 (m, 3H), 3.34 (s, 3H), 
3.51-3.54 (m, 2 H), 3.62-3.66 (m, 4H), 3.70-3.72 (m, 2H), 3.79-3.90 (m, 5 H), 4.13 (t, J = 4.7Hz, 
2H), 4.37 (d, J = 11.0 Hz, 1H), 4.50 (d, J = 11.0 Hz, 1H) 4.85-4.98 (m, 2H), 5.67-5.81 (m, 1H), 
6.81 (s, 2H), 6.92 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 10.3, 24.7, 28.4, 28.6, 33.4, 34.2, 55.7, 
58.9, 68.1, 69.2, 69.9, 70.1, 70.2, 70.9, 71.4, 111.5, 113.1, 114.1, 120.1, 131.1, 138.6, 147.3, 
149.1; EIMS m/z 550 (M+); HRMS C24H39O6I: calcd 550.1791; found 550.1793. 
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Mixture M56b of (R)-4-((1-Iodonon-8-en-2-yloxy)methyl)-2-methoxy-1-(2-(2-methoxy 
ethoxy)ethoxy) benzene 56b and (R)-4-((1-Iodonon-8-en-2-yloxy)methyl)-2-methoxy-1-(2-(2-
(2-(2-methoxyethoxy)ethoxy)ethoxy)ethoxy)benzene 56d: Performing the general procedure 6 
with 14b (0.78 g, 1.4 mol), 14d (1.3 g, 2.0 mmol) and NaI (2.5 g, 17 mmol) gave a mixture of 
56b and 56d (1.8 g, 99%) as light brown oil: 1H NMR (500 MHz, CDCl3) δ 1.29-1.42 (m, 6H) 
(a, a’), 1.60-1.68 (m, 2H) (a, a’), 2.04 (q, J = 7.2, 7.2 Hz, 2H) (a, a’), 3.26-3.32 (m, 3H) (a, a’), 
  
 
3.37 (s, 3H) (a’), 3.40 (s, 3H) (a), 3.54-3.56 (m, 2H) (a’), 3.57-3.59 (m, 2H) (a), 3.64-3.75 (m, 
12H) (a + a’), 3.86-3.91 (m, 5H) (a, a’), 4.17-4.22 (m, 2H) (a, a’), 4.44 (d, J = 11.5 Hz, 1 H) (a, 
a’), 4.56 (d, J = 11.5 Hz, 1H) (a, a’), 4.93-5.02 (m, 2H) (a, a’), 5.76-5.85 (ddt, J = 17.0, 10.3, 6.6, 
6.4 Hz, 1H) (a, a’), 6.84-6.91 (m, 2H) (a, a’), 6.97 (s, 1H) (a, a’). 
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General procedure 7: (3RS,5S)-3-((S)-2-(3-Methoxy-4-(2-methoxyethoxy)benzyloxy)non-8-
enyl)-5-methyl-3-(phenylthio)-dihydrofuran-2(3H)-one (S,S)-15a and (3RS,5S)-3-((R)-2-(3-
Methoxy-4-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)benzyloxy)non-8-enyl)-5-methyl-3-
(phenylthio)-dihydrofuran-2(3H)-one (R,S)-15c: NaHMDS (1 M in THF, 3.2 mL, 3.2 mmol) 
was added to a solution of (S)-5-methyl-3-phenylsulfanyldihydrofuran-2-one (S)-49 (0.70 g, 3.2 
mmol) in THF (20 mL) at 0 oC. The mixture was stirred for 30 min at this temperature and then a 
solution of M56a (1.5 g, 3.0 mmol) in HMPA (3.5 mL) was added. The reaction mixture was 
allowed to warm to room temperature over 2 h followed by refluxing it for 14 h. Then the 
reaction mixture was cooled to room temperature and quenched with saturated NH4Cl solution.  
The organic layer was separated and the aqueous layer was extracted with ethyl acetate. The 
combined organic extracts were washed with brine, dried over MgSO4, concentrated under 
reduced pressure. The crude product was purified by flash chromatography (SiO2) to give (S,S)-
15a (25% ethyl acetate/hexanes, 0.50 g, 76%) followed by (R,S)-15c (50% ethyl acetate/hexanes, 
  
 
0.79 g, 69%)   as  oils. For 15a: 1H NMR (500 MHz, CDCl3, major isomer) δ 1.06 (d, J = 6.4 Hz, 
3H), 1.22-1.41 (m, 6H), 1.54-1.62 (m, 2H), 1.95 (dd, J = 13.5, 7.1 Hz, 2H), 2.00-2.15 (m, 4H), 
2.71 (dd, J = 13.5, 7.6 Hz, 2H), 3.44 (s, 3H), 3.67-3.72 (m, 1H), 3.77-3.80 (m, 2H), 3.86 (s, 3H), 
4.14-4.16 (m, 2H), 4.24 (d, J = 10.5 Hz, 1H), 4.28-4.34 (m, 1H), 4.42 (d, J = 10.5 Hz, 1H), 4.94-
5.05 (m, 2H), 5.77-5.86 (ddt, J = 17.0, 10.1, 6.9 Hz, 1H), 6.80-6.93 (m, 3H), 7.34-7.43 (m, 3H), 
7.57 (d, J = 6.9 Hz, 2H); 13CNMR (75 MHz, CDCl3, major isomer) δ 21.3, 24.3, 28.9, 29.3, 33.7, 
42.1, 42.3, 55.2, 56.0, 59.2, 68.8, 70.9, 71.1, 73.2, 76.4, 112.4, 113.9, 114.4, 120.6, 129.1, 129.9, 
130.8, 131.8, 137.1, 139.0, 148.0, 149.8, 176.8. MS m/z 542 (M+). For 15c 1H NMR (500 MHz, 
CDCl3, major isomer) δ 1.18 (d, J = 6.4 Hz, 3H), 1.23-1.41 (m, 6H), 1.50-1.63 (m, 2H), 1.89 (dd, 
J = 14.2, 6.4 Hz, 1H), 1.95-2.11 (m, 4H), 2.85 (dd, J = 14.0, 7.6 Hz, 1H), 3.38 (s, 3H), 3.55-3.56 
(m, 2H), 3.64-3.70 (m, 4H), 3.74-3.75 (m, 2H), 3.84-3.89 (m, 5H), 3.93-3.96 (m, 1H), 4.15-4.21 
(m, 2H), 4.36-4.44 (m, 2H), 4.55 (d, J = 11.0 Hz, 1H), 4.94-5.02 (m, 2H), 5.80 (ddt, J = 17.0, 
10.3, 6.9 Hz, 1H), 6.80-6.93 (m, 3H), 7.33-7.42 (m, 3H), 7.57 (d, J = 8.5 Hz, 2H); 13C NMR 
(126 MHz, CDCl3, major isomer) δ 21.5, 24.5, 28.9, 29.4, 33.6, 33.7, 39.6, 40.2, 54.9, 56.0, 59.1, 
68.7, 69.7, 70.4, 70.6, 70.7, 70.9, 72.0, 73.3, 75.6, 111.8, 113.6, 114.4, 120.0, 129.1, 129.8, 
130.5, 131.6, 136.8, 139.0, 147.8, 149.7, 177.5 HRMS  for C35H50O8SNa (M + Na)+: calcd 
653.3124; found 653.3109. 
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(3RS,5R)-3-((S)-2-(3-Methoxy-4-(2-(2-methoxyethoxy)ethoxy)benzyloxy)non-8-enyl)-5-
methyl-3-(phenylthio)-dihydrofuran-2(3H)-one (S,R)-15b and (3RS,5R)-3-((R)-2-(3-Methoxy 
-4-(2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethoxy)benzyloxy)non-8-enyl)-5-methyl-3-
(phenylthio)-dihydrofuran-2(3H)-one (S,R)-15d: Following the general procedure 7 with 
M56b (1.8 g, 3.2 mmol) and (R)-49 (0.71 g, 3.4 mmol) gave, after purification by flash column 
chromatography, 15b (40% ethyl acetate/hexanes) (0.57 g, 72%) followed by 15d (60% ethyl 
acetate/hexanes) (0.88 g, 70%) as colorless oils. For 15b: 1H NMR (300 MHz, CDCl3, major 
isomer) δ 1.18 (d, J = 6.6 Hz, 3H), 1.24-1.39 (m, 6H), 1.52-1.64 (m, 2H), 1.66 (s, 1 H), 1.85-1.94 
(m, 1H), 1.98-2.13 (m, 4H), 2.85 (dd, J = 14.0, 8.0 Hz, 1H), 3.39 (s, 3H), 3.56-3.58 (m, 2H), 
3.71-3.74 (m, 2H), 3.84-3.96 (m, 6H), 4.19 (t, J = 5.2 Hz, 2H), 4.35-4.44 (m, 2H), 4.55 (d, J = 
11.0 Hz, 1H), 4.92-5.03 (m, 2H), 5.79 (ddt, J = 16.9, 10.0, 6.6 Hz, 1H), 6.81-6.94 (m, 3H), 7.32-
7.43 (m, 2H), 7.57 (d, J = 6.0 Hz, 2H); 13C NMR (75 MHz, CDCl3, major isomer) δ 21.3, 24.4, 
28.7, 29.2, 33.6, 39.4, 40.1, 54.7, 55.9, 59.0, 68.5, 69.5, 70.2, 70.6, 71.8, 73.1, 75.4, 111.7, 113.4, 
114.3, 119.9, 128.9, 129.6, 130.3, 131.4, 136.6, 138.8, 147.6, 149.5, 177.3. :For 15d 1H NMR 
(500 MHz, CDCl3, major isomer) δ 1.05 (d, J = 6.4 Hz, 3H), 1.28-1.42 (m, 6H), 1.48-1.63 (m, 
2H), 1.91-2.11 (m, 5H), 2.71 (dd, J = 13.7, 7.3 Hz, 1H), 3.36 (s, 3H), 3.53-3.54 (m, 2H), 3.62-
3.68-3.72 (m, 11H), 3.84 (s, 3H), 3.85-3.89 (m, 2H), 4.15 (t, J = 5.3 Hz, 2H), 4.22 (d, J = 10.5 
Hz, 1H), 4.26-4.34 (m, 2H), 4.41 (d, J = 10.5 Hz, 2H), 4.94 (d, J = 10.1 Hz, 1H), 4.93-5.01 (m, 
2H), 5.80 (ddt, J = 17.0, 10.3, 6.6 Hz, 1H), 6.79-6.90 (m, 3H), 7.32-7.40 (m, 3H), 7.56 (d, J = 6.9 
Hz, 2H); 13C NMR (126 MHz, CDCl3, major isomer) δ 21.0, 24.1, 28.6, 29.1, 33.3, 33.5, 41.8, 
42.1, 54.9, 55.7, 58.8, 68.5, 69.5, 70.3, 70.4, 70.6, 70.7, 71.8, 72.9, 76.0, 112.2, 113.5, 114.2, 
120.3, 128.8, 129.6, 130.5, 131.4, 136.6, 136.8, 138.7, 147.7, 149.5, 176.5; IR (neat) cm-1 1763, 
1592, 1514, 1455;  HRMS  for C37H54O9SNa (M + Na)+: calcd 697.3386; found 697.3403. 
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tert-Butyldimethyl-non-8-enyloxy-silane: tert-Butyldimethylsilyl chloride (19 g, 0.13 mol) was 
added to a stirred solution of non-8-en-1-ol (14 g, 0.1mol) and imidazole (9.3 g, 0.14 mol) in 
dichloromethane at 0 oC. The reaction mixture was stirred at 0 oC for 20 min, 1 h at room 
temperature. The reaction mixture was diluted with water, organic layer was separated and the 
aqueous layer was further extracted with dichloromethane. The combined organic layers were 
dried over MgSO4 and concentrated to give tert-butyldimethyl-non-8-enyloxy-silane (25 g, 99%) 
as colorless oil. The crude reaction mixture was taken to the next step without further 
purification. 1H NMR (300 MHz, CDCl3) δ 0.06 (s, 6H), 0.91 (s, 9H), 1.32 (s, 8H), 1.40-1.55 (m, 
2H), 2.05 (q, J = 7.0 Hz, 2H), 3.61 (t, J = 6.3 Hz, 2H), 4.92-5.02 (m, 1H), 5.74-5.88 (ddt, J = 
17.0, 10.3, 6.7 Hz, 1H); 13C NMR (76 MHz, CDCl3) δ-5.2, 18.4, 25.9, 26.1, 29.0, 29.2, 29.4, 
33.0, 33.9, 63.3, 114.2, 139.2; IR (neat) cm-1 2933, 2858, 1471; EIMS m/z 241 (M − CH3), 199 
(M − C4H9);  HRMS for (M − CH3)+ C14H29OSi: calcd 241.1987; found 241.1984. 
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(7R,7S)-tert-Butyldimethyl-(7-oxiranylheptyloxy)silane 63: m-Chloroperbenzoic acid (25 g, 
0.11 mol, 75% w/w in H2O) was added to a solution of tert-butyldimethyl-non-8-enyloxysilane 
(25 g, 98 mmol) in dichloromethane (325 mL) at 0 oC. The reaction mixture was stirred at 0 oC 
for 20 min, room temperature for 1 h and treated with saturated aqueous NaHCO3. The layers 
were separated and the aqueous layer was further extracted with dichloromethane. The combined 
  
 
organic layers were dried over MgSO4, concentrated under reduced pressure and the crude 
product was purified by flash column chromatography (SiO2, 20% Ethyl acetate/hexanes) to give 
tert-butyldimethyl-(7-oxiranylheptyloxy)silane (26 g, 98%) as colorless oil: 1H NMR (300 MHz, 
CDCl3) δ0.02 (s, 6H), 0.87 (s, 9H), 1.30-1.51 (m, 12H), 2.43 (dd, J = 4.9, 2.7 Hz, 1H), 2.69-2.73 
(m, 1H), 2.84-2.90 (m, 1H), 3.57 (t, J = 6.59 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ _5.3, 18.4, 
25.7, 26.0, 29.4, 29.5, 32.5, 32.8, 47.1, 52.3, 63.2; IR (neat) 2933, 2856, 1464; EIMS m/z 215 (M 
− C4H9)+;  HRMS for (M − C4H9)+ C11H23O2Si: calcd 215.1467; found 215.1471. 
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9-(tert-Butyldimethylsilanyloxy)nonane-1,2-diol 65: The (R,R)-Jacobson catalyst7 (0.28 g, 0.46 
mmol) was dissolved in tert-butyldimethyl-(7-oxiranylheptyloxy)silane (25 g, 92 mmol), AcOH 
(110 µL, 1.8 mmol) and 0.3 mL THF. The solution was cooled to 0 oC, treated with H2O (0.74 
mL, 41 mmol) and stirred for 12 h at room temperature. The reaction mixture was distilled bulb-
to-bulb (Kugelrohr) under reduced pressure (0.08 mm Hg, 120-130 oC) to remove residual 
epoxide (14 g, 52 mmol) followed by second distillation (0.08 mm Hg, 180-190 oC) to yield (S)-
9-(tert-Butyldimethylsilanyloxy)nonane-1,2-diol (12 g, 43%, > 99% enantiomeric excess based 
on Mosher ester analysis) as colorless oil; Similar procedure with the above recovered epoxide 
(14g, 51.3 mmol) and (S,S)-Jacobson catalyst (0.28 g, 0.46mmol) resulted in (R)-9-(tert-butyl-
dimethyl silanyloxy) nonane-1,2-diol (12 g, 45%, > 99% ee by Mosher ester analysis)8 as 
colorless oil: [α]D25 for (R)-diol: −0.24 (c 5.83); for (S)-diol: 1.07 (c 1.49); 1H NMR (300 MHz, 
CDCl3) δ 0.02 (s, 6H), 0.87 (s, 9H), 1.28-1.50 (m, 12H), 3.38-3.44 (m, 1H), 3.57 (t, J = 6.6 Hz, 
                                                 
7 Schaus, S. E.; Brandes, B. D.; Larrow, J. F.; Tokunaga, M.; Hansen, K. B.; Gould, A. E.; Furrow, M. E.; Jacobson, 
E. N. J. Am. Chem. Soc. 2002, 124, 1307. 
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8 Dale, J. A.; Mosher, H. S. J. Am. Chem. Soc. 1973, 24, 512. 
  
 
2H), 3.65-3.78 (br m, 4H); 13C NMR (75 MHz, CDCl3) δ _5.2, 18.4, 25.6, 25.8, 26.0, 29.4, 29.7, 
32.9, 33.1, 63.3, 66.8, 72.4. EIMS m/z 259 (M − CH3O)+; HRMS for (M − CH3O)+ C14H31O2Si: 
calcd 259.2093; found 259.2091. 
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Benzenesulfonic acid 9-(tert-butyldimethylsilanyloxy)-2-hydroxynonyl ester 66:  
To a solution of (R)-9-(tert-butyldimethylsilanyloxy)nonane-1,2-diol (12 g, 41 mmol) in CH2Cl2 
(80 mL) were added Bu2SnO (2.0 g, 8.1 mmol), p-TsCl (7.7 g, 41 mmol), and Et3N (5.6 mL, 41 
mmol). After 3 h, the reaction mixture was concentrated and the crude product was purified by 
flash chromatography (SiO2, EtOAc/hexanes = 1:3) to yield toluene-4-sulfonic acid (R)-9-(tert-
butyldimethylsilanyloxy)-2-hydroxynonyl ester (14 g, 76%) as white waxy solid; similar 
procedure with (S)-diol (11 g, 38 mmol) yielded (S)-sulfonyl ester (12 g, 72%) as while waxy 
solid: 1H NMR (300 MHz, CDCl3) δ 0.01 (s, 6H), 0.86 (s, 9H), 1.20-1.48 (m, 12H), 2.41 (s, 3H), 
2.54 (br s, 1H), 3.56 (t, J = 6.4 Hz, 2H), 3.74-3.89 (m, 2H), 3.98 (dd, J = 9.9, 3.0 Hz, 1H), 7.32 
(d, J = 8.0 Hz, 1H), 7.77 (d, J = 8.5 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ _5.3, 18.3, 21.5, 25.1, 
25.6, 25.9, 29.2, 29.4, 32.6, 32.7, 63.2, 69.2, 73.9, 127.9, 129.9, 132.7, 144.9; HRMS for 
C22H40O5SSiNa: calcd 467.2263; found 467.2287. 
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General procedure 8: Toluene-4-sulfonic acid (R)-9-(tert-butyldimethylsilanyloxy)-2-[3-
methoxy-4-(2-methoxyethoxy)benzyloxy]nonyl ester (67a): A solution of (R)-9-(tert-
butyldimethylsilanyloxy)-2-hydroxynonyl ester (2.3 g, 5.2 mmol), 2,2,2-trichloroacetimidic acid 
3-methoxy-4-(2-methoxyethoxy)benzyl ester (3.7 g, 10 mmol) and 10-camphorsulfonic acid 
(0.12 g, 0.52 mmol) in CH2Cl2 (30 mL) was stirred at room temperature for 24 h, and then 
diluted with saturated NaHCO3. The layers were separated and the aqueous layer was extracted 
twice with CH2Cl2. The combined organic layers were dried over MgSO4, concentrated and the 
crude product was purified by flash chromatography (SiO2, EtOAc/hexanes = 3:7) to yield 67a 
(2.0 g, 60%): 1H NMR (300 MHz, CDCl3) δ 0.03 (s, 6H), 0.88 (s, 9H), 1.18-1.46 (m, 12 H), 2.43 
(s, 3H), 3.44 (s, 3H), 3.55-3.60 (m, 3H), 3.76-3.79 (m, 2H), 3.86 (s, 3H), 4.00 (t, J = 4.39 Hz, 
2H), 4.14 (t, J = 4.39 Hz, 2H), 4.41 (d, J = 11.5 Hz, 1H), 4.49 (d, J = 11.5 Hz, 1H), 6.74-6.86 (m, 
3H), 7.31 (d, J = 8.2 Hz, 2H), 7.76 (d, J = 8.2 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ _5.3, 18.4, 
21.6, 25.1, 25.7, 26.0, 29.3, 29.5, 31.3, 32.8, 55.8, 59.1, 63.2, 68.2, 70.9, 71.7, 72.0, 76.1, 111.6, 
113.1, 120.3, 127.9, 129.9, 131.3, 132.8, 144.9, 147.8, 149.4; IR (neat)  2927, 2856, 1597, 1514, 
1461; HRMS (M + Na)+ for C33H54O8SiSNa: calcd 661.3206; found 661.3209.  
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Toluene-4-sulfonic acid (R)-9-(tert-butyldimethylsilanyloxy)-2-{3-methoxy-4-[2-(2-methoxy 
ethoxy)ethoxy]benzyloxy}nonyl ester (67b): Performing the general procedure 8 with (R)-9-
(tert-butyldimethylsilanyloxy)-2-hydroxynonyl ester (2.3 g, 5.2 mmol), 2,2,2-trichloroacetimidic 
acid 3-methoxy-4-[2-(2-methoxyethoxy)ethoxy]benzyl ester (4.6 g, 11 mmol) and 10-
camphorsulfonic acid (0.12 g, 0.52 mmol) gave, after purification by flash chromatography 
(SiO2,ethyl acetate/hexanes = 4:6), 67b (2.2 g, 62%) as colorless oil: 1H NMR (300 MHz, 
CDCl3) δ 0.03 (s, 6H), 0.87 (s, 9H), 1.23-1.48 (m, 12H), 2.42 (s, 3H), 3.36 (s, 3H), 3.52-3.62 (m, 
5H), 3.68-3.73 (m, 2H), 3.82 (s, 3H), 3.86 (t, J = 5.5 Hz, 2H), 3.94-4.06 (m, 2H), 4.17 (t, J = 4.9 
Hz, 2H), 4.40 (d,  J = 11.2 Hz, 1H), 4.47 (d, J = 11.2 Hz, 1H), 6.74-6.85 (m, 3H), 7.30 (d, J = 8.2 
Hz, 2H), 7.75 (d, J = 8.2 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ _5.3, 21.5, 25.1, 25.2, 25.7, 
25.9, 29.2, 29.5, 31.3, 32.8, 55.9, 58.9, 63.1, 68.7, 69.6, 70.6, 71.6, 71.9, 72.0, 76.2, 112.0, 113.8, 
120.3, 127.9, 129.8, 131.5, 133.1, 144.7, 148.0, 149.7; IR (neat) 2928, 2856, 1597, 1514, 1461. 
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Toluene-4-sulfonic acid (S)-9-(tert-butyldimethylsilanyloxy)-2-(3-methoxy-4-{2-[2-(2-meth 
oxyethoxy)ethoxy]ethoxy}benzyloxy)nonyl ester (67c): Performing the general procedure 8 
with (S)-9-(tert-butyldimethylsilanyloxy)-2-hydroxynonyl ester (2.3 g, 5.2 mmol) 2,2,2-
trichloroacetimidic acid 3-methoxy-4-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}benzyl ester (5.1 
g, 11 mmol) and 10-camphorsulfonic acid (0.12 g, 0.52 mmol) gave, after purification by flash 
chromatography (SiO2, ethyl acetate/hexanes = 1:1), 67c (2.4 g, 63%) as an oil: 1H NMR (500 
MHz, CDCl3) δ 0.03 (s, 6H), 0.88 (s, 9H), 1.22-1.48 (m, 12H), 2.43 (s, 3H), 3.36 (s, 3H), 3.53-
3.60 (m, 5H), 3.62-3.68 (m, 4H), 3.71-3.74 (m, 2H), 3.83 (s, 3H), 3.87 (t, J = 5.3 Hz, 2H), 3.97-
4.05 (m, 2H), 4.16 (t, J = 5.0 Hz, 2H), 4.40 (d, J = 11.5 Hz, 1H), 4.47 (d, J = 11.5 Hz, 1H), 6.73-
6.76 (m, 1H), 6.84-6.86 (m, 2H), 7.31 (d, J = 8.2 Hz, 2H), 7.76 (d, J = 8.2 Hz, 2H); 13C NMR 
(126 MHz, CDCl3) δ −5.2, 18.4, 21.7, 25.2, 25.8, 26.0, 29.4, 29.6, 31.4, 32.9, 55.9, 59.1, 63.3, 
68.6, 69.6, 70.6, 70.7, 70.9, 71.7, 72.0, 72.1, 76.2, 111.7, 113.5, 120.3, 128.0, 129.9, 131.3, 
132.9, 144.8, 148.0, 149.6; IR (neat) 2927, 2856, 1597, 1514, 1461; HRMS (M + Na)+ for 
C37H62O10SiSNa: calcd 749.3731; found 749.3740. 
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Toluene-4-sulfonic acid (S)-9-(tert-butyldimethylsilanyloxy)-2-[3-methoxy-4-(2-{2-[2-(2-met 
hoxyethoxy)ethoxy]ethoxy}ethoxy)benzyloxy]nonyl ester (67d): Performing the general 
procedure 8 with (S)-9-(tert-butyldimethylsilanyloxy)-2-hydroxynonyl ester (2.3 g, 5.2 mmol) 
  
 
2,2,2-trichloroacetimidic acid 3-methoxy-4-(2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}ethoxy) 
benzyl ester (5.5 g, 11 mmol) and 10-camphorsulfonic acid (0.12 mg, 0.52 mmol) gave, after 
purification by flash chromatography (SiO2, ethyl acetate/hexanes = 3:2), 67d (2.4 g, 63%) as an 
oil: 1H NMR (500 MHz, CDCl3) δ 0.03 (s, 6H), 0.87 (s, 9H), 1.16-1.50 (m, 12H), 2.41 (s, 3H), 
3.35 (s, 3H), 3.52 (t, J = 4.6 Hz, 2H), 3.57 (t, J = 6.6 Hz, 2H), 3.61-3.67 (m, 9H), 3.71 (t, J = 4.6 
Hz, 2H), 3.82 (s, 3H), 3.84-3.87 (m, 2H), 3.96-4.04 (m, 2H), 4.15 (t, J = 5.0 Hz, 2H), 4.40 (d, J = 
11.0 Hz, 1H), 4.47 (d, J = 11.0 Hz, 1H), 6.75 (m, 1H), 6.81-6.86 (m, 2H), 7.30 (d, J = 8.2 Hz, 
2H), 7.75 (d, J = 8.2 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ _5.4, 18.2, 21.5, 24.9, 25.5, 25.8, 
29.1, 29.3, 31.1, 32.6, 55.7, 58.8, 63.0, 68.5, 69.4, 70.3, 70.4, 70.6, 71.5, 71.7, 71.8, 75.9, 111.6, 
113.3, 120.1, 127.7, 129.7, 131.1, 132.7, 144.6, 147.7, 149.5; IR (neat) 2928, 1514, 1461; HMRS 
(M + Na)+ for C39H66O11SiSNa: calcd 793.3993; found 793.3977. 
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General procedure 9: tert-Butyl-{(R)-9-iodo-8-[3-methoxy-4-(2-methoxyethoxy) benzyloxy] 
nonyloxy}dimethylsilane (68a) and tert-Butyl-[(S)-9-iodo-8-(3-methoxy-4-{2-[2-(2-methoxy 
ethoxy)ethoxy]ethoxy}benzyloxy)nonyloxy] dimethylsilane (68c): A solution of 67a (1.9 g, 
3.0 mmol), 67c (2.3 g, 3.2 mmol) and NaI (9.2 g, 61 mmol) in acetone (35 mL) was refluxed for 
20 h followed by concentration under reduced pressure. The concentrate was treated with water 
and extracted with ethyl acetate. The combined organic extracts were dried over MgSO4 and 
  
 
concentrated to yield a mixture of 68a and 68c as light brown oil (3.9 g, 98%) which was used in 
next step with out further purification. However, characterization purposes a small sample (0.1 g) 
of the mixture M68a was subjected to flash column chromatography (SiO2) gave 68a (ethyl 
acetate/hexanes = 1:4) followed by 68c (ethyl acetate/hexanes = 1:1) as colorless oils. For 68a:  
1H NMR (500 MHz, CDCl3) δ 1H NMR (500 MHz,CDCl3) δ 0.05 (s, 6H), 0.90 (s, 9H), 1.30-
1.64 (m, 12H), 3.21-3.33 (m, 3H), 3.46 (s, 3H), 3.60 (t, J = 6.6 Hz, 2H), 3.76-3.82 (m, 2H), 3.88 
(s, 3H), 4.18 (t, J = 4.9 Hz, 2H), 4.47 (d, J = 11.0 Hz, 1H), 4.58 (d, J = 11.0 Hz, 1H), 6.84-6.89 
(m, 2H), 6.98 (s, 1H); 13C NMR (126 MHz, CDCl3) δ _ 5.2, 10.5, 18.5, 25.3, 25.8, 26.1, 29.4, 
29.6, 32.9, 34.7, 56.0, 59.4, 63.3, 68.5, 71.0, 71.4, 77.7, 111.9, 113.6, 120.4, 131.7, 147.7, 149.7; 
IR (neat) 2929, 2857, 1593, 1514, 1463; HRMS (ESI) (M + Na)+ for C26H47O5SiINa: calcd 
617.2135; found 617.2152.  For 68c: 1H NMR (500 MHz, CDCl3) δ 0.05 (s, 6H), 0.90 (s, 9H), 
1.30-1.62 (m, 12H), 3.26-3.34 (m, 3H), 3.39 (s, 3H), 3.55-3.63 (m, 4H), 3.65-3.72 (m, 4H), 3.75 
(dd, J = 6.2, 3.4 Hz, 2H), 3.88-3.90 (m, 5H), 4.17-4.22 (m, 2H), 4.44 (d, J = 11.5 Hz, 1H), 4.55 
(d, J = 11.5 Hz, 1H), 6.87-6.89 (m, 2H), 6.98 (s, 1H); 13C NMR (126 MHz, CDCl3) δ −5.2, 10.5, 
18.4, 25.3, 25.8, 26.1, 29.4, 29.6, 32.9, 34.7, 56.0, 59.1, 63.3, 68.6, 69.6, 70.5, 70.6, 70.7, 71.3, 
71.9, 77.6, 111.9, 113.5, 120.4, 131.4, 147.9, 149.6; IR (neat) 2929, 2857, 1593, 1515; HRMS 
(M + Na)+ for C30H55O7SiINa: calcd 705.2660; found 705.2686. 
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tert-Butyl-{(R)-9-iodo-8-{3-methoxy-4-[2-(2-methoxyethoxy)ethoxy]benzyloxy} nonyloxy) 
dimethyl-silane (68b) and tert-Butyl-{(S)-9-iodo-8-[3-methoxy-4-(2-{2-[2-(2-methoxyethoxy) 
ethoxy]ethoxy}ethoxy)benzyloxy]nonyloxy}dimethylsilane (68d): Performing the general 
procedure 9 with 67b (2.1 g, 3.1 mmol), 67d (2.4g, 3.1 mmol) and NaI (9.2 g, 61 mmol) gave a 
mixture M68b as light brown oil (4.2 g, 99%) which was used in next step with out further 
purification. However, subjecting a small sample (0.1 g) of the mixture M68b (0.1 g) to flash 
column chromatography (SiO2) gave 68b (ethyl acetate/hexanes 2:3) followed by 68d (ethyl 
acetate/hexanes 3:2) as colorless oils. For 68b: 1H NMR (500 MHz, CDCl3) δ 0.05 (s, 6H), 0.90 
(s, 9H), 1.26-1.68 (m, 12H), 3.25-3.33 (m, 3H), 3.41 (s, 3H), 3.58-3.62 (m, 4H), 3.72-3.76 (m, 
2H), 3.88 (s, 3H), 3.89-3.91 (m, 2H), 4.20 (t, J = 5.3 Hz, 1H), 4.44 (d, J = 11.2 Hz, 1H), 4.55 (d, 
J = 11.2 Hz, 1H), 6.88 (s, 2H), 6.97 (s, 1H); 13C NMR (125 MHz, CDCl3) δ −5.2, 10.6, 18.5, 
25.3, 25.8, 26.1, 29.4, 29.6, 32.9, 34.7, 56.1, 59.2, 63.3, 68.5, 69.5, 70.7, 71.3, 71.9, 77.6, 111.9, 
113.4, 120.5, 131.5, 147.7, 149.5; IR (neat) 2929, 2857, 1593, 1515, 1463; HRMS (ESI) (M + 
Na)+ for C28H51O6SiINa: calcd 661.2397; found 661.2407. For 68d: 1H NMR (500 MHz, CDCl3) 
δ 0.05 (s, 6H), 0.90 (s, 9H), 1.30-1.61 (m, 12H), 3.24-3.33 (m, 3H), 3.37 (s, 3H), 3.52-3.56 (m, 
2H), 3.58-3.62 (m, 2H), 3.62-3.69 (m, 8H), 3.71-3.75 (m, 2H), 3.84-3.89 (m, 5H), 4.20 (t, J = 5.0 
Hz, 2H), 4.43 (d, J = 11.0 Hz, 1H), 4.55 (d, J = 11.0 Hz, 1H),  6.83-6.89 (m, 2H), 6.96 (s, 1H); 
13C NMR (126 MHz, CDCl3) δ −5.4, 10.3, 18.1, 25.0, 25.5, 25.8, 29.1, 29.3, 32.6, 34.4, 55.7, 
58.8, 63.0, 68.4, 69.4, 70.3, 70.4, 70.6, 71.0, 71.7, 77.2, 111.6, 113.3, 120.1, 131.1, 147.7, 149.4; 
IR (neat) IR (neat) 2929, 2857, 1593, 1515, 1463; HRMS (ESI) (M + Na)+ for C32H59O8SiINa: 
calcd 749.2922; found 749.2944. 
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General procedure 10: (3RS,5S)-3-{(R)-9-(tert-Butyldimethylsilanyloxy)-2-[3-methoxy-4-(2-
methoxyethoxy)benzyloxy]nonyl}-5-methyl-3-phenylsulfanyldihydrofuran-2-one 61a and 
(3RS,5S)-3-[(S)-9-(tert-Butyldimethylsilanyloxy)-2-(3-methoxy-4-{2-[2-(2-methoxyethoxy) 
ethoxy]ethoxy}benzyloxy)nonyl]-5-methyl-3-phenylsulfanyldihydrofuran-2-one 61c: 
100 
 A solution of NaHMDS (1.0 M in THF, 5.9 mL, 5.9 mmol) was added to a solution of (S)-5-
Methyl-3-phenylsulfanyldihydrofuran-2-one (S)-49 (1.2 g, 5.9 mmol) in THF (20 mL) at 0 oC. 
The mixture was stirred for 30 min at this temperature and then a solution of iodide M68a (3.6 g, 
5.6 mmol) in HMPA (3.5 mL) was added. The reaction mixture was allowed to warm to room 
temperature over 2 h followed by refluxing it for 14 h. Then the reaction mixture was cooled to 
room temperature and quenched with saturated NH4Cl.  The organic layer was separated and the 
aqueous layer was extracted with ethyl acetate. The combined organic extracts were washed with 
brine, dried over MgSO4 followed by concentration under reduced pressure. The crude product 
was purified by flash chromatography (SiO2) to gave 61a (25% ethyl acetate/hexanes) (1.3 g, 
69%) followed by 61c (50% ethyl acetate/hexanes) (1.5 g, 71%)   as an oils. For 61a: 1H NMR 
(300 MHz, CDCl3, major isomer) δ 0.05 (s, 6H), 0.90 (s, 9H), 1.03 (d, J = 6.0 Hz, 6H), 1.21-1.37 
(m, 10H), 1.48-1.56 (m, 2H), 1.90-2.15 (m, 3H), 2.69 (dd, J = 13.7, 7.1 Hz, 1H), 3.41 (s, 3H), 
3.60 (t, J = 6.6 Hz, 2H), 3.66-3.75 (m, 3H), 3.84 (s, 3H), 4.10-4.14 (m, 2H), 4.22 (d, J = 10.4 Hz, 
  
 
1H), 4.25-4.33 (m, 1H), 4.41 (d, J = 10.4 Hz, 1H), 6.78-6.88 (m, 2H), 6.92 (s, 1H), 7.29-7.40 (m, 
3H), 7.55 (dd, J = 8.0, 1.4 Hz, 2H);  IR (neat) 2929, 1763, 1516, 1458. For 61c: 1H NMR (500 
MHz, CDCl3, major isomer) δ 0.03 (s, 6H), 0.88 (s, 9H), 1.14 (d, J = 6.4 Hz, 3H), 1.21-1.28 (m, 
8H), 1.46-1.52 (m, 3H), 1.55-1.62 (m, 1H), 1.86 (dd, J = 14.2, 6.0 Hz, 1H), 1.92- 2.09 (m, 2H), 
2.81 (dd, J = 14.2, 7.8 Hz, 1H), 3.35 (s, 3H), 3.51-3.52 (m, 2H), 3.58 (t, J = 6.4 Hz, 2H), 3.62-
3.66 (m, 4H), 3.71-3.72 (m, 2H), 3.84- 3.94 (m, 6H), 4.15 (t, J = 5.3 Hz, 2H), 4.32-4.40 (m, 2H), 
4.53 (d, J = 11.0 Hz, 1H), 6.78-6.91 (m, 3H), 7.30-7.38 (m, 3H), 7.54 (d, J = 7.8 Hz, 2H); 13C 
NMR (126 MHz, CDCl3) δ _5.3, 18.3, 21.3, 24.5, 25.7, 25.9, 29.3, 29.7, 32.8, 33.4, 39.4, 40.1, 
54.8, 55.9, 58.9, 63.2, 68.6, 69.5, 70.2, 70.4, 70.6, 70.7, 71.8, 73.0, 75.4, 76.8, 77.3, 111.7, 113.5, 
119.8, 128.9, 129.6, 130.3, 131.4, 136.6, 147.6, 149.5, 177.3; IR (neat) 2929, 1763, 1515, 1463; 
MS m/z 785 (M + Na)+; HMRM (ESI) for C41H66O9SSiNa: calcd 785.4095; found 785.4124. 
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(3RS,5R)-3-((R)-9-(tert-Butyldimethylsilanyloxy)-2-{3-methoxy-4-[2-(2-methoxyethoxy)etho 
xy]benzyloxy}nonyl)-5-methyl-3-phenylsulfanyldihydrofuran-2-one 61b and (3RS,5R)-3-
{(S)-9-(tert-Butyldimethylsilanyloxy)-2-[3-methoxy-4-(2-{2-[2-(2-methoxyethoxy)ethoxy]eth 
oxy}ethoxy)benzyloxy]nonyl}-5-methyl-3-phenylsulfanyldihydrofuran-2-one 61d: 
101 
 Performing the general procedure 10 with NaHMDS (1.0 M in THF, 6.0 mL, 6.0 mmol), (R)-5-
Methyl-3-phenylsulfanyldihydrofuran-2-one (R)-49 (1.3 g, 6.0 mmol) and iodide M68b (3.9 g, 
  
 
5.7 mmol) gave, after purification by flash column chromatography, 61b (2:3 ethyl 
acetate/hexanes) (1.5 g, 73%) as pale yellow oil followed by 61d (7:3 ethyl acetate/hexanes) (1.6 
g, 70%) as pale yellow oil: For 61b: 1H NMR (500 MHz, CDCl3, major isomer) δ 0.05 (s, 6H), 
0.90 (s, 9H), 1.16 (d, J = 6.4 Hz, 3H), 1.24-1.32 (m, 8H), 1.49-1.55 (m, 3H), 1.57-1.63 (m, 1H), 
1.88 (dd, J = 14.2, 6.0 Hz, 1H), 1.94-1.97 (m, J = 2.3 Hz, 1H), 2.03-2.10 (m, 1H), 2.84 (dd, J = 
14.2, 7.8 Hz, 1H), 3.38 (s, 3H), 3.56-3.57 (m, 2H), 3.60 (t, J = 6.6 Hz, 2H), 3.71-3.73 (m, 2H), 
3.86-3.89 (m, 5H), 3.90-3.95 (m, 1H), 4.18 (t, J = 5.3 Hz, 2H), 4.34-4.43 (m, 2H), 4.55 (d, J = 
11.0 Hz, 1H), 6.81-6.92 (m, 3H), 7.32 - 7.41 (m, 3H), 7.56 (d, J = 7.8 Hz, 2H); 13C NMR (126 
MHz, CDCl3) δ −5.2, 18.4, 21.4, 24.7, 25.8, 26.0, 29.4, 29.9, 32.9, 33.6, 39.5, 40.2, 54.9, 56.0, 
59.1, 63.3, 68.7, 69.7, 70.3, 70.8, 72.0, 73.2, 75.6, 76.8, 77.4, 111.9, 113.7, 120.0, 129.0, 129.7, 
130.5, 131.6, 136.8, 147.8, 149.7, 177.4; IR (neat) 2929, 1763, 1515, 1463; EIMS m/z 646.7 (M 
− C4H9); For 61d: 1H NMR (300 MHz, CDCl3, major isomer) δ 0.06 (s, 6H), 0.90 (s, 9H), 1.05 
(d, J = 6.3 Hz, 3H), 1.23-1.36 (m, 8H), 1.51-1.61 (m, 4H), 1.95 (dd, J = 13.7 Hz, 7.1 Hz, 1H), 
2.03-2.18 (m, 2H), 2.70 (dd, J = 13.6, 7.5 Hz, 1H), 3.38 (s, 3H), 3.54- 3.74 (m, 15H), 3.86-3.89 
(m, 5H), 4.09-4.25 (m, 3H), 4.27-4.36 (m, 1H), 4.42 (d, J = 10.4 Hz, 1H), 6.79-6.92 (m, 3H), 
7.34-7.41 (m, 3H), 7.55-7.58 (m, 2H); 13C NMR (76 MHz, CDCl3) δ −5.2, 18.4, 21.2, 24.4, 25.8, 
26.0, 29.4, 29.8, 32.9, 33.5, 42.0, 42.3, 55.2, 55.9, 59.1, 63.3, 68.6, 69.6, 70.6, 73.2, 76.3, 112.2, 
113.4, 120.5, 129.0, 129.8, 130.6, 131.5, 137.0, 147.8, 149.5, 176.8; IR (neat) 2929, 1763, 1516, 
1458; HRMS (ESI) (M + Na)+ for C43H70O10SSiNa: calcd 829.4357; found 829.4396. 
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Lactone mixture M61: m-chloroperbenzoic acid (0.28 g, 1.6 mmol) was added to a solution of a 
mixture of 61a (0.27 g, 0.4 mmol), 61b (0.29 g, 0.4 mmol), 61c (0.31 g, 0.4 mmol), 61d (0.32 g, 
0.4 mmol) in CH2Cl2 (30 mL) at 0 oC. The reaction mixture was stirred for 30 min and then 
quenched with saturated NaHCO3 solution. Layers were separated and the aqueous layer was 
further extracted with CH2Cl2 followed by drying the combined organic layers with MgSO4 and 
concentration. The crude product in 3.5 mL of DMF was heated in microwave9 (personal 
chemistry microwave, 150W, ramped to 160 oC over 2 min and heated for 5 min at that 
temperature) for 5 min at 160 oC. Removal of DMF under reduced pressure followed by 
purification by flash column chromatography on silica gel under gradient elution gave 69a (0.20 
g, 88%) (25% ethyl acetate/hexanes), 69b (0.21 g, 85%) (40% ethyl acetate/hexanes), 69c (0.23 
g, 89%) (60% ethyl acetate/hexanes) and 69d (0.24 g, 85%) (80% ethyl acetate/hexanes) as pale 
yellow oils. 
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(S)-3-{(R)-9-(tert-Butyldimethylsilanyloxy)-2-[3-methoxy-4-(2-methoxyethoxy)benzyloxy] 
nonyl}-5-methyl-5H-furan-2-one 69a: 1H NMR (500 MHz, CDCl3) δ 0.02 (s, 6H), 0.86 (s, 9H), 
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9 Moghaddam, F. M.; Ghaffarzadeh, M. Tetrahedron Lett., 1996, 37, 1855. 
  
 
1.23-1.31 (m, 8H), 1.35 (d, J = 6.9 Hz, 3H), 1.42-1.49 (m, 2H), 1.53-1.58 (m, 2H), 2.48 (d, J = 
6.0 Hz, 2H), 3.41 (s, 3H), 3.56 (t, J = 6.6 Hz, 2H), 3.62-3.67 (m, 1H), 3.72 (t, J = 4.6 Hz, 2H), 
3.82 (s, 3H), 4.11-4.13 (m, 2H), 4.40 (d, J = 11.5 Hz, 1H), 4.44 (d, J = 11.5 Hz, 1H), 4.92 (q, J = 
6.6 Hz, 1H), 6.78-6.84 (m, 3H), 7.05 (s, 1H); 13C NMR (126 MHz, CDCl3) δ −5.3, 18.3, 19.1, 
25.2, 25.7, 25.9, 29.3, 29.6, 32.7, 33.9, 55.8, 59.1, 63.2, 68.5, 70.9, 76.5, 77.5, 111.7, 113.6, 
120.2, 130.5, 131.7, 147.7, 149.6, 151.4, 173.9; IR (neat) 2930, 2856, 1756, 1515, 1464. 
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(R)-3-((R)-9-(tert-Butyldimethylsilanyloxy)-2-{3-methoxy-4-[2-(2-methoxyethoxy)ethoxy] 
benzyloxy}nonyl)-5-methyl-5H-furan-2-one 69b: 1H NMR (500 MHz, CDCl3) δ 0.05 (s, 6H), 
0.90 (s, 9H), 1.29-1.31 (m, 8H), 1.38 (d, J = 6.4 Hz, 3H), 1.40-1.61 (m, 4H), 2.51-2.53 (m, 2H), 
3.40 (s, 3H), 3.57-3.61 (m, 4H), 3.66-3.69 (m, 1H), 3.72-3.74 (m, 2H), 3.86 (s, 3H), 3.89 (t, J = 
5.0 Hz, 2H), 4.19 (t, J = 5.5 Hz, 2H), 4.43 (d, J = 11.5 Hz, 1H), 4.47 (d, J = 11.5 Hz, 1H), 4.99 
(q, J = 6.9 Hz, 1H), 6.81-6.88 (m, 3H), 7.09 (s, 1H); 13C NMR (125 MHz, CDCl3) δ −5.5, 18.1, 
18.9, 25.1, 25.5, 25.8, 29.2, 29.5, 32.6, 33.7, 55.7, 58.8, 63.0, 68.5, 69.4, 70.5, 70.8, 71.7, 76.4, 
77.3, 111.7, 113.5, 120.1, 130.3, 131.6, 147.6, 149.4, 151.3, 173.7; IR (neat); 2930, 2856, 1755, 
1515, 1464;  
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(S)-3-[(S)-9-(tert-Butyldimethylsilanyloxy)-2-(3-methoxy-4-{2-[2-(2-methoxyethoxy)ethoxy] 
ethoxy}benzyloxy)nonyl]-5-methyl-5H-furan-2-one 69c: 1H NMR (500 MHz, CDCl3) δ _0.05 
(s, 6H), 0.80 (s, 9H), 1.16-1.20 (m, 8H), 1.26 (d, J = 6.9 Hz, 2H), 1.40-1.49 (m, 4H), 2.41 (s, 
2H), 3.27 (s, 3H), 3.44-3.45 (m, 2H), 3.50 (t, J = 6.4 Hz, 2H), 3.54-3.61 (m, 5H), 3.61-3.65 (m, 
2H), 3.75 (s, 3H), 3.77 (t, J = 5.0 Hz, 2H), 4.07 (t, J = 5.0 Hz, 2H), 4.34 (d, J = 11.0 Hz, 1H), 
4.37 (d, 11.0 Hz, 1H),  4.88 (q, J = 6.4 Hz, 1H), 6.72-6.78 (m, 3H), 7.01 (s, 1H); 13C NMR (125 
MHz, CDCl3) δ −5.5, 18.0, 18.8, 25.0, 25.4, 25.7, 29.1, 29.4, 32.5, 33.6, 55.6, 58.6, 62.9, 68.4, 
69.3, 70.2, 70.3, 70.5, 70.7, 71.6, 76.3, 77.2, 111.6, 113.4, 120.0, 130.2, 131.5, 147.6, 149.3, 
151.3, 173.6; IR (neat) 2929, 2856, 1755, 1515. HRMS for C35H60O9SiNa: calcd 675.3904, 
found 675.3875. 
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(R)-3-{(S)-9-(tert-Butyldimethylsilanyloxy)-2-[3-methoxy-4-(2-{2-[2-(2-methoxyethoxy) 
ethoxy]ethoxy}ethoxy)benzyloxy]nonyl}-5-methyl-5H-furan-2-one 69d: 1H NMR (500 MHz, 
  
 
CDCl3) δ 0.05 (s, 6H), 0.89 (s, 9H), 1.28-1.34 (m, 8H), 1.39 (d, J = 6.9 Hz, 3H), 1.49-1.60 (m, 
4H), 2.51 (d, J = 6.4 Hz, 2H), 3.38 (s, 3H), 3.53-3.56 (m, 2H), 3.59 (t, J = 6.6 Hz, 2H), 3.65-3.70 
(m, 9H), 3.71-3.75 (m, 2H), 3.85 (s, 3H), 3.87 (t, J = 5.3 Hz, 2H), 4.17 (t, J = 5.3 Hz, 1H), 4.42 
(d, J = 11.5 Hz, 1H), 4.46 (d, J = 11.5 Hz, 1H), 4.95 (q,  J = 6.9 Hz, 1H), 6.80-6.88 (m, 3H), 7.07 
(s, 1H); 13C NMR (125 MHz, CDCl3) δ _5.2, 18.4, 19.2, 25.4, 25.8, 26.1, 29.5, 29.7, 29.8, 32.9, 
34.0, 56.0, 59.1, 63.3, 68.7, 69.7, 70.6, 70.7, 70.9, 71.1, 72.0, 76.7, 77.6, 111.9, 113.7, 120.4, 
130.7, 131.8, 147.9, 149.6, 151.5, 174.0; IR (neat); 2929, 2857, 1754, 1515, 1463; HRMS for 
C37H64O10SiNa: calcd 719.4166, found 719.4186. 
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Alcohol mixture M70: Acetyl chloride10 (11 µL) was added to a 1:1:1:1 mixture of 69a, 69b, 
69c and 69d (0.26 g, 0.39 mmol) in methanol at 0 oC and stirred for 15 min. Then the solution 
was concentrated to yield the alcohol M70. The resulted mixture of alcohol M70 (0.20 g, 99%) 
was spectroscopically pure and was used in next step with out further purification. However, 
spectroscopic data for individual compounds was obtained by repeating the above experimental 
procedure with individual compounds. 
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General procedure 11: (S)-3-{(R)-9-Hydroxy-2-[3-methoxy-4-(2-methoxyethoxy)benzyloxy] 
nonyl}-5-methyl-5H-furan-2-one 70a: Acetyl chloride (11 µL) was added to a solution of 69a 
(30 mg, 0.053 mmol) in methanol and the mixture was stirred for 15 min. Concentration of the 
reaction mixture gave the alcohol 70a (23 mg, 99%) as colorless oil. 1H NMR (300 MHz, 
CDCl3) δ 1.26-1.34 (m, 8H), 1.37 (d, J = 7.1 Hz, 3H), 1.40-1.56 (m, 4H), 1.85 (br s, 1H), 2.49 (d, 
J = 5.5 Hz, 2H), 3.42 (s, 3H), 3.59 (t, J = 6.6 Hz, 2H),  3.63-3.67 (m, 1H), 3.73-3.79 (m, 2H), 
3.84 (s, 3H), 4.13 (t, J = 4.94 Hz, 2H), 4.43 (s, 2H), 4.94 (q, J = 6.59 Hz, 1H), 6.78-6.86 (m, 3H), 
7.07 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 19.1, 25.2, 25.6, 29.3, 29.5, 29.6, 32.7, 33.9, 55.8, 
59.2, 62.8, 68.5, 70.9, 76.4, 111.8, 113.5, 120.4, 130.5, 131.7, 147.8, 149.6, 151.6, 174.0; IR 
(neat) 3406, 2928, 1751, 1515, 1456; EIMS m/z 450 (M+); HRMS for C25H38O7: calcd 450.2617; 
found 467.2637. 
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(R)-3-((R)-9-Hydroxy-2-{3-methoxy-4-[2-(2-methoxyethoxy)ethoxy]benzyloxy}nonyl)-5-
methyl-5H-furan-2-one 70b: General procedure 11 was performed with 69b (20 mg, 0.032 
  
 
mmol) to give 70b (16 mg, 99%) as an oil. 1H NMR (500 MHz, CDCl3) δ 1.26-1.33 (m, 
8H),1.37 (d, J = 6.9 Hz, 3H), 1.39-1.57 (m, 4H), 1.81 (br s, 1H), 2.50-2.54 (m, 2H), 3.39 (s, 3H), 
3.56-3.59 (m, 2H), 3.62 (t, J = 6.64, 2H), 3.63-3.69 (m, 1H), 3.71-3.74 (m, 2H), 3.85 (s, 3H), 
3.88 (t, J = 5.50 Hz, 2H), 4.17 (t, J = 5.0 Hz, 2H), 4.44 (s, 2H), 4.97-5.01 (m, 1H), 6.80 - 6.88 
(m, 3H), 7.08 (s, 1H); 13C NMR (126 MHz, CDCl3) δ 19.1, 25.2, 25.7, 29.4, 29.6, 29.7, 32.8, 
34.0, 56.0, 59.1, 63.0, 68.6, 69.7, 70.8, 71.1, 72.0, 76.5, 77.6, 112.0, 113.6, 120.5, 130.6, 131.7, 
147.9, 149.6, 151.6, 174.1; IR (neat) 3446, 2929, 2857, 1751, 1593, 1515, 1456. EIMS m/z 494. 
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(S)-3-[(S)-9-Hydroxy-2-(3-methoxy-4-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}benzyloxy) 
nonyl]-5-methyl-5H-furan-2-one 70c: General procedure 11 with 69c (35 mg, 0.054 mmol) 
was performed to give 70c (29 mg, 99%) as an oil.  1H NMR (500 MHz, CDCl3) δ 1.23-1.32 (m, 
8H), 1.35 (d, J = 6.9 Hz, 3H), 1.38-1.57 (m, 4H), 1.92 (br s, 1H),  2.46-2.54 (m, 2H), 3.36 (s, 
3H), 3.51-3.54 (m, 2H), 3.59 (t, J = 6.6 Hz, 2H), 3.62-3.67 (m, 5H), 3.70-3.73 (m, 2H), 3.83 (s, 
3H), 3.85(t, J = 5.0 Hz, 2H), 4.15 (t, J = 5.5 Hz, 2H), 4.43 (s, 2H), 3.97 (q, J = 6.9 Hz, 1H), 6.78-
6.86 (m, 3H), 7.08 (s, 1H); 13C NMR (126 MHz, CDCl3) δ 19.1, 25.2, 25.6, 29.3, 29.5, 29.6, 
32.7, 33.9, 55.9, 59.0, 62.8, 68.6, 69.6, 70.5, 70.6, 70.8, 71.0, 71.9, 76.4, 77.5, 111.9, 113.6, 
120.4, 130.5, 131.7, 147.8, 149.5, 151.6, 174.0; EIMS m/z 583 (M + H)+, 582 (M+); HRMS for 
C29H46O9: calcd 538.3142; found 538.3109. 
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(R)-3-{(S)-9-Hydroxy-2-[3-methoxy-4-(2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy} 
ethoxy)benzyloxy]nonyl}-5-methyl-5H-furan-2-one 70d: General procedure with 69d (30 mg, 
0.043) was performed to give 70d (25 mg, 99%) as an oil. 1H NMR (500 MHz, CDCl3) δ 1.20-
1.29 (m, 8H), 1.34 (d, J = 6.9 Hz, 3H), 1.37-1.54 (m, 4H), 2.27 (br s, 1H), 2.46 (d, J = 6.0 Hz, 
2H), 3.32 (s, 3H), 3.48-3.52 (m, 2H), 3.55 (t, J = 6.6 Hz, 2H), 3.58-3.65 (m, 9H), 3.66-3.69 (m, 
2H), 3.80 (s, 3H), 3.82 (t, J = 5.5 Hz, 2H), 4.12 (t, J = 5.0 Hz, 2H), 4.40 (s, 2H), 4.90-4.94 (m, 
1H), 6.75-6.84 (m, 3H), 7.05 (s, 1H); 13C NMR (126 MHz, CDCl3) δ 19.1, 25.1, 25.6, 29.3, 29.4, 
29.5, 32.6, 33.8, 55.8, 58.9, 62.6, 68.6, 69.5, 70.4, 70.5, 70.7, 70.9, 71.8, 76.3, 77.4, 77.5, 111.9, 
113.6, 120.3, 130.4, 131.6, 147.8, 149.5, 151.5, 173.9; IR (neat) 3400, 2929, 1752, 1514, 1456; 
EIMS m/z 583 (M + H)+, 582 (M+); HRMS for C31H50O10: calcd 582.3404; found 582.3430. 
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Adldehyde mixture M62: o-Iodoxybenzoic acid (IBX) (0.40 g, 1.1 mmol) was added to a 
mixture of alcohols M70 (0.18 g, 0.36 mmol) in ethyl acetate (10 mL). The resulting suspension 
was heated, open to the atmosphere, with an oil bath set to 80 oC until TLC indicated complete 
conversion (3 h). Then the reaction mixture was cooled to room temperature, filtered and 
  
 
concentrated to yield a mixture of aldehyde that on column chromatography on silica gel by 
gradient elution (25-70% EtOAc/hexanes) gave the four aldehydes 62 (0.16 g, 0.32 mmol, 90%) 
as separate oils.  
O O
O
O
O
O
O
 
(R)-8-[3-Methoxy-4-(2-methoxyethoxy)benzyloxy]-9-((S)-5-methyl-2-oxo-2,5-dihydrofuran-
3-yl)nonanal (62a): 1HNMR (300 MHz, CDCl3) δ 1.25-1.35 (m, 8H), 1.38 (d, J = 7.1 Hz, 3H), 
1.44-1.63 (m, 2H), 2.41 (td, J = 7.1, 1.6 Hz, 2H), 2.50 (d, J = 5.5 Hz, 2H), 3.43 (s, 3H), 3.61-
3.72 (m, 1H), 3.75-3.78 (m, 2 H), 3.85 (s, 3H), 4.11-4.16 (m, 2H), 4.44 (s, 2H), 4.95 (q, J = 6.6 
Hz, 1H), 6.78-6.89 (m, 3H), 7.07 (s, 1H), 9.75 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 19.2, 22.0, 
25.1, 29.1, 29.4, 29.6, 33.9, 43.9, 55.9, 59.2, 68.5, 71.1, 76.5,111.8, 113.6, 120.4, 130.5, 131.7, 
147.8, 149.6, 151.6, 174.0, 202.8; IR (neat) 2927, 1751, 1720, 1514, 1465; HRMS (ESI) for (M 
+ Na)+ C25H36O7Na: calcd 471.2359; found 471.2380. 
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(R)-8-{3-Methoxy-4-[2-(2-methoxyethoxy)ethoxy]benzyloxy}-9-((R)-5-methyl-2-oxo-2,5-
dihydrofuran-3-yl)nonanal (62b): 1H NMR (500 MHz, CDCl3) δ 1.27-1.32 (m, 8H), 1.35 (d, J 
= 6.9 Hz, 3H), 1.41-1.59 (m, 2H), 2.39 (t, J = 6.6 Hz, 2H), 2.49 (br s, 2H), 3.36 (s, 3H), 3.52-
3.57 (m, 2H), 3.62-3.67 (m, 1 H), 3.67-3.72 (m, 2H), 3.82 (s, 3H), 3.85 (t, J = 5.3 Hz, 2H), 4.15 
  
 
(t, J = 5.3 Hz, 2H), 4.42 (s, 2H), 4.94-4.98 (m, 1H), 6.79 - 6.85 (m, 3H), 7.09 (s, 1H), 9.73 (s, 
1H); 13C NMR (126 MHz, CDCl3) δ 19.0, 21.9, 25.0, 29.0, 29.3, 29.6, 33.8, 43.8, 55.9, 59.0, 
68.6, 69.6, 70.7, 71.0, 71.9, 76.5, 77.5, 111.9, 113.6, 120.3, 130.5, 131.6, 147.8, 149.5, 151.6, 
173.9, 202.7; HRMS (ESI) for (M + Na)+ C27H40O8Na: calcd 515.2621; found 515.2625. 
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O
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(S)-8-(3-Methoxy-4-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}benzyloxy)-9-((S)-5-methyl-2-
oxo-2,5-dihydrofuran-3-yl)nonanal 62c: 1H NMR (300 MHz, CDCl3) δ 1.24-1.28 (m, 8H), 
1.35 (d, J = 6.6 Hz, 2H), 1.41-1.59(m, 2H), 2.40 (t, J = 7.4 Hz, 2H), 2.49 (br s, 2H), 3.36 (s, 3H), 
3.42-3.54 (m, 2H), 3.60-3.76 (m, 9H), 3.83-3.93 (m, 5H), 4.15 (t, J = 5.2 Hz, 2H), 4.33 (s, 2H), 
4.97 (q, J = 6.2 Hz, 1H), 6.79-6.86 (m, 3H), 7.08 (s, 1H), 9.74 (s, 1H); 13C NMR (75 MHz, 
CDCl3) δ 19.0, 21.9, 25.1, 29.0, 29.3, 29.6, 33.8, 43.8, 55.9, 59.0, 68.6, 69.6, 70.5, 70.7, 71.0, 
71.9, 76.5, 76.6, 77.5, 111.9, 113.6, 120.4, 130.5, 131.6, 147.8, 149.5, 151.6, 174.0, 202.8; IR 
(neat) 2927, 1751, 1515, 1457; EIMS m/z 537 (M + H)+, 536 (M+); HRMS for C29H44O9: calcd 
536.2985; found 536.2986. 
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(S)-8-[3-Methoxy-4-(2-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}ethoxy)benzyloxy]-9-((R)-5-
methyl-2-oxo-2,5-dihydrofuran-3-yl)nonanal 62d: 1H NMR (300 MHz, CDCl3) δ 1.26-1.37 
(m, 8H), 1.39 (d, J = 6.6 Hz, 2H), 1.43-1.65 (m, 2H), 2.42 (td, J = 7.1, 1.6 Hz, 2H), 2.51 (d, J = 
5.5 Hz, 2H), 3.38 (s, 3H), 3.53-3.56 (m, 2H), 3.61-3.76 (m, 13H), 3.82-3.92 (m, 5H), 4.17 (t, J = 
5.2 Hz, 2H), 4.44 (s, 2H), 4.91-5.03 (m, 1H), 6.84 (m, 3H), 7.08 (s, 1H), 9.76 (s, 1H); 13C NMR 
(75 MHz, CDCl3) δ 19.1, 21.9, 25.1, 29.1, 29.4, 29.7, 33.9, 43.8, 55.9, 59.0, 68.6, 69.6, 70.6, 
70.8, 71.0, 71.9, 76.5, 76.7, 77.5, 111.9, 113.6, 120.4, 130.5, 131.6, 147.8, 149.6, 151.6, 174.0, 
202.8; IR (neat) 2926, 2855, 1751, 1719, 1515, 1457; HRMS (ESI) (M + Na)+ for C31H48O10Na: 
calcd 603.3145; found 603.3154. 
 
3-[(13R)-2-(3-methoxy-4-n-oligoethoxy-benzyloxy)-13-(4-methoxy-benzyloxy)-13-((2R)-5-
{1-[4-(3-perfluoropropyloxy)benzyloxy]tridecyl}-tetrahydrofuran-2-yl)tridec-9-en-yl]-5-
methyl-5H-furan-2-one (M79) 
O
C12H25
OPMBF OPMB
O
O
O
DMBO1-4
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A solution of sodium hexamethyldisilazane (NaHMDS) (1.0 M in THF, 0.28 mL, 0.28 mmol) 
was added under argon to a solution of the sulfone mixture M13 (0.30 g, 0.26 mmol) in THF at – 
78 ºC. The reaction mixture was stirred for 30 min at – 78 ºC followed by the addition of a 
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solution of the aldehyde mixture M62 (0.14 g, 0.28 mmol) in THF. The resulting mixture was 
then warmed to room temperature overnight and H2O was added. The layers were separated and 
the aqueous layer was further extracted with Et2O (3 x 20mL). The combined organic layers 
were washed with brine, dried over MgSO4 and concentrated under vacuum. The residue was 
purified by gradient flash chromatography (ethyl acetate/hexanes 20%, 40%, 60% and then pure 
ethyl acetate) on silica gel to yield the mixture M79 (0.27 g, 0.18 mmol, 71%) as an oil; LCMS 
(APCI)11 for M79: M79a m/z: 1159 (M1 + 1)+, 1176 (M1 + H2O)+, 1203 (M2 + 1)+, 1220 (M2 + 
H2O)+, 1264 (M3 + H2O)+, 1308 (M4 + H2O)+; M79b m/z: 1259 (M1 + 1)+, 1276 (M1 + H2O)+, 
1303 (M2 + 1)+, 1320 (M2 + H2O)+, 1347 (M3 + 1)+, 1364 (M3 + H2O)+, 1391 (M4 + 1)+, 1408 (M4 
+ H2O)+, 367 [C4F9(CH2)3OC6H4CH2]+; M79c m/z: 1376 (M1 + H2O)+, 1403 (M2 + 1)+, 1420 (M2 
+ H2O)+, 1447 (M3 + 1)+, 1464 (M3 + H2O)+, 1491 (M4 + 1)+, 1508 (M4 + H2O)+, 467 
[C6F13(CH2)3OC6H4CH2]+; M79d m/z: 1459 (M1 + 1)+, 1476 (M1 + H2O)+, 1520 (M2 + H2O)+, 
1564 (M3 + H2O)+, 1608 (M4 + H2O)+, 1444 [M1 - CH3O]+, 1488 [M2 - CH3O]+, 567 
[C8F17(CH2)3OC6H4CH2]+. 
 
Hydrogenation of M79: A solution of alkene M79 (0.27 g, 0.18 mmol), Wilkinson’s catalyst 
(22 mg, 0.024 mmol) in ethanol was stirred under H2 atmosphere (1.0 atm) for 18 h and then 
filtered through a pad of celite. The filtrate was concentrated to give M11 (0.32 g) as dark brown 
oil. The crude product was subjected to simultaneous purification and demixing as described 
below. 
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Demixing of final 16 compounds mixture M11: 
OEG demixing: Purification and OEG demixing of the final mixture M11 was done 
simultaneously by a careful flash column chromatography on silica gel. Gradient elution was 
performed with ethyl acetate/hexanes (20%, 40%, 60%, 80% then pure ethyl acetate). 
Compounds eluted in the following order: 11-O1 (52 mg), 11-O2 (66 mg), 11-O3 (55 mg), and 
11-O4 (50 mg, contaminated by Wilkinson catalyst). LCMS data for the four fractions are given 
below. 
3-{(2R,13R)-2-[3-Methoxy-4-(2-methoxyethoxy)benzyloxy]-13-(4-methoxybenzyloxy)-13-
((2R)-5-{1-[4-(3-perfluoropropyloxy)benzyloxy]tridecyl}-tetrahydrofuran-2-yl)tridecyl}-
(5S)-5-methyl-5H-furan-2-one (11-O1). 
O
C12H25
OPMBF OPMB
O
O
O
DMBO1
 
LCMS (APCI) for 11-O1: 11-O1-F5 m/z: 1178 (M + H2O)+, 965, 581, 267 
[C2F5(CH2)3OC6H4CH2]+; 11-O1-F9 m/z: 1278 (M + H2O)+, 1139 (M - PMB)+, 581, 367 
[C4F9(CH2)3OC6H4CH2]+; 11-O1-F13 m/z: 1378 (M + H2O)+, 1239 (M - PMB)+, 581, 467 
[C6F13(CH2)3OC6H4CH2]+; 11-O1-F17 m/z: 1478 (M + H2O)+, 581, 567, 
[C8F17(CH2)3OC6H4CH2]+. 
3-{(2R,13R)-2-[3-Methoxy-4-[(2-methoxyethoxy)ethoxy]benzyloxy]-13-(4-methoxybenzyl 
oxy)-13-((2R)-5-{1-[4-(3-perfluoropropyloxy)benzyloxy]tridecyl}-tetrahydrofuran-2-yl) 
tridecyl}-(5R)-5-methyl-5H-furan-2-one (11-O2): 
O
C12H25
OPMBF OPMB
O
O
O
DMBO2
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LCMS (APCI) for 11-O2: 11-O2-F5 m/z: 1222 (M + H2O)+, 581, 561, 267 
[C2F5(CH2)3OC6H4CH2]+; 11-O2-F9 m/z: 1322 (M + H2O)+, 581, 561, 367 
[C4F9(CH2)3OC6H4CH2]+; 11-O2-F13 m/z: 1422 (M + H2O)+, 581, 561, 467 
[C6F13(CH2)3OC6H4CH2]+; 11-O2-F17 m/z: 1522 (M + H2O)+, 581, 567 
[C8F17(CH2)3OC6H4CH2]+. 
3-{(2S,13R)-2-(3-Methoxy-4-{[(2-methoxy-ethoxy)-ethoxy]-ethoxy}-benzyloxy)-13-(4-meth 
oxy-benzyloxy)-13-((2R)-5-{1-[4-(3-perfluoropropyloxy)benzyloxy]tridecyl}-tetrahydro 
furan-2-yl)tridecyl}-(5S)-5-methyl-5H-furan-2-one (11-O3). 
O
C12H25
OPMBF OPMB
O
O
O
DMBO3
 
 
LCMS (APCI) for 11-O3: 11-O3-F5 m/z: 1266 (M + H2O)+, 581, 561, 267 
[C2F5(CH2)3OC6H4CH2]+; 11-O3-F9 m/z: 1366 (M + H2O)+, 581, 561, 403, 367 
[C4F9(CH2)3OC6H4CH2]+; 11-O3-F13 m/z: 1466 (M + H2O)+, 581, 561, 467 
[C6F13(CH2)3OC6H4CH2]+; 11-O3-F17 m/z: 1566 (M + H2O)+, 581, 567 
[C8F17(CH2)3OC6H4CH2]+. 
 
3-{(2S,13R)-2-[3-Methoxy-4 -({[(2-methoxy-ethoxy)-ethoxy]-ethoxy}-ethoxy)-benzyloxy]-13 
-(4-methoxy-benzyloxy)-13-((2R)–5-{1-[4-(3-perfluoropropyloxy)-benzyloxy]-tridecyl} 
tetrahydrofuran -2-yl)tridecyl}-(5R) -5-methyl-5H-furan-2-one (11-O4). 
O
C12H25
OPMBF OPMB
O
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O
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LCMS (APCI) for 11-O4: 11-O4-F5 m/z: 1310 (M + H2O)+, 279; 11-O4-F9 m/z: 1410 (M + 
H2O)+, 279; 11-O4-F13 m/z: 1510 (M + H2O)+, 279; 11-O4-F17 m/z: 1610 (M + H2O)+, 279. 
 
General procedure: Fluorous demixing 11-O1: Semiprep HPLC separation was carried out on 
Waters HPLC system using FluoroFlash HPLC column (20 x 250 mm). The mixture 11-O1 (52 
mg) was dissolved in 1.5 mL of CH3CN and filtered through a Wattman filter paper (0.45 µm 
pore size). Two separations using 1.5 mL and another separation using 1 mL were carried out. 
The column was eluted under a linear gradient plus an isocratic for 35min with a flow rate of 15 
mL/min. The gradient started with 85% CH3CN/15% H2O and ended with 100% CH3CN in 
25min. The isocratic was performed with 100% CH3CN for 10min elution. In each injection, the 
four fractions with retention time of ~10min, ~15min, ~19min and ~23min were collected 
separately and concentrated to give 11-O1-F5 (2.5 mg, 2.0 µmol), 11-O1-F9 (4.7 mg, 4.0 µmol), 
11-O1-F13 (8.8 mg, 6.0 µmol) and 11-O1-F17 (23 mg, 15 µmol) respectively.  
 
(S)-3-[(2R,13R)-13-(4-Methoxy-benzyloxy)-2-[3-methoxy-4-(2-methoxy-ethoxy)- benzyloxy] 
-13-((2R,5S)-5-{(R)-1-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-benzyloxy]-tridecyl}-tetrahydro-
furan-2-yl)-tridecyl]-5-methyl-5H-furan-2-one (11-O1-F5) 
O
C12H25
OPMB
O
O
O
OPMBF5
DMBO1
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1H NMR (500 MHz, CDCl3) δ 0.89 (t, J = 6.6 Hz, 3H), 1.25-1.36 (m, 36H), 1.39 (d, J = 6.9 Hz, 
3H), 1.42-1.58 (m, 6H), 1.82-1.91 (m, 2H), 2.02-2.11 (m, 3H), 2.21-2.32 (m, 3H), 2.52 (d, J = 
5.5 Hz, 2H), 3.32-3.37 (m, 1H), 3.45 (s, 3H), 3.51-3.54 (m,1H), 3.65-3.73 (m, 1H), 3.77-3.79 (m, 
5H), 3.86 (s, 3H), 3.88- 3.93 (m, 2H), 4.01 (t, J = 6.0 Hz, 2H), 4.15-4.17 (m, 2H), 4.42-4.50 (m, 
2H), 4.53 (t, J = 10.3 Hz, 2H), 4.62 (d, J = 11.0 Hz, 1 H), 4.71 (d, J = 11.0 Hz, 1H), 4.93-4.97 
(m, 1H), 6.81-6.97 (m, 1H), 7.07 (s, 1H), 7.23-7.32 (m, 4H); 19F NMR (282.4 MHz, CDCl3) δ 
−117.1 (t, J = 19.7 Hz, 2F), −84.2 (3F); 
 
(S)-3-[(2R,13R)-13-(4-Methoxy-benzyloxy)-2-[3-methoxy-4-(2-methoxy-ethoxy)-benzyloxy]-
13-((2R,5S)-5-{(S)-1-[4-(4,4,5,5,6,6,7,7,7-nonafluoro-heptyloxy)-benzyloxy]-tridecyl}-tetra 
hydro-furan-2-yl)-tridecyl]-5-methyl-5H-furan-2-one (11-O1-F9) 
O
C12H25
OPMB
O
O
O
OPMBF9
DMBO1
 
1H NMR (500 MHz,CDCl3) δ  0.89 (t, J = 6.6 Hz, 3H), 1.26-1.36 (s, 36H), 1.39 (d, J = 6.6 Hz, 
3H), 1.43-1.65 (m, 6H), 1.77-1.91 (m, 2H), 2.07-2.14 (m, 3H), 2.22-2.41 (m, 3 H), 2.52 (d, J = 
6.0 Hz, 2H), 3.31-3.42 (m, 2H), 3.45 (s, 3H), 3.64-3.72 (m, 1 H), 3.76-3.81 (m, 5H), 3.86 (s, 
3H), 3.93-3.97 (m, 2H), 4.01 (t, J = 5.8 Hz, 2H), 4.16 (t, J = 4.9 Hz, 2H), 4.41-4.50 (m, 2H), 4.55 
(d, J = 11.0 Hz, 2H), 4.65-4.77 (m, 2H), 4.92-4.98 (m, 1H), 6.81-6.89 (m, 7H), 7.07 (s, 1H), 
7.26-7.28 (m, 4H); 19F NMR (282.4 MHz, CDCl3) δ −124.8 (2F), −123.2 (2F), −113.4 (2F), 
−79.8 (3F); 
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(S)-3-[(2R,13R)-13-(4-Methoxy-benzyloxy)-2-[3-methoxy-4-(2-methoxy-ethoxy)-benzyloxy]-
13-((2R,5R)-5-{(S)-1-[4-(4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluoro-nonyloxy)-benzyloxy]-
tridecyl}-tetrahydro-furan-2-yl)-tridecyl]-5-methyl-5H-furan-2-one (11-O1-F13) 
C12H25
OPMB
O
O
O
OPMBF13
O
DMBO1
 
1H NMR (500 MHz, CDCl3) δ 0.89 (t, J = 6.9 Hz, 3H), 1.25-1.36 (m, 36H), 1.39 (d, J = 6.9 Hz, 
3H), 1.42-1.65 (m, 6H),1.92-1.96 (m, 2H), 2.07-2.13 (m, 3H), 2.26-2.36 (m, 3H), 2.52 (d, J = 5.5 
Hz, 2H), 3.29-3.32 (m, 1H), 3.45 (s, 3H), 3.55-3.59 (m, 1H), 3.67-3.72 (m, 1H), 3.76-3.82 (m, 
5H), 3.86 (s, 3H), 3.98-4.07 (m, 4H), 4.16 (t, J = 5.04 Hz, 2H), 4.43 (d, J = 11.0 Hz, 2H), 4.47 
(d, J = 11.4 Hz, 1H), 4.55 (d, J = 11.0 Hz, 2H), 4.62-4.66 (m, 1H), 4.71 (d, J = 11.0 Hz, 1H), 
4.95 (q, J = 6.6 Hz, 1H), 6.81-6.89 (m, 7H), 7.07 (s, 1H), 7.24- 7.30 (m, 4H); 19F NMR (282.4 
MHz, CDCl3) δ −124.9 (2F), −122.2 (2F), −121.7 (2F), −120.7 (2F), −113.2 (2F), −79.6 (3F); 
 
(S)-3-{(2R,13R)-13-((2R,5R)-5-{(R)-1-[4-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-hepta 
decafluoro-undecyloxy)-benzyloxy]-tridecyl}-tetrahydro-furan-2-yl)-13-(4-methoxy-
benzyloxy)-2-[3-methoxy-4-(2-methoxy-ethoxy)-benzyloxy]-tridecyl}-5-methyl-5H-furan-2-
one (11-O1-F17)  
O
C12H25
OPMB
O
O
O
OPMBF17
DMBO1
 
1H NMR (500 MHz,CDCl3) δ 0.81 (t, J = 6.9 Hz, 3H), 1.18-1.29 (m, 36H), 1.31 (d, J = 6.9 Hz, 
3H), 1.34-1.55 (m, 6H), 1.82-1.87 (m, 2H), 1.97-2.04 (m, 3H), 2.18-2.28 (m, 3H), 2.44 (d, J = 
5.5 Hz, 2H), 3.20-3.28 (m, 2H), 3.37 (s, 3H), 3.69-3.72 (m, 5H), 3.78 (s, 3H), 3.93 (t, J = 5.7 Hz, 
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2H), 3.94-3.99 (m, 2H), 4.08 (t, J = 5.0 Hz, 2H), 4.34 - 4.41 (m, 2H), 4.50 (d, J = 11.0 Hz, 2H), 
4.70 (d, J = 11.0 Hz, 2H), 4.85-4.89 (m, 1H), 6.73-6.80 (m, 7H), 6.99 (s, 1H), 7.19-7.22 (m, 4H); 
13C NMR (126 MHz,CDCl3) δ 14.2, 19.2, 20.7, 22.8, 25.4, 25.8, 28.0, 28.9, 29.4, 29.7, 31.2, 
32.0, 34.1, 55.3, 55.9, 59.2, 66.4, 68.6, 71.0, 72.6, 77.6, 81.4, 111.8, 113.7, 114.2, 120.4, 129.5, 
130.7, 131.6, 131.9, 132.0, 147.9, 149.7, 151.5, 158.0, 159.0, 174.0 19F NMR (282.4 MHz, 
CDCl3) δ −124.9 (2F), −122.2 (2F), −121.5 (2F), −120.7 (4F), −120.5 (2F), −113.2 (2F), −79.6 
(3F). 
 
Demixing of 11-O2: Mixture 11-O2 (66 mg) was demixed by general procedure to give 
compounds 11-O2-F5 (6.3 mg), 11-O2-F9 (7.4 mg), 11-O2-F13 (9.5 mg) and 11-O2-F17 (33 
mg). 
(R)-3-[(2R,13R)-13-(4-Methoxy-benzyloxy)-2-{3-methoxy-4-[2-(2-methoxy-ethoxy)-ethoxy]-
benzyloxy}-13-((2R,5S)-5-{(R)-1-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-ben zyloxy]-tridecyl}-
tetrahydro-furan-2-yl)-tridecyl]-5-methyl-5H-furan-2-one (11-O2-F5) 
O
C12H25
OPMB
O
O
O
OPMBF5
DMBO2
 
1H NMR (500 MHz, CDCl3) δ 0.89 (t, J = 6.9 Hz, 3H), 1.26-1.35 (m, 36H), 1.37 (d, J = 6.9 Hz, 
3H), 1.42 - 1.60 (m, 6H), 1.82 - 1.91 (m, 2H), 2.05 - 2.12 (m, 3H), 2.21-2.32 (m, 3H), 2.52 (m, 
2H), 3.21-3.28 (m, 1H), 3.32-3.38 (m, 2H), 3.40 (s, 3H), 3.51-3.56 (m, 1H), 3.57-3.59 (m, 1H), 
3.65-3.71 (m, 1H), 3.72-3.75 (m, 1H), 3.78 (s, 3H), 3.86 (s, 3H), 3.87-3.91 (m, 4H), 4.19 (t, J = 
5.3 Hz, 2H), 4.42 - 4.50 (m, 3H), 4.50-4.57 (m, 2H), 4.62 (d, J = 11.5 Hz, 1H), 4.71 (d, J = 11.0 
Hz, 1H), 4.76-4.83 (m, 1H), 4.85 (d, J = 6.4Hz, 1H), 4.94-5.01 (m, 1H), 6.83-6.88 (m, 7 H), 7.09 
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(s, 1H), 7.23-7.31 (m, 4H); 19F NMR (282.4 MHz, CDCl3) δ −117.1 (t, J = 19.7 Hz, 2F), −84.2 
(3F). 
 
 (R)-3-[(2R,13R)-13-(4-Methoxy-benzyloxy)-2-{3-methoxy-4-[2-(2-methoxy-ethoxy)-ethoxy]-
benzyloxy}-13-((2R,5S)-5-{(S)-1-[4-(4,4,5,5,6,6,7,7,7-nonafluoro-heptyloxy)-benzyloxy]-
tridecyl}-tetrahydro-furan-2-yl)-tridecyl]-5-methyl-5H-furan-2-one (11-O2-F9) 
O
C12H25
OPMB
O
O
O
OPMBF9
DMBO2
 
1H NMR (500 MHz, CDCl3) δ 0.89 (t, J = 6.9 Hz, 3H), 1.26-1.32 (m, 36 H), 1.37 (d, J = 6.9 Hz, 
3H), 1.40-1.61 (m, 6H), 1.83-1.87 (m, 2H), 2.07-2.12 (m, 3H), 2.26-2.36 (m, 3H), 2.52 (br s, 
2H), 3.21-3.29 (m, 1H), 3.34-3.39 (m, 2H), 3.40 (s, 3H), 3.55-3.60 (m, 2H), 3.65-3.71 (m, 1H), 
3.72-3.75 (m, 2H), 3.79 (s, 3H), 3.86 (s, 3H), 3.87-3.91 (m, 2H), 3.95-3.96 (m, 2H), 4.01 (t, J = 
6.0 Hz, 2H), 4.19 (t, J = 5.3 Hz, 2H), 4.42-4.51 (m, 2H), 4.54-4.57 (m, 2H), 4.73 (dd, J = 11.2, 
3.0 Hz, 2H), 4.76-4.82 (m, 2H), 4.94-5.01 (m, 1H), 6.81-6.90 (m, 7H), 7.08 (s, 1H), 7.25-7.30 
(m, 4H); 19F NMR (282.4 MHz, CDCl3) δ −124.8 (2F), −123.2 (2F), −113.4 (2F), −79.8 (3F). 
 
(R)-3-[(2R,13R)-13-(4-Methoxy-benzyloxy)-2-{3-methoxy-4-[2-(2-methoxy-ethoxy)-ethoxy]-
benzyloxy}-13-((2R,5R)-5-{(S)-1-[4-(4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluoro-nonyloxy)-
benzyloxy]-tridecyl}-tetrahydro-furan-2-yl)-tridecyl]-5-methyl-5H-furan-2-one(11-O2-F13) 
C12H25
OPMB
O
O
O
OPMBF13
O
DMBO2
 
1H NMR (500 MHz, CDCl3) δ 0.89 (t, J = 6.9 Hz, 3H), 1.25-1.32 (m, 36H), 1.37 (d, J = 6.9 Hz, 
3H), 1.40 (s, 2 H), 1.40-1.60 (m, 6H), 1.89-1.96 (m, 2H), 2.06-2.15 (m, 3H), 2.50-2.53 (m, 2H), 
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3.29-3.32 (m, 2H), 3.40 (s, 3H), 3.53-3.60 (m, 2H), 3.66-3.72 (m, 1H), 3.72-3.75 (m, 2H), 3.80 
(s, 3H), 3.86 (s, 3H), 3.87-3.91 (m, 2H), 3.98-4.07 (m, 4H), 4.19 (t, J = 5.3 Hz, 2H), 4.43 (d, J = 
11.5 Hz, 1H), 4.47 (d, J = 11.0 Hz, 1H), 4.53 (d, J = 11.0 Hz, 1H), 4.64 (d, J = 11.0 Hz, 1H), 
4.71 (d, J = 11.0 Hz, 1H), 4.96-5.01 (m, 1H), 6.81-6.90 (m, 7H), 7.09 (s, 1H), 7.24-7.33 (m, 4H); 
19F NMR (282.4 MHz, CDCl3) δ −124.9 (2F), −122.2 (2F), −121.7 (2F), −120.7 (2F),  −113.2 
(2F), −79.6 (3F); 
 
(R)-3-((2R,13R)-13-((2R,5R)-5-{(R)-1-[4-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-hepta decafluo 
ro-undecyloxy)-benzyloxy]-tridecyl}-tetrahydro-furan-2-yl)-13-(4-methoxy-benzyloxy)-2-
{3-cmethoxy-4-[2-(2-methoxy-ethoxy)-ethoxy]-benzyloxy}-tridecyl)-5-methyl-5H-furan-2-
one (11-O2-F17) 
O
C12H25
OPMB
O
O
O
OPMBF17
DMBO2
 
1H NMR (500 MHz, CDCl3) δ 0.88 (t, J = 6.9 Hz, 3H), 1.26-1.31 (m, 36H), 1.37 (d, J = 6.9 Hz, 
3H), 1.41-1.62 (m, 6H), 1.92-1.99 (m, 2H), 2.05-2.14 (m, 3H), 2.27-2.36 (m, 3H), 2.52 (br s, 
2H), 3.28-3.35 (m, 1H), 3.39 (s, 3H), 3.57-3.58(m, 2H), 3.65-3.71 (m, 2H), 3.71-3.76 (m, 2H), 
3.78 (s, 3H), 3.86 (s, 3H), 3.87-3.92 (m, 3H), 4.03-4.06 (m, 5H), 4.19 (t, J = 5.3 Hz, 2H), 4.43 (d, 
J = 11.0 Hz, 1H), 4.47 (d, J = 11.0 Hz, 1H), 4.58 (d, J = 11.0 Hz, 1H), 4.78 (d, J = 11.0 Hz, 1H), 
4.96-5.01 (m, 1H), 6.81-6.91 (m, 7H), 7.08 (s, 1H), 7.26-7.32 (m, 4H); 13C NMR (76 MHz, 
CDCl3) δ 14.1, 19.1, 20.6, 22.7, 25.4, 25.7, 27.7, 28.0, 28.3, 28.9, 29.4, 29.7, 31.2, 32.0, 34.0, 
55.3, 55.9, 59.1, 66.4, 68.7, 69.7, 70.8, 71.1, 72.0, 72.7, 77.3, 81.4, 82.4, 111.9, 113.7, 114.3, 
120.4, 129.5, 130.7, 131.6, 131.8, 132.0, 147.9, 149.6, 151.6, 158.0, 159.0, 174.1; 19F NMR 
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(282.4 MHz, CDCl3) δ −124.9 (2F), −122.2 (2F), −121.5 (2F),  −120.7 (4F), −120.5 (2F), −113.2 
(2F), −79.5 (3F). 
 
Demixing of 11-O3: Mixture 11-O3 (55 mg) was demixed by general procedure to give 
compounds 11-O3-F5 (3.8 mg), 11-O3-F9 (5.9 mg), 11-O3-F13 (6.6 mg) and 11-O3-F17 (15 
mg). 
 
(S)-3-[(2S,13R)-13-(4-Methoxy-benzyloxy)-2-(3-methoxy-4-{2-[2-(2-methoxy-ethoxy)-ethoxy 
]-ethoxy}-benzyloxy)-13-((2R,5S)-5-{(R)-1-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-benzyloxy]-
tridecyl}-tetrahydro-furan-2-yl)-tridecyl]-5-methyl-5H-furan-2-one (11-O3-F5) 
O
C12H25
OPMB
O
OOPMBF5
O
DMBO3
11-O3-F5  
1H NMR (500 MHz, CDCl3) δ 0.89 (t, J = 7.1 Hz, 3H), 1.26-1.36 (m, 36H), 1.37 (d, J = 6.9 Hz, 
3H), 1.40-1.64 (s, 6H), 1.84-1.90 (m, 2H), 2.01-2.11 (m, 3H), 2.21-2.32 (m, 3H), 2.53 (d, J = 5.0 
Hz, 2H), 3.31-3.36 (m, 1H), 3.38 (s, 3H), 3.50-3.58 (m, 3H), 3.65-3.69 (m, 4H), 3.73-3.75 (m, 
2H), 3.78 (s, 3H), 3.85 (s, 3H), 3.87-3.94 (m, 2H), 4.01 (t, J = 6.0 Hz, 2H), 4.17 (t, J = 5.0 Hz, 
2H), 4.43 (d, J = 11.0 Hz, 1H), 4.47 (d, J = 11.0 Hz, 1H) 4.50-4.57 (m, 2H), 4.62 (d, J = 11.0 Hz, 
1H), 4.70 (d, J = 11.0 Hz, 1H), 4.99 (q, J = 6.6 Hz, 1H), 6.81 - 6.90 (m, 7H), 7.08 (s, 1H), 7.23-
7.32 (m, 4H); 19F NMR (282.4 MHz, CDCl3) δ −117.1 (t, J = 19.7 Hz, 2F), −84.2 (3F). 
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(S)-3-[(2S,13R)-13-(4-Methoxy-benzyloxy)-2-(3-methoxy-4-{2-[2-(2-methoxy-ethoxy)-ethoxy 
]-ethoxy}-benzyloxy)-13-((2R,5S)-5-{(S)-1-[4-(4,4,5,5,6,6,7,7,7-nonafluoro-heptyloxy)-benzy 
loxy]-tridecyl}-tetrahydro-furan (11-O3-F9) 
O
C12H25
OPMB
O
OOPMBF9
O
DMBO3
 
1H NMR (500 MHz, CDCl3) δ 0.89 (t, J = 6.9 Hz, 3H), 1.26-1.34 (s, 36H), 1.37 (d, J = 6.9 Hz, 
3H), 1.41-1.64 (m, 6H), 1.81-1.90 (m, 2H), 2.06-2.12 (m, 3H), 2.27-2.36 (m, 3 H), 2.53 (d, J = 
4.6 Hz, 2H), 3.34-3.41 (m, 5H), 3.54-3.58 (m, 2H), 3.65-3.69 (m, 5H), 3.73- 3.75 (m, 2H), 3.79 
(s, 3H), 3.86 (s, 3H), 3.88 (t, J = 5.0 Hz, 2H), 3.93-3.96 (m, 2H), 4.01 (t, J = 5.7 Hz, 2H), 4.17 (t, 
J = 5.3 Hz, 2H), 4.43 (d, J = 11.5 Hz, 1H), 4.47 (d, J = 11.5 Hz, 1H), 4.55 (dd, J = 11.0, 1.8 Hz, 
2H), 4.73 (dd, J = 11.2, 3.0 Hz, 2H), 4.96-5.01 (m, 1H), 6.82-6.88 (m, 7H), 7.08 (s, 1H), 7.26-
7.28 (m, 4H); 19F NMR (282.4 MHz, CDCl3) δ −124.8 (2F), −123.2 (2F), −113.4 (2F), −79.8 
(3F); 
 
(S)-3-[(2S,13R)-13-(4-Methoxy-benzyloxy)-2-(3-methoxy-4-{2-[2-(2-methoxy-ethoxy)-ethoxy 
]-ethoxy}-benzyloxy)-13-((2R,5R)-5-{(S)-1-[4-(4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluoro-nonyl 
oxy)-benzyloxy]-tridecyl}-tetrahydro-furan-2-yl)-tridecyl]-5-methyl-H-furan-2-one (11-O3-
F13) 
C12H25
OPMB
O
OOPMBF13
O
O
DMBO3
 
1H NMR (500 MHz, CDCl3) δ 0.88 (t, J = 6.4 Hz, 3H), 1.25-1.36 (m, 36H), 1.37 (d, J = 6.4 Hz, 
3H), 1.40-1.64 (m, 6H), 1.90-1.96 (m, 2H), 2.07-2.11 (m, 3H), 2.26-2.36 (m, 3H), 2.52 (br s, 
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2H), 3.28-3.33 (m, 1H), 3.39 (s, 3H), 3.56 (br s, 3H), 3.65-3.74 (m, 8H), 3.79 (s, 3H), 3.86-3.88 
(m, 5H), 4.01-4.04 (m, 3H), 4.17 (br s, 2H), 4.43 (d, J = 11.5 Hz, 1H), 4.47 (d, J = 11.5 Hz, 1H),  
4.55 (d, J = 11.0 Hz, 2H), 4.61-4.66 (m, 1H), 4.71 (d, J = 11.0 Hz, 1H), 4.96-5.02 (m, 1H), 6.81-
6.89 (m, 7H), 7.09 (s, 1H), 7.24-7.31 (m, 4H); 19F NMR (282.4 MHz, CDCl3) δ −124.9 (2F), 
−122.2 (2F), −121.7 (2F), −120.7 (2F),  −113.2 (2F), −79.6 (3F). 
 
(S)-3-{(2S,13R)-13-((2R,5R)-5-{(R)-1-[4-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-hepta 
decafluoro-undecyloxy)-benzyloxy]-tridecylnonyl}-tetrahydro-furan-2-yl)-13-(4-methoxy-
benzyloxy)-2-(3-methoxy-4-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-benzyloxy)-tridecyl}-
5-methyl-5H-furan-2-one (M11-O3-F17) 
O
C12H25
OPMB
O
OOPMBF17
O
DMBO3
 
1H NMR (500 MHz, CDCl3) δ 0.89 (t, J = 6.9 Hz, 3H), 1.26-1.33 (m, 36H), 1.37 (d, J = 6.9 Hz, 
3H), 1.40-1.65 (m, 6H), 1.89-1.96 (m, 2H), 2.07-2.13 (m, 3H), 2.26-2.38 (m, 3H), 2.52 (2, 2H), 
3.29-3.33 (m, 1H), 3.38 (s, 3H), 3.55-3.56 (m, 2H), 3.65-3.69 (m, 5H), 3.73-3.76 (m, 2H), 3.78 
(s, 3H), 3.86 (s, 3H), 3.88 (t, J = 5.0 Hz, 2H), 4.00-4.05 (m, 5H), 4.17 (t, J = 5.3 Hz, 2H), 4.43 
(d, J = 11.5 Hz, 1H), 4.47 (d, J = 11.5 Hz, 1H), 4.57 (d, J = 11.5 Hz, 2H), 4.78 (d, J = 11.5 Hz, 
2H), 4.96-5.01 (m, 1H), 6.82-6.88 (m, 7H), 7.09 (s, 1H), 7.25-7.29 (m, 4H); 13C NMR (76 MHz, 
CDCl3) δ 2.0, 14.2, 19.2, 20.7, 22.8, 25.4, 25.8, 28.1, 28.9, 29.5, 29.8, 31.3, 32.0, 34.1, 55.3, 
56.0, 59.1, 66.4, 68.7, 69.7, 70.6, 70.9, 71.1, 72.0, 72.7, 81.4, 82.4, 112.0, 113.7, 114.3, 120.4, 
129.6, 130.8, 131.6, 131.8, 132.1, 148.0, 149.7, 151.6, 158.0, 159.1, 174.1 19F NMR (282.4 
MHz, CDCl3) δ −124.9 (2F), −122.2 (2F), −121.5 (2F), −120.7 (4F), −120.5 (2F), −113.2 (2F), 
−79.6 (3F). 
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O
C12H25
OPMB
O
OOPMBF5
O
DMBO4
O
C12H25
OPMB
O
OOPMBF9
O
DMBO4
 
Demixing of 11-O4: Mixture 11-O4 (45 mg) was demixed by general procedure to give 
compounds 11-O4-F5 (3.8 mg), 11-O4-F9 (6.1 mg), 11-O4-F13 (5.4 mg) and 11-O4-F17 (13 
mg). 
(R)-3-[(2S,13R)-13-(4-Methoxy-benzyloxy)-2-[3-methoxy-4-(2-{2-[2-(2-methoxy-ethoxy)-
ethoxy]-ethoxy}-ethoxy)-benzyloxy]-13-((2R,5S)-5-{(R)-1-[4-(4,4,5,5,5-pentafluoro-pentyl 
oxy)-benzyloxy]-tridecyl}-tetrahydro-furan-2-yl)-tridecyl]-5-methyl-5H-furan-2-one (11-
O4-F5) 
 
 
1H NMR (500 MHz, CDCl3) δ 0.89 (t, J = 6.9 Hz, 3H), 1.25-1.37 (s, 36H),1.39 (d, J = 6.9 Hz, 
3H), 1.42-1.64 (m, 6H), 1.82-1.91 (m, 2H), 2.06-2.11 (m, 3H), 2.23-2.32 (m, 3H), 2.52 (d, J = 
4.6 Hz, 2H), 3.31-3.35 (m, 1H), 3.38 (s, 3H), 3.51-3.57 (m, 3H), 3.64-3.71 (m, 9H), 3.72-3.75 
(m, 2H), 3.78 (s, 3H), 3.85 (s, 3H), 3.86-3.93 (m, 4H), 4.02 (t, J = 5.7 Hz, 2H), 4.17 (t, J = 5.0 
Hz, 1H), 4.43 (d J = 11.5, 1H), 4.47 (d, J = 11.5 Hz, 1H) 4.53 (m, 2H), 4.62 (d, J = 11.0 Hz, 1H), 
4.71 (d, J = 11.0 Hz, 1H), 4.93-4.98 (m, 1H), 6.80-6.88 (m, 7H), 7.07 (s, 1H), 7.23-7.31 (m, 4H); 
19F NMR (282.4 MHz, CDCl3) δ −117.1 (t, J = 19.7 Hz, 2F), −84.2 (3F). 
(R)-3-[(2S,13R)-13-(4-Methoxy-benzyloxy)-2-[3-methoxy-4-(2-{2-[2-(2-methoxy-ethoxy)-
ethoxy]-ethoxy}-ethoxy)-benzyloxy]-13-((2R,5S)-5-{(R)-1-[4-(4,4,5,5,6,6,7,7,7-nonafluoro-
heptyloxy)-benzyloxy]-tridecyl}-tetrahydro-furan-2-yl)-tridecyl]-5-methyl-5H-furan-2-one 
(11-O4-F9) 
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1H NMR (500 MHz, CDCl3) δ 0.89 (t, J = 6.9 Hz, 3H), 1.26-1.36 (m, 36H), 1.39 (d, J = 6.4 Hz, 
3H), 1.42-1.65 (m, 6H), 1.81-1.91 (m, 2H), 2.05-2.12 (m, 3H), 2.21-2.32 (m, 3H), 2.52 (d, J = 
5.5 Hz, 2H), 3.36-3.42 (m, 5H), 3.53-3.59 (m, 2H), 3.64-3.74 (m, 12H), 3.79 (s, 3H), 3.86 (s, 
3H), 3.88 (t, J = 5.0 Hz, 2H), 3.94-3.96 (d, J = 4.1 Hz, 2H), 4.02 (t, J = 6.0 Hz, 2H), 4.17 (t, J = 
5.0 Hz, 2H), 4.43 (d, J = 11.0 Hz, 1H), 4.47 (d, J = 11.0 Hz, 1H), 4.56 (d, J = 11.0 Hz, 1H), 4.73 
(dd, J = 11.5, 2.7 Hz, 2H), 4.96 (q, J = 6.9 Hz, 1H), 6.80-6.89 (m, 7H), 7.07 (s, 1H), 7.26-7.28 
(m, 4H); 19F NMR (282.4 MHz, CDCl3) δ −124.9 (2F), −123.2 (2F), −113.4 (2F), −79.9 (3F). 
 
(R)-3-[(2S,13R)-13-(4-Methoxy-benzyloxy)-2-[3-methoxy-4-(2-{2-[2-(2-methoxy-ethoxy)-
ethoxy]-ethoxy}-ethoxy)-benzyloxy]-13-((2R,5R)-5-{(S)-1-[4-(4,4,5,5,6,6,7,7,8,8,9,9,9-
tridecafluoro-nonyloxy)-benzyloxy]-tridecyl}-tetrahydro-furan-2-yl)-tridecyl]-5-methyl-
5H-furan-2-one (11-O4-F13) 
C12H25
OPMB
O
OOPMBF13
O
O
DMBO4
 
1H NMR (500 MHz, CDCl3) δ 0.88 (t, J = 6.9 Hz, 3H), 1.25-1.36 (m, 36H), 1.39 (d, J = 6.9 Hz, 
3H), 1.41-1.65 (m, 6H) 1.87-1.95 (m, 2H), 2.06-2.14 (m, 3H), 2.26-2.37 (m, 3H), 2.52 (d, J = 5.5 
Hz, 2H), 3.28-3.33 (m, 1H), 3.38 (s, 3H), 3.53-3.58 (m, 3H), 3.64-3.69 (m, 11H), 3.72-3.75 (m, 
3H), 3.78 (s, 3H), 3.85 (s, 3H), 3.88 (t, J = 5.3 Hz, 2H), 3.97-4.07 (m, 4H), 4.17 (t, J = 5.3 Hz, 
2H), 4.43 (d, J = 11.0 Hz, 1H), 4.47 (d, J = 11.0 Hz, 1H), 4.55 (d, J = 9.6 Hz, 2H), 4.62-4.66 (m, 
1H), 4.71 (d, J = 11.0 Hz, 1H), 4.96 (q, J  = 6.6 Hz, 1H), 6.80-6.88 (m, 7H), 7.07 (s, 1H), 7.24-
  
 
127 
7.31 (M, 4H); 19F NMR (282.4 MHz, CDCl3) δ −124.9 (2F), −122.2 (2F), −121.7 (2F), −120.7 
(2F),  −113.2 (2F), −79.6 (3F). 
 
(R)-3-{(2S,13R)-13-((2R,5R)-5-{(R)-1-[4-(4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-Hepta 
decafluoro-undecyloxy)-benzyloxy]-tridecyl}-tetrahydro-furan-2-yl)-13-(4-methoxy-
benzyloxy)-2-[3-methoxy-4-(2-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-ethoxy)-
benzyloxy]-tridecyl}-5-methyl-5H-furan-2-one (11-O4-F17) 
O
C12H25
OPMB
O
OOPMBF17
O
DMBO4
 
1H NMR (500 MHz, CDCl3) δ 0.89 (t, J = 6.9 Hz, 3H), 1.26-1.38 (m, 36H), 1.38-1.66 (m, 9H), 
1.91-2.00 (m, 2H), 2.05-2.14 (m, 3H), 2.27-2.38 (m, 3H), 2.52 (d, J = 5.5 Hz, 2H), 3.28-3.33 (m, 
1H), 3.38 (s, 3H), 3.54-3.56 (m, 2H), 3.63-3.71 (m, 11H), 3.73-3.74 (m, 3 H), 3.77-3.83 (m, 3H), 
3.86 (s, 3H), 3.87-3.90 (m, 2H), 3.98-4.07 (m, 4H), 4.17 (t, J = 5.3 Hz, 2H), 4.43 (d, J = 11.0 Hz, 
1H), 4.47 (d, J = 11.0 Hz, 1H), 4.53-4.60 (m, 2H), 4.66 (d, J = 2.3 Hz, 1H), 4.69 (d, J = 2.8 Hz, 
1H) 6.81 - 6.90 (m, 7H), 7.07 (s, 1H), 7.25-7.32 (m, 4H); 19F NMR (282.4 MHz, CDCl3) δ 
−124.9 (2F), −122.2 (2F), −121.5 (2F), −120.7 (4F), −120.5 (2F), −113.1 (2F), −79.5 (3F). 
 
General procedure for one-pot global deprotection and detagging of fluorous-oeg double-
tagged murisolin isomers (general procedure 3) 3-{(2R,13R)-2,13-Dihydroxy-13-[(2R,5S)-5-
((1R)-1-hydroxytridecyl)tetrahydrofuran -2-yl]tridecyl}-(5S)-5-methyl-5H-furan-2-one (10-
O1-F5) 
C12H25 O O
O
OH
HO OH  
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A solution of butenolide 11-O1-F5 (2.7 mg, 2.3 µmol) and 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (0.84 mg, 3.7 µmol) in CH2Cl2/H2O (1.0 mL/0.05 mL) was stirred at room 
temperature for 1 h followed by dilution with CH2Cl2 (5.0 mL) and brine (1.5 mL). The layers 
were separated and the aqueous layer was further extracted with CH2Cl2 (4 x 10 mL). The 
combined organic layers were dried over MgSO4, and concentrated to give the crude product. 
The crude product was directly subjected to purification with semi-prep HPLC on a Chiralcel 
OD column 2 x 20 cm. The column was eluted under a linear gradient plus a isocratic condition 
for 45 min. The gradient started with hexanes/2-propanol (94/6) and ended with hexanes/2-
propanol (90/10) in 30 min followed by isocratic elution with hexanes/2-propanol for (90/10) for 
15 min. The flow rates in both are 10 mL/min. The butenolide 10-O1-F5 (0.5 mg, 37%) resulted 
as white waxy solid.  Compounds 10-O2-F13, 10-O3-F13, 10-O4-F17 were further purified by 
semi-prep HPLC using a SymmetryPrepTM C18 7µm 19x300mm column. The column was 
eluted under a linear gradient plus an isocratic for 45min. The gradient started with 80% 
CH3OH/20% H2O and ended with 100% CH3OH in 30min. The isocratic was a 100% CH3OH 15 
min elution. The flow rates in both are 12mL/min. 
 
3-{(2R,13R)-2,13-Dihydroxy-13-[(2R,5S)-5-((1S)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5S)-5-methyl-5H-furan-2-one (10-O1-F9). 
C12H25 O O
O
OH
OHHO  
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 Using general procedure 3, butenolide 11-O1-F9 (4.0 mg, 3.2 µmol) was used to yield 10-O1-
F9 (1.1 mg, 59%) as white waxy solid.   
3-{(2R,13R)-2,13-Dihydroxy-13-[(2R,5R)-5-((1S)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5S)-5-methyl-5H-furan-2-one (10-O1-F13). 
C12H25 O O
O
OH
HO OH  
 Using general procedure, butenolide 11-O1-F13 (9.0 mg, 6.6 µmol) was used to yield 10-O1-
F13 (1.9 mg, 50%) as white waxy solid.  
 
3-{(2R,13R)-2,13-Dihydroxy-13-[(2R,5R)-5-((1R)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5S)-5-methyl-5H-furan-2-one (10-O1-F17). 
C12H25 O O
O
OH
HO OH  
Using general procedure 3, butenolide 11-O1-F17 (21 mg, 14.3 µmol) was used to yield M10-
O1-F17 (2.7 mg, 33%) as white waxy solid.  
 
3-{(2R,13R)-2,13-Dihydroxy-13-[(2R,5S)-5-((1R)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5R)-5-methyl-5H-furan-2-one (10-O2-F5).  
O
C12H25
OH
O
OOH
OH
 
 Using general procedure 3, butenolide 11-O2-F5 (11 mg, 9.3 µmol) was used to yield 10-O1-F5 
(0.70 mg, 13%) as white waxy solid. 1H NMR (600MHz, CDCl3) δ 0.89 (t, J = 7.1 Hz, 3H), 
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1.27-1.40 (m, 36H), 1.45 (m, 3H), 1.50 (m, 6H), 1.60 (m, 3H), 1.77-1.81 (m, 2H), 1.96 (m, 2H), 
2.43 (m, 1H), 2.55 (d, J = 14.5 Hz, 1H), 3.47 (m, 1H), 3.87 (m, 3H), 3.92 (m,1H), 5.07 (m, 1H), 
7.20 (m, 1H); LC-MS (ESI) m/z: 619.5 (M + K)+, 603.5 (M + Na)+, 581.5 (M + H)+, 563.5 M + 
H − H2O)+, 545.5 (M + H − 2H2O)+, 527.5 (M + H − 3H2O)+; 
 
 
3-{(2R,13R)-2,13-Dihydroxy-13-[(2R,5S)-5-((1S)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5R)-5-methyl-5H-furan-2-one (10-O2-F9). 
O
C12H25
OH
O
OOH
OH
 
Using general procedure 3, butenolide 11-O2-F9 (14 mg, 10 µmol) was used to yield 10-O2-F9 
(1.1 mg, 18%) as white waxy solid. 1H NMR (600MHz, CDCl3) δ 0.89 (t, J = 7.2 Hz, 3H), 1.27-
1.40 (m, 36H), 1.44 (d, J = 6.8Hz, 3H), 1.46-1.51 (m, 6H), 1.66 (m, 3H), 1.73-1.76 (m, 2H), 
1.93-1.97 (m, 2H), 2.41 (dd, J1 = 15.1Hz, J2 = 8.3Hz, 1H), 2.54 (d, J = 15.1 Hz, 1H), 3.42-3.45 
(m, 2H), 3.82-3.88 (m, 3H), 5.07 (qq, J1 = 6.8Hz, J2 = 1.4Hz, 1H), 7.19 (q, J = 1.3Hz, 1H); LC-
MS (ESI) m/z: 619.5 (M + K)+, 603.5 (M + Na)+, 581.5 (M + H)+, 563.5 (M + H − H2O)+, 545.5 
(M + H − 2H2O)+, 527.5 (M + H − 3H2O)+; 
 
3-{(2R,13R)-2,13-Dihydroxy-13-[(2R,5R)-5-((1S)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5R)-5-methyl-5H-furan-2-one (10-O2-F13). 
O
C12H25
OH
O
OOH
OH
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Using general procedure 3, butenolide 11-O2-F13 (12 mg, 8.7 µmol) was used to yield 10-O2-
F13 (0.90 mg, 18%) as white waxy solid. 1H NMR (600MHz, CDCl3) δ 0.89 (t, J = 7.1Hz, 3H), 
1.27-1.39 (m, 43H), 1.44 (d, J = 6.7Hz, 3H), 1.56 (m, 3H), 1.86-1.93 (m, 2H), 2.01 (m, 1H), 2.41 
(dd, J1 = 14.5Hz, J2 = 8.0Hz, 1H), 2.54 (d, J = 14.6 Hz, 1H), 3.40 (m, 1H), 3.83-3.84 (m, 4H), 
5.07 (q, J = 6.0Hz, 1H), 7.19 (m, 1H); LC-MS (ESI) m/z: 619.5 (M + K)+, 603.5 (M + Na)+, 
581.5 (M + H)+, 563.5 (M + H − H2O)+, 545.5 (M + H − 2H2O)+, 527.5 (M + H − 3H2O)+ 
3-{(2R,13R)-2,13-Dihydroxy-13-[(2R,5R)-5-((1R)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5R)-5-methyl-5H-furan-2-one (10-O2-F17). 
O
C12H25
OH
O
OOH
OH
 
Using general procedure 3, butenolide 11-O2-F17 (28 mg, 19 µmol) was used to yield 10-O2-
F17 (1.8 mg, 16%) as white waxy solid. 1H NMR (600MHz, CDCl3) δ 0.89 (t, J = 7.1Hz, 3H), 
1.27-1.35 (m, 39H), 1.37-1.43 ( m, 3H), 1.44 (d, J = 6.8Hz, 3H), 1.48-1.51 (m, 3H), 1.70 (m, 
2H), 1.98-2.00 (m, 2H), 2.41 (dd, J1 = 15.1Hz, J2 = 8.3Hz, 1H), 2.54 (d, J = 15.1 Hz, 1H), 3.41 
(q, J = 6.0Hz, 2H), 3.81 (q, J = 6.6Hz, 4H), 3.83-3.86 (m, 1H), 5.07 (q, J = 6.9Hz, 1H), 7.19 (m, 
1H); LC-MS (ESI) m/z: 619.5 (M + K)+, 603.5 (M + Na)+, 581.5 (M + H)+, 563.5 (M + H − 
H2O)+, 545.5 (M + H − 2H2O)+, 527.5 (M + H − 3H2O)+; 
 
3-{(2S,13R)-2,13-Dihydroxy-13-[(2R,5S)-5-((1R)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5S)-5-methyl-5H-furan-2-one (10-O3-F5). 
O
C12H25
OH
O
OOH
OH
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Using general procedure 3, butenolide 11-O3-F5 (3.8 mg, 3.0 µmol) was used to yield 10-O3-F5 
(1.0 mg, 57%) as white waxy solid. 1H NMR (600MHz, CDCl3) δ 0.90 (t, J = 6.9Hz, 3H), 1.28-
1.32 (m, 34H), 1.39-1.41 ( m, 2H), 1.46 (d, J = 6.8Hz, 3H), 1.50-1.53 (m, 6H), 1.59 (m, 3H), 
1.75-1.84 (m, 2H), 1.94-2.01 (m, 2H), 2.43 (dd, J1 = 15.1Hz, J2 = 8.2Hz, 1H), 2.56 (d, J = 15.6 
Hz, 1H), 3.47-3.48 (m, 1H), 3.84-3.86 (m, 3H), 3.93 (m, 1H), 5.08 (q, J = 6.5Hz, 1H), 7.19 (m, 
1H); LC-MS (ESI) m/z: 619.5 (M + K)+, 603.5 (M + Na)+, 581.5 (M + H)+, 563.5 (M + H − 
H2O)+, 545.5 (M + H − 2H2O)+, 527.5 (M + H − 3H2O)+; 
 
3-{(2S,13R)-2,13-Dihydroxy-13-[(2R,5S)-5-((1S)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5S)-5-methyl-5H-furan-2-one (10-O3-F9). 
O
C12H25
OH
O
OOH
OH
 
Using general procedure 3, butenolide 11-O3-F9 (6.4 mg, 4.7 µmol) was used to yield 1O-O3-
F9 (1.8 mg, 66%) as white waxy solid. 1H NMR (600MHz, CDCl3) δ 0.89 (t, J = 6.8Hz, 3H), 
1.27-1.41 (m, 36H), 1.44 (d, J = 6.5Hz, 3H), 1.48 (m, 6H), 1.64 (m, 3H), 1.77 (m, 2H), 1.95 (m, 
2H), 2.41 (dd, J1 = 15.2Hz, J2 = 8.3Hz, 1H), 2.54 (d, J = 14.4 Hz, 1H), 3.44 (m, 2H), 3.85 (m, 
3H), 5.07 (q, J = 6.1Hz, 1H), 7.19 (m, 1H); LC-MS (ESI) m/z: 619.5 (M + K)+, 603.5 (M + Na)+, 
581.5 (M + 1)+, 563.5 (M + H − H2O)+, 545.5 (M + H − 2H2O)+, 527.5 (M + H − 3H2O)+; 
3-{(2S,13R)-2,13-Dihydroxy-13-[(2R,5R)-5-((1S)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5S)-5-methyl-5H-furan-2-one (10-O3-F13). 
O
C12H25
OH
O
OOH
OH
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Using general procedure 3, butenolide 11-O3-F13 (7.5 mg, 5.2 µmol) was used to yield 10-O3-
F13 (1.4 mg, 46%) as white waxy solid. 1H NMR (600MHz, CDCl3) δ 0.89 (t, J = 6.9Hz, 3H), 
1.27-1.31 (m, 34H), 1.39 (m, 4H), 1.44 (d, J = 6.8Hz, 3H), 1.47-1.51 (m, 4H), 1.58-1.66 (m, 4H), 
1.86-1.94 (m, 2H), 1.99-2.03 (m, 1H), 2.41 (dd, J1 = 15.2Hz, J2 = 8.3Hz, 1H), 2.54 (d, J = 14.9 
Hz, 1H), 3.40 (q, J = 4.5Hz, 1H), 3.82-3.88 (m, 4H), 5.07 (q, J = 6.5Hz, 1H), 7.19 (m, 1H); LC-
MS (ESI) m/z: 619.5 (M + K)+, 603.5 (M + Na)+, 581.5 (M + H)+, 563.5 (M + H − H2O)+, 545.5 
(M + H − 2H2O)+, 527.5 (M + H − 3H2O)+ 
 
3-{(2S,13R)-2,13-Dihydroxy-13-[(2R,5R)-5-((1R)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5S)-5-methyl-5H-furan-2-one (10-O3-F17). 
O
C12H25
OH
O
OOH
OH
 
Using general procedure 3, butenolide 11-O3-F17(17 mg, 11 µmol) was used to yield 10-O3-
F17 (1.2 mg, 19%) as white waxy solid. 1H NMR (600MHz, CDCl3) δ 0.89 (t, J = 7.0Hz, 3H), 
1.27-1.35 (m, 33H), 1.39-1.43 (m, 4H), 1.44 (d, J = 6.8Hz, 3H), 1.47-1.51 (m, 3H), 1.56 (m, 3H), 
1.69-1.71 (m, 2H), 1.98-2.00 (m, 2H), 2.27 (m, 2H), 2.41 (dd, J1 = 15.1Hz, J2 = 8.2Hz, 1H), 2.54 
(dt, J1 = 15.1Hz, J2 = 1.6Hz, 1H), 3.41 (q, J = 6.0Hz, 2H), 3.81 (q, J = 6.4Hz, 2H), 3.85-3.86 (m, 
1H), 5.07 (q, J = 6.3Hz, 1H), 7.19 (m, 1H); LC-MS (ESI) m/z: 619.5 (M + K)+, 603.5 (M + Na)+, 
581.5 (M + H)+, 563.5 (M + H − H2O)+, 545.5 (M + H − 2H2O)+, 527.5 (M + H − 3H2O)+ 
 
3-{(2S,13R)-2,13-Dihydroxy-13-[(2R,5S)-5-((1R)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5R)-5-methyl-5H-furan-2-one (10-O4-F5). 
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O
C12H25
OH
O
OOH
OH
 
Using general procedure 3, butenolide 11-O4-F5 (3.8 mg, 2.9 µmol) was used to yield 10-O4-F5 
(0.5 mg, 30%) as white waxy solid. 1H NMR (600MHz, CDCl3) δ 0.89 (t, J = 6.9Hz, 3H), 1.26-
1.34 (m, 34H), 1.37-1.39 (m, 3H), 1.44 (d, J = 6.8Hz, 3H), 1.47-1.51 (m, 5H), 1.61 (m, 3H), 
1.73-1.83 (m, 2H), 1.92-1.99 (m, 2H), 2.40 (dd, J1 = 15.2Hz, J2 = 8.3Hz, 1H), 2.55 (d, J = 
15.2Hz, 1H), 3.44-3.66 (m, 1H), 3.81-3.86 (m, 3H), 3.90-3.92 (m, 1H), 5.06 (qq, J1 = 6.9Hz, J2 = 
1.4Hz, 1H), 7.19 (q, J = 1.2Hz, 1H); LC-MS (ESI) m/z: 619.5 (M + K)+, 603.5 (M + Na)+, 581.5 
(M + H)+, 563.5 (M + H − H2O)+, 545.5 M + H − 2H2O)+, 527.5 (M + H − 3H2O)+ 
 
3-{(2S,13R)-2,13-Dihydroxy-13-[(2R,5S)-5-((1S)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5R)-5-methyl-5H-furan-2-one (10-O4-F9). 
O
C12H25
OH
O
O
OH
OH  
Using general procedure 3, butenolide 11-O4-F9 (6.1 mg, 4.4 µmol) was used to yield 10-O4-F9 
(0.8 mg, 31%) as white waxy solid. 1H NMR (600MHz, CDCl3) δ 0.89 (t, J = 6.9Hz, 3H), 1.27-
1.41 (m, 36H), 1.44 (d, J = 6.7Hz, 3H), 1.48 (m, 6H), 1.62 (m, 3H), 1.77 (m, 2H), 1.95 (m, 2H), 
2.40 (dd, J1 = 14.5Hz, J2 = 7.6Hz, 1H), 2.55 (d, J = 14.6Hz, 1H), 3.44 (m, 2H), 3.83 (m, 3H), 
5.06 (q, J = 6.5Hz, 1H), 7.19 (m, 1H); LC-MS (ESI) m/z: 619.5 (M + K)+, 603.5 (M + Na)+, 
581.5 (M + H)+, 563.5 (M + H − H2O)+, 545.5 (M + H − 2H2O)+, 527.5 (M + H − 3H2O)+ 
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3-{(2S,13R)-2,13-Dihydroxy-13-[(2R,5R)-5-((1S)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5R)-5-methyl-5H-furan-2-one (10-O4-F13). 
O
C12H25
OH
O
O
OH
OH  
Using general procedure 3, butenolide 11-O4-F13 (5.4 mg, 3.6 µmol) was used to yield 10-O4-
F13 (0.5 mg, 24%) as white waxy solid. 1H NMR (600MHz, CDCl3) δ 0.89 (t, J = 6.9Hz, 3H), 
1.27-1.30 (m, 34H), 1.37-1.41 (m, 4H), 1.44 (d, J = 6.8Hz, 3H), 1.48-1.52 (m, 4H), 1.60-1.66 
(m, 3H), 1.84-1.99 (m, 2H), 2.00-2.03 (m, 2H), 2.40 (dd, J1 = 15.0Hz, J2 = 8.4Hz, 1H), 2.55 (d, J 
= 14.9Hz, 1H), 3.40-3.41 (m, 1H), 3.82-3.87 (m, 4H), 5.06 (q, J = 6.8Hz, 1H), 7.19 (m, 1H); LC-
MS (ESI) m/z: 619.5 (M + K)+, 603.5 (M + Na)+, 581.5 (M + H)+, 563.5 (M + H − H2O)+, 545.5 
(M + H − 2H2O)+, 527.5 (M + H − 3H2O)+ 
 
3-{(2S,13R)-2,13-Dihydroxy-13-[(2R,5R)-5-((1R)-1-hydroxytridecyl)tetrahydrofuran-2-yl] 
tridecyl}-(5R)-5-methyl-5H-furan-2-one (10-O4-F17). 
O
C12H25
OH
O
O
OH
OH  
Using general procedure 3, butenolide 11-O4-F17 (13 mg, 8.2 µmol) was used to yield 10-O4-
F17 (0.9 mg, 21%) as white waxy solid. 1H NMR (600MHz, CDCl3) δ 0.89 (t, J = 6.9Hz, 3H), 
1.27-1.28 (m, 37H), 1.41 (m, 4H), 1.44 (d, J = 6.8Hz, 3H), 1.48-1.50 (m, 4H), 1.66-1.70 (m, 2H), 
2.00 (m, 2H), 2.41 (dd, J1 = 15.2Hz, J2 = 8.3Hz, 1H), 2.54 (d, J = 15.7Hz, 1H), 3.42 (m, 2H), 
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3.82-3.86 (m, 3H), 5.07 (q, J = 6.7Hz, 1H), 7.19 (m, 1H); LC-MS (ESI) m/z: 619.5 (M + K)+, 
603.5 (M + Na)+, 581.5 (M + H)+, 563.5 (M + H − H2O)+, 545.5 (M + H − 2H2O)+, 527.5 (M + 
H − 3H2O)+ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. CHAPTER 2:  
Tetrafibricin: Synthesis of C1-C20 and C21-C40 fragments 
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2.1. INTRODUCTION 
In course of a screening program for fibrinogen receptor antagonists, Kamiyama and co-workers 
isolated tetrafibricin, a non-peptidic antagonist, from the culture broth of streptomyces 
neyagawaensis NR0577.49 Platelet aggregation is known to have a vital role in normal 
heamostasis and thrombosis. “Platelets first adhere and spread onto the thrombogenic 
components of the vascular subendothelium at the sites of vascular lesions. Upon stimulation by 
an agonist such as ADP, collagen or thrombin, the fibrinogen receptors (GPIIb/IIIa), which exist 
as Ca+2 dependent heterodimer complexes, acquire the ability to bind fibrinogen through 
conformational changes within the molecules. Fibrinogen binding to the receptors on the surface 
of platelets is prerequisite for platelet aggregation. Thus, fibrinogen receptor antagonism is a 
good target for a platelet aggregation inhibitor.”49 Although many types of fibrinogen receptor 
antagonists have been reported,50 most of them are peptide mimetics of RGDS (Arg-Gly-Asp-
Ser), which is the minimal sequence in fibrinogen that is considered necessary to recognize 
fibrinogen receptors during aggregation. Tetrafibricin inhibited the binding of fibrinogen to its 
receptors with an IC50 of 46 nM and inhibited aggregation of human platelets induced by ADP, 
collagen, and thrombin. The ability of tetrafibricin to block fibrinogen from binding to its 
glycoprotein receptor makes it a viable target for the potential therapeutic intervention of arterial 
thrombotic deceases such as coronary occlusion and myocardiac infarction.51
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The Kamiyama group elucidated the structure of tetrafibricin (Figure 2.1) by carrying out 
various NMR, MS and other experiments.52 The molecular formula was determined as 
C41H67NO13 from HRFAB-MS (Calcd: 782.4691, Found: m/z 782.4676 (M + H)+). Positive color 
reactions to ninhydrin and 2,4-dinitrophenylhydrazine suggested the presence of primary amino 
  
 
and carbonyl groups respectively. The IR spectral data of 1 suggested the presence of carboxyl 
and/or carbonyl (3000-2500, 1710 cm −1) along with hydroxyl and/or amino (3400, 1100-1000 
cm−1) functionalities. UV data indicated the presence of a conjugated tetraenoic acid 
chromophore. Due to the instability of 1 in DMSO-d6, a D2O solution of 1 purged with argon 
was used for the NMR experiments.  A combination of the 1H NMR, 13C NMR, 1H-1H COSY, 
HSQC and HMBC experiments were used to deduce partial structures. Additional NMR 
experiments on a solution of N-acetyldihydrotetrafibricin methyl ester in DMSO-d6 were carried 
out to establish the complete connectivity of the partial structures. The structure of tetrafibricin 
as proposed by the Kamiyama group without addressing the stereochemistry is shown in Figure 
2.1.  
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Figure 2.1 Structure of Tetrafibricin 1 as proposed by Kamiyama and co-workers 
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Kishi and co-workers developed the concept and logic for a universal NMR database 
approach to assign the relative and absolute configuration of an unknown compound without 
degradation and/or derivatization.53 They have demonstrated the feasibility, reliability, and 
applicability of this approach in the stereochemical assignment of the desertomycin/oasomycin 
class of natural products,54 as well as the mycolactones.55 In 2003, the Kishi group reported the 
  
 
elucidation of the complete stereochemistry of tetrafibricin by using the NMR databases in 
achiral and chiral solvents without degradation of the carbon framework (Figure 2.2).56  
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Figure 2.2 Complete stereochemistry of Tetrafibricin 1 as proposed by Kishi and Co-workers 
 
The interesting biological properties and unique structure containing primary amine, 
conjugated tetraenoic acid, and 1,3- and 1,5-diols render tetrafibricin an excellent target for a 
synthetic study. The development of an efficient, convergent synthesis of tetrafibricin will allow 
the synthesis of its multiple stereoisomers and facilitate structure-activity relationship studies 
designed to probe its biological properties. 
 
To date, only two research groups have communicated their efforts toward the synthesis 
of tetrafibricin. A sequence of chemoselective cross-metathesis reactions and enantioselective 
allyltitanations of aldehydes has been used by Cossy and BouzBouz to prepare the C1-C13, C15-
C26, and C27-C40 fragments of tetrafibiricn.57 Roush and Lira accomplished the synthesis of 
C1-C19 fragment of tetrafibricin58 via a highly diastereoselective double allylboration developed 
in their laboratory.59
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2.2. RESULTS AND DISCUSSION 
2.2.1. Synthetic analysis of Tetrafibricin 1 
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Our retrosynthetic analysis towards the synthesis of tetrafibricin is outlined in Figure 2.3. We 
envisioned that a series of Kocienski-Julia olefination reactions with appropriate aldehyde and 
sulfones will allow the formation of C20-C21, C30-C31 and C34-C35 bonds. This suggested us 
fragments C35-C40 2, C31-C34 3, and C21-C30 4 as potential building blocks for the 
construction of C20-C40 carbon frame work of tetrafibricin 1. Disconnection at C13-C14 bond 
provides fragments C14-C20 5and C9-C13 6, which are expected to be coupled by alkylation of 
anion of dithiane 6 with iodide 5. Disconnection at C8-C9 provided fragment C1-C8 7 as 
potential partner for Horner-Wadsworth-Emmons (HWE) olefination. 
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Figure 2.3 Retrosynthesis of Tetrafibricin 1 
 
2.2.2. Preparation of Sulfone 2: The (C35-C40) Fragment  
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Our plan for the synthesis of sulfone 2 is shown in figure 2.4. Disconnection at C40-N and C35-
S bonds in 2 suggested 19 as potential precursor. Continuing this analysis by a disconnection at 
  
 
C35-C36 bond led (R)-12, which can be prepared from the commercially available pent-4-en-1-
ol 8 (figure 2.4). 
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Figure 2.4 Synthetic analysis of sulfone 2 
 
Our efforts toward the synthesis of enantiopure epoxide (R)-12 commenced from the 
commercially available pent-4-en-1-ol 8 as shown in scheme 2.1. Alkene 8 was reacted with m-
chloroperbenzoic acid in dichloromethane at 0 oC for 1 h to generate the corresponding epoxide 
9. However, the resulting epoxide 9 rapidly cyclized to form rac-(tetrahydrofuran-2-yl)methanol 
10 upon concentration of the crude reaction mixture.  
 
HO m-CPBA, CH2Cl2 HO
O O
OH
0 oC, 1 h
8 9 10  
Scheme 2.1 Attempted epoxidation of alcohol 8 
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The above result indicated the necessity of initial protection of the primary alcohol 8 
before attempting an epoxidation. Hence, pent-4-en-1-ol 8 was reacted with TBS chloride in 
  
 
presence of imidazole in dichloromethane to afford TBS ether 11 as a crude product (scheme 
2.2). The unpurified TBS ether 11 was treated with m-chloroperbenzoic acid in dichloromethane 
to afford racemic epoxide 12 in 86% overall yield for two steps.  
 
HO TBS-Cl, Imidazole  m-CPBA, CH2Cl2
TBSO
O
TBSO
(86%, two steps)CH2Cl2
8 11
(rac)-12  
Scheme 2.2 Synthesis of epoxide (rac)-12 
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The racemic epoxide 12 was subjected to kinetic resolution with (R,R)-Jacobsen catalyst 
(R,R)-1360 to afford (R)-tert-butyldimethyl(3-(oxiran-2-yl)propoxy)silane (R)-12 in 44% yield 
and in greater than 96% enantiomeric excess (ee) purity (scheme 2.3). It is well known in the 
literature that kinetic resolution of terminal epoxide with (R, R)-Jacobsen catalyst (R,R)-13 will 
provide R-epoxide.61 The absolute configuration of epoxide (R)-12 was assigned by this 
literature precedent.  
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Scheme 2.3 Hydrolytic kinetic resolution of the racemic epoxide 12 
 
The enantiomeric purity of epoxide (R)-12 was assayed by 1H NMR spectroscopy and 
GC analysis of Mosher esters as shown in scheme 2.4. A small portion (100 mg) of (R)-12 was 
treated with methanolic HCl (made from CH3COCl and methanol) to effect the removal of TBS 
protecting group and simultaneous opening of the epoxide to form (S)-(tetrahydrofuran-2-
yl)methanol (S)-10 (92% yield). Then alcohol (S)-10 was acylated with (R)-α-methoxy-α-
trifluoromethyl phenylacetyl chloride (R)-14 (DMAP, CH2Cl2) to give the Mosher ester (S,S)-15 
(84% yield). Similarly, racemic alcohol 10 was acylated with (R)-α-methoxy-α-
trifluoromethylphenylacetyl chloride (R)-14 to give ester (R/S,S)-15 (90% yield).62
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Scheme 2.4 Synthesis of Mosher ester 
 
The 13C NMR spectrum (125 MHz) of compound (R/S,S)-15 showed peaks 
corresponding to two diastereomers at 25.7, 25.8 ppm  and 27.9, 28.0 ppm (figure 2.5). However, 
13C NMR spectrum of compound (S,S)-15 showed peaks for only one diasteromer at 25.7 and 
28.0 ppm, reflecting the high enantiomericpurity of epoxide (R)-12.  
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Figure 2.5 Comparison of selected resonances of the 13C NMR spectra of (R/S,S)-15 (top) with (S,S)-15 (bottom) 
  
GC analyses of (R/S,S)-15 and (S,S)-15 were performed to obtain the quantitative data of 
enantiomeric purity of epoxide (R)-12. GC analysis of (R/S,S)-15 showed two peaks with similar 
intensity at 11.1 and 11.2 min corresponding to two diastereomers. With similar GC analysis of 
(S,S)-15, the enantiomeric excess (ee) was determined as 96%.  
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With enantiopure epoxide (R)-12 in hand, we then attempted its alkylation with lithiated 
dithiane 16. Epoxide (R)-12 was reacted with lithiated 1,3-dithane 16 followed by trapping the 
resulting secondary alcoxide (not shown) with TBS-triflate to afford alkyl dithiane 17 in 83% 
yield (scheme 2.5). Initial attempts to convert the dithiane 17 to aldehyde 18 were unsuccessful 
under standard literature conditions such as [I2,CaCO3, ACN-H2O],63 [PhI(CF3CO2)2, CH3OH],64 
[Hg(ClO4)3, CaCO3, THF-H2O],65,66 [Hg(ClO4)3,2,6-lutidine,THF-H2O].67 However, reaction of 
dithiane 17 with CH3I and K2CO3 in ACN-H2O (6:1) at 45 oC for 5 h gave the aldehyde 18 in 
80% yield.68 Reduction of aldehyde 18 with DiBAL-H gave the corresponding alcohol 19 in 
98% yield. The alcohol 19 was then converted to alkylthiophenyltetrazole 21 in 99% yield by 
reacting it with 1-phenyl-1H-tetrazole-5-thiol 20 in presence of diisopropylazodicarboxylate 
(DIAD). Oxidation of sulfide 21 to the corresponding sulfone 22 was carried out with m-CPBA 
(88% yield). The primary TBS group in compound 22 was then selectively removed with HF•pyr 
in THF to give alcohol 23 in 76% yield. The primary alcohol 23 was reacted with di-tert-butyl-
iminodicarboxylate in presence of DIAD to provide sulfone 2 in 74% yield.69
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Scheme 2.5 Synthesis of sulfone 2 
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2.2.3. Synthesis of Aldehyde 3: The (C31-C34) Fragment 
Synthesis of compound 3 commenced with commercially available (S)-2-(2,2-dimethyl-1,3-
dioxolan-4-yl)ethanol (S)-24 as shown in scheme 2.6. Incorporation of the thiotetrazole via the 
Mitsunobu protocol,70 employing commercially available 1-phenyl-1H-tetrazole-5-thiol 20, 
furnished the corresponding sulfide 25 in 91% yield. Removal of acetonide protecting group 
using HCl in methanol (0.1 equiv AcCl in MeOH) gave diol 26 in 93% yield. Bis-silylation of 
diol 26 with TBS-triflate gave sulfide 27 in 99% yield. Selective deprotection of the primary 
TBS group was accomplished with HF•pyr in 64% yield. Oxidation of alcohol 28 was oxidized 
with Dess-Martin reagent to furnish 5 in 86% yield. 
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Scheme 2.6 Synthesis of aldehyde 3 
 
  
 
2.2.4. Kocienski-Julia olefination of sulfone 2 with aldehyde 3 
With compound 2 and 3 in hand, we attempted the Kocienski-modified71 Julia olefination72 of 
aldehyde 3 with sulfones 2 and 22 to forge the trans C(34-35) double bond. Treatment of sulfone 
22 with potassium bis(trimethylsilyl)amide (KHMDS) in THF at –78 oC for 30 min was followed 
by the addition of aldehyde 3 and warming to ambient temperature. Purification of the crude 
product provided trans C(34,35)-olefinic isomer 29 along with a minor isomer (10/1 ratio, in 
89% yield). The minor isomer was not separable from the E-isomer 29 by silica chromatography. 
However, purification by prep HPLC with Whelk-O column using 98/2 hexane/isopropanol 
solvent furnished pure E-isomer 29 in 81% yield. The E geometry was confirmed by the large 
NMR coupling constant (JH34-35 = 15.6 Hz). 
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Scheme 2.7 Kocienski-Julia olefination of sulfone 22 with aldehyde 3 
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Kocienski-Julia olefination was then attempted with sulfone 2 and aldehyde 3. Anion of 
sulfone was initially generated with KHMDS at at –78 oC followed by the addition of aldehyde 
3. The trans C(34-35) olefin 30 was obtained tagather with a minor isomer after purification of 
the crude product by silica chromatography (95% yield, 9/1 mixture). Pure (E)-isomer 30 was 
obtained (86%) by preparative chiral HPLC with Whelk-O column using 95/5 
hexanes/isopropanol as solvent. The identity of (E)-isomer 30 was again evident from the large 
NMR coupling constant (JH34-H35 = 15.4 Hz) of the olefinic protons.  
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Scheme 2.8 Kocienski-Julia olefination of sulfone 2 with aldehyde 30 
 
2.2.5. Synthesis of Aldehyde 4: The (C21-C30) Fragment 
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The retrosynthetic analysis of compound 4 is outlined in figure 2.6. Disconnection at the C24-
C25 and C25-C26 bonds gave compounds 31, 16, and 32 as potential precursors for the synthesis 
of fragment 4. We further envisioned the synthesis of compound 31 from D-arabitol and 
compound 32 from the commercially available (R)-2-(2,2-dimethyl-1,3-dioxolan-4-yl)ethanol 
(R)-24. 
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Figure 2.6 Retrosynthesis of aldehyde 4 
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The first step towards the synthesis of compound 31 was the regioselective protection of 
arabitol 33 as the 1,2:4,5-bis-acetal product 36. Literature reports revealed that the protection of 
arabitol as its bis-acetonide under typical conditions (CuSO4, H2SO4, acetone, 18 h, rt) resulted 
in the formation of the undesired 2,3:4,5-di-O-isopropylidene arabitol 37.73 Linclau et al. 
reported that74 using 3,3-dimethoxy-pentane (4.4 equiv), CSA (0.3 equiv) and short reaction time 
(5 min) led to the formation of di-O-isopentylidene acetal 34 (scheme 2.9) as the major product 
(80% isolated yield). Gratifyingly, employing the identical reaction conditions with D-33 and 
2,2-dimethoxy-propane gave 1,2:4,5-bis-acetal 36 in 60% isolated yield along with 37 (yield not 
determined). 
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Scheme 2.9 Regioselective protection of arabitol 33 
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The synthesis of compound 40 from 1,2:4,5-bis-acetal 36 requires reduction of the 
secondary hydroxyl group. To this end, the secondary alcohol 36 was reacted with N,N-
thiocarbonyldi-imidazole 38 using 1,2-dichloroethane as solvent under refluxing conditions.75 
Purification of the crude product by silica chromatography furnished carbothioate 39 in 95% 
yield. Reduction of compound 39 with Et3SiH/benzoyl peroxide afforded compound 40 in 66% 
yield.7 5 A solution of compound 40 in methanol was treated with acetyl chloride (~ 0.1 equiv) and 
stirred for 30 min at room temperature. Concentration of the reaction mixture gave tetrol 41 as 
white solid (99% yield). One of the two 1,2- diols in tetrol 41 was protected with 2,2-
dimethoxypropane (DMF, CSA) to furnish diol 42 in 58% yield.76 The primary hydroxy group of 
the diol 42 was selectively functionalized as tosylate 43 in 68% yield by reacting it with p-
toluenesulfonyl chloride in presence of catalytic amount (0.2 equiv) of dibutyltin oxide.77,78 The 
  
 
primary tosylate 43 was then converted to epoxide 31 (K2CO3, methanol) in 90% yield (scheme 
2.10). 
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Scheme 2.10 Synthesis of epoxide 31 
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This seven-step synthesis of epoxide 31 was used initially, but we latter accomplished a 
four-step synthesis as shown in scheme 2.11. Oxidation of the commercially available (S)-2-(2,2-
dimethyl-1,3-dioxolan-4-yl)ethanol (S)-24 using the Parikh-Doering protocol79 (SO3•pyr, 
DMSO) gave the corresponding aldehyde 44 in 86% yield.  Aldehyde 44 was then subjected to 
  
 
Wittig olefination (CH3PPh3Br, BuLi, THF) to give alkene 45 in 83% yield. Alkene 45 was 
oxidized to the corresponding epoxide (S,R/S)-31 using m-CPBA in 98% yield. Epoxide (S,R/S)-
31  (1/1 diastereomeric mixture) was subjected to hydrolytic kinetic resolution conditions with 
(S,S)-Jacobsen catalyst (S,S)-13 to afford diastereomerically pure (by 500 MHz 1H NMR) 
epoxide 31 in 45% yield.  
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Scheme 2.11 A four-step route for the synthesis of epoxide 31 
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The synthesis of compound 47 from 31 is shown in scheme 2.12. 1,3-Dithiane 16 was 
lithiated with t-BuLi at −78 oC, followed by the addition of a solution of epoxide 31 in 
THF/HMPA. This led to the alkylation of epoxide 31 to give secondary alcohol 46 in 83% yield. 
The alcohol 46 was then reacted with TBS-triflate in presence of 2,6-lutidine to give 
alkyldithiane 47 in 91% yield.  
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Scheme 2.12 Synthesis of dithiane 47 
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Epoxide 32, the coupling partner for dithiane 47, was synthesized from the commercially 
available (R)-2-(2,2-dimethyl-1,3-dioxolan-4-yl) ethanol (R)-24 in four steps as described in 
scheme 2.13. A mixture of alcohol (R)-24, 1-phenyl-1H-tetrazole-5-thiol 20, triphenylphosphine 
and diisopropylazodicarboxylate in THF was stirred at room temperature for 3 h. Standard 
workup and purification of the crude product by silica chromatography gave compound (R)-25 in 
90% yield. Exposure of compound (R)-25 to methanolic HCl (AcCl in methanol) gave diol (R)-
26 in 86% yield. Selective sulfonation (p-TsCl, Et3N) of primary alcohol in presence of 
dibutyltinoxide gave the tosylate 48 in 74% yield. Treatment of tosylate 48 with potassium 
carbonate in methanol gave epoxide 32 in 98% yield. 
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We then attempted the alkylation of dithiane 47 with epoxide 32, as shown in scheme 
2.14. Dithiane 47 was reacted with n-BuLi at −30 oC for 30 min followed by the addition of a 
solution of epoxide 32 in THF. Standard workup and purification afforded an unexpected 
product 49 in 56% yield. The structure of compound 49 was consistent with 1H NMR and 2D 
NMR (HH-COSY, HMQC and HMBC) data. However, molecular weight detected by high 
resolution mass spectrometry (HRMS, EI) was 479.1780, which corresponds to the fragment ion 
with molecular formula C21H39O4SiS3 (M – CH3).  
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Scheme 2.14 Alkylation of dithiane 47 with epoxide 32 
 
 
The proposed structure of 49 was supported with a model study conducted by Ms. Reena 
Bajpai (Scheme 2.15). Dithiane 50 was reacted with n-BuLi followed by the addition of tetrazole 
51 to form compound 52 in 61% yield. An authentic sample of compound 52 was prepared by 
reacting anion of dithiane 50 with 1,2-diethyldisulfane. NMR data of the authentic sample was 
identical to compound 52. 
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Scheme 2.15 Synthesis of compound 52 by two different methods 
  
 
 
By considering the above results, we’ve decided to alkylate the dithiane 47 with epoxide 56 
before the introduction of thiophenyltetrazole functionality. To this end, compound 56 with 
PMB-ether on the other terminus of the epoxide was envisioned as a suitable coupling partner for 
the lithiated dithiane 47 (scheme 2.16). A four-step synthesis of epoxide 56 from (R)-2-(2,2-
dimethyl-1,3-dioxolan-4-yl)ethanol (R)-24 was pursued as described in scheme 2.16. 
Deprotonation of alcohol (R)-24 with NaH followed by addition of PMB-Cl gave the PMB-ether 
53 in 84% yield. Removal of 1,2-diol protecting group under catalytic acidic conditions (AcCl in 
methanol) gave the diol 54 in 87% yield. p-Toluenesulfonation of the primary alcohol 54 
followed by reacting the resulted tosylate 55 with potassium carbonate in methanol gave the 
desired epoxide 56 in 65% yield (two steps). Alternatively, reaction of 1,2-diol 54, with DIAD 
and PPh3 80 in toluene at reflux to furnished epoxide 56 in 94% yield. 
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Scheme 2.16 Synthesis of epoxide 56 
 
Dithiane 47 was reacted with n-BuLi for 20 min at 0 oC81 followed by addition of epoxide 
56 to afford compound 57 in 67% yield (scheme 2.17).  
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Scheme 2.17 Alkylation of dithiane 47 with epoxide 56 
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Dithiane 57 was treated with methyl iodide and potassium carbonate in acetonitrile-water 
to furnish ketone 58 in 81% yield (scheme 2.18). The subsequent hydroxyl-directed syn 
reduction of the β-hydroxy ketone 58 with tetramethylammoniumtriacetoxy borohydride 
(Me4NHB(OAc)3)87 proceeded smoothly, affording the corresponding 1,3-anti-diol 59 in 86% 
yield as a single observable diastereomer by 500 MHz 1H NMR spectroscopy. Silylation of diol 
59 (TBSOTf, 2,6-lutidine) gave the compound 60 in 90% yield.  
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Scheme 2.18 Synthesis of PMB-ether 60 
 
Selective removal of 1,2-diol protecting group was attempted by treating the compound 
60 with pyridinium paratoluenesulfonate (PPTS, 0.1 equiv) in methanol. Unfortunately, this 
resulted in loss of both acetonide and TBS protecting groups to afford 61. The crude compound 
was reacted with excess TBSOTf to yield the compound 62 in 77% yield (scheme 2.19).  
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Scheme 2.19 Synthesis of PMB-ether 62 
 
 
To avoid the selective cleavage of acetonide in presence of silyl ethers, an alternative 
synthetic path was envisioned wherein the acetonide can be cleaved in the earlier stages of the 
fragment synthesis (scheme 2.20). Compound 46 was subjected to catalytic acidic conditions 
(AcCl in methanol) to provide triol 63, which was then reacted with TBSOTf to form the tris-
silyl ether 64 in 88% yield. Compound 64 was lithiated with t-BuLi followed by addition of 
epoxide 56 to effect the alkylation to afford the compound 65 in 90% yield.82  
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Scheme 2.20 Synthesis of compound 65 
  
 
Hydrolysis of the dithiane 65 with mercuric perchlorate in presence of 2,6-lutidine67 in 
aqueous THF provided the β-hydroxy ketone 66 in 84% yield. Hydroxy-directed syn-reduction 
with Me4NHB(OAc)3 gave the 1,3-anti-diol 67 which was then silylated to give the compound 
62 in 73% yield. Monodesilylation of 62 with HF•pyr gave the primary alcohol 68 in 49% yield 
(84% based on recovered 62). Oxidation of alcohol 68 with Dess-Martin reagent furnished 
aldehyde 69 in 93% yield (scheme 2.21). The above conversion of alcohol 68 to aldehyde 69 was 
done immediately before using 69 in the next step. 
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Scheme 2.21 Synthesis of aldehyde 69 
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2.2.6. Synthesis of Iodide 5: The (C14-C20) Fragment 
The retrosynthetic analysis of iodide 5 is outlined in figure 2.7. Disconnection at the C16-C17 
bond provided 71 and 75 as potential precursors. We further envisioned the synthesis of 71 from 
(S)-24 and 75 from (S)-74.  
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Figure 2.7 Retrosynthetic analysis of iodide 5 
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Synthesis of compound 5 commenced from commercially available (S)-2-(2,2-dimethyl-
1,3-dioxolan-4-yl)ethanol (S)-24. Oxidation of alcohol (S)-24 to aldehyde (S)-25 was 
accomplished with SO3•pyr in 93% yield (scheme 2.22). Reaction of aldehyde (S)-25 with 
propane-1,3-dithiol and BF3•OEt2 resulted83 in both conversion of aldehyde functionality to a 
dithiane and cleavage of 1,2-diol protecting group to afford compound 70 in 78% yield. 
Silylation of the diol 70 (TBSOTf and 2,6-lutidine) proceeded smoothly to give compound 71 in 
95% yield.  
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Scheme 2.22 Synthesis of dithiane 71 
 
Epoxide 75 was prepared from commercially available (S)-glycidol 74. 3,4-
dimethoxybenzyl alcohol 72 was reacted with SOCl2 and triethylamine in dichloromethane to 
form 3,4-dimethoxybenzyl chloride (DMBCl) 73 in 51% yield.84 Deprotonation of (S)-glycidol 
74 with NaH followed by addition of DMBCl gave the epoxide 75 in 69% yield (scheme 2.23).  
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Scheme 2.23 Synthesis of epoxide 75 
Lithiation of dithiane 71 with n-BuLi followed by the addition of epoxide 75 resulted the 
desired product 77 in 13% yield along with 51% of recovered dithiane 71 (scheme 2.24). 
Dithiane 77 was then reacted with iodomethane and potassium carbonate in aqueous acetonitrile 
to afford the β-hydroxy ketone 78 in 42% yield. Apparently, the poor yields of the above two 
reactions were due to labiality of the DMB protecting group to the reaction conditions or to flash 
column chromatography on SiO2. The syn-diol 79 was prepared via Et2BOMe-mediated NaBH4 
reduction87 of 79 in 63% yield. The diol 79 was reacted with TBSOTf and 2,6-lutidine to form the 
compound 80 in 81% yield. The DMB-ether 80 was treated with DDQ to afford the alcohol 81 in 
quantitative yield. The primary alcohol 81 was then reacted with MsCl and triethyl amine in 
presence of DMAP to form the mesylate 82 in 94% yield.85 The mesylate 82 was subjected to 
Finkelstein reaction conditions (NaI, acetone, reflux) to give the iodide 5 in 96% yield. 
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Scheme 2.24 Synthesis of iodide 5 
 
To address the issue of instability of the DMB- group, we replaced it with PMB-
protecting group during the scale-up of the iodide 5. The required PMB-epoxide81 83 was prepared 
by deprotonating the (S)-glycidol 74 with NaH followed by the addition of PMB-Cl and 
tetrabutyl ammonium iodide (Bu4NI) (scheme 2.25, 73% yield). 
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Scheme 2.25 Synthesis of epoxide 83 
 
Dithiane 71 was treated with t-BuLi at –78 oC followed by alkylation with PMB-epoxide 
83 to afford compound 84 in 77% yield. Hydrolysis of dithiane 84 to ketone using 
mercuryperchlorate [Hg(ClO4)3•3H2O] and 2,6-lutidine in aqueous THF gave the β-hyxroxy 
ketone 85 in 85% yield. The β-hydroxyketone 85 was subjected to diethymethoxyborane 
mediated reduction with NaBH4 to afford the syn-diol 86 in 88% yield. The secondary hydroxyl 
groups in diol 86 were protected as TBS ethers by reacting it with TBS-triflate and 2,6-lutidine 
to form compound 87 in 94% yield. The PMB-ether 87 was reacted with DDQ in CH2Cl2/pH 7 
buffer (19:1) to afford the alcohol 81 in 96% yield (scheme 2.26). The alcohol 81 was then 
directly converted to iodide 5 in 89% using iodine, triphenylphosphine and imidazole in 
dichloromethane solvent.86  
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Scheme 2.26 Synthesis of iodide 5 
 
 
2.2.7. Synthesis of Dithiane 6: The (C9-C13) Fragment 
170 
Disconnection of C11-C12 bond in 6 provides oxazolidinone 88 and aldehyde 89 as potential 
starting materials for combination by an Evans asymmetric aldol reaction36 (figure 2.8).  
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Figure 2.8 Retrosynthesis of dithiane 6 
 
Aldehyde 89 was prepared from commercially available propane-1,3-diol 90 as shown in 
scheme 2.27. Diol 90 was treated with NaH followed by addition of PMB-Cl and 
tetrabutylammonium iodide to form the PMB-ether 91 in 64% yield. Alcohol 91 was subjected to 
Swern oxidation conditions to afford aldehyde 89 in 89% yield.  
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Scheme 2.27 Synthesis of aldehyde 89 
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Boron mediated aldol reaction of (R)-N-propionyl imide 88 with aldehyde 89 gave the 
adduct 92 as a single isomer in 73% yield.87 Protection of the secondary alcohol in 92 as TBS-
ether (TBSOTf, 2,6-lutidine) gave compound 93 in 90% yield. Reductive removal of the chiral 
auxillary with LiBH4 resulted in modest selectivity and gave the primary alcohol 94 in 61% yield 
along with undesired compound 95 in 30% yield (scheme 2.28). The alcohol 94 was oxidized 
with Dess-Martin reagent to give the aldehyde 96 in 81% yield.  
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Scheme 2.28 Synthesis of aldehyde 96 
 
Efforts towards the conversion of aldehyde 96 to dithiane 6 are shown in scheme 2.29. 
Propane-1,3-diol and BF3•OEt2 were added to a solution of aldehyde 96 in CH2Cl2 at88 −78 oC. 
89This reaction led to decomposition of aldehyde 96 with no detectable formation of dithiane 6. 
We then tested the use of TiCl490, in CH2 2 3 2Cl  at −78 C and found the same result as BFo •OEt . 
Employment of mild reaction conditions with MgBr2 2•OEt 91 was also not successful and resulted 
in degradation of aldehyde 96. We suspected that the problem with these reactions might be the 
instability of PMB group to Lewis acids.  Hence, was envisioned that switching to a more stable 
benzyl group would be a viable alternative. 
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Scheme 2.29 Efforts toward the conversion of aldehyde 96 to dithiane 6 
 
173 
Alcohol 97 was prepared from propane-1,3-diol 90 in 81% yield under standard 
conditions (NaH, BnCl, Bu4NI). Alcohol 97 was subjected to Parikh-Doering oxidation 
conditions (SO3•pyr, DMSO, DIEA) to produce aldehyde 98 in 89% yield (scheme 2.30). Evans 
asymmetric aldol reaction of aldehyde 98 with propionyl oxazolidinone 88 gave compound 99 as 
a single isomer (by 1H and 13C NMR spectroscopy) in 79% yield.92 Treatment of oxazolidine 99 
with the aluminum amide of the N,O-dimethyl hydroxylamine [Me(MeO)NH•HCl], AlMe3, 
CH2Cl2] furnished amide93,94 100 in 86% yield. The secondary alcohol in 100 was protected as 
TBS ether to give compound 101 in 85% yield. Reduction of amide 101 with DiBAL-H gave the 
corresponding aldehyde 102 in 89% yield. Reaction of aldehyde 102 with propane-1,3-dithiol 
and MgBr2•OEt2 gave the corresponding dithiane 103  in 74% yield. With the dithiane 103 in 
hand, efforts were focused on removal of benzyl protecting group in compound 103. Initial 
attempts to remove the benzyl protecting group under Pd-catalyzed hydrogenation conditions 
were unsuccessful. Addition of excess of Pd/C was also not effective in driving the reaction due 
to strong poisoning effect of sulfur coordinating to palladium. Since the removal of benzyl 
protecting group in presence of dithiane functionality was not possible, an alternative strategy 
  
 
was envisioned wherein alkene was introduced into C9-C13 fragment, which can be converted to 
alcohol by hydroboration-oxidation sequence.  
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Scheme 2.30 Synthesis of dithiane 103 
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Our approach towards the synthesis of dithiane 109 has been illustrated in scheme 2.31. 
Asymmetric aldol reaction of freshly distilled acrolein with oxazolidinone 88 gave the aldol 
product 105 in 78% yield as a single isomer by 1H and 13NMR spectroscopy.95 The secondary 
alcohol in compound 105 was protected as TBS-ether 106 using TBSOTf and 2,6-lutidine in 
82% yield (scheme 2.31). Reduction of compound 106 with LiBH4 gave the corresponding 
alcohol 107 in 74% yield. The primary alcohol 107 was reacted with Dess-Martin reagent in 
  
 
dichloromethane to afford aldehyde 108 in 88% yield. Addition of propane-1,3-dithiol and 
MgBr2•OEt2 to aldehyde 108 in THF furnished dithiane 109 in 89% yield. 
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Scheme 2.31 Synthesis of dithiane 109 
 
2.2.8. Synthesis of Phosphonate 7: The (C1-C8) Fragment 
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Synthesis of phosphonate 7 commenced from trans-trans-muconic acid 110. Muconic acid was 
treated with acetyl chloride in methanol and refluxed for 2 h to give (2E,4E)-dimethyl hexa-2,4-
dienedioate 111 in 98% yield (scheme 2.32). The ester 111 was soluble in chloroform but was 
partially soluble in THF. Hence the ester 111 was dissolved in chloroform and reduced with 
DiBAL-H to furnish diol 112 in 90% yield. Reaction of diol 112 with TBS-Cl and imidazole in 
DMF gave the desired mono-TBS ether 113 in 45% isolated yield along with recovered 112 and 
bis-TBS-ether (not shown). The TBS ether 113 was readily separated from the crude product by 
flash column chromatography. Addition of MnO2 to a solution of alcohol 113 in 
  
 
dichloromethane efficiently converted the alcohol to aldehyde 114 in quantitative yield.96 
Aldehyde 114 was treated with sodium salt of triethylphosphonoacetate to deliver the ester 115 
in 79% yield. Catalytic acidic conditions (AcCl in methanol) were employed to cleave the TBS 
ether affording alcohol 116 in quantitative yield as white solid. Alcohol 116 was then treated 
with SOBr2 in presence of 2,6-lutidine to afford the corresponding bromide 117 as white solid in 
73% yield. The bromide 117 was reacted with an excess triethylphosphite97 in refluxing toluene 
to give the desired phosphonate 7 as waxy solid in 94% yield. 
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Scheme 2.32 Synthesis of Phosphonate 7: The (C1-C8) Fragment 
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2.2.9. Synthesis of Sulfone 121: The (C21-C40) Fragment 
177 
With all six fragments (2-7) in hand, we began assembly of the C21-C40 carbon framework of 
tetrafibricin (scheme 2.33). Efforts toward the oxidation of sulfide 30 to sulfone 118 using m-
CPBA resulted in a messy reaction product due to competing oxidation of olefin to epoxide. 
However, Mo-catalyst [Mo7O24(NH4)6•H2O, H2O2]98 provided a smooth conversion of sulfide 30 
to sulfone 118 in 92% yield. Deprotonation of sulfone 118 with KHMDS at −78 oC, followed by 
addition of aldehyde 69 and warming to ambient temperature overnight provided the PMB-ether 
119 as a sole C(30,31) (E)-olefinic isomer (JH30,31 = 15.4 Hz) in 94% yield. Removal of PMB 
protecting group (DDQ, pH 7 buffer, CH2Cl2)99 provided the primary alcohol 119 in 88% yield. 
Incorporation of the thiotetrazole via the Mitsunobu protocol, employing commercially available 
1-phenyl-1H-tetrazole-5-thiol (PTSH), followed by oxidation (Mo7O24(NH4)6•H2O, H2O2) of the 
derived sulfide (not shown) furnished sulfone 121 (C21-C40 fragment, 65% yield, two steps).  
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Scheme 2.33 Synthesis of C21-C40 fragment 
 
2.2.10. Synthesis of Aldehyde 127: The (C1-C20) Fragment 
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Efforts toward the synthesis of C1-C20 fragment commenced with alkylation of dithiane 109 
with iodide 5. Deprotonation of dithiane 109 with t-BuLi followed by addition of iodide 5 
provided alkene 122 in 54% yield (scheme 2.34). Hydroboration/oxidation of alkene 122 
provided the primary alcohol 123 in 64% yield. Oxidation of the primary alcohol 123 with 
SO3•pyr provided aldehyde 124 in 60% yield.  
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Scheme 2.34 Synthesis of C9-C20 fragment 
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The formation of C8-C9 double bond was then carried out by deprotonation of 
phosphonate 7 with LiHMDS, generating a dark orange colored anion, which was then added to 
aldehyde 124 furnishing conjugated methyl ester 125 (JH8-H9 = 15.1) in 57% yield (scheme 2.35). 
The primary TBS-ether 125 was cleaved with HF•pyr to provide the primary alcohol 126 in 
modest yield (45%). Oxidation of alcohol 126 to aldehyde 127 was then carried out with SO3•pyr 
(82% yield).  
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Scheme 2.35 Synthesis of C1-C20 fragment 
 
2.2.11. Effort towards the assembly of C1-20 and C21-C40 fragments: 
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With two half fragments (C1-20 and C21-C40) of tetrafibricin in hand, Kocienski-Julia 
olefination of sulfone 121 (15.0 mg, 10.1 µmol) with aldehyde 127 (10.0 mg, 10.3 µmol) was 
attempted. KHMDS was added to a solution of sulfone 121 in THF at −78 oC and the mixture 
was reacted for 30 min to generate the corresponding sulfone anion (scheme 2.36). Then a 
solution of aldehyde 127 in THF was added and the reaction mixture was stirred overnight. 
Unfortunately, product 128 was not formed, leading to decomposition of both sulfone and 
aldehyde (multiple spots on TLC). Presumably aldehyde 127 is not stabe under the reaction 
  
 
conditions due to C10 acidic protons.  We could not re-attempt this reaction due to the lack of 
aldehyde and its precursors. Further synthetic studies are currently in progress in the Curran 
group. 
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Scheme 2.36 Attempted Kocienski-Julia olefination of aldehyde 127 with sulfone 121 
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We’ve also considered the following synthetic route for the assembly of tetrafibricin 
carbon framework. The primary alcohol 123 was protected as benzoate 129 in 83% yield 
(scheme 2.37). Cleavage of the primiary TBS ether with HF•pyr gave the primary alcohol 130 in 
modest yield (39%). With the primary alcohol 130 in hand, we attempted its oxidation to 
aldehyde using Dess-Martin reagent. However, this reaction led to a messy product, presumably 
due to the sensitivity of dithiane functionality towards Dess-Martin reagent,100 with no detectable 
amount of aldehyde. Although we could not proceed further due to the lack of alcohol 126, we 
  
 
envision that this alcohol can be smoothly oxidized to aldehyde 131 with SO3•pyr or Swern 
oxidation reagents.  
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Scheme 2.37 Synthesis of alcohol 130 
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We propose that the aldehyde 131 can be carried through the following sequence of steps 
to complete the synthesis of tetrafibricin. Reaction of aldehyde 131 with sulfone 121 under 
Kocienski-Julia olefination conditions will provide olefin 132 (scheme 2.38). Removal of 
  
 
benzoate ester to furnish the corresponding primary alcohol (not shown), followed by the 
oxidation of alcohol to aldehyde can provide C9-C40 fragment 133. 
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Scheme 2.38 Proposed synthesis of aldehyde 133 
  
183 
Horner-Wadsworth-Emmons olefination of aldehyde 133 with lithiated anion of 
phosphonate 7 will provide tetrafibricin carbon framework 134. The following three deprotection 
steps can be pursued to provide the proposed structure of tetrafibricin (scheme 2.39). Hydrolysis 
  
 
of dithiane, hydrolysis of methyl ester (Et3SnOH)101, followed by global deprotection (removal 
of TBS and Boc protecting groups) with methanolic HCl (AcCl, MeOH) will furnish tetrafibricin 
1.  
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Scheme 2.39 Proposed synthesis of tetrafibricin 
 
2.3. CONCLUSION  
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A convergent synthesis of the proposed structure of tetrafibricin 1 has been explored. In this 
approach, we envisioned a series of Kocienski-Julia olefination reactions with appropriate 
  
 
aldehydes and sulfones to afford fragments 2 (C35-C40), 3 (C31-C35) and 69 (C21-C30). 
Synthesis of sulfone 2 (C35-C40) has been achieved in 11 steps starting with the commercially 
available pent-4-en-1-ol 8 in an overall 25% yield. The secondary alcohol stereocenter (C37) was 
established via hydrolytic kinetic resolution of racemic epoxide 12 in 96% ee. Synthesis of 
aldehyde 3 (C31-C34) commenced with the commercially available (S)-2-(2,2-dimethyl-1,3-
dioxolan-4-yl)ethanol (S)-24 in 5 steps in overall 46% yield. Synthesis of aldehyde 69 (C21-C30) 
involved the alkylation of 1,3-dithiane 16 with epoxides 31 and 56. Two synthetic routes have 
been developed for the synthesis of epoxide 31. The first one commenced from the commercially 
available D-arabital in 7 steps in overall 13% yield. We latter established a four step synthesis of 
epoxide 31 beginning with the commercially available (S)-24 in 31% yield. A total of 16 steps 
are involved in the synthesis of 69 in 4.5% overall yield. Disconnection at C13-C14 bond of 
tetrafibricin provided fragments 5 (C14-C20) and 109 (C9-C13). Synthesis of iodide 5 was 
achieved with the commercially available starting materials, (S)-24 and (S)-74, in 10 steps in 
overall 23% yield. Dithiane 109 was synthesized from acrolein in 5 steps in 37% yield. 
Disconnection at C8-C9 bond in 1 provided phosphonate 7 (C1-C8), that was synthesized from 
the commercially available trans-trans-muconic acid 110 in 8 steps in overall 22% yield. 
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With all six fragments of tetrafibricin 1 in hand, we’ve attempted their assembly. This 
began with Kocienski-Julia olefination of sulfone 2 with aldehyde 3 to form trans-olefin 30 
(C31-C40) in 86% isolated yield. Oxidation of sulfide 30 to sulfone 118 followed by subjecting 
it to Julia-Kocienski olefination with aldehyde 69 (C21-C30) afforded E-olefin 119 (C21-C40) in 
94% yield. PMB-ether 119 was advanced to sulfone 121 to attempt another Kocienski-Julia 
olefination.  
  
 
Alkylation of dithiane 109 with iodide 5 provided C9-C20 carbon skeleton 122 which 
was advanced to aldehyde 124 in two steps. Horner-Wadsworth-Emmons olefination of 
phosphonate 7 (C1-C8) with aldehyde 124 (C9-C20) provided 125 (C1-C20) which was 
advanced to aldehyde 127 in two steps. With this we’ve successfully completed the synthesis of 
two half fragments, aldehyde 127 (C1-C20) and sulfone 121 (C21-C40), of tetrafibricin. 
Although the Kocienski-Julia olefination of sulfone 121 with aldehyde 127 was unsuccessful in 
our hand, we envision that the proposed sequence of steps will complete the synthesis of 
tetrafibricin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
186 
 
  
 
2.4. EXPERIMENTAL 
General:  
187 
All reactions were run under argon unless otherwise noted. Toluene, THF, and benzene were 
freshly distilled from sodium/benzophenone. Dichloromethane was distilled from CaH2. Other 
reagents were used as they were received from Aldrich. 4Å Molecular sieves were dried at 150 
oC for at least 24 h before use. New compounds were characterized by 1H NMR, 13C NMR, IR 
spectroscopy, optical rotation, and mass spectrometry. 1H and 13C NMR spectra were recorded 
on Bruker Avance DPX 300 (300 MHz), Avance DRX 500 (500 MHz) and Avance 600 (600 
MHz) spectrometers. Chemical shifts were reported in ppm. CDCl3 was used as the NMR solvent 
unless otherwise noted. In reporting spectral data, the following abbreviations are used: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, dd = doublet of doublet, br = broad. 
Coupling constants were measured in Hertz (Hz). Infrared spectra were taken on a Mattson 
Genesis Series FTIR using thin film deposition on NaCl plates unless otherwise noted. Peaks are 
reported in wavenumbers (cm–1). Low resolution mass spectra were obtained on a Fision 
Autospec in EI mode at 70 eV and reported in m/z units. High resolution mass spectra were 
obtained on a VG Autospec double focusing instrument and are reported in units of m/z. Optical 
rotations are measured on a Perkin-Elmer 241 polarimeter at the Na D-line (λ = 589 nm) using a 
1 dm cell at 20 oC. HPLC analyses were conducted by using Waters 600 controller and Waters 
2487 dual λ absorbance detector or polymer laboratory PL-ELS 1000 detector controlled with 
the Millennium™ program. Thin layer chromatography (TLC) was performed on silica gel 60 
F254 glass backed plates with a layer thickness of 0.25 mm manufactured by E. Merck. TLC 
visualization was performed by illumination with a 254 nm UV lamp or by staining with 
phosphomolybdic acid in ethanol (50 mg/mL) and subsequent heating. Flash column 
  
 
chromatography was performed on silica gel (230-400 mesh ASTM) purchased from Sorbtech or 
Bodman.  
 
O OH
H
 
rac-(Tetrahydrofuran-2-yl)methanol (10):12 To a solution of m-CPBA (77% w/w in H2O, 4.40 
g, 19.4 mmol) in dichloromethane (200 mL) at 0 oC was added neat pent-4-en-1-ol 8 (1.52 g, 
17.7 mmol). The reaction mixture was stirred at room temperature for 2 h followed by quenching 
it with saturated aqueous sodiumbicarbonate solution. Organic layer was separated and the 
aqueous layer was extracted with dichloromethane. The combined organic layers were dried over 
MgSO4 and concentrated. Purification of the crude product by flash column chromatography 
gave the title compound 10 (1.5 g, 83%) as waxy solid. 1H NMR was identical to the commercial 
sample.2 
 
TBSO  
tert-Butyldimethyl(pent-4-enyloxy)silane (11): To a solution of pent-4-en-1-ol 8 (6.00 g, 69.8 
mmol) in dichloromethane (400 ml) at 0 oC was added tert-butyldimethylsilyl chloride (11.6 g, 
76.7 mmol) and imidazole (5.70 g, 83.7 mmol). The above reaction mixture was stirred at 0 oC 
for 20 min and room temperature for 1.5 h followed by quenching it with water (200 mL). The 
organic layer was separated and aqueous layer was extracted with dichloromethane (100 x 2 
mL). The combined organic extracts were dried over MgSO4 and concentrated to give the title 
compound 11 (14.0 g) as an oil. The crude compound was taken to the next step without further 
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12 CAS # 97-99-4; commercially available from Aldrich. 
  
 
purification: 1H NMR (300 MHz, CDCl3) δ 0.06 (s, 6H), 0.09 (s, 9H), 1.56-1.68 (m, 2H), 2.07-
2.16 (m, 2H), 4.93-5.07 (m, 2H), 5.83 (ddt, J = 17.0, 10.4, 6.6 Hz, 1H); 13C NMR (75 MHz, 
CDCl3) δ −5.2, 18.4, 26.0, 30.1, 32.1, 62.6, 114.6, 138.6. 
 
O
TBSO  
(rac)-tert-Butyldimethyl(3-(oxiran-2-yl)propoxy)silane (12): m-Chloroperbenzoic acid (75% 
w/w in H2O, 16.0 g) was added to a solution of tert-butyldimethyl(pent-4-enyloxy)silane 11 
(14.0 g, 69.8 mmol) in dichloromethane at 0 oC. The reaction mixture was stirred at 0 oC for 20 
min and room temperature for 1 h followed by quenching it with saturated aqueous NaHCO3 
solution (200 mL). The layers were separated and aqueous layer was further extracted with 
dichloromethane (100 x 2 mL). The combined organic layers were dried over MgSO4 and 
concentrated. Bulb-to-bulb (Kugelrohr) distillation of the crude product under reduced pressure 
(0.1 mbar, 90-105 oC oven temperature) gave the title compound 12 (13.0 g, 86%) as an oil: 1H 
NMR (300 MHz, CDCl3) δ 0.06 (s, 6H), 0.90 (s, 9H), 1.53-1.76 (m, 4H), 2.49 (dd, J = 4.9, 2.7 
Hz, 1H), 2.74-2.79 (m, 1H), 2.91-2.99 (m, 1H), 3.59-3.72 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 
−5.3, 18.3, 25.9, 29.0, 29.1, 47.0, 52.1, 62.6; IR (neat) cm-1 2954, 2857, 1472, 1256; EIMS 
(Μ − tBu)+ 159; HRMS for C7H15O2Si (M − tBu)+ : Calcd 159.0841; found 159.0828. 
 
O
TBSO  
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(R)-tert-Butyldimethyl(3-(oxiran-2-yl)propoxy)silane [(R)-12]: The (R,R)-Jacobsen catalyst 
(R,R)-13102 (111 mg, 0.184 mmol) was dissolved in tert-butyldimethyl(3-(oxiran-2-
yl)propoxy)silane 12 (8.00 g, 36.8 mmol), AcOH (44 µL) and THF (0.4 mL). The solution was 
  
 
cooled to 0 oC, water was added (0.37 mL, 20.3 mmol) and stirred for 16 h at room temperature. 
Bulb-to-bulb (Kugelrohr) distillation of crude product under reduced pressure (0.08 mm Hg, 90-
105 oC) gave (R)-tert-butyldimethyl(3-(oxiran-2-yl)propoxy)silane (R)-12 (3.50 g, 16.2 mmol, 
44%, > 96% ee based on Mosher ester analysis) as colorless oil: [α]D 3.74 (c 4.30 CHCl3). Data 
was identical to (rac)-12. 
O
OH  
(S)-(Tetrahydrofuran-2-yl)methanol [(S)-10]:13 To a solution of (R)-tert-butyldimethyl(3-
(oxiran-2-yl)propoxy)silane (R)-12 (100 mg, 0.460 mmol) in methanol (5 mL) was added  a drop 
of acetyl chloride at room temperature. The reaction mixture was stirred for 20 min at room 
temperature followed by concentration. Purification of the crude product by flash column 
chromatography (SiO2, 50% ethyl acetate in hexanes) gave the title compound (S)-10 (43 mg, 
92%) as a waxy solid. 1H NMR was identical to the commercial sample. 
 
O
O
O
CF3
O
Ph  
(S)-((S)-Tetrahydrofuran-2-yl)methyl 3,3,3-trifluoro-2-methoxy-2-phenylpropanoate [(S,S)-
15]: To a solution of (S)-(tetrahydrofuran-2-yl)methanol (S)-10 (20.0 mg, 0.196 mmol) in 
dichloromethane (2 mL) was added (R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoyl chloride 
(R)-14 (50.0 mg, 0.196 mmol) and DMAP (24.0 mg, 0.196 mmol). The reaction mixture was 
stirred at room temperature for 2 h followed by concentration. The crude product was purified by 
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13 CAS # 57203-01-7 
  
 
flash column chromatography (SiO2, 25% ethyl acetate in hexanes) to yield the title compound 
(52 mg, 84%) as an oil: 1H NMR (500 MHz, CDCl3) δ 1.61-1.67 (m, 1H), 1.84-1.91 (m, 2H), 
1.95-2.04 (m, 1H), 3.59 (s, 3H), 3.74-3.85 (m, 2H), 4.14-4.21 (m, 1H), 4.29-4.37 (m, 2H), 7.39-
7.59 (m, 5H); 13C NMR (125 MHz, CDCl3) δ 25.7, 28.1, 55.6, 67.8, 68.5, 76.0, 84.8 (q, JC-F = 
27.9 Hz, 1C), 123.3 (q, JC-F = 289.2 Hz, 1C), 127.5, 128.5, 129.6, 132.4, 166.6; HRMS for 
C15H17O4F3Na (M + Na)+: Calcd 341.0977; found 341.0983. 
 
S
S
TBSO
O
TBS
 
191 
(R)-2-(2,5-bis(tert-Butyldimethylsilyloxy)pentyl)-1,3-dithiane (17): t-BuLi (1.7 M in pentane, 
10.0 mL, 17.0 mmol) was added to a solution of 1,3-dithiane 16 (1.80 g, 15.0 mmol) in THF (60 
mL) at −78 oC. After 30 min at −78 oC, (R)-tert-butyldimethyl(3-(oxiran-2-yl)propoxy)silane 
(R)-12 (3.24 g, 15.0 mmol) in THF (3 mL) was added followed by the addition of dry HMPA (1 
mL). After 2 h −10 oC, the reaction mixture was cooled to −78 oC followed by slow addition of 
TBSOTf (4.36 g, 3.8 mL, 16.5 mmol). After 1 h, the mixture was warmed to room temperature 
and quenched with water (100 mL). The organic layer was separated and the aqueous layer was 
extracted with ethyl acetate. The combined organic layers were dried over MgSO4 and 
concentrated. The crude product was purified by flash column chromatography (SiO2, 10% ethyl 
acetate in hexanes) to provide the title compound 17 (5.6 g, 83%) as an oil: 1H NMR (300 MHz, 
CDCl3) δ 0.04 (s, 6H), 0.07 (s, 3H), 0.10 (s, 3H), 0.90 (s, 18H), 1.50-1.53 (m, 4H), 1.73-1.92 (m, 
3H), 2.05-2.15 (m, 1H), 2.70-2.95 (m, 4H), 3.55-3.60 (m, 2H), 3.92-4.01 (m, 1H), 4.10 (dd, J = 
8.7, 5.8 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ −5.2, −4.5, −4.3, 18.1, 18.4, 26.0, 28.0. 30.2, 
  
 
30.7, 33.7, 42.5, 44.2, 63.2, 68.4; EIMS (M − tBu)+ 393; HRMS for C17H37O2S2Si2 (Μ − tBu)+ : 
Calcd 393.1774; found 393.1780. 
O
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(R)-3,6-bis(tert-Butyldimethylsilyloxy)hexanal (18): Methyl iodide (0.2 mL) and K2CO3 (258 
mg, 1.87 mmol) were added to a solution of (R)-2-(2,5-bis(tertbutyldimethyl silyloxy)pentyl)-
1,3-dithiane 17 (800 mg, 1.77 mmol) in aqueous acetonitrile (MeCN/H2O, 6:1/2.1 mL). The 
reaction mixture was stirred for 5 h at 45 oC and then diluted with ether and water. The organic 
layer was separated and the aqueous layer was extracted with ether. The combined organic layers 
were dried over MgSO4 and concentrated. The crude product was purified by flash column 
chromatography (SiO2, 20% ethyl acetate in hexanes) to give the title compound 18 (514 mg, 
80%) as an oil: [α]D −3.74 (c 1.15 CHCl3); 1H NMR (300 MHz, CDCl3) δ 0.03 (s, 6H), 0.05 (s, 
3H), 0.07 (s, 3H), 0.86 (s, 9H), 0.88 (s, 9H), 1.47-1.65 (m, 4H), 2.49-2.54 (m, 2H), 3.57-3.63 (m, 
2H), 4.19-4.26 (m, 1H), 9.79-9.81 (m, 1H); 13C NMR (75 MHz, CDCl3) δ −5.3, −4.7, −4.4, 18.0, 
18.3, 25.7, 25.9, 28.4, 34.2, 50.7, 62.9, 68.1, 202.2; IR (neat) cm-1 2954, 2929, 2851, 2721, 1723, 
1470, 1249; EIMS (M − tBu)+ 303; HRMS for C14H31O3Si2 (M − tBu)+: Calcd 303.1812; found 
303.1805. 
 
OH
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(R)-3,6-bis(tert-Butyldimethylsilyloxy)hexan-1-ol (19): DiBAL-H (1.0 M in hexane, 2.38 mL, 
2.38 mmol) was added to a solution of (R)-3,6-bis(tert-butyldimethyl silyloxy)hexanal 18 (0.66 
g, 1.83 mmol) in THF (20 mL) at −78 oC and the mixture was stirred for 1 h. The reaction 
  
 
mixture was warmed to 0 oC, followed by the addition of ethanol (1 mL) and saturated sodium-
potassium tartarate solution (15 mL). After stirring for 1 h, the organic layer was separated and 
the aqueous layer was extracted with ethyl acetate. The combined organic layers were dried over 
MgSO4 and concentrated. Purification of the crude product by flash column chromatography 
(25% ethyl acetate in hexanes) provided the title compound 19 (650 mg, 98%) as  an oil: [α]D 
−21.0 (c 0.2 CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.03 (s, 6H), 0.07 (s, 3H), 0.08 (s, 3H), 0.88 
(s, 18H), 1.47-1.53 (m, 2H), 1.54-1.60 (m, 2H), 1.62-1.69 (m, 1H), 1.76-1.83 (m, 1H), 2.60 (br s, 
1H), 3.57-3.63 (m, 2H), 3.67-3.72 (m, 1H), 3.78-3.83 (m, 1H), 3.91-3.95 (m, 1H); 13C NMR 
(126 MHz, CDCl3) δ −5.2, −4.7, −4.3, 18.0, 18.4, 25.9, 26.0, 28.7, 33.3, 37.9, 60.2, 63.2, 71.7; 
IR (neat) cm-1 3366, 2953, 2930, 2857, 1471, 1254, 1096, 835, 775. 
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(R)-5-(3,6-bis(tert-Butyldimethylsilyloxy)hexylthio)-1-phenyl-1H-tetrazole (21):  
193 
Diisopropylazodicarboxylate (589 mg, 2.90 mmol) was added to a solution of (R)-3,6-bis(tert-
butyldimethylsilyloxy)hexan-1-ol 19 (0.65 g, 1.8 mmol), 1-phenyl-1H-tetrazole-5-thiol 20 (486 
mg, 2.73 mmol) and triphenylphosphine (621 mg, 2.36 mmol) in THF (20 mL) at 0 oC. The 
reaction mixture was stirred at room temperature for 2.5 h and quenched with saturated NaCl (20 
mL) solution. The organic layer was separated and the aqueous layer was extracted with ethyl 
acetate. The combined organic layers were dried over MgSO4 and concentrated. Purification of 
the crude product by flash column chromatography (10% ethyl acetate in hexanes) provided (R)-
5-(3,6-bis(tert-butyldimethylsilyloxy)hexylthio)-1-phenyl-1H-tetrazole 21 (940 mg, 99%) as an 
  
 
oil: [α]D −17.8 (c 0.28 CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.03 (s, 6H), 0.047 (s, 3H), 0.053 
(s, 3H), 0.88 (s, 18H), 1.48-1.60 (m, 4H), 1.89-2.05 (m, 2H), 3.36-3.50 (m, 2H), 3.55-3.64 (m, 
2H), 3.82-3.88 (m, 1H), 7.51-7.59 (m, 5H); 13C NMR (126 MHz, CDCl3) δ −5.2, −4.5, −4.3, 
18.1, 18.3, 25.9, 26.0, 28.4, 29.6, 33.3, 36.0, 63.1, 74.3, 123.8, 129.8, 130.1, 133.8, 154.4; 
HRMS for C25H46N4O2SSi2Na (M + Na)+: Calcd 545.2778; found 545.2780. 
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(R)-5-(3,6-bis(tert-Butyldimethylsilyloxy)hexylsulfonyl)-1-phenyl-1H-tetrazole  (22):  
194 
m-Chloroperperbenzoic acid (684 mg, 3.95 mmol) was added to a solution of (R)-5-(3,6-bis(tert-
butyldimethylsilyloxy)hexylthio)-1-phenyl-1H-tetrazole 21 (0.94 g, 1.8 mmol) in 
dichloromethane (20 mL) at 0 oC. The mixture was stirred for 2 h at 0 oC followed by overnight 
stirring at room temperature. The mixture was quenched with saturated NaHCO3 solution (25 
mL) followed by separation of the layers. The aqueous layer was extracted with dichloromethane 
and combined organic layers were dried over MgSO4 and concentrated. Purification of the crude 
product by flash column chromatography (SiO2, 10% ethyl acetate in hexanes) gave the title 
compound 22 (863 mg, 88%) as an oil: [α]D −4.1 (c 1.0 CHCl3); 1H NMR (500 MHz, CDCl3) δ 
0.05 (s, 6H), 0.08 (s, 3H), 0.09 (s, 3H), 0.90 (s, 9H), 0.902 (s, 9H), 1.48-1.67 (m, 4H), 2.01-2.10 
(m, 1H), 2.11-2.20 (m, 1H), 3.58-3.66 (m, 2H), 3.77 (ddd, J = 14.7, 11.0, 4.6 Hz, 1H), 3.85 (ddd, 
J = 14.7, 11.5, 5.5 Hz, 1H), 3.90-3.96 (m, 1H), 7.59-7.63 (m, 3H), 7.69-7.71 (m, 2H); 13C NMR 
(126 MHz, CHCl3) δ −5.2, −4.6, −4.4, 18.1, 18.3, 25.9, 26.0, 28.4, 28.8, 33.2, 52.6, 62.9, 69.9, 
  
 
125.1, 129.7, 131.4, 133.1, 153.5; IR (neat) cm-1 2953, 2930, 2857, 1499, 1463, 1343, 1254, 
1096, 836, 776; HRMS for C25H46N4O4SSi2Na (M + Na)+: Calcd 577.2676; found 577.2680. 
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(R)-4-(tert-Butyldimethylsilyloxy)-6-(1-phenyl-1H-tetrazol-5-ylsulfonyl)hexan-1-ol (23): 
A solution of HF•pyr (10 mL, prepared by slow addition of 6 mL HF•pyr to a solution 24 mL 
pyridine in 50 mL THF at 0 oC) was added to a solution of (R)-5-(3,6-bis(tert-
butyldimethylsilyloxy) hexylsulfonyl)-1-phenyl-1H-tetrazole 22 (0.10 g, 0.18 mmol) in THF at 0 
oC. The reaction mixture was stirred for 6 h at room temperature. The reaction was slowly 
quenched with saturated aqueous NaHCO3 solution, followed by extraction of aqueous layer 
with ethyl acetate. The combined organic layers were washed with CuSO4 solution, dried over 
MgSO4 and concentrated. The crude product was purified by flash column chromatography to 
yield the title compound 23 (81 mg, 76%)  as an oil: [α]D −1.1 (c 0.72 CHCl3); 1H NMR (300 
MHz, CDCl3) δ  0.09 (d, 6H), 0.88-0.99 (m, 9H), 1.57-1.65 (m, 6H), 2.06-2.21 (m, 2H), 3.67 (br 
s, 1H), 3.74-3.87 (m, 2H), 3.95 (m, 2H), 7.26-7.73 (m, 5H); 13C NMR (75 MHz, CHCl3) δ −4.5, 
−4.4, 18.1, 25.9, 28.4, 28.8, 33.1, 52.3, 62.8, 69.8, 125.2, 129.8, 131.5, 133.2, 153.6; IR (neat) 
cm-1 3377, 2953, 2930, 2885, 2858, 1596, 1498, 1463, 1343; EIMS (M + H)+ 441; HRMS for 
C15H23N4O4SiS (M − tBu)+: Calcd 383.1209; found 383.1203. 
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(R)-4-(tert-butyldimethylsilyloxy)-6-(1-phenyl-1H-tetrazol-5-ylsulfonyl) N,N-diBoc-hexan-1- 
amine (2): To a solution of (R)-4-(tert-butyldimethylsilyloxy)-6-(1-phenyl-1H-tetrazol-5-
ylsulfonyl) hexan-1-ol 23 (120 mg, 0.27 mmol) in THF (1 mL)were added triphenylphosphine 
(107 mg, 0.41 mmol), di-tert-butyl-iminodicarboxylate (94 mg, 0.43 mmol)  and 
diisopropylazodicarboxylate (99 mg, 0.49 mmol). After 16 h, the reaction mixture was 
concentrated and the crude product was purified by flash column chromatography to yield the 
title compound 2 (128 mg, 74%)  as an oil: [α]D −3,3 (c 1.21 CHCl3) 1H NMR (500 MHz, 
CDCl3) δ 0.075 (s, 3H), 0.084 (s, 3H), 0.90 (s, 9H), 1.41-1.69 (m, 22H), 2.01-2.08 (m, 1H), 2.11-
2.18 (m, 1H), 3.57 (t, J = 7.0 Hz, 2H), 3.74-3.86 (m, 2H), 3.89-3.93 (m, 1H), 7.60-7.64 (m, 3H), 
7.69-7.72 (m, 2H); 13C NMR (151 MHz, CDCl3) δ −4.5, −4.3, 18.1, 24.9, 25.9, 28.2, 28.9, 34.0, 
46.2, 52.6, 69.7, 82.3, 125.1, 129.8, 131.5, 133.1, 152.8, 153.5;  IR (neat) cm-1 2955, 2930, 2857, 
1734, 1695, 1344; HRMS for C29H49N5O7SiSNa: Calcd 662.3020; found 662.3020. 
 
O
S N
N
NN
O
 
(S)-5-(2-(2,2-Dimethyl-1,3-dioxolan-4-yl)ethylthio)-1-phenyl-1H-tetrazole: [(S)-25]: 
196 
Diisoprop ylazodicarboxylate (2.8 g, 14 mmol) was added to a solution of (S)-2-(2,2-dimethyl-
1,3-dioxolan-4-yl)ethanol (S)-24 (1.2 g, 8.2 mmol), 1-phenyl-1H-tetrazole-5-thiol 20 (2.60 g, 
14.8 mmol) and triphenylphosphine (3.00 g, 11.5 mmol) in THF (20 mL) at 0 oC. The mixture 
  
 
was stirred at room temperature for 3 h and then quenched with water (20 mL). The organic layer 
was separated and the aqueous layer was extracted with ethyl acetate. The combined organic 
layers were dried over MgSO4 and concentrated. The crude product was purified by flash column 
chromatography (25% ethyl acetate in hexanes) to provide the title compound (S)-25 (2.28 g, 
7.44 mmol, 91%) as an oil: [α]D −1.0 (c 1.0 CHCl3); 1H NMR (300 MHz, CDCl3) δ 1.31 (s, 3H), 
1.39 (s, 3H), 1.98-2.18 (m, 2H), 3.36-3.55 (m, 2H), 3.59 (dd, J = 8.1, 6.6 Hz, 1H), 4.06 (dd, J = 
8.1, 6.1 Hz, 1H), 4.18-4.27 (m, 1H), 7.53 (br s, 6H); 13C NMR (75 MHz, CDCl3) δ 25.5, 26.9, 
29.6, 33.4, 68.9, 74.2, 109.2, 123.7, 129.8, 130.1, 133.6, 154.1; IR (neat) cm-1 3070, 2985, 2933, 
2868, 1570, 1500, 1066; EIMS (M − CH3)+ 291; HRMS for C13H15N4O2S (M − CH3)+ : Calcd 
291.0916; found 291.0919. 
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(S)-4-(1-Phenyl-1H-tetrazol-5-ylthio)butane-1,2-diol [(S)-26]: To a solution of (S)-5-(2-(2,2-
dimethyl-1,3-dioxolan-4-yl)ethylthio)-1-phenyl-1H-tetrazole (S)-25 (810 mg, 2.64 mmol) in 
methanol (10 mL) was added a drop of acetyl chloride (21 mg). After 30 min, the mixture was 
concentrated and the crude product was purified by flash column chromatography (SiO2, 80% 
ethyl acetate in hexanes) to provide the title compound (S)-26 (650 mg, 2.45 mmol, 93%) as 
viscous oil: [α]D −7.5 (c 1.82 CHCl3); 1H NMR (500 MHz, CDCl3) δ 1.90-2.09 (m, 2H), 2.55 (br 
s, 1H), 3.42-3.55 (m, 1H), 3.56-3.68 (m, 2H), 3.68-3.81 (m, 1H), 3.85-4.13 (m, 2H), 7.58 (br s, 
5H); 13C NMR (126 MHz, CDCl3) δ 29.8, 33.7, 66.4, 69.5, 124.0, 129.9, 130.4, 133.5, 155.1; IR 
  
 
(neat) cm-1 3384, 2936, 1644, 1596, 1499, 1462, 1388, 1318, 1280; EIMS (M + H)+ 267; HRMS 
for C10H11N4O1S(M − CH3O)+: Calcd 235.0653; found 235.0658. 
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(S)-5-(3,4-bis(tert-Butyldimethylsilyloxy)butylthio)-1-phenyl-1H-tetrazole (27): To a solution 
of  (S)-4-(1-phenyl-1H-tetrazol-5-ylthio)butane-1,2-diol (S)-26 (830 mg, 3.14 mmol) in 
dichloromethane (30 mL) at −78 oC were added 2,6-lutidine (1.98 g, 18.5 mmol) and TBSOTf 
(1.70 g, 6.45 mmol). The reaction mixture was stirred at −78 oC for 1 h followed by warming it 
to 0 oC. The reaction mixture was poured into water followed by separation of the organic layer. 
The aqueous layer was extracted with dichloromethane and the combined organic extracts were 
dried over MgSO4 and concentrated. The crude product was purified by flash column 
chromatography (SiO2, 5% ethyl acetate in hexanes) to yield the title compound 27 (1.54 g, 3.11 
mmol, 99%) as an oil: [α]D −22.6 (c 0.72 CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.04 (s, 3H), 
0.05 (s, 3H), 0.07 (s, 6H), 0.87 (s, 9H), 0.89 (s, 9H), 1.90-1.98 (m, 1H), 2.09-2.16 (m, 1H), 3.41-
3.47 (m, 2H), 3.50-3.60 (m, 2H), 3.80-3.85 (m, 1H), 7.53-7.60 (m, 6H); 13C NMR (126 MHz, 
CDCl3) δ −5.3, −4.7, −4.2, 18.1, 18.3, 25.9, 26.0, 29.5, 33.6, 66.9, 71.7, 123.9, 129.8, 130.1, 
133.8, 154.5; IR (neat) cm-1 2929, 2857, 1598, 1501, 1472, 1388, 1253, 837; HRMS for 
C23H42N4O2Si2S (M + Na)+: Calcd 517.2465; found 517.2424. 
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(S)-2-(tert-Butyldimethylsilyloxy)-4-(1-phenyl-1H-tetrazol-5-ylthio)butan-1-ol (28):  
To a solution of (S)-5-(3,4-bis(tert-Butyldimethylsilyloxy)butylthio)-1-phenyl-1H-tetrazole 27 
(810 mg, 1.63 mmol) in THF (10 mL) at 0 oC was added HF•py (20 mL, prepared by slow 
addition of 6 mL HF•py to a solution of 24 mL pyridine in 50 mL THF at 0 oC). The mixture was 
stirred for 1 h at 0 oC and 5 h at room temperature. The reaction mixture was treated with 
saturated aqueous NaHCO3 solution (40 mL) and the aqueous layer was extracted with ethyl 
acetate. The combined organic layers were washed with sat. aq. CuSO4, dried over MgSO4 and 
concentrated. The crude product was purified by flash column chromatography (SiO2, 25% ethyl 
acetate in hexanes) to yield the title compound 28 (396 mg, 1.04 mmol, 64%) as an oil: [α]D 
−6.76 (c 4.36 CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.08 (s, 6H), 0.89 (s, 9H), 2.06-2.11 (m, 
2H), 2.38 (dd, J = 6.9, 5.0 Hz, 1H), 3.33-3.41 (m, 1H), 3.44-3.51 (m, 1H), 3.55 (ddd, J = 11.5, 
7.3, 4.6 Hz, 1H), 3.62 (dt, J = 10.1, 5.0 Hz, 1H), 3.92 (dt, J = 10.5, 5.0 Hz, 1H), 7.53-7.58 (m, 
5H); 13C NMR (126 MHz, CDCl3) δ −4.6, −4.5, 18.1, 25.8, 29.1, 33.3, 65.8, 71.2, 123.8, 129.8, 
130.2, 133.6, 154.3; IR (neat) cm-1 3441, 3064, 2929, 2884, 2857, 1597, 1500, 1388, 1251; 
HRMS for C13H19N4O2SiS (M − tBu)+: Calcd 323.0998; found 323.0995. 
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(S)-2-(tert-Butyldimethylsilyloxy)-4-(1-phenyl-1H-tetrazol-5-ylthio)butanal (3): To a solution 
of (S)-2-(tert-butyldimethylsilyloxy)-4-(1-phenyl-1H-tetrazol-5-ylthio)butan-1-ol 28 (0.11 g, 
0.28 mmol) in dichloromethane (5 mL) was added sodium bicarbonate (solid, 73 mg) and dess-
martin reagent (184 mg, 0.430 mmol). The reaction mixture was stirred for 1.5 h and then 
quenched with sat. aq. NaHCO3 solution (2 mL). The layers were separated and the aqueous 
layer was extracted with dichloromethane. Combined organic layers were dried over MgSO4 and 
concentrated. The crude product was purified by flash column chromatography (SiO2, 15% ethyl 
acetate in hexanes) to provide the title compound 3 (91 mg, 0.24 mmol, 86%) as an oil: [α]D 
−13.1 (c 2.57 CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.08 (s, 3H), 0.10 (s, 3H), 0.92 (s, 9H), 
2.19 (sex, J = 6.9 Hz, 1H), 2.24-2.31 (m, 1H), 3.47 (t, J = 6.9 Hz, 2H), 4.17 (dd, J = 7.3, 4.6 Hz, 
1H), 7.52-7.59 (m, 5H), 9.64 (s, 1H); 13C NMR (126 MHz, CDCl3) δ −4.9, −4.5, 18.2, 25.8, 28.7, 
32.0, 76.1, 123.9, 129.9, 130.2, 133.6, 153.8, 202.9; IR (neat) cm-1 3071, 2953, 2855, 2709, 
1735, 1593, 1500, 1390; HRMS for C17H27N4O2SSi (M + H)+: Calcd 379.1624; found 379.1648. 
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5-((3S,7R,E)-3,7,10-tris(tert-Butyldimethylsilyloxy)dec-4-enylthio)-1-phenyl-1H-tetrazole 
(29): KHMDS (0.5 M in toluene, 0.2 mL, 0.1 mmol) was added to a solution of sulfone 22 (47 
mg, 86 µmol) in THF (1 mL) at −78 oC. After 30 min, a solution of aldehyde 3 (42.4 mg, 0.112 
mmol) in THF (1 mL) wad added. After stirring for 1 h at _78 oC, the mixture was warmed to 
room temperature and stirred for additional 12 h. Water (1 mL) was added to the reaction 
mixture and the aqueous layer was extracted with ethyl acetate. The combined organic layers 
  
 
were dried over MgSO4 and concentrated. The crude product was purified by flash column 
chromatography (SiO2, 10% ethyl acetate in hexanes) to give the title compound (54 mg, 89%) 
as a clear oil. This was further purified by preparative HPLC using Whelk-O column (98/2 
hexanes/i-propanol) to yield pure E-isomer of the title compound 29 (49.2 mg, 81%); 1H NMR 
(500 MHz, CDCl3) δ 0.03 (s, 3H), 0.04 (s, 6H), 0.05 (s, 3H), 0.88 (s, 9H), 0.89 (s, 9H), 1.37-1.63 
(m, 4H), 1.97-2.02 (m, 2H), 2.19 (t, J = 6.0 Hz, 2H), 3.39-3.47 (m, 2H), 3.58 (t, J = 6.0 Hz, 2H), 
3.67-3.73 (m, 1H), 4.24 (q, J = 6.0 Hz, 1H), 5.44 (dd, J = 15.6, 6.9 Hz, 1H), 5.62 (dt, J = 15.1, 
7.3 Hz, 1H), 7.52-7.61 (m, 5H); 13C NMR (126 MHz, CDCl3) δ −5.2, −4.7, −4.5, −4.3, −4.0, 
18.2, 18.2, 18.4, 26.0, 26.1, 28.9, 29.5, 32.9, 37.5, 40.0, 63.4, 71.9, 72.2, 123.9, 127.7, 129.8, 
130.1, 133.8, 134.6, 154.5; IR (neat) cm-1 2954, 2929, 2852, 1597, 1503, 1462, 1389, 1246; 
HRMS for C35H66N4O3SSi3 (M)+: Calcd 729.4061; found729.4048. 
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(4R,8S,E)-4,8-bis(tert-butyldimethylsilyloxy)-10-(1-phenyl-1H-tetrazol-5-ylthio)-N,N-
bis(Boc) dec-6-en-1-amine (30): KHMDS (0.5 M in toluene, 0.45 ml, 0.225 mmol) was added 
to a solution of sulfone 2 (130 mg, 0.187 mmol) in THF (5 mL) at −78 oC. After 30 min, a 
solution of (S)-2-(tert-butyldimethylsilyloxy)-4-(1-phenyl-1H-tetrazol-5-ylthio)butanal 3 (92.3 
mg, 0.244 mmol) in THF (2 mL) was added. The reaction mixture was stirred at −78 oC for 1.5 h 
followed by overnight stirring at room temperature. The reaction mixture was quenched with 
water and the aqueous layer was extracted with ethyl acetate. The combined organic extracts 
were dried over MgSO4, concentrated and the crude product was purified by flash column 
  
 
chromatography to yield an E/Z mixture (9/1) of product (95 mg, 95%) as an oil. Further 
purification y preparative HPLC with Whelk-O column (95/5 hexane/i-propanol) provided pure 
E-isomer 30 (127 mg, 86%): [α]D +4.3 (c 0.21 CHCl3); 1H NMR (600 MHz, CDCl3) δ 0.02 (s, 
3H), 0.03 (s, 6H), 0.05 (s, 3H), 0.87 (s, 9H), 0.88 (s, 9H), 1.37-1.44 (m, 2H), 1.50 (s, 18H), 1.62-
1.70 (m, 2H), 1.98-2.01 (m, 2H), 2.18 (t, J = 6.4 Hz, 2H), 3.39-3.47 (m, 2H), 3.50-3.57 (m, 2H), 
3.66-3.70 (m, 1H), 4.23 (q, J = 6.0 Hz, 1H), 5.44 (dd, J = 15.4, 6.6 Hz, 1H), 5.60 (dt, J = 15.4, 
7.1 Hz, 1H), 7.54-7.60 (m, 5H); 13C NMR (151 MHz, CDCl3) δ −4.7, −4.5, −4.3, −4.0, 18.1, 
18.2, 25.2, 25.9, 28.2, 29.5, 33.8, 37.5, 40.0, 46.6, 71.8, 72.1, 82.0, 123.9, 127.5, 129.8, 130.1, 
133.8, 134.8, 152.7, 154.5; IR (neat) cm-1 2955, 2928, 2856, 1740, 1698, 1501, 1367, 1124; 
HRMS (M + Na)+ for C39H69N5O6Si2SNa: Calcd 814.4405; found 814.4401. 
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bis((R)-2,2-Dimethyl-1,3-dioxolan-4-yl)methanol (36):14 To a refluxing suspension of D-
arabitol D-33 (1.00 g, 6.58 mmol) in 3,3-dimethoxypropane (3.50 mL, 28.9 mmol) and THF (10 
mL) was added CSA (0.457 g, 1.97 mmol) and the reaction mixture was stirred at reflux for 5 
min. Triethylamine (2 mL) was added to the refluxing reaction mixture, and the mixture was 
concentrated in vacuo and loaded directly onto a silica gel column (35% ethyl acetate in 
hexanes) to yield the title compound 36 (917 mg, 60%) as a colorless oil. Data same as reported 
in the literature.3
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14 CAS # 73543-86-9:  Francisco, C. G.; Leon, E. I.; Martin, A.; Moreno, P.; Rodriguez, M. S.; 
Suarez, E. J. Org. Chem. 2001, 61, 6967. 
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O-bis((R)-2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 1H-imidazole-1-carbothioate (39): To a 
solution of alcohol 36 (1.62 g, 6.95 mmol) in 1,2-dicholoroethane (25 mL) was added N,N-
thiocarbonyldi-imidazole 38 (2.16 g, 12.1 mmol) and the mixture was stirred for 6 h at reflux. 
The resultant reaction mixture was concentrated and purified by flash column chromatography to 
give the title compound 39 (2.26 g, 95%) as a yellow oil.1H NMR (300 MHz, CDCl3) δ 1.32 (s, 
12H), 3.81 (m, 1H), 4.02-4.14 (m, 3H), 4.41-4.53 (m, 2H), 5.89-5.92 (m, 1H), 7.03 (s, 1H), 7.65 
(s, 1H), 8.36 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 24.6, 24.7, 25.8, 26.0, 64.9, 65.4, 74.2, 74.6, 
80.6, 109.2, 109.3, 117.7, 130.7, 136.7, 184.3. 
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bis((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)methane (40): To a solution of compound 39 (1.80 g, 
5.28 mmol) was added Et3SiH (40 mL) and the reaction mixture was brought to reflux. Benzoyl 
peroxide (0.26 g, 1.1 mmol) was added and the reaction mixture, and was refluxed for 2 h, with 
similar quantity added after 30, 60, and 90 min. The reaction mixture was concentrated and the 
crude material was purified by flash column chromatography (gradient, 25 to 50% ethyl acetate 
in hexanes) to yield the title compound 40 (1.14 g, 66%) as a pale yellow oil. 1H NMR (500 
MHz, CDCl3) δ 1.36 (s, 6H), 1.40 (s, 6H), 1.80 (t, J = 6.4 Hz, 2H), 3.55-3.58 (m, 2H), 4.11 (dd, J 
  
 
= 7.8, 6.0 Hz, 2H), 4.19-4.24 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 25.8, 27.0, 38.4, 69.9, 
73.7, 108.9.  
 
OHHO
OH OH
 
(2S,4S)-pentane-1,2,4,5-tetraol (41):15103 To a solution of compound 40 in methanol (10 mL) 
was added acetyl chloride (20 µL). The reaction mixture was stirred for 30 min at room 
temperature followed by concentration to yield the title compound (175 mg, 99%) 41 as a white 
solid. 
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(S)-3-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)propane-1,2-diol (42)16: To a solution of compound 
41 (56.3 mg, 0.413 mmol) in DMF (10 mL) was added 2,2-dimethoxypropane (47.4 mg, 0.455 
mmol) and CSA (9.6 mg, 0.041 mmol). The reaction mixture was stirred for 15 min and then 
quenched with triethylamine (20 mg). Concentration of the reaction mixture followed by 
purification of the crude product by flash column chromatography gave the title compound 42 
(42.2 mg, 58%). 1H NMR (500 MHz, CDCl3) δ 1.36 (s, 3H), 1.42 (s, 3H), 1.67 (ddd, J = 14.2, 
7.8, 3.7 Hz, 1H), 1.74 (ddd, J = 18.3, 8.7, 4.1 Hz, 1H), 2.83 (brs 2H), 3.50 (dd, J = 11.5, 7.3 Hz, 
                                                 
15 CAS # 92691-36-6 Data was same as reported in the literature: Ley, S. V.; Anthony, N. J.; 
Armstrong, A.; Brasca, M. G.; Clarke, T.; Culshaw, D.; Greck, C.; Grice, P.; Jones, A. B. 
Tetrahedron. 1989, 45, 7161. 
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1H), 3.58 (t, J = 7.8 Hz, 1H), 3.66 (dd, J = 11.5, 3.7 Hz, 1H), 3.90-3.95 (m, 1H), 4.09 (dd, J = 
8.3, 6.0 Hz, 1H), 4.30-4.35 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 25.7, 27.0, 36.4, 66.9, 69.5, 
69.6, 73.4; IR (neat) cm-1 2294, 2988, 1374, 1057; HRMS for C7H13O4 (M – CH3): Calcd 
161.0815; found 161.0814.  
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(S)-3-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2-hydroxypropyl 4-methylbenzenesulfonate (43): 
To a solution of diol 42 (760 mg, 4.31 mmol) in CH2Cl2 (35 mL) were added Bu2SnO (107 mg, 
0.430 mmol), p-TsCl (863 mg, 4.53 mmol) and Et3N (480 mg, 4.74 mmol). After 3 h, the 
reaction mixture was concentrated and the crude product was purified by flash column 
chromatography (SiO2, 50% ethyl acetate in hexanes) to yield the title compound 43 (968 mg, 
68%). 1H NMR (500 MHz, CDCl3) δ 1.33 (s, 3H), 1.38 (s, 3H), 1.67-1.72 (m, 2H), 2.46 (s, 3H), 
2.67 (d, J = 4.6 Hz, 1H), 3.56 (t, J = 8.3 Hz, 1H), 3.95 (dd, J = 11.5, 8.3 Hz, 1H), 4.05-4.09 (m, 
3H), 4.26-4.31 (m, 1H), 7.37 (d, J = 8.3 Hz, 2H), 7.81 (d, J = 8.3 Hz, 2H); 13C NMR (126 MHz, 
CDCl3) δ 21.7, 25.6, 27.0, 36.0, 67.1, 69.4, 72.9, 73.4, 109.2, 128.1, 130.0, 132.7, 145.2; HRMS 
for C14H19O6S: Calcd 315.0902; found 315.0894. 
 
O
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(S)-2,2-Dimethyl-4-((S)-oxiran-2-ylmethyl)-1,3-dioxolane (31):17 To a solution of alcohol 43 
(900 mg, 2.72 mmol) in MeOH/CH2Cl2 (5/1, 12 mL) was added K2CO3 (565 mg, 4.09 mmol). 
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The reaction mixture was stirred for 2 h followed by concentration. Then it was diluted with 
ethyl acetate (10 mL) and washed with water (5 mL x 2). The organic layer was dried over 
MgSO4 and concentrated. The crude product was purified by flash column chromatography to 
yield the title compound 31 (387 mg, 90%) as colorless oil. 1H NMR (500 MHz, CDCl3) δ 1.31 
(s, 3H), 1.36 (s, 3H), 1.49 (ddd, J = 13.8, 7.3, 5.5 Hz, 1H), 1.91 (ddd, J = 14.2, 7.8, 4.1 Hz, 1H), 
2.45 (dd, J = 4.6, 2.3 Hz, 1H), 2.75 (t, J = 4.6 Hz, 1H), 2.97-3.00 (m, 1H), 3.53 (t, J = 7.3 Hz, 
1H), 4.05 (dd, J = 7.8, 5.6 Hz, 1H), 4.22 -4.27 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 25.6, 
26.9, 37.1, 47.1, 49.3, 69.3, 73.6, 108.9; IR (neat) cm-1 2987, 2942, 2872, 1454, 1371, 1060; 
HRMS for C7H11O3 (M − CH3)+: Calcd 143.0708; found 143.0706. 
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(S)-4-Allyl-2,2-dimethyl-1,3-dioxolane (45): To a solution of CH3PPh3Br (15.8 g, 44.2 mmol) 
in THF (500 mL) at 0 oC was added n-BuLi (1.6 M in hexane, 27.6 mL, 44.2 mmol). The 
reaction mixture was stirred for 20 min followed by cooling it to –78 oC. A solution of aldehyde 
44 (4.9 g, 34 mmol) in THF (5 mL) was slowly added to the above reaction mixture. After 30 
min, it was allowed to warm to room temperature and stirred overnight. The reaction mixture 
was poured into saturated aqueous NH4Cl (300 mL) and the aqueous layer was extracted with 
Et2O (2 x 300 mL). The combined organic layers were dried over MgSO4 and concentrated. 
Purification of the crude product by flash column chromatography (SiO2, 20% ethyl acetate in 
hexanes) afforded the title compound 45 (4.0 g, 83%) a volatile oil: 1H NMR (300 MHz, CDCl3) 
δ 1.37 (s, 3H), 1.43 (s, 3H), 2.25-2.34 (m, 1H), 2.37-2.48 (m, 1H), 3.59 (dd, J = 8.2, 7.1 Hz, 1H), 
  
 
4.03 (dd, J = 8.2, 6.0 Hz, 1H), 4.13-4.21 (m, 1H), 5.07-5.17 (m, 2H), 5.81 (ddt, J = 17.0, 10.4, 
7.1 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ 25.7, 26.9, 38.1, 69.0, 75.2, 109.0, 117.7, 133.7.  
O
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(S)-1-((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)-3-(1,3-dithian-2-yl)propan-2-ol (46): t-BuLi (1.7 
M in pentane, 5.3 mL, 9.0 mmol) was added to a solution of 1,3-dithiane 16 (1.10 g, 9.04 mmol) 
in THF/HMPA (5 mL/0.3 mL) at −78 oC. After 30 min, a solution of (S)-2,2-dimethyl-4-((S)-
oxiran-2-ylmethyl)-1,3-dioxolane 31 (1.3 g, 8.2 mmol) in THF (3mL) and HMPA (1mL) was 
added to the above reaction mixture. After 1 h at −78 oC, the reaction mixture was allowed to 
warm to 0 oC, followed by quenching it with saturated aqueous NH4Cl solution. Aqueous layer 
was extracted with ethyl acetate, the combined organic layers were dried over MgSO4 and 
concentrated. The crude product was  purified by flash column chromatography (SiO2, 25% ethyl 
acetate in hexanes) to yield the title compound 46 (1.9 g, 83%) as an oil: [α]D +6.75 (c 0.80 
CHCl3); 1H NMR (500 MHz, CDCl3) δ 1.36 (s, 3H), 1.42 (s, 3H), 1.69-1.79 (m, 2 H), 1.84-1.99 
(m, 3H), 2.10-2.16 (m, 1H), 2.67 (d, J = 5.0 Hz, 1H), 2.82-2.95 (m, 4H), 3.59 (t, J = 7.8 Hz, 1H), 
4.09 (dd, J = 8.2, 6.0 Hz, 1H), 4.14-4.20 (m, 1H), 4.27 (dd, J = 8.9, 5.3 Hz, 1H), 4.31-4.36 (m, 
1H); 13C NMR (126 MHz, CDCl3) δ 25.6, 25.9, 26.9, 30.1, 30.3, 39.8, 42.8, 44.2, 66.1, 69.4, 
73.4, 108.9; IR (neat) cm-1 3435, 2983, 2935, 2899, 1456, 1423, 1370; EIMS (M+) 278; HRMS 
for C12H22O3S2 (M+): Calcd 278.1010; found 278.1006. 
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tert-butyl((S)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-(1,3-dithian-2-yl)propan-2-yloxy) 
dimethylsilane (47): To a solution of alcohol 46 (320 mg, 1.15 mmol) and 2,6-lutidine in 
CH2Cl2 at −78 oC was added and TBSOTf. The reaction mixture was stirred for 1.5 h followed 
by pouring it into water (25 mL). Organic layer was separated and the aqueous layer was 
extracted with CH2Cl2. The combined organic layers were dried over MgSO4 and concentrated. 
The crude product was purified by flash column chromatography to yield the title compound 47  
(410 mg, 91%) as an oil: [α]D −1.65 (c 4.79 CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.07 (s, 3H), 
0.09 (s, 3H), 0.87 (s, 9H), 1.30 (s, 3H), 1.36 (s, 3H), 1.59 (ddd, J = 13.7, 8.2, 5.0 Hz, 1H), 1.77 
(ddd, J = 13.7, 7.8, 4.6 Hz, 1H), 1.79-1.88 (m, 3H), 2.05-2.11 (m, 1H), 2.75-2.87 (m, 4H), 3.44 
(t, J = 7.8 Hz, 1H), 3.99-4.09 (m, 3H), 4.11-4.16 (m, 1H), 4.13 (dtd, J = 10.5, 7.8, 5.0 Hz, 1H); 
13C NMR (126 MHz, CDCl3) δ −4.6, −4.4, 25.8, 25.9, 27.1, 30.3, 30.5, 41.4, 43.6, 43.9, 66.6, 
69.9, 72.8, 77.3, 108.5. 
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 (R)-5-(2-(2,2-Dimethyl-1,3-dioxolan-4-yl)ethylthio)-1-phenyl-1H-tetrazole (25): [α]D +12.3 
(c 1.19 CHCl3): Diisopropylazodicarboxylate (2.80 g, 14.0 mmol) was added to a solution of (R)-
2-(2,2-dimethyl-1,3-dioxolan-4-yl)ethanol (1.2 g, 8.2 mmol), 1-phenyl-1H-tetrazole-5-thiol (2.60 
g, 14.8 mmol) and triphenylphosphine (3.00 g, 11.5 mmol) in THF (20 mL) at 0 oC. The reaction 
  
 
mixture was stirred at room temperature for 3 h and quenched with water (20 mL). The aqueous 
layer was extracted with ethyl acetate and the combined organic layers were dried over MgSO4 
and concentrated. Purification of the crude product by flash column chromatography (25% ethyl 
acetate in hexanes) provided (R)-5-(2-(2,2-dimethyl-1,3-dioxolan-4-yl)ethylthio)-1-phenyl-1H-
tetrazole 25 (2.23 g, 7.29 mmol, 89%) as an oil. 
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(R)-4-(1-Phenyl-1H-tetrazol-5-ylthio)butane-1,2-diol 26: [α]D +11 (c 0.78 CHCl3); To a 
solution of (R)-5-(2-(2,2-dimethyl-1,3-dioxolan-4-yl)ethylthio)-1-phenyl-1H-tetrazole (600 mg, 
1.96 mmol) in methanol (10 mL) was added a drop of acetyl chloride (~ 21 mg). After 30 min, 
the reaction mixture was concentrated and the crude product was purified by flash column 
chromatography (80% ethyl acetate in hexanes) to provide (R)-4-(1-phenyl-1H-tetrazol-5-
ylthio)butane-1,2-diol (510 mg, 86 %) as a viscous oil. 
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(R)-2-Hydroxy-4-(1-phenyl-1H-tetrazol-5-ylthio)butyl 4-methylbenzenesulfonate 48: To a 
solution of (R)-4-(1-phenyl-1H-tetrazol-5-ylthio)butane-1,2-diol (290 mg, 1.28 mmol) in CH2Cl2 
(10 mL) were added Bu2SnO (64 mg, 0.26 mmol), p-toluenesulfonyl chloride (244 mg, 1.28 
  
 
mmol), and triethyl amine (130 mg, 1.28 mmol). The reaction mixture was stirred for 3 h 
followed by dilution with water (10 mL). Organic layer was separated and the aqueous layer was 
extracted with CH2Cl2. The combined organic layers were dried MgSO4 and concentrated. The 
crude product was purified by flash column chromatography (SiO2, ethyl acetate/hexanes = 1:1) 
to yield the title compound (400 mg, 74%): [α]D +10.0 (c 0.74 CHCl3); 1H NMR (500 MHz, 
CDCl3) δ 1.87-2.03 (m, 2H), 2.39 (s, 3H), 3.43-3.50 (m, 2H), 3.92-4.03 (m, 4H), 7.30 (d, J = 8.2 
Hz, 2H), 7.53 (s, 5H), 7.75 (d, J = 8.2 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 21.4, 29.2, 32.7, 
66.9, 73.1, 123.6, 127.7, 129.7, 129.8, 130.1, 132.3, 133.3, 144.9, 154.4; IR (neat) cm-1 3400, 
3060, 2946, 1597, 1499, 1387, 1357, 1243; HRMS for C18H20N4O4S2: calcd 443.0824; found 
443.0804. 
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(R)-5-(2-(Oxiran-2-yl)ethylthio)-1-phenyl-1H-tetrazole 32: To a solution of (R)-2-hydroxy-4-
(1-phenyl-1H-tetrazol-5-ylthio)butyl 4-methylbenzenesulfonate (440 mg, 1.05 mmol) in 
CH3OH-DCM (9:1 10 mL) was added K2CO3 (173 mg, 1.25 mmol). The reaction mixture was 
stirred at room temperature for 1 h followed by concentration. Then it was diluted with 
dichloromethane (10 mL) and water (10 mL). The organic layer was separated and the aqueous 
layer was extracted with dichloromethane. The combined organic extracts were dried over 
MgSO4 and concentrated to provide the title compound (211 mg, 81%) as an oil: [α]D +15.0 (c 
1.13 CHCl3); 1H NMR (500 MHz, CDCl3) δ 1.92 (td, J = 14.2, 6.9 Hz, 1H), 2.21-2.29 (t, J = 4.6 
Hz, 1H), 2.52 (dd, J = 4.6, 2.7 Hz, 1H), 2.74-2.78 (m, 1H), 3.01-3.06 (m, 1H), 3.45-3.54 (m, 
  
 
2H), 7.49-7.56 (m, 5H); 13C NMR (126 MHz, CDCl3) δ 29.8, 32.0, 46.8, 50.6, 123.7, 129.8, 
130.1, 133.5, 153.9; IR (neat) cm-1 3056, 2991, 2924, 1596, 1500, 1461; HRMS (EI) for 
C11H12N4O1S: Calcd 248.0732; found 248.0721. 
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tert-Butyl((S)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-(2-(2-((R)-oxiran-2-yl)ethyl thio)-1,3-
dithian-2-yl)propan-2-yloxy)dimethylsilane (49): t-BuLi (1.7 M in pentane, 0.14 mL, 0.24 
mmol) was added to a solution of compound 47 in THF (0.8 mL) at –30 oC. After 30 min,  
epoxide 32 (58.9 mg, 0.284 mmol) in THF (0.2 mL) was added to the reaction mixture and 
stirred for additional 30 min at –30 oC. Then the mixture was warmed to 0 oC and for 2 h. The 
reaction was quenched with saturated aqueous NH4Cl solution and the aqueous layer was 
extracted with ethyl acetate. The combined organic extracts were dried over MgSO4 and 
concentrated. The crude product was purified by flash column chromatography (SiO2, 25% ethyl 
acetate in hexanes) to yield the title compound 49 (66 mg, 56%) as colorless oil. [α]D −21.2 (c 
1.72 CHCl3); 1H NMR (500 MHz, CDCl3) δ 0.12 (s, 3H), 0.16 (s, 3H), 0.89 (s, 9H), 1.33 (s, 3H), 
1.41 (s, 3H), 1.61 (ddd, J = 13.7, 8.3, 4.6 Hz, 1H), 1.81-1.87 (m, 3H), 2.04-2.09 (m, 1H), 2.23-
2.29 (m, 3H), 2.53 (dd, J = 5.0, 2.8 Hz, 1H), 2.58-2.71 (m, 4H), 2.78-2.80 (m, 1H), 2.99-3.04 (m, 
1H), 3.14-3.35 (m, 2H), 3.51-3.54 (m, 1H), 4.06 (dd, J = 7.8, 5.5 Hz, 1H), 4.17-4.23 (m, 1H), 
4.26-4.31 (m, 1H); 13C NMR (126 MHz, CDCl3) δ −4.2, −3.8, 18.1, 24.6, 25.9, 26.1, 27.1, 27.5, 
27.8, 29.6, 31.9, 43.3, 47.2, 51.4, 52.0, 60.4, 67.2, 70.1, 73.2, 108.6; IR (neat) cm-1 2983, 2953, 
2855, 1472, 1252; HRMS (EI) for C21H39O4SiS3 (M − CH3)+: Calcd 479.1779; found 479.1780. 
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(R)-4-(2-(4-Methoxybenzyloxy)ethyl)-2,2-dimethyl-1,3-dioxolane (53):18Alcohol (R)-24 (1.30 
g, 8.07 mmol) was added slowly over 10 min to a suspension of NaH (271 mg, 11.3 mmol) in 
DMF (15 mL) at 0 oC. The mixture was stirred for 30 min followed by the addition of p-
methoxybenzyl chloride (1.33 g, 8.48 mmol). The reaction mixture was allowed to warm to room 
temperature and was stirred overnight. The reaction mixture was quenched with methanol (1 mL) 
and poured into water (100 mL). The aqueous layer was extracted with ether and the combined 
organic extracts were dried over MgSO4 and concentrated. Purification of the crude product by 
flash column chromatography (SiO2, 25% Ethylacete in hexanes) gave the title compound 53 as 
colorless oil: [α]D 0.87 (c 1.2 CHCl3); 1H NMR (500 MHz, CHCl3) δ 1.36 (s, 3H), 1.41 (s, 3H), 
1.79-1.89 (m, 1H), 1.89-1.97 (m,1H), 3.50-3.60 (m, 3H), 3.81 (s, 3H), 4.06 (dd, J = 8.2, 6.0 Hz, 
1H), 4.17-4.25 (m, 1H), 4.44 (s, 2H), 6.88 (d, J = 8.2 Hz, 2H), 7.25 (d, J = 8.2 Hz, 2H); 13C 
NMR (126 MHz, CDCl3) δ 25.9, 27.0, 33.9, 55.3, 66.8, 69.7, 72.8, 74.0, 108.6, 113.9, 129.3, 
130.5, 159.3; IR (neat) cm-1 2985, 2936, 2865, 1613, 1514, 1248; HRMS (EI) for C12H18O4 (M)+: 
Calcd 226.1205; found 226.1199. 
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(R)-4-(4-Methoxybenzyloxy)butane-1,2-diol (54): To a solution of compound 53 (1.70 g, 6.04 
mmol) in methanol (25 mL) was added acetyl chloride (~100 mg). The reaction mixture was 
stirred at room temperature for 2 h followed by concentration of the reaction mixture. The crude 
product was purified by flash column chromatography (SiO2, 80% ethyl acetate in hexanes) to 
yield the title 54 compound as clear colorless oil: [α]D −2.6 (c 1.4 CHCl3); HRMS (EI) for 
C15H22O4 (M)+: Calcd 266.1518; found 266.1514. 
 
OPMB
O
 
(R)-2-(2-(4-Methoxybenzyloxy)ethyl)oxirane (56): To a solution of diol 54 (800 mg, 3.98 
mmol) in toluene (15 mL) were added PPh3 (1.30 g, 4.97 mmol) and DIAD (1.00 g, 4.97 mmol). 
The reaction mixture was refluxed overnight followed by concentration of the reaction mixture. 
The crude reaction product was purified by flash column chromatography (SiO2, 25% ethyl 
acetate in hexanes) to yield the title compound 56 (779 mg, 94%) as an oil: [α]D 12 (c 1.0 
CHCl3); 1H NMR (500 MHz, CDCl3) δ 1.72-1.82 (m, 1H), 1.85-1.95 (m, 1H), 2.53 (dd, J = 5.0, 
2.7 Hz, 1H), 2.79 (t, J = 4.6 Hz, 1H), 3.03-3.10 (m, 1H), 3.55-3.64 (m, 2H), 3.81 (s, 3H), 4.47 (s, 
2H), 6.89 (d, J = 8.7 Hz, 2H), 7.27 (d, J = 8.7 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 33.0, 
47.2, 50.1, 55.3, 66.8, 72.8, 113.9, 129.3, 130.4, 159.3; IR (neat) cm-1 2997, 2924, 2860, 1613, 
1513; HRMS (EI) for C12H16O3 (M)+: Calcd 208.1099; found 208.1094. 
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(R)-4-(4-Methoxybenzyloxy)-1-(2-((S)-2-(tert-butyldimethylsilyloxy)-3-((S)-2,2-dimethyl-
1,3-dioxolan-4-yl)propyl)-1,3-dithian-2-yl)butan-2-ol (57): To a solution of compound 47 
(0.33 g, 0.84 mmol) in THF (1.2 mL) at 0 oC was added n-BuLi (1.6 M in hexane, 0.6 mL). The 
reaction mixture was stirred at 0 oC for 20 min, followed by cooling to –20 oC. Then a solution 
of epoxide 56 (0.18 g, 0.88 mmol) in THF (0.5 mL) was added and stirred at –10 oC for 3 h. The 
reaction mixture was quenched with saturated aqueous NH4Cl and the layers were separated. The 
aqueous layer was extracted with Et2O and the combined organic layers were dried over MgSO4 
and concentrated. The crude product was purified by flash column chromatography (SiO2, 25% 
ethyl acetate in hexanes) to yield the title compound 57 (340 mg, 67%) as clear oil. 1H NMR 
(300 MHz, CDCl3) δ 0.06 (s, 3H), 0.12 (s, 3H), 0.88 (s, 9H), 1.34 (s, 3H), 1.41 (s, 3H), 1.52-1.80 
(m, 3H), 1.88-2.19 (m, 5H), 2.20-2.39 (m, 2H), 2.75-2.99 (m, 4H), 3.51 (t, J = 7.9 Hz, 1H), 3.57-
3.63 (m, 3H), 3.80 (s, 3H), 4.06 (dd, J = 13.5, 7.7 Hz, 1H), 4.12-4.23 (m, 3H), 4.45 (s, 2H); 13C 
NMR (75 MHz, CDCl3) δ –4.2, −3.7, 14.3, 18.0, 24.7, 25.9, 26.0, 26.2, 26.7, 27.1, 37.7, 43.0, 
46.7, 48.2, 51.2, 55.3, 60.4, 67.0, 67.5, 68.0, 70.1, 72.9, 73.3, 108.6, 113.8, 129.4, 130.4, 159.2; 
IR (neat) cm-1 3497, 2974, 2932, 2856, 1613, 1514, 1249, 1093; HRMS (EI) for C30H52O6SiS2 
(M)+: Calcd 600.2975; found 600.2955. 
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(2S,6R)-8-(4-Methoxybenzyloxy)-2-(tert-butyldimethylsilyloxy)-1-((S)-2,2-dimethyl-1,3-
dioxolan-4-yl)-6-hydroxyoctan-4-one (58): To a solution of compound 57 (135 mg, 0.224 
mmol) in acetonitrile and water (6/1, 3 mL) were added MeI (80 mg, 0.56 mmol) and K2CO3 (34 
mg, 0.35 mmol). The reaction mixture was stirred at 45 oC for 6 h. The reaction mixture was 
  
 
diluted with Et2O (5 mL), dried over MgSO4, concentrated and purified by flash column 
chromatography (SiO2, 25% ethyl acetate in hexanes) to yield the title compound 58 (93 mg, 
81%) as an oil.1H NMR (500 MHz, CDCl3) δ 0.09 (s, 3H), 0.13 (s, 3H), 0.91 (s, 9H), 1.36 (s, 
3H), 1.42 (s, 3H), 1.64 (ddd, J = 13.8, 8.3, 6.7 Hz, 1H), 1.71-1.86 (m, 3H), 2.60-2.68 (m, 4H), 
3.41 (d, J = 3.2 Hz, 1H), 3.49 (t, J = 7.8 Hz, 1H), 3.61-3.70 (m, 2H), 3.83 (s, 3H), 4.06 (dd, J = 
7.8, 6.0 Hz, 1H), 4.13-4.20 (m, 1H), 4.25-4.31 (m, 1H), 4.33-4.38 (m, 1H), 4.47 (s, 2H), 6.91 (d, 
J = 8.7 Hz, 2H), 7.28 (d, J = 8.7 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ −4.7, −4.5, 18.0, 25.9, 
27.1, 36.2, 41.6, 50.9, 52.0, 55.3, 66.2, 66.4, 67.6, 69.8, 72.7, 72.9, 108.8, 113.9, 129.3, 130.2, 
159.3, 209.5; IR (neat) cm-1 3466, 2952, 2931, 1708, 1514, 1302, 1090, 777; HRMS (ES) for 
C27H46O7SiNa (M + Na)+: Calcd 533.2911; found 533.2886. 
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(3R,5S,7R)-1-(4-Methoxybenzyloxy)-7-(tert-butyldimethylsilyloxy)-8-((S)-2,2-dimeth yl-1,3-
dioxolan-4-yl)octane-3,5-diol (59): To a solution of compound 58 (88 mg, 0.17 mmol) in 
acetonitrile (0.54 mL) at –25 oC was added a solution of (CH3)4NBH(OAc)3 (68 mg, 0.26 mmol) 
in acetic acid (0.1 mL). The reaction mixture was stirred at that temperature for 48 h, quenched 
with aqueous sodium potassium tartarate (1.0 M, 0.8 mL), diluted with ethyl acetate and 
neutralized with sodium bicarbonate. The aqueous layer was extracted with ethyl acetate; the 
combined organic layers were dried over MgSO4 and concentrated to yield the title compound 
(76 mg, 86%) as an oil. The crude compound 59 was taken to the next step without further 
purification. 1H NMR (500 MHz, CDCl3) δ 0.12 (s, 3H), 0.14 (s, 3H), 0.90 (s, 9H), 1.34 (s, 3H), 
1.38 (s, 3H), 1.50-1.62 (m, 3H), 1.66-1.75 (m, 2H), 1.78-1.92 (m, 3H), 3.48 (t, J = 8.0 Hz, 1H), 
  
 
3.57 (brs, 1H), 3.60-3.71 (m, 2H), 3.80 (s, 3H), 3.89 (brs, 1H), 4.05 (dd, J = 7.8, 6.0 Hz, 1H), 
4.09-4.24 (m, 3H), 4.26-4.34 (m, 1H), 4.45 (s, 2H), 6.87 (d, J = 8.7 Hz, 2H), 7.24 (d, J = 8.7 Hz, 
2H); 13C NMR (76 MHz, CDCl3) δ −4.8, −4.4, 18.0, 25.9, 27.1, 36.9, 40.4, 43.1, 43.9, 55.3, 66.0, 
68.4, 68.8, 69.3, 69.9, 70.1, 72.8, 73.0, 108.9, 113.9, 129.3, 130.3, 159.4; IR (neat) cm-1 3449, 
2984, 2934, 2857, 1613, 1514, 1249; HRMS (EI) for C27H48O7SiNa (M + Na)+: Calcd 535.3067; 
found 535.3072. 
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(S)-4-((2S,4S,6R)-8-(4-Methoxybenzyloxy)-2,4,6-tris(tert-butyldimethylsilyloxy)octyl)-2,2-
dimethyl-1,3-dioxolane (60): To a solution of compound 59 (44.0 mg, 0.0858 mmol) in 
dichloromethane (5 mL) at 0 oC were added TBSOTf (46.5 mg, 0.176 mmol) and 2,6-lutidine 
(54.3, 0.506 mmol). The reaction mixture was stirred at that temperature for 1 h followed by 
quenching it with water. The aqueous layer was extracted with dichloromethane and the 
combined organic layers were dried over MgSO4 and concentrated. Purification of the crude 
reaction mixture by flash column chromatography (SiO2, 10% ethyl acetate in hexanes) gave the 
title compound 60 (50 mg, 80%) as clear oil. 1H NMR (300 MHz, CDCl3) δ 0.07 (s, 18H), 0.88 
(s, 18H), 0.89 (s, 9H), 1.33 (s, 3H), 1.38 (s, 3H), 1.48-1.87 (m, 8H), 3.42-3.52 (m, 3H), 3.75-3.84 
(m, 4H), 3.85-3.94 (m, 2H), 4.00-4.04 (m, 1H), 4.13-4.26 (m, 1H), 4.41 (s, 2H), 6.87 (d, J = 8.8 
Hz, 2H), 7.25 (d, J = 7.7 Hz, 2H); 13C NMR (76 MHz, CDCl3) δ 13C NMR (75 MHz, CDCl3) δ  
−4.4, −4.2, −4.1, −3.7, −3.5, 18.1, 26.0, 27.2, 37.9, 41.3, 46.3, 47.3, 55.3, 66.7, 67.4, 67.5, 67.7, 
70.0, 72.7, 108.6, 113.8, 129.3, 130.8, 159.1; IR (neat) cm-1 2953, 2857, 1511, 1250; HRMS (EI) 
for C39H76O7Si3Na (M + Na)+: Calcd 129.0552; found129.0550. 
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2-((2S,4S)-2,4,5-tris(tert-butyldimethylsilyloxy)pentyl)-1,3-dithiane (64): To a solution of (S)-
1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-(1,3-dithian-2-yl)propan-2-ol 46 (1.9 g. 6.8 mmol) in 
methanol (16 mL) was added acetyl chloride (200 µL). The reaction mixture was stirred for 1 h 
followed by concentration. To the crude compound (triol, 63) in dichloromethane (30 mL) were 
added 2,6-lutidine (2.4 g, 22.4 mmol) and TBSOTf (5.90 g, 22.4 mmol) at 0 oC. After 1 h, the 
reaction mixture was poured into water. The organic layer was separated and the aqueous layer 
was extracted with dichloromethane. The combined organic extracts were dried over MgSO4 and 
concentrated. Purification of the crude product by flash column chromatography (5% ethyl 
acetate in hexanes) provided the title compound 64 (3.25 g, 88%) as an oil: 1H NMR (300 MHz, 
CDCl3) δ 0.06 (s, 6H), 0.08 (s, 3H), 0.10 (s, 6H), 0.12 (s, 3H), 0.89 (s, 9H), 0.90 (s, 18H), 1.47-
1.56 (m, 1H), 1.76-1.96 (m, 4H), 2.06-2.19 (m, 1H), 2.75-2.94 (m, 4H), 3.42 (dd, J = 10.2, 5.8 
Hz, 1H), 3.54 (dd, J = 10.2, 5.2 Hz, 1H), 3.69-3.79 (m, 1H), 4.02-4.14 (m, 2H); 13C NMR (75 
MHz, CDCl3) δ −5.2, −4.3, −4.1, −3.9, −3.8, 18.2, 18.5, 26.1, 30.4, 30.8, 43.4, 44.0, 44.2, 67.0, 
67.8, 71.2; IR (neat) cm-1 2954, 2929, 2897, 2857, 1472, 1463, 1255; HRMS for C23H51O3S2Si3 
(M – t-Bu): Calcd 523.2587; found 523.2607.  
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(R)-1-(2-((2S,4S)-2,4,5-tris(tert-Butyldimethylsilyloxy)pentyl)-1,3-dithian-2-yl)-4-(4-
methoxybenzyloxy)butan-2-ol (65): t-BuLi (1.7 M in pentane, 1 mL, 1.7 mmol) was added to a 
solution of 2-((2S,4S)-2,4,5-tris(tert-butyldimethylsilyloxy)pentyl)-1,3-dithiane 64 (0.9 g, 1.55 
mmol) in THF (2.4 mL)-HMPA (0.6 mL) at –78 oC. After 10 min, (R)-2-(2-(4-
methoxybenzyloxy)ethyl)oxirane 56 (0.36 g, 1.7 mmol) in THF (1 mL) was added. The reaction 
mixture was stirred at −78 oC for 15 min, then warmed to 0 oC and stirred for 1 h. The reaction 
mixture was quenched with saturated aqueous NH4Cl solution (10 mL). The layers were 
separated and the aqueous layer was extracted with ethyl acetate. The combined organic layers 
were dried over MgSO4 and concentrated. Purification of the crude product by flash column 
chromatography (SiO2, 20% ethyl acetate in hexanes) provided the title compound 65 (1.1 g, 
90%) as an oil: [α]D −5.0 (c 0.9 CHCl3); 1H NMR (300 MHz, CDCl3) δ 0.09-0.16 (m, 18H), 0.91 
(s, 9H), 0.93 (s, 9H), 0.94 (s, 9H), 1.66-2.47 (m, 11H), 2.68-2.83 (m, 2H), 2.84-3.04 (m, 2H), 
3.46-3.74 (m, 5H), 3.81 (s, 3H), 4.18-4.33 (m, 2H), 4.47 (s, 2H), 6.89 (d, J = 8.8 Hz, 2H), 7.28 
(d, J = 8.5 Hz, 2H); 13C NMR (76 MHz, CDCl3) δ −5.3, −4.4, −3.8, −3.6, −3.1, 14.2, 18.0, 18.2, 
18.4, 24.6, 26.0, 26.3, 37.6, 45.0, 46.5, 48.3, 51.4, 55.1, 60.3, 66.9, 67.4, 67.5, 67.9, 71.3, 72.7, 
113.7, 129.2, 130.4, 159.1; IR (neat) cm-1 2953, 2928, 2855, 1614, 1514, 1463, 1250; HRMS for 
C39H76O6S2Si3Na: Calcd 811.4289; found 811.4284. 
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(3R,7S,9S)-1-(4-Methoxybenzyloxy)-7,9,10-tris(tert-butyldimethylsilyloxy)-3-hydro 
xydecan-5-one (66): To a solution of (R)-1-(2-((2S,4S)-2,4,5-tris(tert-butyldimethylsilyloxy) 
pentyl)-1,3-dithian-2-yl)-4-(4-methoxybenzyloxy)butan-2-ol 65 (610 mg, 0.77 mmol) in 
THF/H2O (4:1, 10 mL)  and 2.6-lutidine (662 mg, 6.18 mmol) was added Hg(ClO4)3•H2O (1.05 
  
 
g, 2.32 mmol) in portions at 0 oC. After 45 min, the mixture was filtered through a pad of celite 
and the filter cake was rinsed with ethyl acetate. The filtrate was diluted with ethyl acetate and 
saturated aqueous NH4Cl. The layers were separated and the aqueous layer was extracted with 
ethyl acetate. The combined organic layers were dried over MgSO4, concentrated and the crude 
product was purified by flash column chromatography (20% ethyl acetate in hexanes) to yield 
the title compound 66 (454 mg84%) as an oil: [α]D −6.53 (c 1.73 CHCl3); 1H NMR (300 MHz, 
CDCl3) δ 0.08 (s, 3H), 0.09 (s, 6H), 0.12 (s, 3H), 0.13 (s, 6H), 0.89 (s, 9H), 0.92 (s, 9H), 0.93 (s, 
9H), 1.48-1.60 (m, 1H), 1.70-1.83 (m, 3H), 2.54-2.70 (m, 4H), 3.36-3.43 (m, 2H), 3.50-3.63 (m, 
3H), 3.64-3.76 (m, 1H), 3.80 (s, 3H), 4.15-4.35 (m, 2H), 4.44 (s, 2H), 8.87 (d, J = 8.6 Hz, 2H), 
7.25 (d, J = 8.6 Hz, 2H), 13C NMR (75 MHz, CHCl3) δ −5.3, −4.5, −4.3, −4.2, −3.9, 18.0, 18.2, 
18.4, 25.9, 25.99, 26.0, 36.2, 43.4, 50.9, 52.1, 55.3, 66.3, 67.0, 67.6, 67.8, 71.2, 72.9, 113.9, 
129.3, 130.4, 159.3, 209.9; IR (neat) cm-1 3509, 2954, 2929, 2857, 1709, 1614, 1514, 1472, 
1251; HRMS for C36H70O7Si3Na (M + Na)+: Calcd 721.4327; found 721.4329. 
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1-(((3R,5S,7R,9S)-3,5,7,9,10-pentakis(tert-Butyldimethylsilyloxy)decyloxy)methyl)-4-
methoxybenzene (62): To a solution of (3R,7S,9S)-1-(4-methoxybenzyloxy)-7,9,10-tris(tert-
butyldimethylsilyloxy)-3-hydro xydecan-5-one 66 (445 mg, 0.64 mmol) in acetonitrile (2 mL) at 
−25 oC was added (CH3)4NBH(OAc)3 (253 mg, 0.96 mmol) as a solution in acetic acid (0.4 mL). 
The reaction mixture was stirred at that temperature for 48 h, quenched with aqueous sodium 
potassium tartarate solution (1.0 M, 3 mL), diluted with ethyl acetate and neutralized with 
sodium bicarbonate. The aqueous layer was extracted with ethyl acetate; the combined organic 
  
 
layers were dried over MgSO4 and concentrated. To the crude compound 67 (412 mg) in 
dichloromethane at 0 oC were added 2,6-lutidine (189 mg, 1.77 mmol) and TBSOTf (327 mg, 
1.24 mmol). The reaction mixture was stirred at that temperature for 1 h and quenched with 
water. The layers were separated and the aqueous layer was extracted with dichloromethane. The 
combined organic extracts were dried over MgSO4, concentrated and the crude product was 
purified by flash column chromatography (SiO2, 10% ethyl acetate in hexanes) to yield the title 
compound 62 (434 mg, 73%) as an oil:  1H NMR (600 MHz, CDCl3) δ 0.04 (s, 3H), 0.055 (s, 
3H), 0.06 (s, 3H), 0.063 (s, 3H), 0.07 (s, 3H), 0.076 (s, 6H), 0.08 (s, 3H), 0.082 (s, 3H), 0.084 (s, 
3H), 0.877 (s, 9H), 0.88 (s, 9H), 0.883 (s, 9H), 0.888 (s, 9H), 0.90 (s, 9H), 1.45-1.50 (m, 1H), 
1.52-1.58 (m, 1H), 1.59-1.67 (m, 3H), 1.67-1.75 (m, 2H), 1.79-1.84 (m, 1H), 3.41 (dd, J = 10.2, 
5.5 Hz, 1H), 3.49-3.54 (m, 3H), 3.76-3.80 (m, 1H), 3.81 (s, 3H), 3.83-3.87 (m, 1H), 3.87-3.92 
(m, 2H), 4.42 (s, 2H), 6.87 (d, J = 8.8 Hz, 2H), 7.26 (d, J = 9.6 Hz, 2H); 13C NMR (151 MHz, 
CDCl3) δ −5.2, −4.4, −4.2, −3.8, −3.7, −3.5, −3.4, 18.1, 18.2, 18.3, 18.5, 26.1, 26.1, 26.1, 26.1, 
37.7, 42.6, 46.0, 46.8, 55.3, 66.8, 67.2, 67.4, 67.5, 67.6, 70.8, 72.6, 113.8, 129.2, 130.9, 159.1; 
HRMS for C48H100O7Si5Na (M + Na)+: Calcd 951.6213; found 951.6311. 
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(2S,4R,6S,8R)-10-(4-Methoxybenzyloxy)-2,4,6,8-tetrakis(tert-butyldimethylsilyloxy) decan-
1-ol (68): To a solution of 1-(((3R,5S,7R,9S)-3,5,7,9,10-pentakis(tert-butyldimethylsilyloxy) 
decyloxy)methyl)-4-methoxybenzene 62 (70 mg, 0.075 mmol) in THF (0.5 mL) was added 
HF•py in pyridine (1 mL). The reaction mixture was stirred at room temperature for 6 h followed 
by quenching the reaction with saturated aqueous sodium bicarbonate solution (5 mL). Aqueous 
  
 
layer was extracted with ethyl acetate. The combined organic layers were dried over over MgSO4 
and concentrated. Purification of the crude product by flash column chromatography (SiO2, 10% 
ethyl acetate in hexanes) provided the title compound 68 (30 mg, 49%) (84% based on recovered 
sm) as colorless oil along with recovered starting material 62 (29 mg, 0.031 mmol): [α]D +16.5 
(c 0.2 CHCl3); 1H NMR (600 MHz, CDCl3) δ 0.05 (s, 3H), 0.07 (s, 3H), 0.072 (s, 6H), 0.08 (s, 
6H), 0.10 (s, 3H), 0.104 (s, 3H), 0.88 (s, 18H), 0.883 (s, 9H), 0.91 (s, 9H), 1.55-1.73 (m, 7H), 
1.80-1.85 (m, 1H), 1.91 (t, J = 6.0 Hz, 1H), 3.44 (ddd, J = 11.8, 7.1, 5.2 Hz, 1H), 3.50 (t, J = 7.1 
Hz, 2H), 3.61 (ddd, J = 11.0, 5.5, 3.6 Hz, 1H), 3.80-3.85 (m, 6H), 3.85-3.89 (m, 1H), 4.41 (ddd, 
J = 19.8, 11.5, 5.0 Hz, 1H), 6.88 (d, J = 8.5 Hz, 2H), 7.76 (d, J = 8.5 Hz, 2H);  13C NMR (151 
MHz, CDCl3) δ −4.3, −4.3, −4.2, −3.7, −3.6, −3.59, −3.5, 18.1, 18.2, 26.0, 37.5, 42.4, 46.3, 46.5, 
55.3, 66.6, 66.7, 67.1, 67.2, 67.4, 70.4, 72.6, 113.7, 129.2, 130.8, 159.1; IR (neat) cm-1 3420, 
2950, 2925, 2929, 2852, 1614, 1511, 1462, 1251, 1102; HRMS for C42H86O7Si4Na (M + Na)+: 
Calcd 837.5348; found 837.5363. 
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(2S,4R,6S,8R)-10-(4-Methoxybenzyloxy)-2,4,6,8-tetrakis(tert-butyldimethylsilyloxy) decanal 
(69): To a solution of (2S,4R,6S,8R)-10-(4-methoxybenzyloxy)-2,4,6,8-tetrakis(tert-
butyldimethylsilyloxy) decan-1-ol 68 (28 mg, 0.034 mmol) in DCM (2 mL) were added solid 
NaHCO3 (15 mg) and dess-martin reagent (17 mg, 0.041 mmol). The reaction mixture was 
stirred at room temperature for 1 h followed by quenching the reaction with saturated NaHCO3 
solution. Organic layer was separated and the aqueous layer was extracted with DCM. The 
combined organic layers were dried over MgSO4, concentrated and the crude product was 
  
 
purified by flash column chromatography (10% ethyl acetate in hexanes) to yield the title 
compound 69 (26 mg, 93%) as an oil: 1H NMR (600 MHz, CD2Cl2) δ 0.05 (s, 3H), 0.06 (s, 3H), 
0.08 (s, 9H), 0.09 (s, 6H), 0.10 (s, 3H), 0.97 (s, 9H), 0.88 (s, 9H), 0.89 (s, 9H), 0.93 (s, 9H), 
1.53-1.60 (m, 2H), 1.66-1.81 (m, 6H), 3.47-3.52 (m, 2H), 3.79 (s, 3H), 3.82-3.86 (m, 1H), 3.91-
3.95 (m, 1H), 3.95-4.00 (m, 1H), 4.15-4.18 (m, 1H), 4.38 (s, 2H), 6.85 (d, J = 8.8 Hz, 2H), 7.24 
(d, J = 8.5 Hz, 2H), 9.58 (d, J = 1.7 Hz, 1H); 13C NMR (151 MHz, CD2Cl2) δ −4.3, −3.9, −3.8, 
−3.5, −3.4, −3.1, −3.0, 18.5, 18.7, 26.3, 26.4, 38.4, 41.2, 46.3, 47.1, 55.8, 67.2, 67.6, 67.6, 68.0, 
73.1, 76.1, 114.1, 129.7, 131.6, 159.7, 203.8; IR (neat) cm-1; 2954, 2929, 2894, 2857, 1736, 
1653, 1635, 1558, 1251; HRMS for C42H84O7Si4Na (M + Na)+: Calcd 835.5192; found 
835.5197. 
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(S)-2-(2,2-Dimethyl-1,3-dioxolan-4-yl)acetaldehyde (S)-25: To a solution of (S)-2-(2,2-
dimethyl-1,3-dioxolan-4-yl)ethanol (S)-24 (5.00 g, 34.1 mmol) in dichloromethane (200 mL) at 0 
oC was added diisopropylethylamine (26.3 mL, 153.9 mmol) and stirred for 5 min. DMSO (24.3 
mL, 341 mmol) was added to the above reaction mixture and stirred for another 10 min. At this 
time, SO3•pyr (13.6 g, 85.5 mmol) was added and the mixture was stirred for 45 min. saturated 
aqueous NaHCO3 was added to the reaction mixture and allowed to warm to room temperature. 
The layers were separated and the aqueous layer was extracted with dichloromethane. The 
combined organic layers were washed with brine, dried over MgSO4 and concentrated. The crude 
product was purified by flash column chromatography (35% ethyl acetate in hexanes) to yield 
the title compound (S)-25 (4.30 g, 29.4 mmol, 86%) as an oil: [α]D +8.1 (c 3.8 CHCl3); 1H NMR 
(300 MHz, CDCl3) δ 1.37 (s, 3H), 1.42 (s, 3H), 2.65 (ddd, J = 17.3, 6.0, 1.1 Hz), 2.85 (ddd, J = 
  
 
17.3, 6.6, 1.9 Hz, 1H), 3.60 (dd, J = 8.5, 6.9 Hz, 1H), 4.19 (dd, J = 8.5, 6.0 Hz, 1H), 4.54 (p, J = 
6.3 Hz, 1H), 9.8 (t, J = 1.4 Hz, 1H); 13C NMR (76 MHz, CDCl3) δ 25.5, 26.9, 47.9, 69.2, 70.7, 
109.3, 199.9; IR (neat) cm-1 2987, 2936, 2735, 1725, 1372, 1217; HRMS (EI) for C6H9O3 (M 
− CH3)+: Calcd 129.0552; found129.0550. 
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(S)-3-(1,3-Dithian-2-yl)propane-1,2-diol (70): To a solution of aldehyde (S)-25 (1.80 g, 12.5 
mmol) in CH2Cl2 (130 mL) were added 1,3-propanedithiol (2.60 mL, 37.5 mmol, 3 equiv) and 
BF3•Et2O (4.7 mL)  at 0 oC for 1 h. The reaction mixture was diluted with ether, washed with 3% 
aqueous NaOH. The aqueous layer was extracted with ethyl acetate, and the combined organic 
layers were washed with saturated aqueous NH4Cl solution, dried over MgSO4 and concentrated. 
The crude product was purified by flash column chromatography (100% ethyl acetate) to yield 
the title compound 70 (1.9 g, 9.8 mmol, 78%): [α]D −9.5 (c 0.4 CHCl3); 1H NMR (300 MHz, 
CDCl3) δ 1.79-1.99 (m, 3H), 2.08-2.18 (m, 1H), 2.49 (br s, 1H), 2.81-2.98 (m, 5H), 3.48 (dd, J = 
11.0, 7.1 Hz, 1H),  3.67 (dd, J = 11.0, 2.2 Hz, 1H), 3.99-4.10 (m, 1H), 4.26 (dd, J = 8.8, 5.5 Hz, 
1H); 13C NMR (75 MHz, CHCl3) δ 25.8, 30.0, 30.3, 38.5, 43.8, 66.5, 69.1; IR (neat) cm-1 3386, 
2931, 2899, 1422, 1276; EIMS (M+) 194, (M − H2O)+ 176; HRMS for C7H14O2S2: Calcd 
194.0435; found 194.0442. 
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(S)-2-(2,3-bis(tert-Butyldimethylsilyloxy)propyl)-1,3-dithiane (71): To a solution of  (S)-3-
(1,3-dithian-2-yl)propane-1,2-diol 70 (1.4 g, 7.2 mmol) in dichloromethane (30 mL) were added 
  
 
2,6-lutidine (0.88 mL, 15 mmol) and TBSOTf (1.7 mL, 15 mmol) at −78 oC. Then the mixture 
was warmed to 0 oC and stirred for additional 1 h. It was poured into water (30 mL) and the 
layers were separated. The aqueous layer was extracted with dichloromethane. The combined 
organic extracts were dried over MgSO4 and concentrated. Purification of the crude product by 
flash column chromatography (5% ethyl acetate in hexanes) gave the title compound 71 (2.9 g, 
6.9 mmol, 95%): [α]D −28.3 (c 11.9 CHCl3); 1H NMR (300 MHz, CDCl3) δ 0.06 (s, 6H), 0.09 (s, 
3H), 0.13 (s, 3H), 0.90 (s, 18H), 1.77 (ddd, J = 13.7, 8.8, 4.7 Hz, 1H), 1.84-1.97 (m, 1H), 1.99-
2.16 (m, 2H), 2.78-2.91 (m, 4H), 3.40 (dd, J = 10.1, 6.6 Hz, 1H), 3.58 (dd, J = 10.1, 5.0 Hz, 1H), 
3.92-4.00 (m, 1H), 4.16 (dd, J = 10.1, 4.7 Hz, 1H); 13C NMR (75 MHz, CHCl3) δ −5.3, −4.7, 
−4.2, 18.1, 18.3, 25.9, 26.0, 26.1, 29.9, 30.5, 40.4, 43.8, 67.5, 69.5; IR (neat) cm-1 2929, 2897, 
2857, 1472, 1256; EIMS (M+) 422, (M − CH3)+ 407, (M − tBu)+ 365;  HRMS for C19H42O2Si2S2: 
Calcd 422.2165; found 422.2150. 
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(R)-2-((3,4-Dimethoxybenzyloxy)methyl)oxirane (75): To a solution of sodium hydride (2.43 
g, 101 mmol) in THF (40 mL) at 0 oC was added (S)-glycidol (5.00 g, 67.6 mmol) in THF (10 
mL). After 1h, 3,4-dimethoxybenzyl chloride (18.8 g, 101 mmol) and tetra-n-butylammonium 
iodide (2.50 g, 10.2 mmol) were added. The reaction mixture was allowed to warm to room 
temperatuare and stirred overnight. Then it was poured into water (100 mL) and the aqueous 
layer was extracted with Et2O (4 x 100 mL). The combined organic layers were washed with 
H2O and brine, dried over MgSO4 and concentrated. Flash column chromatography on silica gel 
(25% EtOAc in hexanes) gave the title compound 75 (10.5 g, 69%) as a pale yellow oil: 1H NMR 
  
 
(300 MHz, CHCl3) δ 2.56 (dd, J = 4.9, 2.7 Hz, 1H), 2.75 (dd, J = 4.9, 4.1 Hz, 1H), 3.13 (ddt, J = 
5.8, 4.1, 2.7 Hz, 1H), 3.36 (dd, J = 11.2, 5.8 Hz, 1H), 3.71 (dd, J = 11.5, 3.0 Hz, 1H), 3.82 (s, 
3H), 3.84 (s, 3H), 4.45 (d, J = 11.5 Hz, 1H), 4.50 (d, J = 11.5 Hz, 1H), 6.76 - 6.89 (m, 3H); 13C 
NMR (75 MHz, CHCl3) δ 44.1, 50.7, 55.7, 70.5, 73.0, 110.9, 111.1, 120.2, 130.4, 148.6, 149.0; 
HRMS for C12H12O4: Calcd 224.1049; found 224.0999. 
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(R)-1-(2-((S)-2,3-bis(tert-Butyldimethylsilyloxy)propyl)-1,3-dithian-2-yl)-3-(3,4-
dimethoxybenzyloxy)propan-2-ol (77): To a solution of compound 71 (2.90 g, 6.86 mmol) in 
THF (60 mL) at 0 oC was added n-BuLi (1.6 M in hexane, 4.3 mL). The reaction mixture was 
stirred at room temperature for 15 min followed by re-cooling it to 0 oC. A solution of epoxide 
76 (1.69 g, 7.54 mmol) in THF (1 mL) was added and allowed to stir at room temperature 
overnight. The reaction mixture was poured into saturated aqueous NH4Cl, and the aqueous layer 
was extracted with ethyl acetate. The combined organic layers were dried over MgSO4, and 
concentrated. The crude product was purified by flash column chromatography (SiO2, 25% ethyl 
acetate in hexanes) to provide the title compound 77 (580 mg, 13%) as an oil along with 
recovered compound 71 (1.47 g, 3.47 mmol). [α]D −8.58 (c 2.47 CHCl3); 1H NMR (300 MHz, 
CDCl3) δ  0.04 (s, 6H), 0.07 (s, 3H), 0.09 (s, 3H), 0.84 (s, 9H), 0.88 (s, 9H), 1.82-2.04 (m, 4H), 
2.24 (dd, J = 15.4, 8.2 Hz, 1H), 2.59 (dd, J = 15.8, 2.7 Hz, 1H), 2.65-2.96 (m, 4H), 3.14 (d, J = 
2.7 Hz, 1H), 3.32-3.45 (m, 3H), 3.57 (dd, J = 9.9, 4.9 Hz, 1H), 3.84 (s, 3H), 3.86 (s, 3H), 4.00-
4.10 (m, 1H), 4.22-4.34 (m, 1H), 4.47 (s, 2H), 6.77-6.90 (m, 3H); 13C NMR (75 MHz, CHCl3) δ  
  
 
−5.3, −3.9, 18.0, 18.3, 24.7, 26.0, 26.4, 43.6, 51.6, 55.7, 67.3, 67.5, 70.9, 73.0, 74.1, 110.8, 
111.0, 120.2, 130.7, 148.4, 148.9; IR (neat) cm-1 3508, 2929, 2856, 1608, 1594, 1516, 1258, 835; 
HRMS for C31H58O6Si2S2Na: Calcd 669.3111; found 669.3151. 
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(2R,6S)-1-(3,4-Dimethoxybenzyloxy)-6,7-bis(tert-butyldimethylsilyloxy)-2-hydroxy heptan-
4-one (78): A mixture of DMB ether 77 (580 mg, 0.896 mmol), methyl iodide (1 mL) and 
K2CO3 (1.15 g) were dissolved in aqueous acetonitrile (MeCN:H2O, 6:1, 14 mL) and stirred for 5 
h at 45 oC. The reaction mixture was poured into water (15 mL) and the aqueous layer was 
extracted with ether. The combined organic layers were washed with brine, dried over MgSO4 
and concentrated. Purification of the crude product by flash column chromatography (SiO2, 25% 
ethyl acetate in hexanes) gave the title compound (210 mg, 42%) as a colorless oil: 1H NMR 
(300 MHz, CDCl3) δ 0.04 (s, 9H), 0.05 (s, 3H), 0.85 (s, 9H), 0.88 (s, 9H), 2.56 (dd, J = 15.6, 7.4 
Hz, 1H), 2.64-2.75 (m, 3H), 3.04 (d, J = 3.6 Hz, 1H), 3.34-3.50 (m, 3H), 3.57 (dd, J = 10.2, 4.9 
Hz, 1H), 3.89 (s, 3H), 3.90 (s, 3H), 4.11-4.22 (m, 1H), 4.23-4.32 (m, 1H), 4.49 (s, 2H), 6.82-6.89 
(m, 3H); 13C NMR (75 MHz, CHCl3) δ −5.5, −5.4, −5.0, −4.6, 14.1, 17.9, 18.2, 20.9, 25.7, 25.8, 
47.4, 48.3, 55.7, 55.8, 60.2, 66.6, 66.9, 69.5, 73.0, 73.2, 110.9, 111.1, 120.3, 130.4, 148.6, 149.0, 
209.4; IR (neat) cm-1 2954, 2929, 2857, 1712, 1516, 1258. 
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(2R,4S,6S)-1-(3,4-Dimethoxybenzyloxy)-6,7-bis(tert-butyldimethylsilyloxy)heptane-2,4-diol 
(79): To a solution of compound 78 (200 mg, 0.359 mmol) in THF (3.2 mL) and methanol (0.8 
mL) at –78 oC was added diethylmethoxyborane (1.0 M in THF, 0.44 mL, 0.44 mmol). After 30 
min, sodium borohydride (19 mg, 0.50 mmol) was added in portions and the mixture and was 
stirred for 3 h at –78 oC. Water was added (2.5 mL) followed by diluting the mixture with ether 
(10 mL).  The layers were separated and the aqueous layer was extracted with Et2O. The 
combined organic layers were washed with brine, dried over MgSO4 and concentrated. The 
crude product was purified by flash column chromatography (25% ethyl acetate in hexanes) to 
yield the title compound (126 mg, 63%)  as a colorless oil: [α]D −11.1 (c 1.67 CHCl3); 1H NMR 
(300 MHz, CDCl3) δ 0.06 (s, 6H), 0.09 (s, 6H), 0.89 (s, 18H), 1.53-1.80 (m, 4H), 3.40-3.50 (m, 
3H), 3.56-3.63 (m, 1H), 3.74 (brs, 1H), 3.88 (s, 3H), 3.89 (s, 3H), 3.98 (brs, 1H), 4.02-4.17 (m, 
3H), 4.50 (s, 2H), 6.81-6.89 (m, 3H); 13C NMR (126 MHz, CHCl3) δ −5.6, −5.0, −4.4, 17.8, 
18.1, 25.7, 25.7, 40.0, 42.3, 55.6, 55.7, 67.4, 69.6, 70.6, 71.9, 73.1, 74.0, 110.7, 111.0, 120.2, 
130.6, 148.4, 148.8; IR (neat) cm-1 3472, 2953, 2857, 1564, 1517, 1464, 1257. 
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4-(((2R,4S,6S)-2,4,6,7-tetrakis(tert-Butyldimethylsilyloxy)heptyloxy)methyl)-1,2-
dimethoxybenzene (80): To a solution of compound 79 (190 mg, 0.339 mmol) in 
dichloromethane (3 mL) at 0 oC were added 2,6-lutidine (79.9 mg, 0.746 mmol) and TBSOTf 
(185 mg, 0.698 mmol). After 1 h, the mixture was poured into water, and the aqueous layer was 
extracted with dichloromethane. The combined organic layers were dried over MgSO4 
concentrated. The crude product was purified by flash column chromatography (10% ethyl 
  
 
acetate in hexanes) to yield the title compound (215 mg, 81%) as an oil: [α]D −1.54 (c 2.60 
CHCl3); 1H NMR (600 MHz, CDCl3) δ 0.04-0.07 (m, 24H), 0.87-0.89 (m, 36H), 1.56-1.63 (m, 
2H), 1.69-1.76 (m, 2H), 3.32 (dd, J = 9.6, 6.3 Hz, 1H), 3.42 (dd, J = 9.6, 3.6 Hz, 1H), 3.45 (dd, J 
= 9.1, 6.0 Hz, 1H), 3.52 (dd, J = 9.3, 4.4 Hz, 1H), 3.78-3.82 (m, 1H), 3.83-3.87 (m, 1H), 3.88 (s, 
6H), 3.95-4.01 (m, 1H), 4.43 (d, J = 11.8 Hz, 1H), 4.67 (d, J = 11.8 Hz, 1H), 6.82 (d, J = 8.2 Hz, 
1H), 6.85 (d, J = 8.0 Hz, 1H), 6.89 (s, 1H); 13C NMR (75 MHz, CHCl3) δ −5.3, −4.6, −4.3, −4.1, 
18.0, 18.2, 18.4, 26.0, 42.6, 42.9, 55.8, 55.9, 66.8, 67.8, 69.2, 70.7, 73.2, 74.8, 110.8, 111.0, 
120.1, 131.2, 148.4, 149.0; IR (neat) cm-1 2954, 2929, 2894, 2857, 1517, 1471, 1256, 1104, 835; 
HRMS for C40H82O7Si4Na: Calcd 809.5035; found 809.5085. 
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(2R,4S,6S)-2,4,6,7-tetrakis(tert-Butyldimethylsilyloxy)heptan-1-ol (81): A solution of 
(((2R,4S,6S)-2,4,6,7-tetrakis(tert-butyldimethylsilyloxy)heptyloxy)methyl)-4-methoxybenzene 
80 (1.10 g, 1.45 mmol) and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (428  mg, 1.88 mmol) in 
CH2Cl2/pH 7 buffer (19 mL/1 mL) was stirred at room temperature for 1 h followed by dilution 
with CH2Cl2 (20 mL) and saturated sodium bicarbonate solution (30 mL). The layers were 
separated and the aqueous layer was further extracted with CH2Cl2 (4 x 10 mL). The combined 
organic layers were dried over MgSO4, concentrated and the crude product was purified by flash 
column chromatography to yield the title compound (890 mg, 96%) as an oil: [α]D _1.9 (c 0.63 
CHCl3); 1H NMR (300 MHz, CDCl3) δ 0.05-0.10 (m, 24H), 0.89-0.90 (m, 36H), 1.59-1.82 (m, 
4H), 2.71 (dd, J = 7.8, 5.5 Hz, 1H), 3.38-3.52 (m, 3H), 3.53-3.58 (m, 1H), 3.61-3.78 (m, 1H), 
3.90-3.98 (m, 2H); 13C NMR (75 MHz, CHCl3) δ −5.3, −3.27, −2.3, −4.7, −4.6, −4.58, −4.55, 
  
 
−4.5, −4.4, −4.3, −3.9, 14.2, 18.0, 18.1, 18.12, 18.4, 22.7, 25.9, 26.0, 26.04, 31.7, 41.8, 42.3, 
66.5, 67.2, 67.8, 69.9, 70.8; HRMS for C31H72O5Si4Na: Calcd 659.4355; found 659.4352. 
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(2R,4R,6S)-2,4,6,7-tetrakis(tert-Butyldimethylsilyloxy)heptylmethanesulfonate (82): To a 
solution of alcohol 81 (380 mg, 0.6 mmol), triethylamine (78 mg, 0.80 mmol), and DMAP (20 
mg) in dichloromethane (6 mL) at 0 oC was added methanesulfonyl chloride (82 mg, 0.70 
mmol). The solution was stirred for 45 min and quenched via addition of saturated sodium 
bicarbonate solution. Organic layer was separated and the aqueous layer was extracted with 
dichloromethane. The combined organic layers were dried over MgSO4, concentrated and the 
crude product was purified by flash column chromatography to yield the title compound 82 (392 
mg, 92%) as an oil: [α]D −1.93 (c 15.5 CHCl3); 1H NMR (300 MHz, CDCl3) δ 1H NMR (300 
MHz, CDCl3) δ 0.05 (s, 3H), 0.06 (s, 3H), 0.0637 (s, 3H), 0.07 (s, 9H), 0.09 (s, 3H), 0.11 (s, 3H), 
0.89 (s, 9H), 0.893 (s, 9H), 0.90 (s, 18H), 1.62-1.82 (m, 4H), 3.00 (s, 3H), 3.45 (dd, J = 9.9, 5.8 
Hz, 1H), 3.51 (dd, J = 9.9, 5.2 Hz, 1H), 3.67-3.79 (m, 1H), 3.87-3.98 (m, 1H), 4.01 (dd, J = 10.1, 
6.9 Hz, 1H), 4.07 - 4.18 (m, 2H), 4.35 (dd, J = 10.2, 2.5 Hz, 1 H); 13C NMR (76 MHz, CDCl3) δ 
−5.3, −4.6, −4.5, −4.4, −4.2, −4.0, 14.2, 18.0, 18.1, 18.4, 22.7, 25.9, 25.9, 26.0, 31.7, 37.4, 41.5, 
42.4, 66.4, 67.6, 67.7, 70.6, 73.3; IR (neat) cm-1 2955, 2930, 2887, 2857, 1472, 1463, 1361, 
1256, 1179, 1106; HRMS for C32H74O7Si4SNa (M + Na) Calcd 737.4130; found 737.4129. 
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(2S,4R,6R)-1,2,4,6-tetrakis(tert-Butyldimethylsilyloxy)-7-iodoheptane 5: To a solution of 
(2R,4R,6S)-2,4,6,7-tetrakis(tert-butyldimethylsilyloxy)heptyl methanesulfonate 82 (380 mg, 0.53 
mmol) in acetone (10 mL) was added Sodium iodide (398 mg, 2.65 mmol). The reaction mixture 
was refluxed for 36 h and then the acetone was removed under reduced pressure. The resulting 
solid was suspended in 50% ethyl acetate in hexanes and washed with saturated aqueous sodium 
bicarbonate, brine and water. Drying the organic layer with MgSO4 and concentration provided 
the title compound 5 (380 mg, 96%) as an oil: [α]D −3.2 (c 0.53 CHCl3) 1H NMR (500 MHz, 
CHCl3) δ 0.058 (s, 3H), 0.06 (s, 3H), 0.079 (s, 3H), 0.08 (s, 3H), 0.087 (s, 3H), 0.09 (s, 3H), 0.10 
(s, 3H), 0.13 (s, 3H), 0.899 (s, 9H), 0.90 (s, 9H), 0.91 (s, 9 H), 0.92 (s, 9H), 1.63 (ddd, J = 13.9, 
7.3, 5.4 Hz, 1H), 1.68 (ddd, J = 3.9, 7.3, 5.4  1H), 1.73 (ddd, J = 13.9, 7.6, 5.0 Hz, 1H), 1.80 
(ddd, J = 13.9, 7.3, 5.0 Hz, 1H), 3.21 (dd, J = 10.0, 5.0 Hz, 1H), 3.35 (dd, J = 10.1, 4.1 Hz, 1H), 
3.46-3.52 (m, 2H), 3.67 (tt, J = 7.3, 4.7 Hz, 1H), 3.74 - 3.79 (m, 1H), 3.83 (tt, J = 7.3, 5.0 Hz, 
1H); 13C NMR (126 MHz,CDCl3) δ −5.2, −5.2, −4.4, −4.3, −4.2, −4.1, −3.9, 15.3, 18.1, 18.1, 
18.2, 18.5, 26.0, 26.1, 42.8, 45.3, 66.8, 67.6, 68.3, 70.7;  IR (neat) cm-1 2929, 2857, 1472, 1408, 
1389; HRMS for C27H62O4Si4I (M − tBu)+ : Calcd 689.2770; found 689.2789. 
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(R)-1-(2-((S)-2,3-bis(tert-Butyldimethylsilyloxy)propyl)-1,3-dithian-2-yl)-3-(4-methoxybenzy 
loxy)propan-2-ol (84): t-BuLi (1.7 M in pentane, 1 mL, 1.7 mmol) was added to a solution of 
  
 
(S)-2-(2,3-bis(tert-butyldimethylsilyloxy)propyl)-1,3-dithiane 71 (682 mg, 1.61 mmol) in THF 
(2.4 mL) and HMPA (0.7 mL) at –78 oC. After 10 min, (R)-2-((4-methoxybenzyloxy)methyl) 
oxirane 83 (196 mg, 1.77 mmol) in THF (1 mL) was added. After 15 min, it was warmed to 0 oC 
and stirred for 1 h. The reaction mixture was poured into saturated aqueous NH4Cl solution (20 
mL) and the aqueous layer was extracted with ethyl acetate. The combined organic layers were 
dried over MgSO4, concentrated and the crude product was purified by flash column 
chromatography (SiO2, 20% ethyl acetate in hexanes) to provide the title compound 84 (765 mg, 
77%) as an oil: [α]D −1.0 (c 0.24 CHCl3); 1H NMR (600 MHz, CDCl3) δ 0.08 (doubled, 6H), 
0.10 (s, 3H), 0.13 (s, 3H), 0.88 (s, 9H), 0.92 (s, 9H), 1.90-1.99 (m, 3H), 2.03-2.06 (m, 1H), 2.26 
(dd, J = 15.4, 8.2 Hz, 1H), 2.60 (dd, J = 15.4, 3.0 Hz, 1H), 2.73-2.77 (m, 1H), 2.84-2.93 (m, 3H), 
3.11 (d, J = 3.0 Hz, 1H), 3.39-3.45 (m, 3H), 3.60 (dd, J = 9.6, 4.7 Hz, 1H), 3.81 (s, 3H), 4.06-
4.10 (m, 1H), 4.27-4.33 (m, 1H), 4.50 (s, 2H), 6.88 (d, J = 8.8 Hz, 2H), 7.27 (d, J = 8.8 Hz, 2H); 
13C NMR (75 MHz, CDCl3) δ −5.3, −3.9, 18.0, 18.3, 24.8, 26.0 (doubled), 26.5, 43.7, 43.8, 51.7, 
55.2, 67.5, 67.6, 71.0, 72.9, 74.2, 113.7, 129.3, 159.2; IR (neat) cm-1 3467, 2953, 2927, 2855, 
1613, 1513, 1249, 1100, 835; EIMS (M − tBu)+ 559;  HRMS for C26H47O5Si2S2 (M − tBu)+ : 
Calcd 559.2404; found 559.2411. 
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(2R,6S)-1-(4-Methoxybenzyloxy)-6,7-bis(tert-butyldimethylsilyloxy)-2-hydroxyheptan-4-one 
(85): A solution of ((R)-1-(2-((S)-2,3-bis(tert-butyldimethylsilyloxy)propyl)-1,3-dithian-2-yl)-3-
(4-methoxybenzyloxy)propan-2-ol 84 (2.00 g, 3.24 mmol) in THF/H2O (4:1, 45 mL) was cooled 
to 0 oC followed by addition of 2.6-lutidine (2.9 mL) at once and Hg(ClO4)3•H2O (3.5 g) in 
  
 
portions. The reaction mixture was stirred at 0 oC for 1.5 h then filtered through a pad of celite 
and followed by a rinse with ethyl acetate. The filtrate was diluted with ethyl acetate and 
saturated aqueous NH4Cl. The layers were separated and the aqueous layer was extracted with 
ethyl acetate. The combined organic layers were dried over MgSO4, concentrated and the crude 
product was purified by flash column chromatography (SiO2, 25% ethyl acetate in hexanes) to 
yield the title compound (1.44 g, 85%) as an oil: [α]D −7.36 (c 0.53 CHCl3); 1H NMR (300 MHz, 
CDCl3) δ 0.04 (s, 6H), 0.05 (s, 3H), 0.07 (s, 3H), 0.85 (s, 9H), 0.88 (s, 9H), 2.55 (dd, J = 15.6, 
7.4 Hz, 1H), 2.65-2.74 (m, 3H), 3.02 (d, 1H), 3.36-3.48 (m, 3H), 3.57 (dd, J = 9.9, 4.9 Hz, 1H), 
3.81 (s, 3H), 4.14-4.20 (s, 1H), 4.22-4.29 (s, 1H), 4.49 (s, 2H), 6.89 (d, J = 8.5, 2H), 7.26 (d, J = 
8.5 Hz, 2H); 13C NMR (151 MHz, CDCl3) δ −5.3, −5.3, −4.8, −4.4, 18.1, 18.4, 25.9, 26.0, 47.5, 
48.5, 55.4, 66.8, 67.0, 69.7, 73.0, 73.1, 113.9, 129.5, 130.1, 159.4, 209.8; IR (neat) cm-1 3456, 
2954, 2929, 2856, 1720, 1609, 1507, 1462, 1246, 1099, 837; HRMS for C27H50O6NaSi2 (M + 
Na)+: Calcd 549.3044; found 549.3051. 
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(2R,4S,6S)-1-(4-Methoxybenzyloxy)-6,7-bis(tert-butyldimethylsilyloxy)heptane-2,4-diol 
(86): To a solution of (2R,6S)-1-(4-methoxybenzyloxy)-6,7-bis(tert-butyldimethylsilyloxy)-2-
hydroxyhe ptan-4-one (2.1 g, 4.0 mmol) in THF (32 mL) and methanol (8 mL) at –78 oC was 
added diethylmethoxyborane (1.0 M in THF, 4.4 mL, 4.4 mmol) and the reaction mixture was 
stirred at that temperature for 30 min. Sodium borohydride (181 mg, 4.8 mmol) was added in 
portions to the above reaction mixture and was stirred for 3 h at –78 oC. The reaction mixture 
was quenched with H2O (25 mL) and diluted with Et2O (100 mL). The layers were separated and 
  
 
the aqueous layer was extracted with Et2O. The combined organic layers were washed with 
brine, dried over MgSO4, concentrated and purified by flash column chromatography (25% ethyl 
acetate in hexanes) to yield the title compound (1.85 g, 88%)  as a colorless oil: [α]D −8.29 (c 
1.52 CHCl3); 1H NMR (600 MHz, CHCl3) δ 0.07 (s, 3H), 0.07 (s, 3H), 0.10 (s, 6H), 0.89 (s, 9H), 
0.90 (s, 9H), 1.56-1.17 (m, 4H), 3.39-3.45 (m, 2H), 3.48 (dd, J = 10.2, 6.6 Hz, 1H), 3.6 (dd, J = 
10.2, 4.4 Hz, 1H), 3.65 (br s, 1H), 3.81 (s, 3H), 3.87-3.93 (m, 1H), 3.94 (br s, 1H), 4.02-4.12 (m, 
2H), 4.50 (s, 2H), 6.89 (d, J = 8.5 Hz, 2H), 7.27 (d, J = 8.2 Hz, 2H); 13C NMR (151 MHz, 
CDCl3) δ −5.3, −4.7, −4.1, 18.1, 18.4, 25.9, 26.0, 26.1, 40.3, 42.5, 55.3, 67.7, 69.9, 70.9, 72.3, 
73.1, 74.2, 113.9, 129.4, 130.4, 159.3; IR (neat) cm-1 3436, 2953, 2929, 2857, 1613, 1514, 1250, 
1094; 835; 777; HRMS for C27H52O6NaSi2(M + Na)+ : Calcd 551.3200; found 551.3206. 
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1-(((2R,4S,6S)-2,4,6,7-tetrakis(tert-Butyldimethylsilyloxy)heptyloxy)methyl)-4-methoxybenz 
ene (87): To a solution of (2R,4S,6S)-1-(4-methoxybenzyloxy)-6,7-bis(tert-butyldimethyl 
silyloxy)heptane-2,4-diol 86 (1.8 g, 3.4 mmol) in dichloromethane (30 mL) at 0 oC were added 
2,6-lutidine (1.13 g, 10.5 mmol) and TBSOTf (2.00 g, 7.83 mmol). The reaction mixture was 
stirred at that temperature for 1 h. Then the mixture was poured into water (30 mL) and layers 
were separated. The aqueous layer was extracted with dichloromethane, the combined organic 
extracts were dried over MgSO4, and concentrated. Purification of the crude product by flash 
column chromatography (10% ethyl acetate in hexanes) gave the title compound (2.4 g, 94%) as 
an oil: [α]D 0.41 (c 0.72 CHCl3); 1H NMR (601 MHz, CHCl3) δ 0.03 (s, 3H), 0.04 (s, 3H), 0.05 
(s, 3H), 0.06 (s, 3H),  0.88 (s, 9H), 0.90 (s, 27 H), 1.55-1.62 (m, 2H), 1.67-1.75 (m, 2H), 3.30 
  
 
(dd, J = 9.9, 6.3 Hz, 1H), 3.40 (dd, J = 9.9, 3.6 Hz, 1H), 3.45 (dd, J = 10.2, 6.3 Hz, 1H), 3.51 
(dd, J = 10.2, 4.7 Hz, 1H), 3.78-3.85 (m, 5H), 3.93-3.99 (m, 1H), 4.42 (d, J = 11.5 Hz, 1H), 4.47 
(d, J = 11.8 Hz, 1H), 6.87 (d, J = 8.2 Hz, 2H), 7.25 (d, J = 8.5 Hz, 2H); 13C NMR (151 MHz, 
CHCl3) δ −5.3, −5.2, −4.6, −4.6, −4.4, −4.3, −4.1, −4.0, 18.0, 18.2, 18.2, 18.5, 26.0, 26.0, 26.1, 
42.7, 42.9, 55.3, 66.8, 67.8, 69.2, 70.7, 72.9, 74.6, 113.7, 129.2, 130.8, 159.1; IR (neat) cm-1 
2955, 2929, 2895, 2857, 1614, 1514, 1472, 1251; HRMS for C39H80O6NaSi4(M + Na)+: Calcd 
779.4930; found 551.4893.  
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(R)-3-((2R,3S)-5-(4-Methoxybenzyloxy)-3-hydroxy-2-methylpentanoyl)-4-benzyloxa zolidin-
2-one (92): Di-n-butylboryl trifluoromethanesulfonate (1.0 M solution in DCM, 2.3 mL, 2.3 
mmol) was added slowly to a solution of (R)-4-benzyl-3-propionyloxazolidin-2-one (450 
mg,1.93 mmol) in dichloromethane (5 mL) at 0 oC and stirred for 5 min followed by drop wise 
addition of triethylamine (255 mg, 2.51 mmol). The above reaction mixture was stirred for 10 
min and then cooled to −78 oC. Freshly prepared aldehyde 89 (413 mg, 2.13 mmol, 1.1 equiv) 
was added slowly to the above reaction mixture. After 1 h, the solution was warmed to 0 oC and 
stirred at that temperature for 1 h. The reaction mixture was slowly quenched by addition of 3 
mL of 3:1 pH 7 aqueous buffer: methanol at 0 oC followed by the addition of 2.5 mL of 2:1 
methanol: 30% aqueous H2O2 and stirring for an additional 1 h. The volatiles were removed 
(rotovap) and the residue was extracted with ether (3 x 5 mL). The combined organic extracts 
were washed with sat.aq. NaHCO3 solution, sat. aq. NaCl solution, dried over MgSO4 and 
  
 
concentrated. The crude product was purified by flash column chromatography (SiO2, 50% ethyl 
acetate in hexanes) to provide the title compound (750 mg, 90%). [α]D −68.1 (c 1.2 CHCl3); 1H 
NMR (600 MHz, CDCl3) δ 1.29 (d, J = 7.1 Hz, 3H), 1.70-1.77 (m, 1H), 1.83-1.91 (m, 1H), 2.79 
(dd, J = 13.5, 9.6 Hz, 1H), 3.27 (dd, J = 13.5, 3.3 Hz, 1H), 3.32 (d, J = 2.5 Hz, 1H), 3.61-3.66 
(m, 1H), 3.67-3.70 (m, 1H), 3.79-3.84 (m, 4H), 4.14-4.23 (m, 3H), 4.45 (s, 2H), 4.67-4.71 (m, 
1H), 6.88 (d, J = 8.1 Hz, 2H), 7.21 (d, J = 7.4 Hz, 2H), 7.26 (d, J = 8.8 Hz, 2H), 7.29 (d, J = 7.1 
Hz, 1H), 7.35 (d, J = 7.4 Hz, 2H); 13C NMR (75 MHz, CHCl3) δ 11.1, 33.7, 37.7, 42.5, 55.18, 
55.21, 66.0, 68.0, 70.4, 72.8, 113.8, 127.3, 128.9, 129.3, 129.4, 130.1, 135.1, 153.0, 159.2, 
176.6; IR (neat) cm-1 3448, 2935, 2864, 1779, 1695, 1513, 1247; EIMS m/z (M+) 427; HRMS 
(EI) for C24H29O7NO6: Calcd 427.1995; found 427.1961. 
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(R)-3-((2R,3S)-5-(4-Methoxybenzyloxy)-3-(tert-butyldimethylsilyloxy)-2-methylpen tanoyl)-
4-benzyloxazolidin-2-one (93): To a solution of compound 92 (720 mg, 1.68 mmol) in 
dichloromethane (20 mL) were added 2,6-lutidine (217 mg, 2.02 mmol) and TBSOTf (490 mg, 
1.85 mmol) at −78 oC. After 15 min, the reaction mixture was warmed to 0 oC stirring for 2 h. 
The reaction mixture was poured into water and the aqueous layer was extracted with 
dichloromethane. The combined organic extracts were dried over MgSO4, concentrated and the 
crude product was purified by flash column chromatography to provide the title compound (848 
mg, 93%) as an oil: 1H NMR (300 MHz, CDCl3) δ 0.07 (s, 6H), 0.92 (s, 9H), 1.28 (d, J = 7.1 Hz, 
3H), 1.84-2.02 (m, 2H), 2.77 (d, J = 13.2, 9.3 Hz, 1H), 3.26 (dd, J = 13.2, 2.7 Hz, 1H), 2.48-3.55 
  
 
(m, 1H), 3.59-3.66 (m, 1H), 3.81 (s, 3H), 3.83-3.96 (m, 2H), 4.08 (dd, J = 8.8, 1.7 Hz, 1H), 4.11-
4.19 (m, 1H), 4.40 (d, J = 11.5 Hz, 1H), 4.43 (d, J = 11.5 Hz, 1H), 4.50-4.60 (m, 1H), 6.88 (d, J 
= 8.9 Hz, 1H), 7.20-7.38 (m, 7H); 13C NMR (75 MHz, CDCl3) δ −4.7, −4.4, 13.7, 14.2, 18.0, 
21.1, 25.8, 35.1, 37.7, 43.1, 55.3, 55.5, 60.4, 65.9, 66.0, 71.1, 72.6, 113.7, 127.3, 128.9, 129.3, 
129.5, 130.7, 135.4, 152.9, 159.1, 175.5; IR (neat) cm-1 2955, 2931, 2856, 1781, 1695, 1514, 
1384, 1248; HRMS for C30H43NO6Si: Calcd 541.2860; found 541.2881. 
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(2S,3S)-5-(4-Methoxybenzyloxy)-3-(tert-butyldimethylsilyloxy)-2-methylpentan-1-ol (94): 
236 
To a solution of compound 93 (840 mg, 1.55 mmol) in THF (3 mL) at 0 oC was added ethanol 
(0.45 mL, 7.8 mmol) and LiBH4 (2.0 M in THF, 3.88 mL). The reaction mixture was stirred for 1 
h at 0 oC followed by an additional 1 h at room temperature. Then it was cooled to 0 oC, 
quenched with sat. aq. sodium-potassium tartarate solution (5 mL), diluted with ethyl acetate (15 
mL) and sat. aq. sodium-potassium tartarate solution (10 mL). The reaction mixture was stirred 
for 30 min at room temperature followed by separation of layers. The aqueous layer was 
extracted with ethyl acetate, and the combined organic layers were dried over MgSO4 and 
concentrated. The crude product was purified by flash column chromatography (25% ethyl 
acetate in hexanes) to provide the title compound (348 mg, 61%) as an oil: 1H NMR (300 MHz, 
CDCl3) δ  0.06 (s, 3H), 0.10 (s, 3H), 0.81 (d, J = 7.0 Hz, 3H), 0.89 (s, 9H), 1.71-1.81 (m, 2H), 
1.90-2.00 (m, 1H), 2.89 (br s, 1H), 3.46-3.54 (m, 3H), 3.61-3.67 (m, 1H), 3.79 (s, 3H), 3.90-3.95 
(m, 1H), 4.39 (d, J = 11.4 Hz, 1H), 4.3 (d, J = 11.4 Hz, 1H), 6.87 (d, J = 8.6 Hz, 2H), 7.25 (d, J = 
  
 
8.6 Hz, 2H); 13C NMR (75 MHz, CDCl3) δ −4.8, −4.5, 12.3, 14.2, 17.9, 25.8, 32.8, 40.0, 55.2, 
65.8, 66.8, 72.5, 72.6, 113.7, 129.3, 130.4, 159.1; IR (neat) cm-1 3414, 2955, 2929, 1607, 1250. 
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(2R,3S)-5-(4-Methoxybenzyloxy)-3-(tert-butyldimethylsilyloxy)-2-methylpentanal (96): To a 
solution of alcohol 94 (350 mg, 0.896 mmol) in DCM (5 mL) was added sodium bicarbonate 
(98.9 mg, 1.17 mmol) and dess-martin reagent (456 mg, 1.08 mmol) at room temperature. The 
reaction mixture was stirred for 45 min followed by pouring it into saturated aqueous 
sodiumbicarbonate solution. The aqueous layer was extracted with DCM, the combined organic 
layers were dried over MgSO4 and concentrated. Purification of the crude product by flash 
column chromatography (SiO2, 15% ethyl acetate in hexanes) afforded the title compound (266 
mg, 81%) as an oil: [α]D −47.2 (c 1.12 CHCl3); 1H NMR (300 MHz, CDCl3) δ 0.05 (s, 3H), 0.07 
(s, 3H), 0.87 (s, 9H), 1.06 (d, J = 7.1 Hz, 3H), 1.70-1.89 (m, 2H), 2.44-2.52 (m, 1H), 3.49 (t, J = 
6.0 Hz, 2H), 3.82 (s, 3H), 4.29-4.34 (m, 1H), 4.40 (d, J = 11.5 Hz, 1H), 4.44 (d, J = 11.5 Hz, 
1H), 6.89 (d, J = 8.9 Hz, 2H), 7.26 (d, J = 8.8 Hz, 2H), 9.78 (d, J = 1.1 Hz, 1H); 13C NMR (75 
MHz, CD2Cl2) δ −4.4, −4.3, 8.0, 18.3, 26.0, 35.0, 52.0, 55.5, 66.7, 69.7, 73.0, 114.0, 129.6, 
131.0, 159.7, 205.0; IR (neat) cm-1 2954, 2930, 2857, 2709, 1726, 1613, 1514, 1250; HRMS for 
C20H34O4SiNa: Calcd 389.2124; found 389.2092. 
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(R)-4-Benzyl-3-((2R,3S)-3-hydroxy-2-methylpent-4-enoyl)oxazolidin-2-one (105): Di-n-butyl 
boryltrifluoromethanesulfonate (1.0 M in CH2Cl2, 29.8 mL, 29.8 mmol) was added slowly to a 
solution of (R)-4-benzyl-3-propionyloxazolidin-2-one (5.8 g, 24.9 mmol) in dichloromethane (50 
mL) at 0 oC and stirred for 5 min followed by drop wise addition of triethylamine (4.5 mL, 32.3 
mmol). After 10 min, the mixture cooled to −78 oC and freshly distilled acrolein (1.5 g, 27.4 
mmol) was added. After 1 h, the solution was warmed to 0 oC and stirred at that temperature for 
1 h. The reaction was slowly quenched by addition of 100 mL of 3:1 pH 7 aqueous buffer: 
methanol at 0 oC followed by the addition of 80 mL of 2:1 methanol: 30% aqueous H2O2 and 
stirring for an additional 1 h. The volatiles were removed (rotovap) and the residue was extracted 
with ether (3 x 100 mL). The combined organic extracts were washed with sat.aq. NaHCO3 
solution, sat. aq. NaCl solution, dried over MgSO4 and concentrated. The crude product was 
purified by flash column chromatography (SiO2, 30% ethyl acetate in hexanes) to provide the 
title compound (5.6 g, 78%) as white solid. [α]D −51 (c 0.94 CHCl3); 1H NMR (601 MHz, 
CDCl3) δ 1.26 (d, J = 6.9 Hz, 3H), 2.82 (dd, J = 13.4, 9.6 Hz, 1H), 3.17 (br s, 1H), 3.25 (dd, J = 
13.4, 3.3 Hz, 1H), 3.90 (qd, J = 7.1, 3.8 Hz, 1H), 4.19 (dd, J = 9.1, 2.7 Hz, 1H), 4.21-4.25 (m, 
1H), 4.49-4.52 (m, 1H), 4.72 (ddt, J = 12.4, 7.7, 3.0 Hz, 1H), 5.23 (dt, J = 10.7, 1.7 Hz, 1H), 5.36 
(dt, J = 17.3, 1.7 Hz, 1H), 5.88 (ddd, J = 17.3, 10.7, 5.5 Hz, 1H), 7.22 (d, J = 6.9 Hz, 2H), 7.27-
7.31 (m, 1H), 7.32-7.36 (m, 2H); 13C NMR (151 MHz, CDCl3) δ 11.1, 37.7, 42.5, 55.1, 66.2, 
72.7, 116.2, 127.3, 128.9, 129.4, 135.0, 137.3, 153.2, 176.4; IR (neat) cm-1; 3496, 2981, 1779, 
1697, 1388; HRMS for C12H22O2Si (M + Na)+: Calcd 312.1212; found 312.1217. 
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(R)-4-Benzyl-3-((2R,3S)-3-(tert-butyldimethylsilyloxy)-2-methylpent-4-enoyl)oxazolidin-2-
one (106): To a solution of (R)-4-benzyl-3-((2R,3S)-3-hydroxy-2-methylpent-4-enoyl) 
oxazolidin-2-one 105 (4.2 g, 14.5 mmol) in dichloromethane (150 mL) were added 2,6-lutidine 
(1.90 g, 17.4 mmol) and TBSOTf (4.2 g, 16 mmol) at −78 oC. After 15 min, it was warmed to 0 
oC and allowed to stir for 2 h. The reaction was quenched with water, organic layer was 
separated and the aqueous layer was extracted with dichloromethane. The combined organic 
extracts were dried over MgSO4, concentrated and the crude product was purified by flash 
column chromatography (15% ethyl acetate in hexanes) to provide the title compound (4.8 g, 
82%) as an oil: [α]D −50.8 (c 0.94 CHCl3); 1H NMR (601 MHz, CDCl3) δ 0.02 (s, 3H), 0.03 (s, 
3H), 0.89 (s, 9H), 1.22 (d, J = 6.9 Hz, 3H), 2.78 (dd, J = 13.5, 9.9 Hz, 1H), 3.29 (dd, J = 13.1, 
3.0 Hz, 1H), 3.99 (dq, J = 6.9, 6.9 Hz, 1H), 4.12-4.18 (m, 2H), 4.32-4.36 (m, 1H), 4.59-4.63 (m, 
1H), 5.09-5.13 (m, 1H), 5.18-5.23 (m, 1H), 5.86 (ddd, J = 17.0, 10.4, 6.6 Hz, 1H), 7.22-7.23 (m, 
2H), 7.28-7.30 (m, 1H), 7.32-7.36 (m, 2H); 13C NMR (76 MHz, CDCl3) δ −5.0, −4.3, 12.5, 18.2, 
25.9, 37.9, 44.1, 55.7, 66.0, 75.3, 115.8, 127.4, 129.0, 129.6, 135.5, 139.3, 153.3, 174.6; IR 
(neat) cm-1 2956, 2929, 2857, 1782, 1701, 1381; EIMS (M − CH3)+ 388, (M − tBu)+ 346; HRMS 
for C18H24NO4Si: Calcd 346.1475; found 346.1473. 
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(2S,3S)-3-(tert-Butyldimethylsilyloxy)-2-methylpent-4-en-1-ol (107): To a solution of (R)-4-
benzyl-3-((2R,3S)-3-(tert-butyldimethylsilyloxy)-2-methylpent-4-enoyl)oxazolidin-2-one 106 
(3.12 g, 7.73 mmol) in THF (40 mL) and ethanol (2.3 mL, 39 mmol) at 0 oC  was added LiBH4 
(2.0 M in THF, 19.3 mL). After 1 h, it was warmed to room temperature and stirred for an 
additional 1 h. Then it was cooled to 0 oC, quenched with sat. aq. sodium-potassium tartarate 
solution (10 mL) followed by dilution with ethyl acetate (50 mL), sat. aq. sodium-potassium 
tartarate solution (50 mL). The reaction mixture was stirred for 30 min at room temperature. The 
layers were separated and the aqueous layer was extracted with ethyl acetate. The combined 
organic extracts were dried over MgSO4, concentrated and the crude product was purified by 
flash column chromatography (SiO2, 15% ethyl acetate in hexanes) to provide the title compound 
(1.31 g, 74%) as an oil: 1H NMR (300 MHz, CDCl3) δ 0.06 (s, 3H), 0.09 (s, 3H), 0.81 (d, J = 7.1 
Hz, 3H), 0.92 (s, 9H), 1.84-2.05 (m, 1H), 2.82 (br s, 1H), 3.49-3.52 (m, 1H), 3.63-3.70 (m, 1H), 
4.23-4.26 (m, 1H), 5.17-5.27 (m, 2H), 5.89 (ddd, J = 17.0, 10.5, 6.2 Hz, 1H). 
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(2R,3S)-3-(tert-Butyldimethylsilyloxy)-2-methylpent-4-enal (108): To a solution of (2S,3S)-3-
(tert-butyldimethylsilyloxy)-2-methylpent-4-en-1-ol (1.20 g, 5.25 mmol) in dichloromethane (20 
mL) were added NaHCO3 (solid, 0.60 g, 6.8 mmol) and dess-martin reagent (2.90 g, 6.83 mmol). 
The reaction mixture was stirred for 1.5 h at room temperature followed by pouring it into sat. 
aq. NaHCO3 solution (20 mL). The organic layer was separated and the aqueous layer was 
extracted with dichloromethane. The combined organic layers were dried over MgSO4, 
concentrated and purified by flash column chromatography (SiO2, 15% ethyl acetate in hexanes) 
  
 
to yield the title compound (1.04 g, 88%) as an oil: [α]D −51.6 (c 0.5 CHCl3);1H NMR (300 
MHz, CDCl3) δ 0.04 (s, 3H), 0.06 (s, 3H), 0.89 (s, 9H), 1.07 (d, J = 6.9 Hz, 3H), 2.39-2.53 (m, 
1H), 4.50-4.57 (m, 1H), 5.14 - 5.20 (m, 1H), 5.22-5.30 (m, 1H), 5.74-5.89 (m, 1H), 9.77 (d, J = 
1.4 Hz, 1H); 13C NMR (75 MHz, CDCl3) δ −5.0, −4.2, 8.4, 25.8, 52.8, 52.6, 73.6, 116.1, 138.5, 
204.6; IR (neat) cm-1 2957, 2928, 2856, 1726, 1257; EIMS (M − CH3)+ 213;  HRMS for 
C8H15O2Si (M − CH3)+: Calcd 171.0841; found 171.0842. 
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((3S,4R)-4-(1,3-Dithian-2-yl)pent-1-en-3-yloxy)(tert-butyl)dimethylsilane (109): To a solution 
of (2R,3S)-3-(tert-butyldimethylsilyloxy)-2-methylpent-4-enal (1.0 g, 4.4 mmol) in ether (15 
mL) at 0 oC were added MgBr2•OEt2 (2.3 g, 8.8 mmol) and propane-1,3-dithiol (0.72 g, 6.6 
mmol). The reaction mixture was stirred at 0 oC for 30 min, room temperature for 30 min 
followed by quenching the reaction with 1 N NaOH solution (5 mL). The organic layer was 
separated and the aqueous layer was extracted with ether (3 x 10 mL). The combined organic 
extracts were washed with 1 N NaOH (5 mL), sat. aq. NaCl, water, dried over MgSO4, and 
concentrated. The crude product was purified by flash column chromatography (SiO2, 10% ethyl 
acetate in hexanes) to yield the title compound (1.25 g, 89%) as an oil: [α]D −10 (c 0.29 CHCl3); 
1H NMR (300 MHz,CDCl3) δ 0.02 (s, 3H), 0.08 (s, 3H), 0.89 (s, 9H), 1.09 (d, J = 6.9 Hz, 3H), 
1.77-1.92 (m, 2H), 2.01-2.15 (m, 1H), 2.78-2.92 (m, 4H), 4.08 (d, J = 6.6 Hz, 1H), 4.32-4.45 (m, 
1H), 5.13 (d, J = 10.4 Hz, 1H), 5.22 (d, J = 17.0 Hz, 1H), 5.80 (ddd, J = 17.3, 10.4, 6.6 Hz, 1H); 
  
 
13C NMR (76 MHz, CDCl3) δ −4.7, −4.0, 11.8, 18.3, 26.0, 26.3, 30.4, 30.9, 44.5, 51.6, 74.5, 
115.7, 140.5; IR (neat) cm-1 2928, 2896, 2856, 1472, 1252, 1078, 836, 776; EIMS 318, (M 
− tBu)+ 261;  HRMS for C15H30OSiS2 : Calcd 318.1507; found 318.1497. 
 
O
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(2E,4E)-Dimethyl hexa-2,4-dienedioate (111): Acetyl chloride (23 mL) was added slowly to a 
solution of trans,trans-muconic acid 110 (8.1 g, 57 mmol) in methanol (150 mL) at 0 oC and 
stirred at that temperature for 5 min followed by refluxing the reaction mixture for 2 h. Then the 
reaction mixture was allowed to cool to room temperature and the solvent was removed under 
reduced pressure to give the title compound (9.5 g, 98%) as while solid which was used in the 
next step without further purification: 1H NMR (300 MHz, CDCl3) δ 3.78 (s, 6H), 6.14-6.26 (m, 
2H), 7.26-7.38 (m, 2H); 13C NMR (75 MHz, CHCl3) δ 52.0, 128.1, 141.0, 166.4; HRMS for 
C8H10O4: Calcd 170.0579; found 170.0580. 
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(2E,4E)-Hexa-2,4-diene-1,6-diol (112): To a solution of (2E,4E)-dimethyl hexa-2,4-dienedioate 
111 (3.23 g, 19.0 mmol) in chloroform (190 mL) at 0 oC was added DiBAL-H (1.0 M in hexane, 
95 mL) and the reaction mixture was stirred at that temperature for 1 h. Then the reaction 
mixture was slowly treated with methanol (19 mL) and stirred for additional 15 min at 0 oC. Sat. 
aq. sodium-potassium tartarate (150 mL) was added to the reaction mixture and stirred at room 
temperature for 1 h. The organic layer was separated and the aqueous layer was extracted with 
  
 
ethyl acetate (3 x 100 mL). The combined organic layers were dried over MgSO4 and 
concentrated to yield the title compound (2.05 g, 18.0 mmol, 95%) as white waxy solid: 1H NMR 
(300 MHz, CD3OD) δ 4.20 (d, J = 5.2 Hz, 4H), 5.00 (br s, 2H), 5.84-6.00 (m, 2H), 6.32-6.45 (m, 
2H); 13C NMR (75 MHz, CD3OD) δ 63.2, 131.4, 133.5; EIMS (M)+ 114, (M − H2O)+ 96; HRMS 
for C6H10O2: Calcd 114.0681; found 114.0678. 
HO
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(2E,4E)-6-(tert-Butyldimethylsilyloxy)hexa-2,4-dien-1-ol (113): To a solution of (2E,4E)-
hexa-2,4-diene-1,6-diol (2.00 g, 17.5 mmol) in DMF (150 mL) at room temperature were added 
imidazole (1.25 g, 18.4 mmol) and tert-butyldimethylsilyl chloride (2.77 g, 18.4 mmol, 1.05 
equiv). The reaction mixture was stirred for 12 h followed by quenching it with water (150 mL) 
and dilution with ethyl acetate (150 mL). The organic layer was separated and the aqueous layer 
was extracted with ethyl acetate (2 x 100 mL). The combined organic layers were dried over 
MgSO4, concentrated and the crude product was purified by flash column chromatography (25% 
ethyl acetate in hexanes) to yield the title compound (1.8 g, 45%) as an oil: 1H NMR (300 MHz, 
CDCl3) δ 0.08 (s, 6H), 0.92 (s, 9H), 4.16-4.26 (m, 4H), 5.73-5.88 (m, 2H), 6.20-6.32 (m, 2H); 
13C NMR (76 MHz, CDCl3) δ −5.2, 18.4, 25.9, 63.0, 63.4, 129.1, 130.6, 131.7, 132.8; IR (neat) 
cm−1 3357, 2929, 2955, 2885, 2857, 1684, 1472, 1463, 1377. 
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(2E,4E)-6-(tert-Butyldimethylsilyloxy)hexa-2,4-dienal (114): To a solution of (2E,4E)-6-(tert-
butyldimethylsilyloxy)hexa-2,4-dien-1-ol (848 mg, 3.71 mmol) in dichloromethane (50 mL) at 
room temperature was added MnO2 (3.2 g, 37.1 mmol, activated, obtained from Fulka). The 
  
 
reaction mixture was stirred at room temperature for 45 min, filtered and the filtrate was 
concentrated to yield the title compound (839 mg,100%) as an oil: 1H NMR (300 MHz, CD2Cl2) 
δ 0.09 (s, 6H), 0.93 (s,9H), 4.33 (dd, J = 3.8, 1.9 Hz, 2H), 6.11 (dd, J = 15.4, 8.0 Hz, 1H), 6.34 
(dt, J = 15.1, 4.1 Hz, 1H), 6.50-6.64 (m, 1H), 7.15 (dd, J = 15.1, 11.0 Hz, 1H), 9.54 (d, J = 8.0 
Hz, 1H); 13C NMR (75 MHz, CD2Cl2) δ −5.0, 18.8, 26.3, 63.4, 127.2, 131.7, 145.0, 152.1, 194.0; 
IR (neat) cm-1 2955, 2930, 2857, 2729, 1684, 1646, 1254;  HRMS for C16H19NO4Na: Calcd 
226.1389; found 226.1384. 
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(2E,4E,6E)-Methyl 8-(tert-butyldimethylsilyloxy)octa-2,4,6-trienoate (115): To a suspension 
of NaH (98 mg, 4.1 mmol) in THF (15 mL) at 0 oC was added methyldiethylphosphonoacetate 
(857 mg, 4.10 mmol). The reaction mixture was stirred at room temperature for 20 min followed 
by cooling to −78 oC. The above reaction mixture was added via cannula to a solution of 
(2E,4E)-6-(tert-butyldimet hylsilyloxy)hexa-2,4-dienal (839 mg, 3.71 mmol) in THF (15 mL) at 
−78 oC. The above reaction mixture was stirred at room temperature for 2 h followed by 
quenching the reaction with saturated aqueous NaHCO3 solution. The aqueous layer was 
extracted with ethyl acetate. The combined organic layers were washed with saturated aqueous 
NaCl solution, dried over MgSO4 and concentrated. The crude product was purified by flash 
column chromatography (SiO2, 5% ethyl acetate in hexanes) to yield the title compound (828 
mg, 2.93 mmol, 79%): 1H NMR (300 MHz, CDCl3) δ 0.08 (s, 6H), 0.92 (s, 9H), 3.75 (s, 3H), 
4.28 (d, J = 4.7 Hz, 2H), 5.88 (d, J = 15.1 Hz, 1H), 5.99 (dt, J = 15.1, 4.7 Hz, 1H), 6.28-6.41 (m, 
2H), 6.58 (dd, J =  14.8, 10.7, 1H), 7.32 (dd,  J = 15.6, 11.5 Hz, 1H); 13C NMR (76 MHz, 
CDCl3) δ −5.3, 18.4, 25.9, 51.4, 63.1, 120.2, 128.5, 129.2, 137.8, 140.3, 144.7, 167.4; IR (neat) 
  
 
cm-1 2947, 2929, 2886, 2857, 1715, 1621; EIMS (M+) 282, (M − tBu)+ 225; HRMS for 
C15H26O3Si1: Calcd 282.1651; found 282.1641. 
 
OHMeOOC
 
(2E,4E,6E)-Methyl 8-hydroxyocta-2,4,6-trienoate (116): To a solution of (2E,4E,6E)-methyl 
8-(tert-butyldimethylsilyloxy)octa-2,4,6-trienoate (0.82 g, 2.9 mmol) in 2: 1 mixture of dichloro 
methane: methanol (40 mL) was added acetyl chloride (~25 mg) at room temperature. After 30 
min, the mixture was concentrated to yield the title compound (488 mg, 2.90 mmol, 100%) as 
pale yellow solid: 1H NMR (601 MHz, CDCl3) δ 1.51 (br s, 1H), 3.76 (s, 3H), 4.27 (d, J = 5.2 
Hz, 1H), 5.90 (d, J = 15.1 Hz, 1H), 6.05 (dt, J = 15.1, 5.5 Hz, 1H), 6.30-6.40 (m, 2H), 6.58 (dd, J 
= 14.8, 11.0 Hz, 1H), 7.32 (dd, J = 15.4, 11.3 Hz, 1H); 13C NMR (76 MHz, CDCl3) δ 51.6, 62.7, 
120.5, 129.6, 129.7, 137.3, 140.1, 144.6, 167.6. 
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(2E,4E,6E)-Methyl 8-bromoocta-2,4,6-trienoate (117): To a solution of (2E,4E,6E)-methyl 8-
hydroxyocta-2,4,6-trienoate (470 mg, 2.79 mml) in THF (10 mL) at −20 oC were added 2,6-
lutidine (658 mg, 6.15 mmol) and thionyl bromide (0.4 ml, 5.0 mmol). The reaction mixture was 
stirred at −20 oC for 40 min followed by 2 h at room temperature. Then the mixture was poured 
into saturated aqueous NaHCO3 solution (20 mL). The layers were separated and the aqueous 
layer was extracted with ethyl acetate. The combined organic extracts were dried over MgSO4 
and concentrated. Purification of the crude product by flash column chromatography (10% ethyl 
acetate in hexanes) gave the title compound (473 mg, 73%) as white solid: 1H NMR (500 MHz, 
CHCl3) δ 3.75 (s, 3H), 4.05 (d, J = 7.8 Hz, 2H), 5.92 (d, J = 15.1 Hz, 1H), 6.03-6.12 (m, 1H), 
  
 
6.32-6.41 (m, 2H), 6.53 (dd, J = 15.1, 11.0 Hz, 1H), 7.30 (dd, J = 15.6, 11.4 Hz, 1H); 13C NMR 
(126 MHz, CDCl3) δ 32.3, 51.7, 121.9, 131.7, 132.9, 133.8, 138.7, 143.9, 167.3; IR (neat) cm-1 
3027, 2989, 2946, 1619, 1430, 1353, 1234, 1195; HRMS for C9H11O2Br: Calcd 229.9942; found 
229.9935. 
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(2E,4E,6E)-Methyl 8-(diethoxyphosphoryl)octa-2,4,6-trienoate (7): To a solution of 
(2E,4E,6E)-methyl 8-bromoocta-2,4,6-trienoate (469 mg, 2.03 mmol) in 10 mL toluene was 
added triethylphosphite. The reaction mixture was refluxed over night followed by 
concentration. Purification of the crude product by flash column chromatography (25 to 100% 
ethyl acetate in hexanes, gradient flash column) gave the title compound (550 mg, 94%) as waxy 
solid: 1H NMR (600 MHz, CHCl3) δ 1.32 (t, J = 7.1 Hz, 6H), 2.70 (d, J = 23.0, 7.1 Hz, 2H), 3.75 
(s, 3H), 4.08-4.14 (m, 4H), 5.83-5.90 (m, 2H), 6.24-6.30 (m, 2H), 6.54 (dd, J = 15.1, 10.7 Hz, 
1H), 7.29 (dd, J = 15.4, 11.3 Hz, 1H);  13C NMR (151 MHz, CDCl3) δ  16.1 (JC-P = 6 Hz), 30.2 
(JC-P = 139 Hz), 51.6, 62.2 (JC-P = 7 Hz), 120.9, 127.4 (JC-P = 13 Hz), 129.6 (JC-P = 5 Hz), 134.2 
(JC-P = 16 Hz), 139.8 (JC-P = 6 Hz), 144.4, 167.5; EIMS (M+) 288; HRMS for C13H21O5P: Calcd 
288.1127; found 288.1133. 
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(4R,8S,E)-4,8-bis(tert-butyldimethylsilyloxy)-10-(1-phenyl-1H-tetrazol-5-ylsulfonyl)-N,N-
bis(Boc)-dec-6-en-1-amine (118): To a solution of sulfide 30 (62 mg, 0.078 mmol) in ethanol 
  
 
(1.5 mL) was added oxidant (0.3 mL, prepared from 0.6 g of Mo7O24(NH4)6•4H2O in 2.5 mL of 
30% w/v aq H2O2).104 After 18 h, it was quenched with water (5 mL), and the aqueous layer was 
extracted with ethyl acetate. The combined organic layers were dried over MgSO4, concentrated 
and the crude product was purified by flash column chromatography (SiO2, 10% ethyl acetate in 
hexanes) to yield the title compound (60 mg, 92%) as an oil: [α]D +4.47 (c 0.67 CHCl3); 1H 
NMR (600 MHz, CDCl3) δ 0.04 (s, 9H), 0.07 (s, 3H), 0.87 (s, 9H), 0.89 (s, 9H), 1.24-1.26 (m, 
2H), 1.37-1.41 (m, 2H), 1.49 (s, 18H), 1.60-1.17 (m, 1H), 2.06-3.73 (m, 1H), 3.78 (t, J = 8.0 Hz, 
2H), 4.33 (q, J = 14.8, 7.1 Hz, 1H), 7.57-7.63 (m, 3H), 7.68 (d, J = 7.4 Hz, 2H); 13C NMR (151 
MHz,CDCl3) δ −4.8, −4.5, −4.4, −4.2, 18.1, 18.2, 25.2, 25.9, 25.9, 28.1, 30.3, 33.8, 39.9, 46.5, 
52.4, 70.8, 71.6, 82.0, 125.1, 128.4, 129.7, 131.4, 133.1, 133.6, 152.6, 153.5; IR (neat) cm-1 
2954, 2930, 2857, 1743, 1696, 1367, 1343, 1124; HRMS (M + Na)+ for C39H69N5O8Si2SNa: 
Calcd 846.4303; found 846.4291. 
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(4R,6E,8S,10E,12S,14R,16S,18R)-20-(4-methoxybenzyloxy)-4,8,12,14,16,18-hexakis(tert-
butyldimethylsilyloxy)-N,N-bis(Boc)-icosa-6,10-dien-1-amine (119): KHMDS (0.5 M in 
toluene, 55 µL, 0.225 mmol`) was added to a solution of sulfone 118 (20 mg, 0.023 mmol, 1 
equiv) in THF (1 mL) at −78 oC. After 30 min, a solution of (2S,4R,6S,8R)-10-(4-
methoxybenzyloxy)-2,4,6,8-tetrakis(tert-butyldimethylsilyloxy) decanal 69 (24 mg, 0.029 mmol) 
in THF (1 mL) was added. The reaction mixture was stirred at −78 oC for 1.5 h followed by 
overnight stirring at room temperature. The reaction mixture was quenched with water and the 
  
 
aqueous layer was extracted with ethyl acetate. The combined organic layers were dried over 
MgSO4, concentrated and the crude product was purified by flash column chromatography (10% 
ethyl acetate in hexanes) to yield the title compound 119 (26 mg, 80%) as a colorless oil:  [α]D 
−1.5 (c 0.6 CHCl3); 1H NMR (600 MHz, CDCl3) δ 0.00-0.12 (m, 35H), 0.876 (s, 9H), 0.879 (s, 
9H), 0.885 (s, 18H), 0.89 (s, 9H), 0.896 (s, 9H), 1.36-1.45 (m, 3H), 1.59-1.84 (m, 9H), 2.15-2.24 
(m, 4H), 3.48-3.59 (m, 4H), 3.66-3.70 (m, 1H), 3.81 (s, 3H),  3.83-3.86 (m, 1H), 3.87-3.94 (m, 
2H), 4.07 (q, J = 6.0 Hz, 1H), 4.18 (td, J = 7.7, 3.8 Hz, 1H), 4.42 (s, 2H), 5.41 (dd, J = 15.4, 7.7 
Hz, 1H), 5.46 (dd, J = 15.4, 6.3 Hz, 1H), 5.52-5.58 (m, 2H), 5.87 (d, J = 8.5 Hz, 2H), 7.25 (d, J = 
8.7 Hz, 2H); 13C NMR (151 MHz, CDCl3) δ −4.6, −4.5, −4.3, −4.2, −4.1, −3.8, −3.76, −3.5, −3.4, 
−3.38, −3.3, 18.2, 18.25, 18.3, 25.3, 25.99, 26.0, 26.2, 28.2, 29.8, 33.8, 37.9, 40.2, 41.6, 45.7, 
46.68, 46.7, 46.8, 55.3, 66.8, 67.1, 67.2, 67.5, 71.1, 72.0, 72.6, 73.5, 82.0, 114.0, 129.0, 131.0, 
152.7, 159.1; IR (neat) cm-1 2955, 2929, 2857, 1748, 1698, 1614, 1514, 1472, 1463, 1252; 
HRMS (M + Na)+ for C74H148NO12Si6Na: Calcd 1433.9515, found 1433.9498. 
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(3R,5S,7R,9S,10E,13S,14E,17R)-20-amino-3,5,7,9,13,17-hexakis(tert-butyldimethylsilyloxy)-
N,N-bis(Boc)-icosa-10,14-dien-1-ol (120): DDQ (12 mg, 0.052 mmol) was added to a solution 
of the PMB-ether 119 (52 mg, 0.037 mmol) in DCM (1 mL) and pH 7 buffer (0.1 mL) at room 
temperature. The reaction mixture was stirred at room temperature for 2 h followed by diluting it 
with DCM (5 mL) and saturated aqueous NaHCO3 (3 mL). Organic layer was separated and 
aqueous layer was extracted with DCM (3 mL). The combined organic layers were dried over 
MgSO4 and concentrated. The crude product was purified by flash column chromatography to 
  
 
yield the title compound (42 mg, 88%) as an oil. 1H NMR (600 MHz, CHCl3) δ :0.01-0.10 (m, 
36H), 0.88-0.90 (m, 54H), 1.23-1.47 (m, 6H), 1.51 (s, 18H), 1.55-1.91 (m, 6H), 2.16-2.25 (m, 
4H), 2.33 (t, J = 5.2 Hz, 1H), 3.50-3.59 (m, 2H), 3.65-3.74 (m, 2H), 3.77-3.91 (m, 3H), 3.95-4.01 
(m, 1H), 4.07 (dd, J = 11.8, 8.5 Hz, 1H), 4.14 (dd, J = 12.6, 6.9 Hz, 1H), 5.39-5.48 (m, 2H), 
5.51-5.58 (m, 2H); 13C NMR (151 MHz, CHCl3) δ −4.6, −4.5, −4.4, −4.3, −4.2, −3.6, −3.4, 14.2, 
18.1, 18.1, 18.3, 18.3, 22.7, 25.3, 25.4, 26.0, 26.1, 28.2, 31.7, 33.8, 38.5, 40.2, 41.6, 45.3, 46.4, 
46.7, 47.2, 60.3, 67.1, 67.4, 69.5, 71.1, 72.0, 73.5, 82.0, 126.5, 126.8, 135.5, 136.0, 152.7. 
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(4R,6E,8S,10E,12S,14R,16R,18S)-4,8,12,14,16,18-hexakis(tert-butyldimethylsilyloxy)-20-(1-
phenyl-1H-tetrazol-5-ylsulfonyl)-N,N-bis(Boc)-icosa-6,10-dien-1-amine (121): To a solution 
of alcohol 120 (40 mg, 0.031 mmol) in THF (1 mL) were added thiophenyltetrazole (7.2 mg, 
0.040 mmol), triphenylphosphine (12 mg, 0.46 mmol) and DIAD (9.4 mg, .046 mmol) at room 
temperature. After 16 h, it was diluted with ethyl acetate (5 mL) and water (3 mL). Organic layer 
was separated and the aqueous layer was extracted with ethyl acetate. The combined organic 
extracts were dried over MgSO4 and concentrated to yield the crude product (49 mg). To the 
crude compound in EtOH (1.5 mL) was added a solution of the oxidant (made from 0.6 g of 
Mo7O24(NH4)6•4H2O in 2.5 mL of 30% w/v aqueous H2O2). The reaction mixture was stirred at 
room temperature for 18 h, quenched with water (4 mL) and extracted with ethyl acetate. The 
combined organic layers were dried over MgSO4 and concentrated. The crude product was 
purified by flash column chromatography (SiO2, 10% ethyl acetate in hexanes) to yield the title 
  
 
compound 121 (30 mg, 65%) as an oil. [α]D −24.1 (c 0.12 CHCl3);.1H NMR (600 MHz, CHCl3) 
δ  0.00-0.11 (m, 36H), 0.88-0.91 (m, 54H), 1.36-1.47 (m ,6H), 1.51 (s, 18H), 1.61-1.76 (m, 6H), 
2.02-2.09 (m, 1H), 2.14-2.25 (m, 3H), 3.50-3.59 (m, 2H), 3.66-3.70 (m, 1H), 3.74-2.85 (m, 3H), 
3.86-3.91 (m, 1H), 4.05-4.10 (m, 2H), 4.21 (td, J = 8.2, 3.4 Hz, 1H), 5.39 (dd, J = 15.4, 7.7 Hz, 
1H), 5.46 (dd, J = 15.4, 6.3 Hz, 1H), 5.53-5.58 (m, 2H), 7.59-7.65 (m, 3H), 7.70-7.72 (m, 2H);  
13C NMR (151 MHz, CHCl3) δ −4.6, −4.5, −4.5, −4.3, −4.2, −3.8, −3.8, −3.3, −3.2, 14.2, 18.1, 
18.1, 18.3, 18.3, 22.7, 25.3, 26.0, 26.0, 26.1, 28.2, 30.0, 31.7, 33.8, 40.2, 41.6, 44.7, 46.5, 46.7, 
46.9, 52.2, 66.8, 67.2, 67.5, 71.0, 72.0, 73.5, 82.0, 125.1, 126.4, 126.9, 129.8, 131.5, 133.2, 
135.6, 136.2, 152.7, 153.5; IR (neat) cm-1 2928, 2856, 1501, 1472, 1361, 1251, 1122.  
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2-((2R,4S,6S)-2,4,6,7-tetrakis(tert-Butyldimethylsilyloxy)heptyl)-2-((2R,3S)-3-(tert-butyldime 
thylsilyloxy)pent-4-en-2-yl)-1,3-dithiane (122): To a solution of compound 109 (122 mg, 0.383 
mmol) in THF (0.5mL) and HMPA (0.05 mL) at –78 oC  was added t-BuLi (1.7 M in pentane, 
0.25 mL, 0.42 mmol). After 30 min, a solution of iodide 5 (286 mg, 0.383 mmol) in THF (0.1 
mL) was added. The reaction mixture was stirred at –78 oC for 2 h. The reaction mixture was 
warmed to 0 oC and quenched with saturated aqueous NH4Cl. The aqueous layer was extracted 
with ethyl acetate followed by drying of the combined organic extracts over MgSO4. 
Concentration and purification of the crude compound by flash column chromatography (SiO2, 
5% ethyl acetate in hexanes) provided the title compound (194 mg, 54%) as an oil.1H NMR (600 
MHz, CHCl3) δ 0.02 (s, 3H), 0.05 (s, 6H), 0.07 (s, 3H), 0.08 (s, 3H), 0.10 (s, 6H), 0.12 (s, 3H), 
  
 
0.15 (s, 3H), 0.22 (s, 3H), 0.90 (s, 27H), 0.91 (s, 18H), 1.10 (d, J = 6.9Hz, 1H), 1.65 (ddd, J = 
13.4, 7.4, 5.2 Hz, 1H), 1.69-1.84 (m, 4H), 1.90-1.97 (m, 3H), 2.28 (q, J = 6.9 Hz, 1H), 2.51-2.59 
(m, 2H), 2.80-2.88 (m, 2H), 3.44 (dd, J = 10.2, 7.1 Hz, 1H), 3.62 (dd, J = 9.9, 3.5 Hz, 1H) 3.76-
3.80 (m, 1H), 4.22 (qn, J = 5.2 Hz, 1H), 4.95 (d, J = 7.7 Hz, 1H), 5.02 (d, J = 10.7 Hz, 1H), 5.13 
(d, J = 17.0 Hz, 1H), 5.95 (ddd, J = 17.6, 10.2, 7.7 Hz, 1H); 13C NMR (151 MHz, CDCl3) δ  
−5.3, −5.2, −4.4, −4.2, −4.1, −4.0, −3.8, −3.0, −2.9, 8.9, 14.2, 18.1, 18.3, 18.3, 18.5, 22.7, 24.5, 
25.9, 26.1, 26.1, 26.3, 26.3, 31.7, 42.8, 44.0, 44.3, 49.4, 58.2, 67.0, 67.5, 67.8, 71.2, 73.5, 113.6, 
143.4.  
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(3S,4R)-4-(2-((2R,4S,6S)-2,4,6,7-tetrakis(tert-Butyldimethylsilyloxy)heptyl)-1,3-dithian-2-
yl)-3-(tert-butyldimethylsilyloxy)pentan-1-ol (123): To a solution of alkene 122 in THF (2 mL) 
was added 9-BBN (0.5 M in THF, 1.32 mL, 0.66 mmol). The reaction mixture was stirred at 
room temperature for 10 h. Then the reaction mixture was cooled to 0 oC, followed by the 
addition of H2O2 and aqueous 3 N NaOH (1.3 mL). The reaction mixture was stirred at room 
temperature for 6 h. Then the mixture was diluted with ethyl acetate (10 mL) and water (5 mL). 
Organic layer was separated and the aqueous layer was extracted with ethyl acetate. The 
combined oraganic layers were dried over MgSO4 and concentrated. The crude product was 
purified by flash column chromatography (SiO2, 10% ethyl acetate in hexanes) to yield the title 
compound (128 mg, 64%) as an oil: 1H NMR (600 MHz, CDCl3) δ 0.05 (s, 6H), 0.06 (s, 3H), 
0.08 (s, 3H), 0.10 (s, 3H), 0.11 (s, 3H), 0.12 (s, 3H), 0.14 (s, 6H), 0.19 (s, 3H), 0.89 (s, 9H), 
0.894 (s, 18H), 0.90 (s, 9H), 0.904 (s, 9H), 1.06 (d, J = 6.9 Hz, 3H), 1.39-2.03 (m, 11H), 2.42 (q, 
  
 
J = 7.0 Hz, 1H), 2.56-2.66 (m, 2H), 2.79 (ddd, J = 13.7, 11.3, 2.5 Hz, 1H), 2.89 (ddd, J = 14.3, 
11.8, 2.8 Hz, 1H), 3.43 (dd, J = 10.2, 7.1 Hz, 1H), 3.62 (dd, J = 10.0, 3.5 Hz, 1H), 3.69-3.82 (m, 
3H), 3.86-3.91 (m, 1H), 4.18-4.21 (m, 1H), 4.48 (dd, J = 9.3, 3.3 Hz, 1H); 13C NMR (151 MHz, 
CDCl3) δ −5.3, −5.2, −4.4, −4.2, −4.0, −3.9, −3.0, −2.9, 10.1, 14.2, 18.1, 18.3, 18.3, 18.5, 22.7, 
24.5, 25.3, 25.4, 26.0, 26.1, 26.2, 27.5, 31.7, 33.4, 34.8, 34.8, 40.7, 41.5, 42.0, 42.6, 44.5, 49.4, 
58.1, 60.0, 67.1, 67.4, 67.8, 69.2, 71.2, 72.3; HRMS for C46H102O6S2Si5Na (M + Na): Calcd 
977.5862; found 977.5826. 
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(3S,4R)-4-(2-((2R,4S,6S)-2,4,6,7-tetrakis(tert-Butyldimethylsilyloxy)heptyl)-1,3-dithian-2-
yl)-3-(tert-butyldimethylsilyloxy)pentanal (124): To a solution of alcohol 123 (126 mg, 0.132 
mmol) in dichloromethane (5 mL) at 0 oC was added diisopropylethylamine (77 mg, 0.59 mmol) 
and the resulting mixture was stirred for 5 min. DMSO (17 mg, 0.21 mmol) was added to the 
above reaction mixture and stirred for another 10 min. At this time, SO3•pyr (27 mg, 0.17 mmol) 
was added and the resulting mixture was stirred for 2 h. saturated aqueous NaHCO3 was added to 
the above reaction mixture and allowed to warm to room temperature. The layers were separated 
and the aqueous layer was extracted with dichloromethane. The combined organic layers were 
washed with brine, dried over MgSO4 and concentrated. The crude product was purified by flash 
column chromatography (SiO2, 15% ethyl acetate in hexanes) to yield the title compound (76 
mg, 60%) as an oil: 1H NMR (600 MHz, CD2Cl2) δ 0.05 (s, 3H), 0.06 (s, 3H), 0.07 (s, 6H), 0.09 
(s, 3H), 0.117 (s, 3H), 0.12 (s, 3H), 0.18 (s, 3H), 0.22 (s, 3H), 0.89 (s, 3H), 0.89 (s, 9H), 0.895 (s, 
  
 
9H), 0.898 (s, 9H), 0.90 (s, 9H), 0.905 (s, 9H), 1.09 (d, J = 6.9 Hz, 3H), 1.63-1.68 (m, 2H), 1.70-
1.82 (m, 3H), 1.86-2.00 (m, 3H), 2.31 (q, J = 7.0 Hz, 1H), 2.50-2.60 (m, 2H), 2.62-2.76 (m, 2H), 
2.76-2.89 (m, 2H), 3.44 (dd, J = 10.2, 6.9 Hz, 1H), 3.61 (dd, J = 10.2, 3.8 Hz, 1H), 3.78-3.82 (m, 
1H), 3.83-3.88 (m, 1H), 4.22-4.26 (m, 1H), 5.00 (dd, J = 8.5, 3.8 Hz, 1H), 9.80 (s, 1H); HRMS 
for C46H100O6S2Si5Na (M + Na)+: Calcd 975.5705; found 975.5742. 
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(2E,4E,6E,8E,11S,12R)-Methyl 12-(2-((2R,4S,6S)-2,4,6,7-tetrakis(tert-butyldimethylsilyloxy) 
heptyl)-1,3-dithian-2-yl)-11-(tert-butyldimethylsilyloxy)trideca-2,4,6,8-tetraenoate (125): To 
a solution of compound 7 (13 mg, 0.046 mmol) in THF (2 mL) at −78 oC was added a solution of 
LiHMDS in THF (1.0 M in THF, 0.043 mL, 0.043 mmol) and stirred at that temperature for 15 
min. A solution of aldehyde 124 (28 mg, 0.029 mmol) in THF (2 mL) was added to the above 
reaction mixture and stirred for 30 min at −78 oC and 0 oC for 30 min. The reaction mixture was 
quenched with saturated aqueous NH4Cl and extracted with ethyl acetate. The combined organic 
extracts were dried over MgSO4 and concentrated. The crude product was purified by flash 
column chromatography (5% ethyl acetate in hexanes) to yield the title compound 125 (18 mg, 
57%) as an oil. [α]D 20.6 (c 0.67 CHCl3); 1H NMR (600 MHz, CHCl3) δ 0.05 (m, 30H), 0.89-
0.90 (m, 45H), 1.03 (d, J = 6.9 Hz, 3H), 1.64-1.86 (m, 7H), 1.87-1.95 (m, 2H), 2.29-2.36 (m, 
2H), 2.39-2.52 (m, 2H), 2.70-2.79 (m, 2H), 3.43 (dd, J = 9.9, 7.1 Hz, 1H), 3.63 (dd, J = 10.2, 3.3 
Hz, 1H), 3.72-3.78 (m, 4H), 3.87-3.92 (m, 1H), 4.15-4.21 (m, 1H), 4.51 (dd, J = 9.9, 3.8 Hz, 
1H), 5.82 (ddd, J = 15.1, 9.1, 6.0 Hz, 1H), 5.88 (d, J = 15.4 Hz, 1H), 6.08-6.27 (m, 2H), 6.30-
  
 
6.40 (m, 2H), 6.57 (dd, J = 14.8, 11.0Hz, 1H), 7.33 (dd, J = 15.1, 11.5 Hz, 1H); 13C NMR (151 
MHz, CDCl3) δ −5.3, −5.2, −4.4, −4.2, −4.0, −3.9, −3.8, −3.0, −3.0, 9.4, 14.2, 14.3, 18.1, 18.3, 
18.5, 22.8, 22.8, 25.9, 26.0, 26.1, 26.2, 26.3, 29.8, 31.7, 32.0, 40.5, 42.2, 42.6, 44.6, 49.7, 51.6, 
57.9, 67.0, 67.5, 67.8, 70.9, 71.2, 120.1, 129.7, 130.6, 132.8, 134.3, 137.0, 140.9, 144.7, 167.6; 
IR (neat) cm-1 2954, 2928, 2856, 1720, 1620, 1598, 1255; MS (API-ES) m/z 1109.4 (M + Na)+. 
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(2E,4E,6E,8E,11S,12R)-Methyl 12-(2-((2R,4S,6S)-2,4,6-tris(tert-butyldimethyl silyl oxy)-7-
hydroxyheptyl)-1,3-dithian-2-yl)-11-(tert-butyldimethylsilyloxy)trideca-2,4,6,8-tetraenoate 
(126): To a solution of compound 125 (33 mg, 0.030 mmol) in THF (2 mL) was added HF•py in 
pyridine in THF (1.5 mL). The reaction mixture was stirred at room temperature for 6 h and 
poured into saturated aqueous NaHCO3 solution. Organic layer was separated and the aqueous 
layer was extracted with ethyl acetate. The combined organic layers were dried over MgSO4 and 
concentrated. The residue was purified by flash column chromatography (SiO2, 10% ethyl 
acetate in hexanes) to yield the title compound 126 (11.2 mg, 45%) as an oil. 1H NMR (600 
MHz, CHCl3) δ 0.06 (s, 3H), 0.098 (s, 3H), 0.104 (s, 6H), 0.12 (s, 3H), 0.14 (s, 3H), 0.17 (s, 3H), 
0.22 (s, 3H), 0.892 (s, 9H), 0.893 (s, 9H), 0.898 (s, 9H), 0.905 (s, 9H), 1.02 (d, J = 6.9 Hz, 3H), 
1.71-2.04 (m, 7H), 2.28-2.37 (m, 2H), 2.42-2.56 (m, 3H), 2.70-2.77 (m, 1H), 2.78-2.86 (m, 2H), 
3.47 (ddd, J = 11.5, 7.1, 5.5 Hz, 1H), 3.59 (ddd, J = 11.0, 6.0, 4.9 Hz, 1H), 3.76 (s, 3H), 3.90-
3.96 (m, 1H), 4.08-4.17 (m, 2H), 4.44 (dd, J = 9.9, 3.8 Hz, 1H), 5.81 (ddd, J = 15.1, 9.3, 5.8 Hz, 
1H), 5.88 (d, J = 15.1, 1H), 6.18-6.28 (m, 2H), 6.30-6.40 (m, 2H), 6.57 (dd, J = 14.8, 11.2 Hz, 
  
 
2H), 7.32 (dd, J = 15.4, 11.8 Hz, 1H); 13C NMR (151 MHz,CDCl3) δ −4.6, −4.5, −4.3, −4.1, 
−4.0, −4.0, −2.9, −2.8, 9.5, 18.1, 18.1, 18.2, 18.3, 24.3, 25.7, 26.0, 26.1, 26.2, 29.8, 40.3, 41.4, 
42.2, 45.1, 49.2, 51.6, 57.7, 66.5, 66.9, 67.6, 70.3, 70.8, 120.2, 129.8, 130.7, 132.9, 134.2, 136.9, 
140.8, 144.7, 167.6.  
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(2E,4E,6E,8E,11S,12R)-Methyl12-(2-((2R,4S,6S)-2,4,6-tris(tert-butyldimethylsilyloxy)-7-
oxoheptyl)-1,3-dithian-2-yl)-11-(tert-butyldimethylsilyloxy)trideca-2,4,6,8-tetraenoate 
(127): To a solution of alcohol 126 (12.3 mg, 0.0126 mmol) in DCM (2 mL) were added DIEA 
(37 mg, 0.28 mmol), DMSO (49 mg, 0.63 mmol) and SO3•pyr (25 mg, 0.16 mmol). The reaction 
mixture was stirred at 0 oC for 30 min followed by pouring the reaction mixture into saturated 
sodium bicarbonate solution. Organic layer was separated and the aqueous layer was extracted 
with DCM. The combined organic layers were dried over MgSO4 and concentrated. The crude 
product was purified by flash column chromatography (SiO2, 10% ethyl acetate in hexanes) to 
yield the title compound 127 (10 mg, 82%) as an oil: 1H NMR (600 MHz, CHCl3) δ 0.06-0.21 
(m, 24H), 0.88-0.93 (m, 36H), 1.02 (d, J = 6.9 Hz, 3H), 1.71-2.08 (m, 6H), 2.10-2.16 (m, 1H), 
2.29-2.41 (m, 3H), 2.42-2.58 (m, 3H), 2.70-2.81 (m, 2H), 3.76 (s, 3H), 4.00-4.07 (m, 1H), 4.10-
4.17 (m, 1H), 4.20-4.26 (m, 1H), 4.43-4.48 (m, 1H), 5.78-5.84 (m, 1H), 5.88 (d, J = 15.4 Hz, 
1H), 6.17-6.29 (m, 2H), 6.30-6.41 (m, 2H), 6.57 (dd, J = 14.6, 11.0 Hz, 1H), 7.30-7.35 (m, 1H), 
9.61 (d, J = 1.7 Hz, 1H). 
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(3S,4R)-4-(2-((2R,4S,6S)-2,4,6,7-tetrakis(tert-Butyldimethylsilyloxy)heptyl)-1,3-dithian-2-
yl)-3-(tert-butyldimethylsilyloxy)pentyl benzoate (129): To a solution of alcohol 123 (50 mg, 
0.052 mmol) in dichloromethane (5 mL) were added triethyl amine (0.1 mL), DMAP (20 mg) 
and benzyl chloride (200 mg). The reaction mixture was stirred at room temperature for 2 h and 
quenched with saturated aqueous sodium bicarbonate solution (5 mL). Organic layer was 
separated and the aqueous layer was extracted with dichloromethane. The combined organic 
layers were dried over MgSO4 and concentrated. Purification of the crude product by flash 
column chromatography (SiO2, 15% ethyl acetate in hexanes) gave the title compound (46 mg, 
83%) as an oil: [α]D 16.3 (c 0.7 CHCl3);1H NMR (600 MHz, CDCl3) δ 0.05 (s, 6H), 0.07 (s, 3H), 
0.08 9s, 3H), 0.10 (s, 3H), 0.11 (s, 3H), 0.13 (s, 3H), 0.14 (s, 3H), 0.16 (S, 3H), 0.19 (s, 3H), 
0.89 (s, 9H), 0.90 (s, 9H), 0.905 (s, 9H), 0.909 (s, 9H), 0.915 (s, 9H), 1.10 (d, J = 6.9 Hz, 3H), 
1.24-1.35 (m, 2H), 1.60-2.13 (m, 8H), 2.42-2.55 (m, 3H), 2.72-2.87 (m, 2H), 3.44 (dd, J = 10.2, 
7.1 Hz, 1H), 3.63 (dd, J = 10.2, 3.3 Hz, 1H), 3.76-3.84 (m, 1H), 3.87-3.94 (m, 1H), 4.18-4.25 (m, 
1H), 4.31-4.38 (m, 1H), 4.38-4.46 (m, 1H), 4.66 (d, J = 9.1, 3.3 Hz, 1H), 7.42-7.48 (m, 2H), 
7.55-7.60 (m, 1H), 8.04-8.09 (m, 2H); 13C NMR (151 MHz, CDCl3) δ −5.3, −5.2, −4.4, −4.2, 
−4.0, −3.9, −3.9, −3.8, −3.1, −3.0, 9.8, 14.2, 18.1, 18.1, 18.3, 18.4, 18.5, 22.7, 24.4, 25.9, 26.1, 
26.3, 31.7, 37.2, 41.2, 42.6, 44.6, 49.6, 57.8, 62.1, 67.0, 67.5, 67.8, 68.9, 71.2, 128.4, 129.6, 
130.3, 133.0, 166.7; IR (neat) cm-1 2950, 2929, 2850, 1723, 1472, 1275, 1252, 1109, 835.  
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(3S,4R)-4-(2-((2R,4S,6S)-2,4,6-tris(tert-Butyldimethylsilyloxy)-7-hydroxyheptyl)-1,3-dithian-
2-yl)-3-(tert-butyldimethylsilyloxy)pentyl benzoate (130): To a solution of compound 129 (45 
mg, 0.042 mmol) in THF (0.5 mL) was added HF•pyr (1 mL) and the reaction mixture was 
stirred at room temperature for 5 h. The reaction mixture was diluted with THF (5 mL) and 
quenched with saturated aqueous sodium bicarbonate (15 mL).  Organic layer was separated and 
the aqueous layer was extracted with ethyl acetate. The combined organic layers were dried over 
MgSO4 and concentrated. Purification of the crude product by flash column chromatography 
(SiO2, 15% ethyl acetate in hexanes) gave the title compound (16 mg, 39%) as an oil along with 
recovered compound 130 (20 mg): [α]D 14.3 (c 0.3 CHCl3); 1H NMR (300 MHz, CDCl3) δ  
0.06-0.20 (m, 24H), 0.88-0.91 (m, 36H), 1.09 (d, J = 6.9 Hz, 3H), 1.66-2.20 (m, 11H), 2.44-2.53 
(m, 2H), 2.60-2.90 (m, 3H), 3.35-3.51 (m, 1H), 3.55-3.66 (m, 1H), 3.80-3.99 (m, 1H), 4.05-4.18 
(m, 2H), 4.29-4.44 (m, 2H), 4.56-4.61 (m, 1H), 7.42-7.47 (m, 2H), 7.54-7.60 (m, 1H), 8.04-8.07 
(m, 2H); 13C NMR (126 MHz, CDCl3) δ −4.6, −4.5, −4.3, −4.1, −3.9, −3.0, −2.9, 10.0, 18.1, 
18.1, 18.2, 18.4, 26.0, 26.1, 26.2, 26.4, 37.1, 41.1, 41.4, 45.2, 49.2, 57.6, 62.0, 66.6, 67.0, 67.6, 
68.8, 70.3, 128.4, 129.6, 130.3, 133.1, 166.7; IR (neat) cm-1 2954, 2929, 2852, 1724, 1475, 1270, 
1249, 1107, 833, 768, 702, 662; HRMS for C47H92O7NaSi4S2(M + Na)+ : Calcd 967.5259; found 
967.5 
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55.34
66.79
67.17
67.40
67.47
67.64
70.78
72.64
113.77
129.22
130.90
159.10
62
280
G
VG
313P_001000FID.ESP
9.5
9.0
8.5
8.0
7.5
7.0
6.5
6.0
5.5
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
Chem
icalShift(ppm)
0.08
0.09
0.10
0.87
0.88
0.89
0.93
1.55
1.58
1.70
1.70
1.71
1.72
1.73
1.74
1.75
1.80
3.47
3.48
3.49
3.50
3.79
3.83
3.84
3.85
3.93
3.94
3.97
3.98
4.16
4.38
6.85
6.86
7.23
7.25
9.57
9.58
69
281
G
VG
313P_002000FID.ESP
200
192
184
176
168
160
152
144
136
128
120
112
104
96
88
80
72
64
56
48
40
32
24
16
8
0
Chem
icalShift(ppm)
-3.88
-3.83
-3.46
-3.14
-3.03
18.52
18.68
26.35
38.36
41.16
46.35
47.11
55.75
67.17
67.56
68.05
73.06
76.07
114.13
129.68
131.55
159.69
203.75
69
282
G
VG
219-P_002000FID.ESP
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
-5
Chem
icalShift(ppm)
-5.25
-5.20
-4.39
-4.26
-4.21
-4.15
-3.93
15.34
18.06
18.13
18.20
18.46
25.89
25.99
26.09
42.82
45.28
66.85
67.63
68.31
70.69
76.88
77.09
77.30
5
283
G
VG
347HP_001000FID.ESP
7.0
6.5
6.0
5.5
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
Chem
icalShift(ppm)
3.5
2.8
9.7
3.1
2.1
1.0
4.2
1.0
1.0
2.1
1.1
0.02
0.08
0.89
1.08
1.10
1.77
1.80
1.82
1.84
1.86
1.87
2.05
2.05
2.06
2.07
2.10
2.79
2.80
2.82
2.83
2.85
2.87
2.88
4.06
4.09
4.34
4.36
4.38
5.11
5.14
5.19
5.25
5.74
5.77
5.78
5.80
5.82
5.84
5.86
1
9
284
G
VG
347HP_002000FID.ESP
160
152
144
136
128
120
112
104
96
88
80
72
64
56
48
40
32
24
16
8
0
Chem
icalShift(ppm)
-4.74
-3.99
11.85
18.26
25.95
26.28
30.38
30.89
44.48
51.55
74.46
115.65
140.53
1
9
285
G
VG
324_001000FID.ESP
7.0
6.5
6.0
5.5
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
Chem
icalShift(ppm)
5.8
0.9
2.2
3.0
3.7
1.9
2.1
1.1
1.2
1.31
1.32
1.33
1.75
2.67
2.68
2.71
2.72
3.75
4.09
4.10
4.11
4.11
4.11
4.12
4.13
4.13
5.83
5.84
5.86
5.87
5.88
5.90
6.24
6.25
6.26
6.27
6.28
6.29
6.30
6.52
6.53
6.54
6.56
7.27
7.29
7.29
7.31
7
286
G
VG
324_001000FID.ESP
7.0
6.5
6.0
5.5
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
Chem
icalShift(ppm)
5.8
0.9
2.2
3.0
3.7
1.9
2.1
1.1
1.2
1.31
1.32
1.33
1.75
2.67
2.68
2.71
2.72
3.75
4.09
4.10
4.11
4.11
4.11
4.12
4.13
4.13
5.83
5.84
5.86
5.87
5.88
5.90
6.24
6.25
6.26
6.27
6.28
6.29
6.30
6.52
6.53
6.54
6.56
7.27
7.29
7.29
7.31
7
287
G
VG
324_002000FID.ESP
168
160
152
144
136
128
120
112
104
96
88
80
72
64
56
48
40
32
24
16
Chem
icalShift(ppm)
16.54
30.79
31.71
51.60
62.16
120.87
127.32
127.41
129.63
134.23
134.34
139.76
139.79
144.44
167.46
324
288
G
VG
309P_001000FID.ESP
7.5
7.0
6.5
6.0
5.5
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
Chem
icalShift(ppm)
0.07
0.87
0.89
1.23
1.25
1.26
1.38
1.39
1.40
1.41
1.46
1.49
1.52
2.04
2.10
2.12
2.13
2.19
2.21
2.21
3.51
3.52
3.54
3.55
3.69
3.70
3.71
3.77
3.78
3.79
4.12
4.33
4.34
4.35
5.40
5.41
5.42
5.43
5.65
5.66
5.67
5.68
5.69
7.27
7.59
7.60
7.61
7.62
7.68
7.69
231
289
G
VG
309P_002000FID.ESP
152
144
136
128
120
112
104
96
88
80
72
64
56
48
40
32
24
16
8
0
Chem
icalShift(ppm)
-4.84
-4.50
-4.36
-4.24
18.10
18.16
25.15
25.85
25.92
28.13
30.30
33.81
39.87
46.54
52.39
70.80
71.57
82.05
125.11
128.43
129.71
131.43
133.12
133.60
152.65
153.51
3
9
290
G
VG
235P_001000FID.ESP
7.0
6.5
6.0
5.5
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
Chem
icalShift(ppm)
36.0
57.0
3.4
8.6
3.3
4.0
0.8
3.0
0.8
2.0
1.1
1.5
1.7
2.1
0.04
0.05
0.07
0.12
0.87
0.88
0.88
0.89
0.89
0.90
0.90
1.41
1.42
1.43
1.51
1.59
1.62
1.63
1.65
1.68
1.76
2.17
2.18
2.19
2.21
2.23
3.48
3.49
3.49
3.50
3.51
3.52
3.54
3.55
3.81
3.84
3.88
3.91
4.07
4.08
4.18
4.42
5.43
5.44
5.45
5.47
5.48
5.53
5.54
5.55
5.57
6.86
6.88
7.25
7.26
7.27
7. 7
291
gvg314cr_002000fid.esp
192
184
176
168
160
152
144
136
128
120
112
104
96
88
80
72
64
56
48
40
32
24
16
8
0
-8
Chem
icalShift(ppm)
-4.5
-4.2
-4.1
-3.7
-3.4
-3.3
18.2
18.3
18.3
26.0
26.2
28.2
33.8
37.9
40.2
41.6
46.7
55.3
66.8
67.1
67.2
67.5
71.1
72.0
72.6
73.5
82.1
113.8
126.4
126.7
129.2
130.9
135.6
136.3
152.7
159.1
292
G
VG
317P_001000FID.ESP1.ESP
7.5
7.0
6.5
6.0
5.5
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
Chem
icalShift(ppm)
36.0
59.6
4.8
2.8
8.9
1.4
3.7
0.7
1.7
1.9
3.2
1.1
1.0
1.7
0.04
0.05
0.06
0.08
0.09
0.10
0.86
0.88
0.88
0.89
0.90
0.92
0.93
1.27
1.27
1.27
1.51
1.62
1.67
1.68
1.69
1.70
2.16
2.17
2.18
2.22
2.33
2.34
3.53
3.54
3.68
3.69
3.71
3.80
3.81
3.87
3.99
4.07
4.08
4.14
4.15
5.43
5.44
5.46
5.47
5.53
5.54
5.55
5.55
5.56
7.27
293
G
VG
317P_002000FID.ESP
190
180
170
160
150
140
130
120
110
100
90
80
70
60
50
40
30
20
10
0
-10
-20
Chem
icalShift(ppm)
-4.6
-4.5
-4.3
-4.2
-3.6
-3.4
14.2
18.1
18.1
18.3
22.7
25.3
26.0
26.1
28.2
31.7
33.8
38.5
40.2
41.6
45.3
46.4
46.7
47.2
60.3
67.1
67.4
69.5
71.1
72.0
73.5
82.0
126.5
126.8
135.5
136.0
152.7
294
G
VG
318P_001000FID.ESP
8.5
8.0
7.5
7.0
6.5
6.0
5.5
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
Chem
icalShift(ppm)
41.5
65.6
5.5
8.6
1.2
5.5
2.1
1.1
1.1
2.1
1.0
2.0
2.8
0.0
0.0
0.1
0.1
0.1
0.1
0.9
0.9
0.9
0.9
1.3
1.4
1.4
1.4
1.5
1.5
1.6
1.7
1.7
1.7
1.7
2.2
2.2
2.2
2.2
2.2
3.5
3.5
3.5
3.6
3.7
3.8
3.8
3.8
3.8
4.1
4.1
4.1
4.2
4.2
5.4
5.4
5.5
5.5
5.5
5.5
5.5
5.6
5.6
7.3
7.4
7.6
7.6
7.6
7.6
7.6
7.6
7.7
7.7
295
G
VG
318P_002000FID.ESP
192
184
176
168
160
152
144
136
128
120
112
104
96
88
80
72
64
56
48
40
32
24
16
8
0
Chem
icalShift(ppm)
-4.3
-4.2
-3.3
-3.2
14.2
18.1
18.1
18.3
18.3
25.3
26.0
26.0
26.1
28.2
30.0
33.8
40.2
41.6
44.7
46.5
46.7
46.9
52.2
66.8
67.2
67.5
71.0
72.0
73.5
82.0
125.1
126.4
126.9
129.8
131.5
133.2
135.6
136.2
152.7
153.5
296
G
VG
301P_001000FID.ESP
7.0
6.5
6.0
5.5
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
Chem
icalShift(ppm)
3.6
3.3
59.9
3.6
6.7
3.7
1.1
2.3
2.3
1.2
1.1
1.2
1.1
1.1
1.2
1.0
122
297
G
VG
301P_002000FID.ESP
144
136
128
120
112
104
96
88
80
72
64
56
48
40
32
24
16
8
0
Chem
icalShift(ppm)
-4.1
-4.0
-3.8
-3.0
-2.9
8.9
14.2
18.1
18.3
18.3
18.5
22.7
24.5
25.9
26.1
26.3
31.7
42.8
44.0
44.3
49.4
58.2
67.0
67.5
67.8
71.2
73.5
113.6
143.4
122
298
G
VG
326P_001000FID.ESP
9.5
9.0
8.5
8.0
7.5
7.0
6.5
6.0
5.5
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
Chem
icalShift(ppm)
36.3
60.6
2.7
2.2
3.1
1.0
2.4
1.8
1.0
0.9
1.2
0.8
0.8
0.7
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.9
0.9
0.9
0.9
1.1
1.1
1.7
1.7
1.7
1.7
1.8
1.8
1.9
2.3
2.3
2.6
2.6
2.6
2.7
3.4
3.4
3.5
3.6
3.6
3.6
3.6
3.8
3.8
4.2
4.2
4.3
4.4
5.0
5.0
5.0
5.0
5.3
9.8
124
299
G
VG
365P_001000FID.ESP
7.0
6.5
6.0
5.5
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
Chem
icalShift(ppm)
24.3
44.6
6.0
13.4
2.7
3.4
1.0
1.9
1.0
1.0
2.8
1.0
2.1
1.0
0.8
1.6
1.8
0.7
0.8
0.1
0.1
0.1
0.1
0.2
0.2
0.9
0.9
0.9
1.0
1.0
1.7
1.7
1.8
1.8
1.8
1.8
1.8
1.9
1.9
2.0
2.0
2.4
2.4
2.5
2.7
2.8
2.8
2.8
2.8
3.5
3.5
3.6
3.6
3.6
3.6
3.8
3.8
3.8
3.9
4.1
4.1
4.1
4.1
4.4
4.4
4.5
5.8
5.8
5.9
5.9
6.2
6.3
6.3
6.3
6.3
6.3
6.4
6.4
6.6
6.6
6.6
6.6
7.3
7.3
7.3
7.3
126
300
G
VG
365P_005000FID.ESP
168
160
152
144
136
128
120
112
104
96
88
80
72
64
56
48
40
32
24
16
8
0
Chem
icalShift(ppm)
-4.6
-4.5
-4.1
-4.0
-2.8
9.5
18.1
18.2
18.3
24.3
25.7
26.0
26.2
29.8
40.3
41.4
42.2
45.1
49.2
51.6
57.7
66.5
66.9
67.6
70.3
70.8
120.2
129.8
130.7
132.9
134.2
136.9
140.8
144.7
167.6
126
301
G
VG
366P_001000FID.ESP
9.5
9.0
8.5
8.0
7.5
7.0
6.5
6.0
5.5
5.0
4.5
4.0
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
Chem
icalShift(ppm)
32.9
60.7
6.1
19.3
7.6
14.4
1.7
3.1
4.5
2.9
3.6
1.4
1.3
1.2
1.0
2.1
0.9
1.2
0.9
0.1
0.1
0.1
0.2
0.9
0.9
0.9
1.0
1.0
1.8
1.8
1.8
1.8
1.9
2.0
2.0
2.0
2.3
2.3
2.4
2.5
2.5
2.7
2.8
2.8
3.8
4.0
4.0
4.1
4.1
4.2
4.2
4.2
4.2
4.4
4.5
4.5
5.8
5.9
5.9
6.2
6.2
6.3
6.3
6.3
6.3
6.4
6.4
6.6
6.6
6.6
7.3
7.3
7.3
7.3
7.3
9.6
127
302
